Contents Section I: Biochemistry Chapter 1. Acid-Base Equilibrium and Buffering ........................... 3 Chapter 2...
137 downloads
2177 Views
21MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
Contents Section I: Biochemistry Chapter 1. Acid-Base Equilibrium and Buffering ........................... 3 Chapter 2. Proteins, Enzymes, and Coenzymes ........................... 7 Chapter 3. Bioenergetics ............................................ 23 Chapter 4. Carbohydrates ........................................... 37 Chapter 5. Lipids .................................................. 63 Chapter 6. Amino Acid Metabolism ................................... 89 Chapter 7. Summary of Metabolism .................................. 103
Section II: Molecular Biology Chapter 1. Nucleic Acids ........................................... 115 Chapter 2. The Nucleus, the Cell Cycle, and Meiosis ..................... 123 Chapter3. DNA Replication and Repair ............................... 129 Chapter 4. Transcription ............................................ 135 Chapter 5. Protein Synthesis ........................................ 143 Chapter 6. Regulation of Gene Expression ............................. 151 Chapter 7. Genetic Engineering ...................................... 159
I KAPLAlf med lea
vii
Section III: Cell Biology Chapter 1. Overview of Cell Types .................................... 177 Chapter 2. Nucleus and Nucleolus ................................... 183 Chapter 3. Subcellular Organelles .................................... 187 Chapter 4. Cytoskeleton ........................................... 199 Chapter 5. Cellular Adhesion and Extracellular Matrix ..................... 205
Section IV: Genetics Chapter 1. Mendelian Inheritance .................................... 213 Chapter 2. Chromosomal Abnormalities ............................... 223 Chapter 3. Linkage ............................................... 237 Chapter 4. Population Genetics ...................................... 243
Section V: Microbiology Chapter 1. Introduction ............................................ 251 Chapter 2. Bacteriology Overview .................................... 255 Chapter 3. Bacteriology: Gram-Positive Cocci .......................... 267 Chapter 4. Bacteriology: Gram-Positive Bacilli .......................... 277 Chapter 5. Bacteriology: Gram-Negative Organisms ..................... 283 Chapter 6. Bacteriology: Anaerobes .................................. 299 Chapter 7. Bacteriology: Mycobacteria and Actinomycetes ................ 303 Chapter 8. Bacteriology: Rickettsiae and Chlamydiae .................... 309 Chapter 9. Bacteriology: Spirochetes ................................. 315 Chapter 10. Bacteriology: Mycoplasma and Ureaplasma ................. 321
viii
meClical
----------- ----- - - - - - - -
Chapter 11. Virology .............................................. 323 Chapter 12. Mycology ., ........................................... 343 Chapter 13. Protozoa .............................................. 351 Chapter 14. Helminths ............................................ 359 Chapter 15. Antimicrobial Agents .................................... 365
Section VI: Immunology Chapter 1. Basic Immunology ....................................... 405 Chapter 2. Clinical Immunology ..................................... 449 Index ............. , .. , .......... " ...... , .. , .. " .......................... 483
meClical
ix
SECTION I
Biochemistry
Acid-Base Equilibrium and Buffering Homeostasis requires that the pH of biologic fluids be maintained at a constant and characteristic value. The control of pH in body fluids and subcellular compartments is achieved by a number of biologic buffers. The most important buffers in physiologic systems are bicarbonate, phosphate, and proteins. Buffers consist of a weak acid and its conjugate base that are in equilibrium and are able to donate and accept protons from the surrounding medium. The relationship between pH, pKa, and the concentration of the conjugate acid and base of a buffering system is described by the HendersonHasselbalch equation. Disturbances in the acid-base balance can lead to acidosis (a plasma pH less than 7.35) or alkalosis (a plasma pH greater than 7.45). This chapter reviews the concepts underlying acid-base equilibrium, the pH of various body fluids, and the properties of the buffer systems that resist fluctuations in pH.
ACID-BASE EQUILIBRIUM The most appropriate biochemical definition for acids and bases is that acids are proton donors and bases are proton acceptors. Many important compounds found in biologic fluids, including amino acids, lactic acid, and acetoacetic acid, are weak acids. A. Properties of weak acids. Weak acids, in contrast to strong acids such as Hel or H 2S04, are not completely dissociated under the conditions that exist within biologic systems. The undissociated form (HA) that retains the proton is known as the conjugate acid, whereas the corresponding deprotonated form (A-) is a conjugate base that can accept a proton to recreate the acid. The reaction that describes the dissociation of a weak acid is shown in Figure I-l-l.
HA
~,============~'
conjugate acid
H+
+ conjugate base
Figure 1-1-1. Dissociation of a weak acid.
KAPLlIf . ._ I me 1C8
3
Biochemistry
B. The Henderson-Hasselbalch equation shown in Figure 1-1-2 describes the relationship
between pH and the concentration of a weak acid and its conjugate base. In this equation, pH is defined as the negative log of [H+], and pKa is defined as the negative log of the . . constant Ka' were h Ka = [H+] [A-] . For any weak'd K'IS a constant t h at · d IssoClatlOn [HA] aCl, th epa
Note
is characteristic of that particular ionizing group. The Henderson-Hassselbach equation is
A corollary of the equation: When the pH is greater than the pKa, the base (A-) form is dominant; when the pH is less than the PKa, the acid (HA) form is dominant.
useful because it provides a meaningful definition of pKa and permits calculation of the amounts of the undissociated acid and its conjugated base at any pH.
Figure 1-1-2. Henderson-Hasselbalch equation.
1. A functional definition of pKa can be deduced from the Henderson-Hasselbalch equation. The pKa of any ionizing group can be defined as the pH where the concentrations of the acid (HA) and its conjugate base (A-) are equal. When the pH is equal to the pKa of the acid, the concentrations of HA and A-are equal. Inspection of the equation indicates that when [HA] = [A-J, the last term of the equation becomes zero, and the equation reduces to pH = pKa. 2. The logarithmic nature of the Henderson-Hasselbalch equation indicates that small changes in pH will bring about large changes in the relative concentrations of HA and A-. These effects are summarized in Table I-I-I, where lactic acid, having a pKa of 3.8, is considered as an example of a weak acid. The same principles apply for any weak acid, i.e., a change of 1 pH unit results in a lO-fold change in the ratio of conjugate acid to conjugate base. Table 1-1-1. Effect of pH on the relative amounts of lactic acid and lactate. pH 1.8 12.8 pKa 3.8 4.8 5.8
[Lactic Acid] I [Lactate-] 100 101 1 0.1 0.01
TITRATION AND BUFFERING PROPERTIES OF WEAK ACIDS Titration can be defmed as the addition of a strong base to a weak acid (or a strong acid to a weak base) for the purpose of buffering the solution, i.e., maintaining a constant pH. A. Titration curve. The addition of a strong base such as sodium hydroxide to a weak acid may be written as:
4
KAPLA~. I meulca
Acid-Base Equilibrium and Buffering
As NaOH is added, the protons released by the weak acid combine with hydroxide to form water. The continued addition of sodium hydroxide progressively decreases the [H+J and increases the pH. A graph of the titration of a weak acid with a strong base is shown in Figure 1-1-3.
---------- ~--z-~--~h7'77T
Buffering range
HA
o
0.5
1.0
NaOH (equivalents) Figure 1-1-3. Titration curve for a weak acid.
At the midpoint in the titration, half of the acid has been neutralized and, therefore, [HAJ = [A-J. The Henderson-Hasselbalch equation shows that when [HAJ = [A-J, the pH of the solution is equal to the pKa of the weak acid. B. Buffering capacity. Buffers are mixtures of weak acids and their conjugate bases. The capac-
ity of a buffer, to resist change in pH is dependent on two factors: the concentration of the buffer, and the pH at which it is used. A buffer is most effective when it is used in a pH range near the pKa. It is clear from Figure 1-1-3 that in the pH range defined by 1.0 pH unit above and below the pKa' the addition of either strong acid or strong base will result in minimal change in the pH.
Note The best buffering occurs when pKa = pH, resulting in 50% of acid and 50% of base. This system can then handle either an addition of base or an addition of acid.
PHYSIOLOGICALLY IMPORTANT BUFFERING SYSTEMS The three most important buffering systems in biologic fluids are proteins, bicarbonate, and phosphate. The conjugate acid-base pairs and the pKa values for these buffers are summarized in Table 1-1-2. The major buffer in plasma and interstitial fluid is bicarbonate, whereas protein and organic phosphate esters are the major buffers of intracellular fluid. A. Protein buffering systems. The cytosol of cells contains high concentrations of proteins with amino acid side chains that are weak acids and bases. These side chains impart great buffering capacity to proteins. The acidic amino acids (glutamic and aspartic acids) and the basic amino acids (lysine, histidine, and arginine) all contain ionizable side chains (discussed in the next chapter). However, histidine is the only amino acid with good buffering capacity at physiologic pH. The imidazole side chain of histidine has a pKa that ranges from 5.6-7.0, depending on its microenvironment within the protein.
Bridge to Physiology Histidine is frequently found in the catalytic site of enzymes where the imidazole ring can donate or accept protons in the formation and breaking of bonds.
meCtical
5
Biochemistry
Table 1-1-2. Properties of major physiologic buffers. Buffering System Protein systems: Histidine side chains
5.6-7.0
Bicarbonate system: HC03-ICOz
6.1
Phosphate systems: HP042-/HzP04-
6.8
Organic phosphate esters
6.5-7.5
The buffering reaction for proteins is shown in Figure 1-1-4, in which the imidazole side chain of histidine can reversibly donate and accept protons. The presence of multiple histidine side chains within each protein molecule contributes to the buffering capacity of the protein. Histidine plays a key role in making hemoglobin an excellent buffer in red blood cells.
O rotein
Bridge to Physiology Acidosis, a plasma pH below 7.35, can result from the accumulation of acids such as lactic acid, acetoacetic acid, and B-hydroxybutyric acid (resulting in a metabolic acidosis), or from hypoventilation that results in the accumulation of CO 2 (respiratory acidosis). Alkalosis, a plasma pH above 7.45, can result from a loss of stomach acids due to excessive vomiting (metabolic alkalosis) or from hyperventilation (respiratory alkalosis). Acidosis and alkalosis are discussed in greater detail in the Respiratory Physiology and Renal Physiology sections.
6
KAPLAN"d_
me lea
I
CH
I
NH
=
CH
I
+ NH
H
+
+
orotein CH = I NH
"~
"
CH
CH
CH
I
N
~
Figure 1-1-4. Protein buffering system. B. Bicarbonate buffering system. The bicarbonate-C0 2 system is the most important buffer in
maintaining the pH of blood plasma and interstitial fluid at its normal value of 7.4. Figure I -1-5 summarizes the properties of this buffering system. Carbonic acid (H 2 C03 ) is the proton donor, bicarbonate anion (HC0 3-) is the proton acceptor, and the pKa for this reaction is 6.1. The strength of this buffering system lies in the ability of carbonic acid to be converted to carbon dioxide.
pKa = 6.1
Figure 1-1-5. The bicarbonate/C0 2 buffering system.
C. Phosphate buffering system. Intracellular fluids contain high concentrations of inorganic
phosphate and many organic phosphate esters that contribute significantly to the buffering power of the cytosol. The phosphate buffering system is of little importance in plasma and interstitial fluid because of the low concentrations of phosphates in extracellular fluids. The phosphate buffering system consists of H 2 P0 4- as the proton donor and HPoi- as the proton acceptor. The pKa of 6.8 is sufficiently close to the normal intracellular pH to make it an ideal buffer in those fluids that contain high concentrations of phosphates, such as red blood cells and kidney tubules.
- - - - - - - - - -
-------
- - - -
Proteins, Enzymes, and Coenzymes Proteins are linear polymers of amino acids, each having distinct chemical and structural properties. They are the largest class of molecules found in living systems and are responsible for most of the diverse functions of the cell. They act as transport proteins, storage proteins, hormone receptors, structural proteins, regulatory proteins, and enzymes. Each protein has a unique amino acid sequence that determines its precise three-dimensional conformation and specifies its function. The most versatile class of proteins is enzymes, which act as biologic catalysts, enhancing the rate of chemical reactions occurring in cells. Most enzymes catalyze only one reaction, and their catalytic activities may be stringently regulated, allowing the cell to control and coordinate its metabolic pathways. The kinetic parameters, Km and Vmax, are constants that describe the catalytic properties of enzymes. The function of many enzymes requires a cofactor-a metal or a small organic coenzyme derived from a vitamin precursor. This chapter reviews the structure and properties of amino acids that are found in proteins, the kinetic and regulatory properties of enzymes, and the relationship between coenzymes and their vitamin precursors.
AMINO ACIDS: THE BUILDING BLOCKS OF PROTEINS A. Amino acid structure. The building blocks for proteins are the 20 common amino acids that are encoded in the DNA of the cell. 1. General structure. Nineteen of the twenty common amino acids can be represented by the structure shown in Figure 1-2-1. They all have a central carbon atom attached to a carboxyl group, an amino group, and a hydrogen atom. The amino acids differ from one another only in the chemical nature of the side chain (R). The only amino acid that is not described by this structure is proline, an imino acid in which the side chain forms a cyclic structure with the amino group (Figure 1-2-2). NH2
I R-Ca-COOH I H
In a Nutshell Amino Acids with Hydrophobic Side Chains
Figure 1-2-1. General structure of a-amino acids.
2. Classification. The amino acids can be classified as either hydrophobic or hydrophilic, depending on the ease with which their side chains interact with water. This particular method of classification is especially useful when considering amino acids as the building blocks of proteins. The properties of amino acid side chains influence how the protein folds into more compact structures. In general, proteins fold so that the hydrophobic side
Aliphatic Ala Val Leu lie Pro
Aromatic Phe Tyr Trp
meClical
7
Biochemistry
In a Nutshell
chains are in the interior of the molecule, where they are protected from water, and the hydrophilic side chains are on the surface.
Amino Acids with Hydrophilic Side Chains Positive Negative Lys Asp Arg Glu His
a. Hydrophobic amino acids have side chains with aliphatic groups or aromatic ring structures (Figure 1-2-2).
Neutral Ser
b. Hydrophilic amino acids have side chains that contain 0, N, or S atoms. Some of the hydrophilic side chains are charged at physiologic pH. The acidic amino acids (aspartic and glutamic acids) have carboxyl groups that are negatively charged, whereas the basic amino acids (lysine, arginine, and histidine) have nitrogen atoms that are positively charged. Other hydrophilic amino acids with uncharged side chains contain hydroxyl groups (serine and threonine), a sulfur atom (cysteine), or amide groups (asparagine and glutamine). The structures of the R groups for the hydrophilic amino acids are shown in Figure 1-2-3. Methionine, tyrosine, cysteine, and glycine may be found either in the interior or on the surface of globular proteins.
Thr Cys Met Asn Gin
Nonpolar, Aliphatic Side Chains
coo· + I H3N -C-H
GJ Glycine
coo· I
H3N+-C --ti
coo· I
H3N+-C-H
~ Alanine
CH2
Leucine
+
H3N~-H
CH CH3/
'CH3
Valine
H3N -C -H
COO· +
I
H3N -C-H
oQ OH
Phenylalanine
I
I
CH3 Isoleucine
Proline
Figure 1-2-2. The hydrophobic amino acids.
8
I
H3~-C-H
CH
"CH 3
coo·
I
I
H-C-CH3
CH 3/
coo·
coo·
CH2
I
Aromatic Side Chains
liP LIN"iIme leaI
- - - - - - - - -
Tyrosine
Tryptophan
Proteins, Enzymes, and Coenzymes
Positively charged R groups
Polar, uncharged R groups
coo +
coo
I
+
H3 N - C -H
I
H3N -C-H
I
I
CH 2
H-C-OH
CH 2
CH 3
I
I
I
CH 2
I
Serine
Threonine
Cysteine
Methionine
Asparagine
Glutamine
NH
I
+
C=NH 2
I
NH2 Lysine
Arginine
Histidine
Negatively charged R groups
coo +
I
H3 N - C-H
I CH 2
I
COO
Aspartate
Glutamate
Figure 1-2-3. The hydrophilic amino acids.
3. Modified amino acids. In addition to the 20 common amino acids that are encoded by DNA, proteins often contain other amino acids that are generated by modification of the common amino acids after the protein has been synthesized. This process is called posttranslational modification. a. Cystine is formed in proteins by the reaction of two cysteine side chains to form a disulfide linkage. It is found most frequently in extracellular proteins where the disulfide bond stabilizes the three-dimensional structure of the protein. b. Hydroxyproline is formed in an oxygen-dependent hydroxylation reaction that occurs in t1broblasts. It is found in collagen, where it stabilizes the triple helical structure. c. Phosphotyrosine, phosphoserine, and phosphothreonine are formed by transferring
phosphate from ATP to the hydroxyl group of serine, tyrosine, or threonine. These amino acids are found in many enzymes and proteins, where they serve as regulatory signals.
In a Nutshell • S-S bridges:
Cystine
• Collagen triple helix:
Hydroxyproline
Phosphotyrosine • Signal transduction: Phosphoserine Phosphothreonine
meCtical
9
Biochemistry
B. Properties of amino acids. The properties of proteins are influenced by the properties of
Note There are other amino acids, like ornithine and citrulline, that play important roles in the cell but that are not building blocks for protein synthesis.
their constituent amino acids. In particular, the stereochemistry and ionic properties of amino acids have an impact on the structure and/or properties of the protein. 1. Stereochemistry. The a-carbon atom of all amino acids except glycine is linked to four
different chemical groups, making the a-carbon atom an asymmetric center. As shown in Figure 1-2-4, an asymmetric center has two stereoisomers (enantiomers) that are mirror images of each other and are designated as D- and L-amino acids. Only L-amino acids are incorporated into proteins.
coo-
cooI
I
H-C- NH3+
I
+H N-C-H
I
3
CH3
CH 3 D-alanine
L-alanine
Figure 1-2-4. Stereoisomers of an a-amino acid.
2. Ionic properties. Depending on the pH, an amino acid may have no net charge, or it may have either a positive or a negative charge. The pH at which a molecule is electrically neutral is defined as the isoelectric point (pI). The equilibrium between the ionic forms of an amino acid is shown in Figure 1-2-5. The pKa values for the a-carboxyl and a-amino groups are approximately 2.1 and 9.8, respectively. At a pH below the pKa' the protonated species predominates, whereas at a pH above the pKa' the deprotonated species predominates. The pI for the amino acid shown in Figure 1-2-5 is the average of the two pKa values. At neutral pH, the species that has both positive charge and negative charge is called a zwitterion.
+NH3
+NH3 NH2 pK a = 2.1 I pK a 9.8 \ ....R -CH -COO ~ ...==~"" R-CH-COOR -CH -COOH ...
I
Net charge = + 1 pH = 1
Net charge = 0 pH = 7
Net charge = -1 pH = 11
Figure 1-2-5. The ionic equilibrium for an a-amino acid.
The acidic and basic amino acids also have ionizing groups in their side chains. Aspartic and glutamic acids have side chain carboxyl groups with a pKa of approximately 4.0 and are negatively charged at physiologic pH. Lysine and arginine have side chains with protonated nitrogen atoms having pKa values of approximately 10 and 12, respectively, and are positively charged at physiologic pH. Histidine has an imidazole side chain with a pKa of approximately 6.0, a value sufficiently close to the physiologic pH to allow some of the histidine side chains to be positively charged, whereas others have no charge. The ratio of positively charged histidine side chains to uncharged side chains at any pH can be calculated from the Henderson-Hasselbalch equation (described in the previous chapter).
10
KAPLAlfdme leaI
Proteins, Enzymes, and Coenzymes
PROTEINS Each protein has a unique three-dimensional structure dictated by its amino acid sequence and is responsible for the highly specific function of the protein. A. Structural features. The amino acids in a protein are linked together by peptide bonds in which the a-carboxyl of one amino acid is linked to the a-amino group of another amino acid (Figure 1-2-6). The peptide (amide) bond has partial double-bond character, making it planar and rigid, thereby imposing limitations on higher orders of structural organization in a protein. 1. Primary structure. The sequence in which the amino acids occur in the polypeptide is
defined as the primary structure. This sequence is encoded by the DNA, and it determines how the protein folds into a more compact three-dimensional structure. 2. Native conformation. The final structure that a particular protein assumes proceeds through several levels of organization. In contrast to the primary structure, which is stabilized by strong covalent bonds, higher orders of structure are stabilized by numerous weak non covalent interactions.
+
H[JR I
H N-C 3
I
R
II
C-NH
0
I
II
CHlEJNH CH-C-COO-
II
I
0
R
Figure 1-2-6. The peptide bond.
a. Secondary structure in proteins is organized around the polypeptide backbone and is stabilized by large numbers of hydrogen bonds formed between the amide hydrogen atom of one peptide bond and the carbonyl oxygen atom of another. Proteins contain two major types of secondary structure: a-helical structure, which is stabilized by intrachain hydrogen bonds, and 13-sheet structure, which is stabilized by interchain hydrogen bonds. In some fibrous proteins, the highest order of structure is secondary. These proteins are elongated asymmetrical proteins that frequently function as structural components of cells and tissues. Simple combinations of a few secondary structural elements are called motifs and are often repeated multiple times in proteins. An example of a motif would be a 13-a-13 loop motif that can be used to connect two parallel13 strands. The a-helix in the middle of the two 13 strands allows for the reversal of direction. b. Tertiary and quaternary structure. Segments of secondary structure in globular proteins associate with one another and fold into a tertiary structure that is stabilized by non covalent interactions between amino acid side chains. The fundamental unit of tertiary structure is the domain, a part of the polypeptide chain that folds into a stable tertiary structure and is encoded by an exon in DNA. Proteins that are composed of more than one polypeptide chain have quaternary structure. Both tertiary and quaternary structures are stabilized by ionic and hydrophobic interactions and by hydrogen bonding between side chains. 3. Denaturation is defined as the loss of native conformation, resulting in a random coil that has little, if any, of the biologic activity of the native protein. Denaturation may be caused by heat, extremes in pH, or detergents.
In a Nutshell 1° structure: • Amino acid sequence
2° structure: • a-helix
• 13-sheet 3° structure: • Overall protein
structure • How a-helix and 13-sheet fold with respect to each other 4° structure: • Mutiple polypeptide chains
• How chains fold with
respect to each other
meClical
11
Biochemistry
B. Function. Proteins perform most of the important functions of the cell. Many of the pro-
teins in skin, bone, muscle, and hair perform structural roles. Other proteins carry out the dynamic functions of the cell. Many plasma proteins transport small molecules such as iron or oxygen; immunoglobulins and clotting factors participate in defense functions; hormones, hormone receptors, and transcription factors play critical regulatory roles in the cell; and enzymes function as biologic catalysts.
ENZYMES Virtually all biologically important reactions are catalyzed by enzymes. Most of these reactions occur under very mild conditions of temperature and pH that are compatible with living organisms. In the absence of enzymes, reactions in the cell would proceed at insignificant or undetectable rates. Enzymes differ from inorganic catalysts in their specificity, catalytic efficiency, and regulatory properties. A. Classification. Enzymes are divided into six different classes on the basis of the types of reactions they catalyze (Table 1-2-1). All of the thousands of different reactions occurring in cells fall into one of these six types of reactions. B. Specificity. The high specificity of enzyme-catalyzed reactions occurs because enzymes have
active sites composed of a small number of amino acid side chains. The side chains come together to form a three-dimensional site on the surface of the enzyme that is complementary to the structure of the substrate. Some of the amino acid side chains in the active site participate in binding the substrate to the enzyme; others act as catalytic groups and enhance the rate of the reaction by acting as acids, bases, or nucleophiles.
Table 1-2-1. The six classes of enzymes.
12
KAPLAlfdme leaI
Class
Type of Reaction
Oxidoreductases
Oxidation-reduction reactions Frequently use coenzymes NAD+, FAD, NADP+' or O 2 as electron acceptors (dehydrogenase, oxidase, reductase)
Transferases
Transfer of a chemical group from a donor to an acceptor Groups transferred include amino, carboxyl, acyl, glycosyl, phosphoryl (transaminase, kinase)
Hydrolases
Cleavage of a bond between carbon and some other atom by the addition of water (protease, phosphatase, amylase)
Lyases
Nonhydrolytic cleavage of carbon-carbon, carbon-sulfur, and some carbon-nitrogen bonds (aldolase, decarboxylase, dehydratase)
Isomerases
Interconversion of isomers (epimerase, mutase)
Ligases
Formation of bonds between carbon and oxygen, nitrogen, or sulfur atoms in reactions that require energy (carboxylase, thiokinase)
Proteins, Enzymes, and Coenzymes
C. Catalytic properties. The energy profile of a chemical reaction, as it proceeds from substrate
to product, is shown in Figure 1-2-7. The highest point on the curve is the energy of the transition state, an intermediate whose properties resemble both the substrate and the product. The energy barrier created by the transition state is also known as the activation energy (Act) of the reaction. To initiate the reaction, energy must be expended to overcome the energy barrier. The rate of a reaction is inversely proportional to the magnitude of the activation energy. As shown by the dotted line in Figure 1-2-7, enzymes increase the rate of a reaction by decreasing the activation energy barrier. They have no effect on the equilibrium constant for the reaction, which is related to ~G, the energy difference between the products and substrates.
Transition state
~-.-__ ~_ ~ minus enzyme
>OJ .....
\3s
Q)
~
~-------
" -------------- - --
.... ;
Q)
c
~G* = G TS - G s
/",-
Q)
"
LL
~G
plus enzyme
= Gp-G s
Reaction progress Figure 1-2-7. Energy profile for a catalyzed and uncatalyzed reaction.
D. Kinetic properties of enzymes. Kinetics is the study of the rate at which chemical reactions occur. 1. Factors affecting the rate of enzyme-catalyzed reactions include temperature, pH, enzyme concentration, and substrate concentration. Typical rate responses to these factors are shown in Figure 1-2-8. a. Temperature. The rate of most reactions increases approximately twofold with a 1O.ODC increase in temperature. For enzyme-catalyzed reactions, however, there is an optimum temperature beyond which the rate rapidly decreases due to denaturation of the enzyme. b. pH. The optimal activity of most enzymes occurs between pH 5 and 9. The shape of the rate-versus-pH curve reflects different ionization states for specific amino acid side chains that are required for substrate binding or for catalysis.
mectical
13
Biochemistry
Mnemonic STEP up the reaction rate: Substrate concentration Temperature Enzyme concentration
c. Enzyme concentration. The rate of an enzyme-catalyzed reaction is directly proportional to the concentration of enzyme provided the substrate is present in concentrations sufficient to saturate the binding sites. d. Substrate concentration. At very low concentrations of substrate, first -order kinetics are observed, with the rate being directly proportional to [S]. When the concentration of substrate is sufficiently high that all of the binding sites are occupied, zero-order kinetics are seen, with the rate being independent of [5]. 2. The Mic:haelis-Menten equation is an expression that quantifies the relationship between the rate of an enzyme-catalyzed reaction and the substrate concentration. In deriving an equation for the curve shown in Figure 1-2-SD, it is assumed that the limiting rate observed at an infinitely high substrate concentration is due to a finite number of sites on the enzyme and that when all of the sites are occupied, the maximum rate is obtained. The Michaelis-Menten expression for velocity is illustrated by the following equation:
pH
In this expression, Vmax and Km are constants that are characteristic of the enzyme. They are defined as follows: a. The maximum velocity, Vmax' is the rate obtained when all of the enzyme is present as an E·S complex, with substrate bound to the active site. The Vmax increases as the concentration of enzyme increases.
In a Nutshell • Vmax: theoretical rate when all enzymes are working
• Km: substrate concentration at which the reaction is running at half of the maximum rate (where V= 1/2 Vmax>
b. The Km is the substrate concentration that is required to achieve half of the maximum velocity and is independent of the enzyme concentration. These relationships are shown in Figure 1-2-9. Rough estimates of the Vmax and Km values can be obtained from this figure. However, values for both Vmax and Km obtained from this type of graph are inherently subject to large errors because of the shape of the curve; the value for Vmax must be extrapolated from an infinitely large value for [S]. Much more accurate values of these two kinetic parameters can be obtained from secondary plots, as described below.
A.
>
~
B.
0
~
Temp C.
pH
D.
zer~ order
> Q)
iii '-
~order Enzyme Concentration
Substrate Concentration
Figure 1-2-8. Factors affecting the rate of enzyme-catalyzed reactions.
14
KAPLA~.
I
meulCa
Proteins, Enzymes, and Coenzymes
Vm~r-------------------~====~
t
>
0.5
Vm~ 1----7/'
[Sl~
Figure 1-2-9. Dependence of rate on substrate concentration.
3. Lineweaver-Burk plot. A more useful graph for obtaining values of Km and Vmax can be obtained by taking the reciprocal of the Michaelis-Menten equation and rearranging it to give the Lineweaver-Burk equation: 1
Km
1
1
V
Vmax
5
Vmax
Note Remember that the equation for a straight line is:
-=--e-+--
As shown in Figure I-2-lO, this equation describes a straight line when IN is plotted against 1/[S]. The slope of the line is equal to KmNmax, the intercept of the line on the y-axis is equal to l/Vmax' and the intercept on the x-axis is equal to -l/Km.
y=mx+b, where m = slope and b = y-i ntercept.
In a Nutshell Lineweaver-Burk Plot x-axIs: y-axIs: slope: x-intercept: y-intercept:
o
1
[8]
Note • Km
Figure 1-2-10. Lineweaver-Burk plot.
4. Significance of Km and Vmax' Each of these kinetic constants reflects an intrinsic property of the enzyme.
l/[S] 1/V = l/rate Km/Vmax -l/Km l/Vmax
oc
l/affinity
. .i Km ~ i
substrate
affinity Km ~ .i substrate affinity
· i
meClical
15
Biochemistry
a. Km is related to the affinity of the enzyme for the substrate. The lower the value for Km , the higher the affinity of the enzyme for the substrate, and vice versa. Frequently, the Km value of an enzyme for its substrate is approximately equal to the substrate concentration found in the cell. b. Vmax is related to the efficiency with which substrate is converted to product when all of the active sites are occupied. Some enzymes, such as catalase, are highly efficient, with the rate of product formation approximating the rate of substrate binding; others, like RNA polymerase, are much less efficient at converting substrate to product. E. Inhibitors of enzyme activity. Much of toxicology and pharmacology is based on the principles of enzyme inhibition. Many metabolic poisons, such as insecticides and nerve gases, are enzyme inhibitors. Similarly, many drugs are inhibitors of key enzymes in metabolic pathways and often have structures similar to the normal enzyme substrate. There are two large classes of enzyme inhibitors: reversible and irreversible. 1. Reversible inhibitors alter the kinetic properties of an enzyme by binding noncova-
In a Nutshell Competitive Inhibition
• Vmax is unchanged • Slope increases • y-intercept is unchanged
lently to the enzyme through multiple interactions with amino acid side chains. The effect of a reversible inhibitor is removed by its dissociation from the enzyme. There are three types of reversible inhibitors: competitive, noncompetitive, and uncompetitive. a. Competitive inhibitors are structural analogs of the substrate and compete with the substrate for binding to the active site. The effect of a competitive inhibitor can be overcome by increasing the concentration of substrate. The Km for the substrate is increased (i.e., because both inhibitor and substrate are competing for the same site, more substrate is needed to reach half-maximum velocity). Vmax remains unchanged. Competitive inhibitors are easily identified by Lineweaver-Burk plots (Figure 1-2-11), in which the slope is increased but the intercept on the 1IV axis is unchanged. The intercept on the x-axis is shifted closer to zero (corresponding to an increase in Km).
• x-intercept shifts to the right
In a Nutshell Noncompetitive Inhibition • Km is unchanged
• -tV max • Slope increases • y-intercept shifts upward • x-intercept is unchanged
16
meclical
o
1
[8]
Figure 1-2-11. Lineweaver-Burk plot of competitive inhibition.
b. Noncompetitive inhibitors bind to some site other than the active site and are not structural analogs of the substrate. The Vmax of the reaction is decreased, but the Km for the substrate remains unchanged. The effect of a noncompetitive inhibitor cannot be overcome by increasing the substrate concentration. In a Lineweaver-Burk plot (Figure 1-2-12), the intercept on the 1IV axis is increased (corresponding to a decrease in Vmax ), and the intercept on the 11[5] axis is unchanged.
Proteins, Enzymes, and Coenzymes
In a Nutshell Uncompetitive Inhibition •
Km and Vmax are changed
• Slope remains the same • x-intercept shifts to the left
o
1
• y-intercept shifts upward
[8] Figure 1-2-12. Lineweaver-Burk plot of noncompetitive inhibition.
c. Uncompetitive inhibitors bind directly to the enzyme substrate complex but not to
free enzyme. This binding causes a conformational change at the active site that renders the enzyme inactive. Both Vmax and Km are changed. Both Vmax and Km decrease, but the slope of the inhibited reaction is parallel with the slope of the uninhibited reaction (Km/Vmax)' Lineweaver-Burk plots at various concentrations of the inhibitor will be a series of parallel lines. 2. Irreversible inhibitors covalently bind to the enzyme, resulting in permanent inactivation of the enzyme. Some irreversible inhibitors are referred to as "mechanism-based inhibitors" or "suicide substrates" because they bind to the active site and mimic the enzyme by beginning to undergo catalysis; however, the catalytic cycle is never completed because they become covalently linked to the enzyme. The effect of irreversible inhibitors on the kinetic parameters of an enzyme is identical to that of a noncompetitive inhibitor. F. Regulation of enzyme activity. Homeostasis requires that the rate of metabolic pathways be carefully regulated and coordinated with one another. This is typically achieved by the regulation of one or two key enzymes in each pathway. The key enzymes that are regulated usually catalyze either the rate-limiting reaction in the pathway or a reaction that is essentially irreversible. There are three major mechanisms for controlling the activity of enzymes. 1. Allosteric regulation. The activity of allosteric enzymes is regulated by the reversible bind-
ing of an effector molecule to a site other than the active site. Substrate saturation curves for allosteric enzymes are usually sigmoidal (Figure 1-2-13). Allosteric effectors can be either positive (activators) or negative (inhibitors) and act by altering either the K m , Vmax' or both. Activators either decrease the Km or increase the Vmax' whereas inhibitors increase the Km or decrease the Vmax' Common types of effectors include end products of pathways (heme, cholesterol, purine, and pyrimidine nucleotides) or molecules that reflect the energy state of the cell (ATP, ADP, AMP, NADH, NAD+, acetyl-CoA).
Clinical Correlate Lead toxicity is caused by lead's inhibitory effect on a number of enzymes having essential sulfhydryl groups in their active sites. The sulfhydryl groups react covalently with lead, resulting in irreversible inactivation of the enzyme. Two enzymes in the pathway of heme synthesis (aminolevulinic acid dehydratase and ferrocheletase) are inactivated by low levels of lead, resulting in decreased synthesis of heme and hemoglobin and increased excretion of aminolevulinic acid. Treatment with chelators such as penicillamine decreases the toxicity by forming nontoxic complexes with lead.
In a Nutshell Allosteric Regulation • Activators: J, Km or i Vmax
i
Km or
J, Vmax
KAPLA~. I meulca
17
• Inhibitors:
Biochemistry
Clinical Correlate Growth factors (i.e., hormones) activate receptors via tyrosine phosphorylation; the newly phosphorylated tyrosine can induce signal transduction in the cell. In many cancers, this pathway is often disregarded and the growth signal is always on, causing unregulated cell proliferation.
v
Figure 1-2-13. Substrate saturation curve for an allosteric enzyme.
Clinical Correlate Patients with chest pain who are suspects for acute myocardial infarction (AMI) are evaluated by EKG and serial measurements of serum creatine phosphokinase (CPK) and lactate dehydrogenase (LDH) isoenzymes. The CPKMB isoenzyme is a marker for cardiac tissue damage. In patients with AMI, the tissue damage results in a transient increase of CPK-MB measurable 6-8 hours after the infarction, peaking between 12 and 24 hours, and returning to normal within 48-72 hours. If the patient is admitted 24 hours after the AMI, LDH isoenzyme analysis is performed. Following an AMI, the total serum LDH is elevated and the relationship between LDH1 and LDH2 is inverted, so that LDH1 > LDH2. The change in LDH isoenzymes occurs within 24-36 hours post-AMI.
18
meClical
2. Covalent modification. The activity of many enzymes is regulated by a phosphorylation/dephosphorylation cycle in which a specific serine, threonine, or tyrosine side chain becomes modified (Figure 1-2-14). The addition and removal of the phosphate group are catalyzed by a family of protein kinases and protein phosphatases that respond to hormonal stimulation of cells. Phosphorylation can increase or decrease the activity of an enzyme, or it can alter the regulatory properties.
Protein kinase
0
00-p~=
0H
Altered activity Protein phosphatase
Figure 1-2-14. Regulation of enzyme activity by covalent modification.
3. Induction and repression of enzyme synthesis. Because enzyme activity is directly proportional to the amount of enzyme present, one way to regulate enzyme-catalyzed reactions is to alter the rate at which enzymes are synthesized. This type of regulation is frequently mediated by steroid or thyroid hormones that act in the nucleus to increase or decrease the rate of transcription, and, secondarily, protein synthesis. G. Isoenzymes. Isoenzymes are different proteins that catalyze the same reaction but have different catalytic and regulatory properties and frequently differ in tissue and/or organelle specificity. The appearance of tissue-specific isoenzymes in plasma is of diagnostic value in identifying sites of tissue damage.
Proteins, Enzymes, and Coenzymes
COENZYMES AND VITAMINS Most enzymes that catalyze transfer reactions or oxidation/reduction reactions require a coenzyme that serves as an intermediate carrier of some specific functional group. Coenzymes are small organic molecules that are more stable than proteins. Coenzymes are derived from vitamins. Vitamins cannot be synthesized de novo by human tissues and must therefore be supplied by the diet. In addition to dietary sources, some vitamins are also synthesized by bacteria normally present in the intestinal flora. Vitamins may be classified as either water soluble or fat soluble. All of the water-soluble vitamins and some of the fat-soluble vitamins serve as precursors for coenzymes. Other fat-soluble vitamins control the rate of transcription of specific genes, thereby influencing the rate of enzyme-catalyzed reactions by altering the amount of enzyme present in the cell. A. Water-soluble vitamins 1. Niacin, also known as vitamin B3 or nicotinic acid, is present in whole grains, meat, and
nuts. Up to 50% of the body's niacin supply can be derived from the amino acid tryptophan. Niacin is converted to nicotinamide, which is then incorporated into the coenzymes NAD+ and NADP+. These coenzymes are very important in both lipid and carbohydrate metabolism, where they act as carriers of hydride ions (two electrons and a proton) in oxidation and reduction reactions. NAD+ is generally involved in oxidative, catabolic pathways and is more concentrated in mitochondria than in cytosol; NADPH is used in reductive, anabolic pathways and is found primarily in the cytosol. 2. Riboflavin, vitamin Bz, is present in organ meat, whole grains, and dairy products. The two coenzymes derived from riboflavin are FMN and FAD, both of which act as carriers of hydrogen atoms in oxidation and reduction reactions. These coenzymes are important in the oxidation of carbohydrates, lipids, and amino acids and are found primarily in the mitochondria. Human riboflavin requirements increase with increased protein use during growth periods, pregnancy, lactation, and wound healing. Patients with a deficiency of riboflavin develop lesions of the lips, mouth, skin, and genitalia. 3. Thiamine, vitamin Bl> is present in meat, beans, peas, and grains. The coenzyme derived
from thiamine is thiamine pyrophosphate, which functions in oxidative decarboxylation of a-ketoacids. The four major enzymes requiring thiamine pyrophosphate are pyruvate dehydrogenase, a-ketoglutarate dehydrogenase, branched-chain a-keto acid dehydrogenase, and transketolase. 4. Pyridoxine, vitamin B6, is present in many foods, including most meats and vegetables. The coenzyme derived from this vitamin is pyridoxal phosphate, which acts as a carrier of amino groups in transamination, decarboxylation, racemization, and dehydration reactions. Pyridoxine deficiency may develop during pregnancy, alcoholism, with prolonged exposure to isoniazid or penicillamide therapy, and in women on oral contraceptives. Both a deficit and excess of pyridoxine may lead to peripheral neuropathy and dermatitis.
Clinical Correlate Side effects of exogenous niacin use include vasodilatation, flushing, and itching. Deficiency results in pellagra, producing the clinical triad of the three Os: diarrhea, dermatitis, and dementia. (If untreated, a fourth possible "0" is death.)
Clinical Correlate Mild thiamine deficiency leads to peripheral neuropathy (dry beriberi). More severe vitamin depletion leads to high-output cardiac failure (wet beriberi) and the dementia, ataxia, and ophthalmoplegia of the W~nicke-Korsakoff syndr~ll}e
frequently seen in chronic alcoholics.
5. Pantothenic acid is widely distributed in foods, particularly in meats and grains. The coenzyme derived from this vitamin is coenzyme A, which acts as a carrier of acyl groups and is particularly important in lipid metabolism. The key feature of this coenzyme is a sulfhydryl group that forms a high-energy thioester linkage with the carboxyl group of fatty acids. Pantothenic acid deficiency is rare. 6. Biotin is present in many foods, including liver, grains, and eggs. It is also synthesized by intestinal bacteria. The conversion to a coenzyme simply requires that it be covalently linked to the appropriate enzymes. Biotin acts as a carrier of "activated carboxyl" groups for three key enzymes that catalyze carboxylation reactions. The enzymes and the pathways they participate in are: pyruvate carboxylase (gluconeogenesis), acetyl-CoA
meClical
19
Biochemistry
Clinical Correlate Folic acid deficiency is most commonly seen in pregnancy and alcoholism. Deficiency states can result in megaloblastic anemia and neural tube defects. Supplementation is recommended before and during pregnancy.
Clinical Correlate Vitamin C deficiency results in scurvy, characterized by poor wound healing and bone formation, gum changes, and petechiae.
carboxylase (fatty acid synthesis), and propionyl-CoA carboxylase (branched-chain amino acid catabolism). Biotin deficiency is rare. Excessive consumption of raw egg impairs biotin absorption because of the presence of a biotin-binding protein, avidin, in egg whites. Antibiotics that alter the intestinal flora can also lead to biotin deficiency. Symptoms of deficiency include alopecia, skin and bowel inflammation, and muscle pain. 7. Folic acid is present in liver, fresh fruit, and leafy green vegetables. The coenzyme form of this vitamin is tetrahydrofolic acid (THF), which acts as a carrier of one-carbon fragments in metabolism. THF carries one-carbon units at all stages of oxidation except carboxyl groups. The coenzyme is important in amino acid catabolism and in the synthesis of purines and pyrimidines. The donors of the one-carbon units are serine, histidine, glycine, and tryptophan; the acceptors are intermediates in the pathways of purine and pyrimidine nucleotide synthesis. 8. Vitamin C, or ascorbic acid, is found in fresh fruits and vegetables. This vitamin exists in both oxidized and reduced forms, with the reduced form being the active form. Vitamin C facilitates iron absorption from the gut and is also required in a number of hydroxyl ation reactions, including proline and lysine hydroxylation for collagen synthesis and dopamine hydroxylation in catecholamine synthesis. Vitamin C also serves as an antioxidant in cells. 9. Vitamin B12, or cobalamin, is synthesized exclusively by microorganisms but is conserved in animal tissues, where it is found in high concentrations in the liver and kidney. It is required as the coenzyme for two reactions in human biochemistry: the methylation of homocysteine to methionine, and the conversion of methylmalonyl-CoA to succinylCoA. The absorption of vitamin B12 requires intrinsic factor, a protein synthesized by parietal cells of the gastric mucosa. A deficiency of vitamin B12 is rare, with the most common cause being a defect in absorption. A deficiency of vitamin B12 leads to megaloblastic anemia, with or without an associated neuropathy due to widespread demyelination. B. Fat-soluble vitamins
Clinical Correlate
1. Vitamin A is supplied by several sources, including yellow and orange vegetables, liver, milk, and eggs. Vitamin A exists in three forms: retinal, retinol, and retinoic acid. Retinal acts as a cofactor for the protein opsin to form a rhodopsin complex, which acts as the light receptor in the visual process. Retinol and retinoic acid are required for growth, differentiation, and maintenance of epithelial cells; they bind to nuclear receptors and regulate the rate of transcription of specific genes, including the gene for keratin. Patients with fat malabsorption or celiac disease may become vitamin A deficient, producing night blindness and dryness of the conjunctiva, cornea, and skin (hyperkeratosis). Excessive amounts of this vitamin are also toxic to humans, producing joint pain, headache, and long-bone thickening.
A deficiency of vitamin D occurs with lack of sunshine or renal failure and leads to rickets in children and osteomalacia in adults. Excessive amounts of vitamin D lead to hypercalcemia and widespread calcification of soft tissues.
2. Vitamin D is found in high concentrations in fish oils, liver, and fortified milk. It can also be synthesized in human skin by ultraviolet irradiation of sterols. The vitamin is metabolically activated by sequential hydroxylation in the liver and kidney to produce the active form of the vitamin 1,25-(OH)z-Vit D. One of the major roles of vitamin D is to increase intestinal calcium and phosphate absorption. It binds to nuclear receptors and increases the rate of transcription of the gene coding for a protein that transports calcium from the lumen into the intestinal mucosal cell. It also acts in concert with parathyroid hormone to mobilize calcium from bone.
Bridge to Pharmacology Isotretinoin, a form of retinoic acid, is used in the treatment of acne. It is teratogenic and is therefore used with caution in women of child-bearing age.
3. Vitamin K is synthesized by intestinal bacteria and is supplied by leafy green vegetables. Vitamin K acts as a coenzyme for glutamate carboxylase, an enzyme that catalyzes the carboxylation of glutamic acid side chains in several of the clotting factors (factors II, VII, IX, and X). A deficiency of vitamin K results in an accumulation of preprothrombin, a
20
meClical
Proteins, Enzymes, and Coenzymes
deficiency in prothrombin, and an increase in clotting time. Newborns are vitamin K deficient because their intestinal tract is still sterile. Antibiotic sterilization of the gut or malabsorption of fat can lead to deficiency and bleeding complications. 4. Vitamin E, also known as tocopherol, is found in leafy vegetables, vegetable oils, and grains. The major function of vitamin E is as an antioxidant, where its first line of defense is against peroxidation of polyunsaturated fatty acids found in cellular membranes. Fat malabsorption may lead to vitamin E deficiency. In newborns, symptoms include hemolytic anemia; in adults, sensory ataxia due to spinocerebellar degeneration may occur. In humans, vitamin E deficiency is seen frequently in premature infants and malabsorption syndromes.
Bri~Je to .~~~rma~()I()fl' Warfarin, an oral anticoagulant, acts as an antagonist to vitamin K and interferes with the synthesis of vitamin K-dependent clotting factors. Vitamin K can be administered to reverse the effects of warfarin. Warfarin is discussed in greater detail in the HematologicfLymphoreticular Pharmacology chapter of Organ Systems Book 1 (Volume III).
KAPLAlf I med1C8
21
Bioenergetics
Cells extract energy from food by the oxidation of carbohydrates, proteins, and fats to CO2 and H20. Catabolic (degradative) pathways involve oxidation reactions that release energy, most of which is captured in the high-energy phosphate bonds of ATP. In contrast, anabolic (synthetic) pathways involve reduction reactions that require the input of energy, with the reducing power and energy being supplied by NADPH and ATP, respectively. The pathways for catabolism of the metabolic fuels converge at acetyl-CoA, a common intermediate in the degradation of carbohydrates, proteins, and fats. Acetyl-CoA is oxidized in the mitochondria via the citric acid cycle. The released energy is conserved as electron pairs that are transferred from acetyl-CoA to NADH and FADH2. The electrons are then transferred sequentially from NADH and FADH2 to O2, resulting in the formation of H20. The oxidation of NADH and FADH2 by molecular oxygen, a process catalyzed by the electron transport chain, is a highly exergonic process. The energy released is used to drive the phosphorylation of ADP to form ATP, an endergonic reaction. Most of the ATP supply in the cell is derived from oxidative phosphorylation. The regulation of oxidative phosphorylation and the citric acid cycle are closely linked-they are both dependent upon the availability of molecular oxygen. This chapter reviews the principles of thermodynamics and oxidation-reduction reactions that form the basis for energy metabolism.
METABOLIC SOURCES OF ENERGY Energy is extracted from food via oxidation, resulting in the end products of carbon dioxide and water. This process occurs in four stages (Figure 1-3-1). In the first stage, metabolic fuels are hydrolyzed to a diverse set of monomeric building blocks, including glucose, amino acids, and fatty acids. In the second stage, the building blocks are degraded by various pathways to a common metabolic intermediate, acetyl-CoA. Most of the energy contained in metabolic fuels is conserved in the chemical bonds (electrons) of acetyl-CoA. In stage three, the citric acid (Krebs, or tricarboxylic acid, TCA) cycle oxidizes acetyl-CoA to CO 2, and the electron pairs present in the carbon-carbon and carbon-hydrogen bonds are transferred to the electron carriers NADH and FADH 2 . The final stage in the extraction of energy from food is oxidative phosphorylation, where the energy in the electron pairs of NADH and FADH2 is released via the electron transport chain (ETC) and is used to synthesize ATP.
I KAPLAlf medlea
23
Biochemistry
Stage
Carbohydrate
Protein
Gluctse
AminJ Acids
~pyruvate
t
Fat Fatt}Acids
________
-------------Acetyl-Co~
II
III
IV
Figure 1-3-1. Extraction of energy from metabolic fuels.
THERMODYNAMIC PRINCIPLES The principles underlying energy metabolism are based on the thermodynamics of chemical reactions. Some of the abbreviations and corresponding definitions involved are: G = free energy (energy available to do work)
= enthalpy (heat content of a compound) S = entropy (randomness of a system) H
T = absolute temperature (measured in OK) R = gas constant (l.987 cal/mol·degree) F = Faraday's constant (23 kcal/volt·mol) A. Free energy change (ilG) of reactions. The free energy change of a system is the portion of the total energy that is available for useful work. For any chemical reaction, the ilG is equal to the difference in energy between the products and the reactants. The free energy change predicts the direction in which a reaction will proceed spontaneously. ilG = ilH - TilS = Gproducts - Greactants O
The standard free energy change (ilG is a constant for any given reaction. (The superscript indicates "standard conditions:' which are pH 7, 25°C, and all reactants and products at 1.0 M concentration.) The ilGo is related to the equilibrium constant, Keq. For the reaction )
A+B - - - - - - i..~ C + D
24
KAPLA~.
meulCa
I
Bioenergetics
the equilibrium constant is defined as:
[C] [D] Keq = [A] [B]
LlGo = -RT In Ke q = -2.3 RT log Keq
Therefore, if the concentrations of reactants and products at equilibrium are known, the Ke q and the LlGo for the reaction can be calculated. B. Exergonic and endergonic reactions are distinguished on the basis of whether the LlG of the
reaction is positive or negative. Exergonic reactions have a negative LlG and will proceed spontaneously in the direction written. In contrast, endergonic reactions have a positive LlG and require the input of energy to proceed in the direction written. If LlG = 0, the reaction is at equilibrium, and the rates of the forward and the reverse reactions are equal. C. Coupled reaction systems. Endergonic reactions in metabolism frequently proceed by being
coupled to an exergonic reaction. The requirement for a coupled reaction system is that the product of the first reaction must be the substrate for the second reaction. Many enzymecatalyzed reactions that use ATP are examples of coupled reactions, where the energy released by the hydrolysis of ATP is used to drive an endergonic reaction. For example, consider the phosphorylation of glucose to glucose-6-phosphate, a reaction that occurs in all cells and is catalyzed by hexokinase.
Glucose + Pi
----il .....
Glucose-6-phosphate
LlGo
= +3.3 kcalimol
Because this reaction is endergonic, it will not proceed spontaneously in the direction of glucose-6-phosphate formation unless energy is supplied. However, if the formation of glucose-6-phosphate is coupled to the hydrolysis of ATP, the sum of the two reactions is exergonic.
ATP+HzO Glucose + Pi Sum:
Glucose + ATP
---I..... ---I..... ---I....
ADP + Pi Glucose-6-phosphate Glucose-6-phosphate + ADP
In a Nutshell • LlG < 0 ---7 spontaneous reaction • LlG > 0 ---7 nonspontaneous reaction • LlG = 0 ---7 equilibrium
Note Cells often couple energetically unfavorable reactions with ATP hydrolysis to force the reaction to proceed.
=-7.3 kcalimol = +3.3 kcalimol LlGo = -4.0 kcalimol LlGo LlGo
The function of hexokinase, therefore, is to couple these two reactions so that the formation of glucose-6-phosphate is thermodynamically favorable. D. Central role of adenine nucleotides in energy transduction. Some of the common
phosphate-containing compounds found in cells and the energy released by hydrolysis of their phosphate bonds under standard conditions are shown in Table 1-3-1.
KAPLAN'iIme leaI
25
Biochemistry
Table 1-3-1. Energy of hydrolysis of phosphate compounds. ~GO
Compound
(kcallmol)
Phosphoenolpyruvate
-14.8
1,3-Bisphosphoglycerate
-11.8
Creatine phosphate
-10.3
Pyrophosphate
-8.0
ATP Glucose-l-phosphate
1-7.31 -5.0
Fructose-6-phosphate
-3.8
AMP
-3.4
Glucose-6-phosphate
-3.3
Glycerol-3-phosphate
-2.2
The positioning of these compounds in the table illustrates important concepts in energy transfer reactions. Note the structure of ATP (Figure 1-3-2).
000 II II II
Adenine-rib0-;Jse --0 -~
-0
0-
ester bond (low energy)
\~O(~ 0-
-0-
0-
anhydride bonds (high energy)
Figure 1-3-2. Structure of ATP.
The energy in the terminal anhydride bond of ATP is greater than the energy found in the compounds listed after it in Table 1-3-1. Therefore, the energy released by hydrolysis can be used to drive the synthesis of these compounds. Conversely, the compounds listed before ATP ATP formation via substrate-level have more energy in their phosphate bonds than does ATp, thus allowing these compounds phosphorylation occurs with: to transfer their phosphate groups to ADP with the formation of ATP. The conversion of ADP • PhosPhOenOlPyrUvate} . glycolysIs to ATP by the use of high-energy phosphate metabolites is known as substrate-level phosphorylation. As shown in Table 1-3-1, there are three phosphorylated intermediates in • l,3-Bisphosphoglycerate cells with sufficient energy to participate in substrate-level phosphorylation. Phospho• Creatine phosphate ~ enolpyruvate and 1,3-bisphosphoglycerate are intermediates in glycolysis, and muscle creatine phosphate serves as a reservoir of high-energy phosphate bonds in muscle.
In a Nutshell
E. Other high-energy carriers. Many chemical groups that are transferred in metabolic reactions require "high-energy carriers" for the reaction to be exergonic. Examples of some groups that are transferred, their high-energy carriers, and the types of reactions and/or pathways in which they participate are summarized in Table 1-3-2.
26
KAPLAlfdI me lea
------------~
.---~~
Bioenergetics
Table 1-3-2. High-energy carriers of chemical groups in metabolism. Group p.
Carrier
Pathways/reactions
ATP
Kinase reactions
Sugars
UDP-sugar
Polysaccharide synthesis
Acetate
Acetyl-CoA
Fatty acid synthesis
Fatty acids
Acyl-CoA
Triacylglycerol synthesis
Amino acids
AMP-amino acid
Protein synthesis
Methyl
SAM*
Methylation reactions
Carboxyl
Carboxy-biotin
Carboxylation reactions
Sulfate
PAPst
Sulfation reactions
1
*S-adenosylmethionine; t phosphoadenosine phosphosulfate
OXIDATION-REDUCTION REACTIONS The principles of oxidation and reduction are an integral part of energy conservation in cells. The energy contained in metabolic fuels is released through a series of oxidation-reduction (redox) reactions that occur mainly in the mitochondria. Approximately 40% of this energy is conserved as ATP. A. General principles. Oxidation-reduction reactions involve the transfer of electrons between a donor and an acceptor. 1. Definitions. Oxidation is defined as the loss of electrons, and reduction is defined as the gain of electrons. Every oxidation is accompanied by a reduction, each of which is considered to be a half-reaction. 2. The standard reduction potential, E", is a constant that describes the tendency of a compound to act as a reducing agent (lose electrons). It is expressed in volts and is measured under standard conditions defined as 2SoC, pH 7, and at concentrations of 1.0M for electron donors and acceptors. Values of standard reduction potentials for some common half-reactions are shown in Table 1-3-3. Stronger electron donors have a more negative reduction potential. Thus, under standard conditions, NADH with an E' of -0.32 volt will reduce pyruvate (or any other compound with a less negative E').
Mnemonic LEO the lion says GER: loss of electrons = oxidation gain of electrons = reduction OIL RIG: oxidation is loss (of electrons) reduction is gain (of electrons)
Table 1-3-3. Standard reduction potentials for common redox pairs. * E'(V)
Half-reaction NAD+ + 2e- + H+
~
NADH
-0.32
Pyruvate + 2e- + 2H+
~
Lactate
-0.19
Oxaloacetate + 2e- + 2H+~
Malate
-0.17
FAD + 2e- + 2H+
~
FADH2
-0.06
CoQ + 2e- + 2H+
~
COQH2
+0.10
Fumarate + 2e- + 2H+
~ ~
Succinate Cyt a (Fe2+)
+0.13
Cyt a (Fe3 +) + e-
+0.29
112 O2 + 2e- + 2H+
~
H 2O
+0.82
*Note that all of the reactions are written as reductions.
KAPLAlf I meillea
27
Biochemistry
Note If the reduction potential is given, reverse the sign to find the oxidation potential:
3. Relationship between ABO and LiGO. The change in the standard reduction potential for an oxidation-reduction reaction is related to the standard free energy change (LiGO) for the reaction by the expression shown below, where n is the number of electrons transferred, F is the Faraday constant, and LiEO = EO electron acceptor - E' electron donor' LiG = -nFLiEo O
E'red = -0.32 ~ E'QX = +0.32
From this relationship, it is clear that for an oxidation-reduction reaction to be exergonic and to proceed spontaneously, LiEO must be a positive value. 4. Example. These thermodynamic principles can be illustrated by considering the transfer of electrons from NADH to molecular oxygen. In this example, NADH is the electron donor (it has the more negative standard reduction potential), and oxygen is the electron acceptor. The overall oxidation-reduction reaction can be written as the sum of two half-reactions. Oxidation of NADH: NADH ----~..~ NAD+ + H+ + 2eReduction of 0: - - - - - - l.. ~ H 20 Overall reaction:
NADH + 1/2 O 2 + H+ ~ NAD+ + H 20
LiEO LiEo
= +0.32 volt = +0.82 volt
LiEo = + 1.14 volt
The positive value of LiEO indicates that the reaction will proceed spontaneously. As defined above, the change in standard free energy can be calculated (n = 2 electrons being transferred, and F = 23 kcal/volt) as follows: AGO = -nFLiEo AGO = -(2)(23 kcallvolt)(1.14 volt) = -52.4 kcal Because AGO is negative, the oxidation of NADH by oxygen is an exergonic reaction. This exergonic reaction is the overall reaction catalyzed by the electron transport chain. The electrons in NADH are transferred sequentially through a series of carriers to oxygen, where each electron carrier is reduced by the preceding carrier. B. Major electron carriers. A wide variety of dehydrogenases participate in the oxidation of
In a Nutshell • Electron acceptors
~
• Electron donors
~
NAD+ FAD NADPH NADH
metabolic fuels. Most of these enzymes use either NAD+ or FAD as electron acceptors. The major carrier of electrons in reductive biosynthetic reactions is NADPH . 1. NAD+ is the electron accceptor in reactions involving oxidation of hydroxylated carbon
atoms (Figure 1-3-3). NAD+ accepts a hydride ion, H- (two electrons and a proton), to form NADH, and the hydroxyl group is oxidized to a carbonyl group.
OH
I
o II
R-C-COOH + NAD+ ~ R-C-COOH + NADH + H+
I
H Figure 1-3-3. The reduction of NAD+ to NADH.
2. FAD is the electron acceptor in reactions involving the oxidation of two adjacent carbons, resulting in the formation of a carbon-carbon double bond (Figure 1-3-4). A hydrogen atom is removed from each carbon atom and is transferred to FAD to form FADH2•
28
KAPLA~. I meulca
Bioenergetics
H I
H I
I
I
R-C-C-R' + FAD
~
R-C =C -R' + FADH
H H
I H
I H
2
Figure 1-3-4. The reduction of FAD to FADH 2 •
3. NADPH is the major source of reducing power for biosynthetic pathways. In contrast to NADH, which is generated and used primarily in the mitochondria, most of the NADPH is formed and used in extramitochondrial reactions (described in Chapter 4 of this section).
CITRIC ACID CYCLE The citric acid cycle, also known as the tricarboxylic acid (TCA) cycle or the Krebs cycle, is localized in the mitochondria. A. Functions. The pathway is amphibolic, playing important roles in both catabolic and anabolic pathways. 1. Catabolic function. The major catabolic function of the citric acid cycle is to transfer
electron pairs (potential energy) from acetyl-CoA to NAD+ and FAD. With every turn of the cycle, two carbon atoms enter as acetyl-CoA, two carbon atoms leave as COl> and the four pairs of electrons in the carbon-hydrogen and the carbon-carbon bonds are transferred to NAD+ and FAD. The overall reaction for the oxidation of acetyl-CoA is shown in Figure 1-3-5.
Acetyl-CoA + 3 NAD+ + FAD + GDP + Pi -----. 2 C02 + 3 NADH + FADH2 + GTP + CoA Figure 1-3-5. Stoichiometry of the citric acid cycle.
Oxidation of acetyl-CoA to CO 2 results in the production of one high-energy phosphate bond (GTP) by substrate level phosphorylation. Assuming adequate oxygen is available, subsequent oxidation of NADH and FADH2 will result in the synthesis of 11 molecules of ATP by oxidative phosphorylation (described below). Therefore, the complete oxidation of one molecule of acetyl-CoA to CO 2 and H 20 results in the synthesis of 12 ATP equivalents. 2. Anabolic functions. Intermediates in the citric acid cycle are used as substrates for vari-
ous biosynthetic pathways. a. Citrate is a substrate for fatty acid synthesis. b. Oxaloacetate is the first intermediate in gluconeogenesis. c. Succinyl-CoA is required for the synthesis of heme.
Note Some amino acids can be converted to a-ketoglutarate and can enter the citric acid cycle at this intermediate.
d. Oxaloacetate and a-ketoglutarate are substrates for amino acid synthesis.
I KAPLAlf med lea
29
Biochemistry
B. Reactions of the citric acid cycle. The reactions by which acetyl-CoA is oxidized to CO 2 are
shown in Figure 1-3-6. AcetylCoA
~Citr"e~
NADHfo.cel.,e
c;o-\.,e
L-M~late
Isocltrate
[7
3
Fumarate
a-Ketoglutarate
FADH,.\ 6 \
~NADH+CO'
fNADH + CO, Sucdnyl-CoA
Succinate
5
GTP
Enzymes 1. Citrate synthase 2. Aconitase 3. Isocitrate dehydrogenase 4. a-Ketoglutarate dehydrogenase 5. Succinyl-CoA thiokinase 6. Succinate dehydrogenase 7. Fumarase 8. Malate dehydrogenase
Figure 1-3-6. The citric acid cycle.
Mnemonic Citric acid is Krebs starting substrate for mitochondrial oxidation: citrate, cis-aconitate, isocitrate, a-ketoglutarate, succinyl-CoA, succinate, fumarate, malate, oxaloacetate
The entry of acetyl-CoA into the cycle involves condensation with oxaloacetate to produce citrate, a C6 tricarboxylic acid. After isomerization to isocitrate, two sequential oxidative decarboxylation reactions occur, resulting in the formation of succinyl-CoA. Each of these reactions releases CO 2 and transfers electrons to NADH. Succinyl-CoA contains a thioester linkage that has sufficient energy to drive the synthesis of a high-energy phosphate bond. Thus, in the next reaction, hydrolysis of succinyl-CoA is coupled with the synthesis of GTP from GDP and Pi. GTP is energetically equivalent to ATP, and the two molecules are interconvertible. The remaining reactions complete the cycle by regenerating oxaloacetate. They include two oxidation reactions: the oxidation of succinate to fumarate, producing FADH2 ; and the oxidation of malate to oxaloacetate, producing NADH. All of the enzymes of the cycle are located in the mitochondrial matrix except for succinate dehydrogenase, which is embedded in the inner mitochondrial membrane. The localization of these enzymes provides for efficient transfer of electrons from the carriers, NADH and FADH2 , to the electron transport chain.
e. Key
enzymes. The four dehydrogenases (isocitrate, a-ketoglutarate, succinate, and malate) all catalyze oxidation reactions. In the isocitrate and a-ketoglutarate dehydrogenase reactions, decarboxylation also occurs. Isocitrate dehydrogenase catalyzes one of the
30
meClical
Bioenergetics
rate-limiting steps in the cycle. This enzyme is allosterically inhibited by ATP and NADH and is activated by ADP. Secondary sites of regulation are a-ketoglutarate dehydrogenase and citrate synthase, which are also inhibited by ATP and NADH. These three enzymes catalyze reactions that are essentially irreversible. Although pyruvate dehydrogenase is not an enzyme in the citric acid cycle, it oxidizes pyruvate to acetyl-CoA, thereby allowing carbohydrate to be oxydized to COz. D. Anaplerotic ("filling-up") reactions. When intermediates of the cycle are removed for synthetic purposes, they must be replenished in order to ensure that acetyl-CoA can continue to be oxidized. The most important reaction for replenishing the cycle with intermediates is the conversion of pyruvate to oxaloacetate. This reaction, catalyzed by pyruvate carboxylase, requires biotin, ATP, and bicarbonate as substrates, and it has an absolute requirement for acetyl-CoA as an allosteric activator (Figure 1-3-7). The accumulation of acetyl-CoA, due to insufficient levels of oxaloacetate, activates the synthesis of this intermediate.
In a Nutshell Enzyme
Inhibitors Activators
Pyruvate ATP dehydrogenase Acetyl-CoA NADH
ADP CoASH NAD+ Ca 2+ Insulin
Citrate synthase
ATP
Iso citrate ATP dehydrogenase NADH
ADP
a-Ketoglutarate Succinyl-CoA dehydrogenase NADH ATP
biotin pyruvate + HC03 - + ATP - - - - - - - - - - - - - - . . . Oxaloacetate + ADP + Pi pyruvate carboxylase
0 acetyl-CoA Figure 1-3-7. The pyruvate carboxylase reaction.
ELECTRON TRANSPORT AND OXIDATIVE PHOSPHORYLATION The final step in the aerobic oxidation of metabolic fuels is achieved by the electron transport chain (ETC). The ETC accepts electrons from NADH and FADH z and passes them, through a series of carriers, to molecular oxygen, forming water. The energy released at specific steps in the ETC is used to synthesize ATP via a process called oxidative phosphorylation. All of the enzymes and cofactors required for electron transport and oxidative phosphorylation are localized in the inner mitochondrial membrane. A. The electron transport chain 1. Components. The ETC is composed of a specific sequence of enzymes and their coenzymes, including NAD+ and FAD-linked dehydrogenases, iron-sulfur proteins (FeS), coenzyme Q, and several cytochromes (Figure 1-3-8). The components of the chain can be separated into four protein-lipid complexes (I, II, III, and IV) and two mobile components (CoQ and cyt c) that move freely in the lipid bilayer.
meCtical
31
Biochemistry
Succinate
Complex II FAD FeS
Complex III
Complex I NADH
~
Complex IV ~
FMN
~
FeS
cytc
~
cyt a
t
~cyt
a3
~~
fatty acyl-CoA
a-glycerol-P
Figure 1-3-8. Components of the electron transport chain.
2. Sources ofNADH and FADH. The electrons in NADH arise mainly from the mitochondrial oxidations and to a lesser extent from cytosolic oxidations. Almost all of the FADH arises from mitochondrial oxidations.
a. Mitochondrial oxidations. Several substrates, including isocitrate, a-ketoglutarate, malate, pyruvate, and glutamate, are oxidized in mitochondria with the formation of NADH. The electrons in FADH2 come from the oxidation of succinate, fatty acylCoA, and a-glycerol phosphate. The electrons from NADH and FADH2 enter at different positions along the electron transport chain. Electrons from NADH enter at complex I, whereas electrons from several FAD-linked dehydrogenases enter at CoQ. Note that complex II is succinate dehydrogenase, the same enzyme utilized in the citric acid cycle. b. Shuttles for getting cytoplasmic NADH electrons into mitochondria. Although most oxidations occur in the mitochondria, there are a few oxidative reactions in the cytosol that produce NADH. The mitochondrial membrane, however, is impermeable to NADH; thus, the transfer of electrons from cytosolic NADH into the mitochondria for oxidation by the electron transport chain requires special shuttle systems. Two types of shuttles are found in cells: the malate shuttle and the a-glycerol phosphate shuttle (Figure 1-3-9). In these shuttles, malate and a-glycerol phosphate act as carriers of electrons across the inner mitochondrial membrane. In the malate shuttle, electrons originating in the cytosol are incorporated into mitochondrial NADH, whereas in the a-glycerol phosphate shuttle, cytosolic electrons are incorporated into mitochondrial FADH 2.
32
meClical
Bioenergetics
Inner mitochondrial membrane
Cytosol
Malate Shuttle
NADH
X
NAD+
X
Mitochondrial matrix
Aspartate
Aspartate
t
t
Oxaloacetate
Oxaloacetate
Malate
Malate
X
NAD+
a-Glycerol-P Shuttle NADH NAD+
NADH
Dihydroxyacetone-P
Dihydroxyacetone-P
a-Glycerol-P
a-Glycerol-P
X FAD
Figure 1-3-9. Shuttles for getting cytosolic NADH electrons into the mitochondria.
3. Energetics. A simplified version of the electron transport chain is shown in Figure 1-3-10. The carriers in the electron transport chain are arranged so that the reduction potential progressively increases from negative to positive values. Thus, as electrons move from one carrier to the next in the chain, the ~EO > 0 and the ~GO < 0, ensuring that electrons flow spontaneously to oxygen. FADH2
NADH
~
---J"~ CoQ
-0.32
+0.10
\.."--'y~
__~1
..
cyt b
..
+0.07
\
cyt c
+0.25
Tm
I
+0.42 volt
+0.18
-19.3 kcal/mol
-9.4 kcal/mol
..
..
cyt a
..
cyt a3
+0.55
+0.29
\
1/202 +0.82 volt
I
T +0.53 volt
-24.4 kcal/mol
Figure 1-3-10. Energy released by electron flow through the ETC.
B. Oxidative phosphorylation. The energy required for synthesis of ATP is 7.3 kcal/mol. It is clear from Figure 1-3-10 that transfer of electrons from 1 mol ofNADH through complexes I, III, and IV releases sufficient energy to drive the synthesis of ATP. Thus, it is at these three sites in the electron transport chain that energy can be harnessed for oxidative phosphorylation. Note that electrons from FADH 2 bypass complex I and flow through only two of these energy transduction sites.
I KAPLAlf medlea
33
Biochemistry
In a Nutshell P/O ratio NADH FADH2
3 2
DNP (2A-dinitrophenol, an uncoupler that dissipates the W gradient) has a P/O ratio of o.
1. PIO ratio. By definition, the PIO ratio is the number of ATP molecules produced per 0 atom reduced. Thus, substrates that are oxidized with the generation of NADH (malate, isocitrate, a-ketoglutarate) support the synthesis ofthree molecules of ATP and have PIO ratios of 3. Substrates that are oxidized with the production of FADH2 (succinate, aglycerol phosphate) have PIO ratios of 2. 2. Efficiency. The calculations shown below indicate that the oxidation ofNADH by the ETC releases a total of 53 kcal of energy. LlE' LlG'
= E' oxygen -
E' NADH
= -nFL\E' = -(2)
= +0.82 -
(-0.32)
= 1.14 volts
(23 kcallvolt) (1.14 volt) = -53 kcal
The synthesis of ATP requires 7.3 kcal. Thus, in theory, the oxidation of 1 mole of NADH should release sufficient energy to drive the synthesis of 7 moles of ATP. However, because only 3 moles of ATP are synthesized per mole of NADH oxidized, the efficiency of oxidative phosphorylation is approximately only 40%. The remainder of the energy is released as heat. 3. Mechanism of energy transduction. The chemiosmotic hypothesis is the most widely accepted theory for how electron transport is coupled with ATP synthesis (Figure 1-3-11). This theory is based on the observation that when electrons are flowing through the ETC, complexes I, III, and IV are pumping protons out of the matrix, creating a proton gradient across the inner mitochondrial membrane. Complex II does not pump protons. The chemiosmotic hypothesis asserts that the protomotive force associated with the proton gradient drives the synthesis of ATP. The movement of protons down the gradient as they re-enter the matrix releases energy that is available for ATP synthesis. ATP synthase, also known as complex V, is associated with the inner mitochondrial membrane in close proximity to the electron transport chain (Figure 1-3-11).
Clinical Correlate LHON (Leber hereditary optic neuropathy) is a disease that affects the central nervous system, resulting in the loss of bilateral vision secondary to insufficient ATP to support neuronal activity. The disease has been shown to arise from point mutations in regions of mitochondrial DNA that code for proteins in complex I and complex III of the electron transport chain. Mutations in either of these genes impairs ATP production by oxidative phosphorylation. Patients frequently present with lactic acidosis arising from an inhibition of pyruvate dehydrogenase secondary to NADH accumulation.
34
KAPLAN"dme leaI
ADP+ Pi
Matrix
NADH
l e-
ATP
FADH2
!
e-
Inner mitochondrial membrane
Cytosol
Figure 1-3-11. Structure of mitochondrial ATP synthase.
ATP synthase consists of two types of subunits. The Fo subunits span the membrane, creating a proton channel that allows protons to move back into the matrix. The FI subunit protrudes into the matrix and, in the presence of a proton gradient, catalyzes the condensation of ADP and Pi to form ATP.
Bioenergetics
4. Inhibitors of oxidative phosphorylation. A large number of compounds inhibit oxidative phosphorylation. The sites at which selected inhibitors exert their effects are shown in Figure 1-3-12. Inhibitors of oxidative phosphorylation always decrease ATP production. They are organized into three major classes based on their effects. a. Inhibitors of electron transport bind to specific components of the electron transport chain, blocking electron transfer. This blockage results in a decreased proton gradient and decreased ATP synthesis. For example, cyanide binds to cyt a3 and blocks the transfer of electrons from complex IV to oxygen; antimycin binds to complex III and blocks the transfer of electrons from cyt b to cyt c; rotenone and barbiturates bind to complex I and inhibit the transfer of electrons to CoQ.
NADH
..
------~~
Rotenone, Amytal
cyt b
---
~
cyt c
..
-----I~ cyt a
Antimycin A
~
o
Cyanide
Figure 1-3-12. Inhibitors of electron transport.
b. Inhibitors of ATP synthase bind directly to the enzyme. For example, oligomycin binds to the Fo subunit and prevents re-entry of protons into the mitochondrial matrix. The increased proton gradient across the inner mitochondrial membrane eventually leads to diminished electron transport. c. Uncouplers of oxidation and phosphorylation make the membrane permeable and
abolish the proton gradient. Electron transport is increased by uncouplers, but ATP synthesis cannot occur because the energy cannot be harnessed. The energy resulting from electron transport is dissipated as heat. Examples of uncouplers are dinitrophenol and the protein thermogenin, which is found in the mitochondrial membrane of brown fat. Brown fat surrounds the major blood vessels of the neonate, where it functions to keep the blood warm.
Clinical Correlate Cyanide binds to the heme Fe3+ of cytochrome a3 in the ETC, blocking the transfer of electrons to oxygen and, consequently, the synthesis of ATP. Inhibition of mitochondrial respiration can lead to coma and death unless diagnosed and treated early.
COORDINATE REGULATION OF THE CITRIC ACID CYCLE AND OXIDATIVE PHOSPHORYLATION The rates of oxidative phosphorylation and the citric acid cycle are closely coordinated and are dependent mainly upon the availability of O 2 and ADP. If O 2 is limited, the rate of oxidative phosphorylation decreases, and the concentrations of NADH and FADH2 increase. The accumulation of NADH, in turn, inhibits the citric acid cycle. The coordinated regulation of these pathways is known as "respiratory control." In the presence of adequate 02> the rate of oxidative-phosphorylation is dependent upon the availability of ADP. The concentrations of ADP and ATP are reciprocally related; an accumulation of ADP is accompanied by a decrease in ATP and the amount of energy available to the cell. Therefore, ADP accumulation signals the need for ATP synthesis. ADP allosterically activates isocitrate dehydrogenase, thereby increasing the rate of the citric acid cycle and the production of NADH and FADH 2. The elevated levels of these reduced coenzymes, in turn, increases the rate of electron transport and ATP synthesis.
KAPLAdlf • me leaI
35
Biochemistry
CONGENITAL DEFECTS IN OXIDATIVE PHOSPHORYLATION Mitochondrial DNA contains genes coding for ATP synthase and for some of the proteins in each of the complexes of the electron transport chain. Defects in several of these components have been found. Infants and children present with various combinations of seizures, hypotonia, failure to thrive, and delay of developmental milestones. Focal deficits include abnormalities of eye movements and stroke-like symptoms. Identified entities include mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). All of the defects arising from mutations in mitochondrial DNA are inherited maternally.
36
KAPLllfilme leaI
Carbohydrates
Carbohydrates participate in many metabolic pathways and serve as structural components of cells and tissues. In human biochemistry, there are three major classes of carbohydrates: monosaccharides, disaccharides, and polysaccharides. The most important monosaccharide in human metabolism is glucose. All cells and tissues require the use of some glucose for energy. The brain relies almost entirely on glucose for its energy, and red blood cells derive all of their energy from glucose. Following a highcarbohydrate meal, glycogenesis in liver and skeletal muscle provides a pathway for storage of excess glucose. Conversely, the mobilization of glucose from glycogen is achieved via glycogenolysis. Gluconeogenesis is the pathway for de novo synthesis of glucose from amino acids, glycerol, propionate, and lactate. This chapter emphasizes the role that these pathways play in homeostasis, the tissues where they occur, the key enzymes involved, and the mechanisms for regulation. Numerous clinical examples are provided that stress the importance of carbohydrates in both health and disease.
CLASSIFICATION Carbohydrates are chains of carbon atoms with attached hydrogen and hydroxyl groups. The length of the carbon chain may vary, and carbohydrates can generally be represented by the formula Cn(H 2 0)n, where n is a minimum of three carbons. This formula emphasizes the idea that this class of molecules are "hydrates of carbon:' In some specialized monosaccharides, one of the hydroxyl groups may be replaced by another chemical group, such as a hydrogen atom (deoxyribose in DNA), an amino group (glucosamine in proteoglycans), or phosphate groups (most intermediates of carbohydrate metabolism pathways). A. Monosaccharides. The simplest carbohydrates are the monosaccharides. Most monosaccharides in human metabolism are trioses (C 3 ), pentoses (Cs ), and hexoses (C 6 ). Monosaccharides containing an aldehyde are known as aldoses, and those containing a keto group are called ketoses. The most important monosaccharide is D-glucose, a hexose and an aldose whose structure is shown in Figure 1-4-1.
meClical
37
Biochemistry
---I."
Aldehyde group (Anomeric carbon)
---I."
Penultimate carbon
D-Glucose Figure 1-4-1. Structure of o-glucose.
1. Nomenclature and definitions. The numbering system for monosaccharides always starts with the carbon atom nearest the carbonyl group (::::C=O). a. Anomeric carbon. The carbonyl carbon is defined as the anomeric carbon. This carbon participates in internal ring structures and glycosidic bonds between monosaccharides (discussed below). b. Penultimate carbon. The penultimate carbon is the next-to-the-last carbon in the chain. For hexoses, it is C-5; for pentoses it is C-4. c. D and L isomers. The "D" designation describes the configuration around the penulti-
mate carbon. If the hydroxyl group is on the right, it is a D-sugar; if it is on the left, it is an L-sugar. Almost all important monosaccharides in human biochemistry have the D configuration. d. Epimers. Two monosaccharides are epimers if they differ in the configuration around a single carbon atom. For example, galactose is a 4-epimer of glucose. Thus, knowing the structure of glucose allows you to automatically recognize the structure of galactose. Enzymes that catalyze the interconversions of these compounds are epimerases. e. Aldose-ketose isomers. Glucose, an aldose, and fructose, a ketose, differ only in the position of the carbonyl group. In glucose, the carbonyl group is at C-1, whereas in fructose, it is at C-2. 2. Cyclic structure of monosaccharides. The straight chain structure of monosaccharides exists in equilibrium with a ring structure, resulting from the reaction of the hydroxyl of the penultimate carbon with the anomeric carbon. The cyclic structure of glucose is a sixmember ring (a pyranose) that can be drawn in one of two ways (Figure 1-4-2).
or
Figure 1-4-2. Cyclic structures for l3-o-glucose.
38
meClical ~~~~~~~~~-
~--
------~---
~
Carbohydrates
In the structure on the right, the ring projects from the plane of the paper and the hydroxyl and hydrogen groups project up and down from the carbons in the ring. By convention, hydroxyl groups on the right point down, and those on the left point up. When a ring structure is formed, the anomeric carbon can exist in two configurations, (J, and ~. In (J,-Dglucose, the hydroxyl group on C-l points down, whereas in ~-D-glucose it points up. The predominant form of glucose in the body is ~-D-glucose. D-fructose, shown in Figure 1-4-3, is an important hexose that forms a five-member ring (a furanose).
6
----J.~ ~:J;OH '~6H OH a-O-Fruclose
Figure 1-4-3. Structure of fructose.
3. Derivatives of glucose. Glucose can be modified to give three important compounds found in metabolism (Figure 1-4-4). a. D-gluconic acid is formed by the oxidation of the aldehyde at C-l, producing an "aldonic" acid. The phosphorylated form of gluconic acid is an important intermediate in the hexose monophosphate shunt. b. D-glucuronic acid is formed by oxidation of the alcohol at C-6, producing a "uronic" acid. Ascorbic acid (vitamin C) is synthesized from glucuronic acid. The activated carrier of glucuronic acid (UDP-glucuronic acid) is used in the synthesis of proteoglycans. c. D-glucosamine is formed by the substitution of an amino group for the hydroxyl group of C-2, resulting in glucosamine. Glucosamine and galactosamine are important structural components of glycoproteins and proteoglycans.
CHO
COOH
I
I
H-C-OH
H-C-OH
I
I
HO-C-H
HO-C-H
I
I
H-C-OH
H-C-OH
I
I
H-C-OH
H-C-OH
I
I
COOH
CHpH
O-Gluconic Acid
O-Glucuronic Acid
In a Nutshell • D-gluconic acid ~ hexose monophosphate shunt • D-glu(uronic acid proteoglycans
~
• D-glucosamine ~ glycoproteins, proteoglycans, and glycoilpids
CHO
I I
H-C-NH 2
HO-C-H
I
H-C-OH
I
H-C-OH
I
CH2 0H
O-Glucosamine
Figure 1-4-4. Derivatives of D-glucose. B. Disaccharides are formed when two monosaccharides are connected by a glycosidic linkage.
The anomeric carbon of one monosaccharide is usually linked to a hydroxyl group on the
,mattical
39
Biochemistry
Clinical Correlate Primary lactose intolerance is caused by a hereditary deficiency of lactase, most commonly found in persons of Asian and African descent. Secondary lactose intolerance can be precipitated at any age by gastrointestinal disturbances such as celiac sprue, colitis, or viral-induced damage to intestinal mucosa. Common symptoms of lactose intolerance include vomiting, bloating, explosive and watery diarrhea, cramps, and dehydration. The symptoms can be attributed to bacterial fermentation of lactose to a mixture of CH 4, H2, and small organic acids. The acids are osmotically active and result in the movement of water into the intestinal lumen. Diagnosis is based on a positive hydrogen breath test following an oral lactose load. Treatment is by dietary restriction of milk and milk products or by lactase pills, which can be added to the diet.
Note Heparan is a proteoglycan found in the extracellular matrix and is associated with the cell surface of skin and fibroblasts; heparin is a proteoglycan found mainly in mast cell granules and functions primarily as an anticoagulant.
40
meClical
second monosaccharide. The glycosidic bond is designated as a or 13, depending on the configuration of the anomeric carbon in the linkage. The two most important disaccharides in human biochemistry are lactose and sucrose (Figure 1-4-5).
Galactose
Glucose Lactose
Glucose
Fructose Sucrose
Figure 1-4-5. Structures of lactose and sucrose.
1. Lactose, also known as milk sugar, is a disaccharide of galactose linked through its
anomeric carbon to the 4-hydroxyl group of glucose. Thus, the monosaccharides are joined by a 13-1,4 glycosidic linkage. Lactose is hydrolyzed to glucose and galactose by lactase, an enzyme found in the brush border membrane of the small intestine. 2. Sucrose, or table sugar, is a disaccharide of glucose and fructose linked together through their anomeric carbon atoms in an a-l,2 linkage. Sucrose is hydrolyzed to glucose and fructose in the small intestine by the enzyme sucrase. C. Oligo saccharides are arbitrarily defined as having between 2 and 10 monosaccharides
linked by glycosidic bonds. They are found in mucoproteins and glycolipids. D. Polysaccharides are arbitrarily defined as having more than 10 monosaccharide units. They
serve as structural components of cells and the extracellular matrix, as storage forms for monosaccharides, and as dietary fiber. The most common polysaccharides are starch, glycogen, cellulose, and proteoglycans. 1. Starch and glycogen are both storage forms for glucose. Starch, the major plant polysac-
charide, is composed of amylose and amylopectin. Amylose is a long, unbranched chain of glucose units linked by a-l,4 bonds. Amylopectin has a similar structure, but it also contains branches, where the monosaccharide at the branch point is linked to a monosaccharide in the straight chain by an a-l,6 glycosidic bond. Glycogen, the major animal polysaccharide, is structurally similar to amylopectin, except it is more highly branched. 2. Cellulose is a linear plant polysaccharide composed of glucose units linked together by 131,4 glycosidic bonds. Cellulose is not digested by humans because there is no intestinal enzyme for hydrolyzing glucose units linked by 13-1,4 glycosidic bonds. Therefore, cellulose acts as a dietary fiber, providing "roughage" in the diet. 3. Proteoglycans, also known as mucopolysaccharides, are major structural components of the extracellular matrix. Examples are hyaluronic acid, chondroitin sulfate, dermatan sulfate, heparan sulfate, and keratan sulfate. These compounds are linear carbohydrate polymers with more than one kind of monosaccharide, linked covalently to a protein core. The carbohydrate portions of proteoglycans are known as glycosaminoglycans (GAGs). GAGs contain repeating disaccharides, usually a hexosamine (glucosamine or galactosamine) and a uronic acid (either glucuronic acid or iduronic acid). The polymers are usually sulfated, and the hexosamines are acylated. The exception is hyaluronic acid; it is not linked to a protein core, it is not sulfated, and it is the only member of this class of compounds found in bacterial sources. The proteoglycans are highly asymmetrical and have a high density of negative charge, allowing them to absorb large quantities of water and form
Carbohydrates
viscous solutions. These physical properties account for their ability to serve as excellent shock absorbers and lubricants. a. Mucopolysaccharidoses are a group of diseases that result from the inability of lysosomes to degrade proteoglycans because of a deficiency of a number of lysosomal hydrolases. The enzyme deficiency leads to excessive storage and urinary excretion of partially degraded mucopolysaccharides. Musculoskeletal deformities and mental retardation are seen in affected individuals. Table 1-4-1 lists the enzyme defect, the urinary metabolite, and the signs and symptoms of the various mucopolysaccharidoses. The enzymatic defects in the mucopolysaccharidoses are inherited in an autosomal recessive manner, except for Hunter disease, which is X-linked recessive.
Mnemonic A Hunter will aim for the X: Hunter disease is the only mucopolysaccharidosis that is X-linked recessive.
Table 1-4-1. Mucopolysaccharidoses. Urinary Metabolites'
Signs and Symptomst
a-L-iduronidase Iduronosulfate sulfatase 4 variants, incl. heparan N-sulfatase (sulfamidase) N-acetylglucosaminidase N-acetylgalactosamine-6sulfatase a-L-iduronidase N-acetylgalactosamine-4sulfatase
HS,DS HS,DS HS
C, MS, CNS, CV MS,CNS MS,CNS
KS, C-6-S
C,MS,CV
HS,DS DS
C,MS,CV C,MS,CV
~-glucuronidase
HS,DS
C(+/-), MS, CNS( +/-), CV
Type
Enzyme Defect
III
(Hurler) (Hunter) (Sanfilippo)
IV
(Morquio)
V VI
(Scheie) (MaroteauxLamy) (Sly)
II
VII
*HS = heparan sulfate; DS = dermatan sulfate; KS = keratan sulfate; C-6-S = chondroitin-6-sulfate. corneal clouding; MS = musculoskeletal abnormalities (dwarfism); CNS = neurologic deterioration; CV = cardiovascular abnormalities.
Clinical Correlate
tc =
4. Glycoproteins and mucoproteins also contain carbohydrate covalently linked to protein, but there are no repeating disaccharides, and the carbohydrate portion usually contains fewer than 20 monosaccharides. Glycoproteins are found in connective tissue (collagen), in plasma (plasma proteins and some peptide hormones), on cell surfaces as antigens (i.e., blood groups), and as components of mucus. There are three types of linkages between protein and carbohydrate. The amino acid side chains involved in the protein-carbohydrate linkage are: a. Asparagine (N-linkage) is found in plasma and cell surface proteins. b. Serine (O-1inkage) is found in mucous and connective tissue proteins. c. 5-Hydroxylysine (O-linkage) is found in collagen.
Glycoprotein synthesis starts in the endoplasmic reticulum and is completed in the Golgi. One of the last steps in glycoprotein synthesis is putting "zip codes" on proteins that are targeted for a particular destination. For example, glycoproteins that are targeted for lysosomes have mannose-6-phosphate in their carbohydrate chains. Receptors on lysosomes recognize this signal and vesicles containing these proteins pinch off and fuse with lysosomes.
I-cell disease is characterized by coarse facial features, musculoskeletal deformities, and recurrent respiratory problems; death usually occurs within the first decade. The distinguishing feature of I-cell disease is a deficiency of mUltiple lysosomal enzymes and the presence of high concentrations of these enzymes in the plasma. The enzymes are being synthesized but are being sent to the wrong destination due to a deficiency in N-acetylglucosaminylphosphotransferase, resulting in the absence of mannose-6-phosphate.
meClical
41
Biochemistry
GLUCOSE ENTRY AND TRAPPING IN CELLS Circulating glucose supplies all cells with a source of energy. The entry of glucose into cells is mediated by a group of carrier proteins (GLUT proteins) that span the plasma membrane. Net transport across the membrane is ensured by coupling glucose transport with phosphorylation, a process that keeps the intracellular glucose concentration low and continues to shift the equilibrium toward glucose uptake by cells (Figure 1-4-6). The membrane is highly impermeable to the phosphorylated compounds. Therefore, phosphorylation renders glucose transport irreversible.
Hexokinase (all tissues)
[Glucose]
[Glucose]
mM
J..LM
--------il..~
Glu-6-P
Glucokinase (liver)
GLUT Carrier protein (tissue specific)
Figure 1-4-6. Glucose transport and trapping in cells.
A. Glucose carriers (GLUT proteins). A family of homologous proteins, known as GLUT proteins, are responsible for transporting glucose into the cell. These proteins differ in tissue specificity, their affinity for glucose, and the maximum rate at which they can transport glucose across the plasma membrane. 1. Skeletal muscle and adipose tissue respond to insulin by increasing their uptake of glucose. These tissues contain GLUT-4, a glucose carrier with spare copies in the Golgi membrane. Stimulation by insulin results in translocation of spare carriers into the plasma membrane. 2. Liver has a high density of GLUT-2, a transporter that has a low affinity (high Km) for glucose and is not saturated by the increased concentration of glucose in the portal circulation following a high-carbohydrate meal.
Mnemonic Hexokinase places a hex on glucose, with lKm and lv max. Hexokinase is inhibited by i[G6P]. Glucokinase is a glutton for glucose, with iKm and ivmax ; it does not seem to be affected by the amount of glucose-6-phosphate.
3. The brush-border membrane of intestinal and kidney cells contains S-GLUT, a carrier that requires sodium for glucose transport.
4. Brain and red blood cells are rich in GLUT-I. This transporter has a high affinity (low Km) for glucose and is normally saturated, ensuring a constant supply of glucose to these tissues. B. Glucose phosphorylation and trapping. The phosphorylation of glucose in most cells is catalyzed by hexokinase. Liver contains glucokinase, an isozyme that has a much lower affinity (higher Km) for glucose and is never saturated under physiologic conditions. Therefore, the properties of glucokinase, in concert with GLUT-2, allow the liver to reduce the concentration of glucose in the portal circulation following a meal.
GLYCOLYSIS Glycolysis, also known as the Embden-Myerhof pathway, is the central pathway of glucose metabolism. It occurs in the cytosol of all cells. Glycolysis is defined as the pathway that converts glucose to pyruvate. For each mol of glucose converted to pyruvate, 2 mols of ATP are consumed and 4 mols are generated, with a net production of 2 mols of ATP per mol of glucose (discussed below). In the presence of well oxygenated mitochondria, pyruvate can be completely oxidized to CO 2 and H 20, resulting in a total of 36-38 mols ATP per mol of glucose. Under anaerobic conditions, however, pyruvate is converted to lactate. The formation of lactate provides a mechanism
42
KAPLA~. I me....ca
Carbohydrates
for regenerating NAD+ from NADH, a condition that is essential for glycolysis to continue. Anaerobic glycolysis plays an important role in ATP production under conditions where O2 is limited, e.g., in exercising skeletal muscle or in cells that lack mitochondria, such as red blood cells. A. Functions. Glycolysis generates ATP and provides intermediates that can be used in other pathways. For example, both glucose-6-phosphate and pyruvate act as branch points in metabolism because they are substrates for enzymes in other pathways. B. Pathway and enzymes. The pathway of glycolysis is shown in Figure 1-4-7. It can be divided
into two stages. The first stage requires the expenditure of ATP, whereas the second stage results in the net production of ATP.
*2(3-Phosphoglycerate)
a-D-glucose
A~+1 Glucokinase Hexokinase
COOH I H-C-OH
Mg ADP
I Glucose-6-Phosphate
1
1
~I Phosphoglucoisomerase
CH -o-® 11 Phosphoglycerate ~ Mutase
I
Fructose-6-®
M;;+1 ADP
1
*2(2-Phosphoglycerate)
H-1~:~
Phosphofructokinase- 1 1
I
CH20H
~
Fructose-1 ,6-bisphosphate
1:
HjJ
Glyceraldehyde-3-®
Dihydroxyacetone- ®
H-?=O H-C-OH
9H2- 0- ® C=O
I
CH2-0-®
R
NAD+
~
NADH + H+
Enolase 1
1
[AfdOfase]
I C~OH
~ *2(2-Phosphoglycerate)
Triosephosphate Isomerase
IGlyceraldehyde-3P-Dehydrogenase I
*2( Phosphoenolpyruvate) COOH I c-cr® II CH 2
2ADP~
I
I
MgH pyruvate Kinase . . 2ATP *2(Enolpyruvate) 00H
9
C-OH II CH 2
*2(1,3)-Bisphosphoglycerate
tSpontaneous
O=?-O-® H-C-OH
2(Pyruvate)
I
2A~;~~ ::hogl~emte K'oose I 1
*2ATP
2(3-Phosphoglycerate) - - - - - - - - - - - - '
EH NADH+~ NAD
+
.-'L-a-,ct-at;-e----, Dehydrogenase
*2 (Lactate) COOH I
HO-C-H I
*2 moles per mole glucose
CH3
Figure 1-4-7. Glycolysis.
meClical
43
Biochemistry
1. Stage 1 of glycolysis. Glucose is converted to fructose-1,6-P 2 through three sequential reac-
tions. ATP is required for the addition of phosphate groups to both ends of the monosaccharide. The two key enzymes in stage 1 are hexokinase and phosphofructokinase-1 (PFK-1). a. Hexokinase (or glucokinase in liver) uses ATP to convert glucose to glucose-6phosphate. In the next step, glucose-6-phosphate is isomerized to fructose-6-phosphate. b. PFK-l uses ATP to add phosphate to the C-1 of fructose-6-phosphate, with the formation of fructose-1,6-bisphosphate. This reaction is the rate-limiting step in glycolysis. PFK-1 is therefore the primary site of regulation in glycolysis. c. Phosphofructokinase-l and phosphofructokinase-2 both use fructose-6-phosphate as substrate. However, these enzymes have distinctly different functions. The product of the PFK-1 reaction is fructose-1 ,6-P 2, an intermediate in glycolysis. The product of the PFK-2 reaction is fructose-2,6-P 2 • The only known function offructose-2,6-P 2 is to act as an allosteric effector that activates glycolysis and inhibits the opposing pathway of gluconeogenesis. The relationship between PFK-1 and PFK-2 is shown in Figure 1-4-8.
GLUCOSE ~-------
!i
Fructose-6-phosphate
Pi Fructose-1,6-bisphosphatase
f
\ : Fructose-2,6-bisphosphate
..... . . . . .
/
',,+, . . . . . .v_/ /
!i
Fructose-1,6-bisphosphate
---- ----------
' - ....... (activator)
.........
/ /
PYRUVATE ..-/
/
/
e
(inhibitor)
/ /"
Figure 1-4-8. Relationship between PFK-1 and PFK-2.
2. Stage 2 of glycolysis. The function of the second stage is to produce ATP. It begins with the cleavage of fructose-1,6-bisphosphate by aldolase into two phosphorylated trioses (dihydroxyacetone phosphate and glyceraldehyde-3-phosphate). These two compounds are interconvertible through the action of triosephosphate isomerase. This reaction allows both trioses to proceed by a common pathway. Thus, beginning from this step in glycolysis, each mol of glucose can be considered to produce two mols of glyceraldehyde-3-phosphate and all subsequent intermediates. The remaining steps in the pathway are concerned with generating intermediates having high-energy phosphate groups that can be transferred to ADP with the formation of ATP. Two intermediates, 1,3-bisphosphoglycerate and phosphoenolpyruvate, have enough energy to drive the synthesis of ATP. There are three important enzymes in stage 2 of glycolysis: glyceraldehyde-3-phosphate dehydrogenase (G-3-P DH), 3-phosphoglycerate kinase, and pyruvate kinase. Under anaerobic conditions, lactate dehydrogenase is an also important enzyme in glycolysis. a. Glyceraldehyde-3-phosphate dehydrogenase catalyzes a reversible reaction that occurs in two steps. First, the aldehyde group is oxidized to a carboxylic acid, with NAD+ being reduced to NADH. (Note that this is the only oxidation reaction in glycolysis.) Second,
44
KAPLA~. I meulca
---------------
Carbohydrates
inorganic phosphate is covalently linked to the carboxyl group, forming 1,3bisphosphoglycerate. The phosphate bond created in this reaction is a high-energy bond, with a L1GO of -ll.S kcal/mol (only 7.3 kcal/mol are needed to convert ADP to ATP). b. 3-Phosphoglycerate kinase transfers the high-energy phosphate group from 1, 3-bisphosphoglycerate to ADP, producing ATP and 3-phosphoglycerate. Thus, 3-phosphoglycerate kinase is one of the ATP-producing enzymes in glycolysis. At this point, the energy consumed in stage 1 has been replaced. In the next two reactions, the phosphate group of 3-phosphoglycerate is rearranged to form another high-energy bond. Phosphoglycerate mutase moves the phosphate group from carbon-3 to carbon2, forming 2-phosphoglycerate. Enolase then dehydrates 2-phosphoglycerate to form phosphoenolpyruvate, a high-energy compound with a L1GO of -14.S kcal/mol.
In a Nutshell Intermediate Enzyme
Product
1,3-bisphospho- Phosphoglycerate glycerate kinase
ATP
Phosphoenolpyruvate
Pyruvate ATP kinase (irreversible)
Glyceraldehyde- G-3P 3-phosphate dehydrogenase
NADH
c. Pyruvate kinase catalyzes the last reaction in glycolysis. The phosphate group from phosphoenolpyruvate is transferred to ADP with the formation of ATP and pyruvate. Thus, the pathway results in a net of mols of ATP per mol of glucose. This reaction is irreversible, and pyruvate kinase is a secondary site for regulation of glycolysis.
d. Lactate dehydrogenase participates in glycolysis only under anaerobic conditions. Lactate dehydrogenase reduces pyruvate to lactate in a reaction that uses NADH and regenerates NAD+. In cells with well oxygenated mitochondria, lactate does not form in significant amounts. However, when oxygenation is poor, as in heavily exercising muscle, shock, or cardiopulmonary arrest, both the citric acid cycle and oxidative phosphorylation become relatively inactive, and most of the cellular ATP is generated by glycolysis. Because glycolysis requires NAD+ (step "a" above), the formation of lactate serves as a mechanism for regenerating NAD+ so that glycolysis can continue. In states of prolonged anoxia, large amounts oflactate accumulate. The lactate is transported to the liver where it can be used to resynthesize glucose. C. Regulation of glycolysis. There are three steps in glycolysis that are regulated: The primary
site of regulation is PFK-1, the enzyme that catalyzes the slowest step in the pathway. Secondary sites of regulation are hexokinase/glucokinase and pyruvate kinase. The regulatory properties of these enzymes are summarized in Table 1-4-2. PFK-1 is inhibited by ATP and citrate, molecules that indicate a high-energy status. When AMP accumulates, signaling the need for ATP, PFK-1 is activated. Pyruvate kinase is also inhibited by molecules that indicate a high-energy state (ATP and acetyl-CoA). When fructose-1,6-bisphosphate accumulates, it feeds forward and activates pyruvate kinase. In liver, the most important activator of glycolysis is fructose-2,6-bisphosphate, a compound whose concentration is increased by insulin and decreased by glucagon.
Table 1-4-2. Regulation of glycolysis. Enzyme
Mode of Regulation
Effect
Hexokinase
Allosteric
Inhibition: glucose-6-P*
Glucokinase t
Enzyme synthesis
Induced by insulin, not inhibited by glucose-6-P
PFK-1
Allosteric
Activation: AMP, fructose-2,6-P 2 t Inhibition: ATP, citrate
Pyruvate kinase
Allosteric
Activation: fructose-1 ,6-P2 Inhibition: ATP, acetyl-CoA, alanine t
Covalent t
Inhibited by phosphorylation t
Clinical Correlate Hemolytic anemia is caused by excessive destruction of red blood cells. A deficiency in pyruvate kinase is a common enzyme deficiency that results in premature lysis of the red blood cell. The red blood cell has no mitochondria and is totally dependent on glycolysis for ATP. A deficiency in pyruvate kinase, therefore, markedly decreases the ability to synthesize ATP. Maintenance of the biconcave shape of the red blood cell is dependent on ATP. Loss of shape signals uptake and turnover by the spleen. In addition, decreased ion pumping by Na+/K+ ATPase results in loss of ion balance and causes osmotic fragility, leading to swelling and lysis.
'Accumulates when ATP is high. t Effects are liver specific.
meCtical
45
Biochemistry
D. Fate(s) of pyruvate. Pyruvate, the end product of glycolysis, plays a central role in metabolism, as shown in Figure 1-4-9. Pyruvate can be reversibly converted to lactate and to alanine. Both of these reactions occur in the cytosol. Lactate is generated under anaerobic conditions by lactate dehydrogenase. Alanine is formed mainly in skeletal muscle, where it serves as a vehicle for transferring amino groups from muscle to liver, where they are then incorporated into urea (discussed in Chapter 6 of this section). Pyruvate also undergoes two irreversible reactions, both occurring in the mitochondria. It can be carboxylated to oxalo-acetate, which can replenish TCA cycle intermediates or be used for gluconeogenesis. The oxidative decarboxylation of pyruvate results in acetyl-CoA, which can be used as a building block for fatty acids, or it can be oxidized to C02 and H 20 by the TCA cycle and oxidative phosphorylation to generate ATP.
Pyruvate
2
Lactate
4
Alanine
3
Acetyl-CoA
Oxaloacetate
/~
/~ Fatty acids
TeA cycle
Gluconeogenesis
Enzymes: 1. Lactate dehydrogenase; 2. transaminase; 3. pyruvate carboxylase; 4. pyruvate dehydrogenase
Figure 1-4-9. Metabolic fates of pyruvate.
1. Pyruvate dehydrogenase (PDR). PDH is a multienzyme complex (Figure 1-4-10) that
converts pyruvate to acetyl-CoA by oxidative decarboxylation. This reaction is irreversible, and there is no enzyme in humans that will reverse the reaction. The overall reaction catalyzed by PDH is: Pyruvate + CoA + NAD+
46
KAPLAlfdme leaI
-7
Acetyl-CoA + CO 2 + NADH
The enzyme complex is located in the mitochondria and consists of three distinct enzyme activities (decarboxylase, dihydrolipoyl transacetylase, and dihydrolipoyl dehydrogenase). Five coenzymes are required (thiamine pyrophosphate, lipoic acid, Coenzyme A, FAD, and NAD+). The reaction occurs in several steps as shown in Figure 14-10. In the first step, the decarboxylase (E 1) and its cofactor, thiamine pyrophosphate (TPP), release CO 2. The C2 fragment that remains is oxidized by lipoic acid, transferred to CoA, and finally released as acetyl-CoA. These reactions are catalyzed by dihydrolipoyl transacetylase (E z). The last step, catalyzed dihydrolipoyl dehydrogenase (E 3 ), requires FAD and NAD+ to regenerate the initial oxidized form of lipoic acid. The cofactors TPP, lipoic acid, and FAD never leave the enzyme complex.
carbohydrates
CHTCH-TPP
I OH
Figure 1-4-10. The pyruvate dehydrogenase complex.
2. Regulation of pyruvate dehydrogenase. The activity of PDH is dependent on the energy state of the cell as reflected by the levels of acetyl-CoA, ATP, and NADH. It is activated by ADP, CoA, and NAD+. Acetyl-CoA and NADH are powerful inhibitors of pyruvate dehydrogenase activity. As shown in Figure 1-4-11, PDH undergoes phosphorylation/dephosphorylation. A specific protein kinase and protein phosphatase are associated with the multienzyme complex. The kinase is activated by acetyl-CoA and NADH. The phosphatase is activated by insulin. The regulation of pyruvate dehydrogenase is important to fuel conservation. For example, the oxidation of carbohydrate, fat, and proteins all produce acetyl-CoA and NADH (as seen in Figure 1-3-1 in the Bioenergetics chapter). Thus, when fatty acids are being oxidized, carbohydrate (pyruvate) and protein are conserved.
NADH ~~ Acetyl-CoA
.lG> Kinase
Insulin
~ Phosphatase
Figure 1-4-11. Regulation of PDH activity.
KAPLA~.
I
meulC8
47
Biochemistry
3. Homology of pyruvate dehydrogenase with other enzymes. Two other multienzyme complexes in human metabolism have similar structures to pyruvate dehydrogenase. These are a-ketoglutarate dehydrogenase (in the TCA cycle) and branched-chain keto acid dehydrogenase (in amino acid catabolism). All three of these multienzyme complexes catalyze the oxidative decarboxylation of a-ketoacids. They all have E1> E2> and E3 enzyme activities that require the same five coenzymes.
Clinical Correlate Lactic acidosis arising from a deficiency in pyruvate dehydrogenase (PDH) may be an acquired or an inherited condition. The inherited form frequently presents in the neonatal period with vomiting, hypotonia, neurologic deficits, and persistent acidosis. The accumulation of pyruvate behind the metabolic block pushes the equilibrium of the reversible lactate dehydrogenase and alanine transaminase reactions, thus accumulating lactate and alanine. Acquired PDH deficiency is frequently seen in chronic alcoholics who have a thiamine deficiency. The elevated fat content of the diet given as treatment results in an excess of acetyl-eoA, which is converted to ketones. The ketones can be used as fuel by the brain, thereby bypassing the PDH reaction.
E. Energetics of glycolysis. The amount of ATP derived from glucose oxidation is dependent on the availability of oxygen. 1. Anaerobic glycolysis. When oxygen is limited, glycolysis can be summarized by the equation given below. For each mol of glucose consumed, 2 mols oflactate and 2 mols of ATP are produced. There is no net accumulation of NADH. Glucose + 2 ADP + 2 Pi ~ 2 lactate + 2 ATP 2. Aerobic glycolysis. When oxygen is plentiful, glycolysis can be summarized as follows: Glucose + 2 NAD+ + 2 ADP + 2 Pi ~ 2 pyruvate + 2 ATP + 2 NADH For each mol of glucose consumed, 2 mols each of pyruvate, ATP, and NADH are produced. The NADH can undergo oxidative phosphorylation, producing either 2 or 3 mols of ATP, depending on how electrons in the cytosolic NADH are transported into the mitochondria. Use of the malate shuttle results in 3 mols of ATP per NADH, whereas use of the a-glycerol-phosphate shuttle results in 2 mols of ATP per NADH. Additionally, each mol of pyruvate can be transported into the mitochondria and oxidized to CO 2 and H 2 0 by the TCA cycle and oxidative phosphorylation, resulting in 15 mols of high-energy phosphate (ATP or GTP) per mol of pyruvate. The enzymes involved in generating ATP (or GTP) from glucose are summarized in Table 1-4-3.
F. Poisons of glycolysis. Many compounds shut down the glycolytic pathway by inhibiting one or more of the enzymes. 1. 2-Deoxyglucose is converted by hexokinase to 2-deoxyglucose-6-phosphate. This compound is not a substrate for phosphoglucoisomerase. It accumulates and inhibits hexokinase, preventing the phosphorylation of glucose to glucose-6-phosphate. 2. Iodoacetate and other reagents that react with sulfhydryl groups inactivate glyceraldehyde3-phosphate dehydrogenase, which has an essential sulfhydryl group in its active site. 3. Fluoride inhibits enolase by complexing with 2-phosphoglycerate and Mg2+, making the substrate unavailable. 4. Arsenate inhibits ATP production by acting as a substrate for glyceraldehyde-3-phosphate dehydrogenase, producing a compound that breaks down spontaneously to 3-phosphoglycerate and arsenate. Thus, no ATP is formed in the reaction.
48
meclical
Carbohydrates
Table 1-4-3. Energetics of aerobic oxidation of glucose. Pathway
Enzyme
Product
Method of Energy Generation
1. Glyceraldehyde-3-P dehydrogenase
2 NADH
Oxidative phosphorylation
2 Phosphoglycerate kinase
2 ATP
Substrate-level phosphorylation
2
3. Pyruvate kinase
2 ATP
Substrate-level phosphorylation
2
ATP/Glucose
(Cytosol) Glycolysis 4-6*
ATP produced/glucose ATP consumed/glucose (hexokinase and phosphofructokinase)
8-10*
Net ATP produced/glucose
6-8*
(Mitochondria) PDH & TCA Cycle 1. Pyruvate dehydrogenase
-2
2 NADH
Oxidative phosphorylation
6
2. Isocitrate dehydrogenase
2 NADH
Oxidative phosphorylation
6
3. a-Ketoglutarate dehydrogenase
2 NADH
Oxidative phosphorylation
6
4. Succinate thiokinase
2 GTP
Substrate-level phosphorylation
2
5. Succinate dehydrogenase
2 FADH2
Oxidative phosphorylation
4
6. Malate dehydrogenase
2 NADH
Oxidative phosphorylation
6
Net ATP produced/glucose
30
Total ATP per glucose (aerobic oxidation) = 36-38* Total ATP per glucose (anaerobic oxidation) = 2 (Reactions 2 and 3 of glycolysis) *Transfer of electrons in cystolic NADH via malate shuttle produces mitochondrial NADH and 3 ATP, whereas transfer via a-glycerol-P shuttle produces FADH2 and 2 ATP.
GLUCONEOGENESIS Gluconeogenesis is the pathway for de novo synthesis of glucose from C 3 and C 4 precursors. This pathway is distinct from glycogenolysis, which gives rise to preformed glucose. Gluconeogenesis occurs mainly in the liver and kidney, with a small amount occurring in the epithelium of the small intestine. The pathway requires both mitochondrial and cytosolic enzymes. A. Function. The role of gluconeogenesis in homeostasis is to maintain proper blood glucose levels and to provide glucose for the body. The brain, central nervous system, and red blood cells are dependent on glucose for all or most of their energy. When fasting persists for more than 12 to 24 hours, liver glycogen stores are exhausted and gluconeogenesis provides glucose for these tissues. The primary precursors for de novo glucose synthesis are lactate (from KAPLAlf I meillea
49
Biochemistry
red blood cells and anaerobic muscle), glycerol (from triacylglycerol degradation in adipocytes), and amino acids (from protein degradation in skeletal muscle).
Clinical Correlate
B. Pathway and key enzymes. Gluconeogenesis uses the seven enzymes in the glycolytic pathway that catalyze reversible reactions. Additionally, there are four enzymes unique to gluconeogenesis that are required to bypass the three irreversible reactions in glycolysis (Figure 1-4-12).
A deficiency in any of the four key enzymes used in gluconeogenesis will result in hypoglycemia.
GLUCONEOGENESIS
GLYCOLYSIS
E
GK
Pyruvate Kinase
PFK-1
f \G6P~F6P f \F-1,6-P2~)
DHAP
Glu
"---/
G6Pase
G3P~ 3PG~
"---/
2PG~
Pyruvate
PEP
/
\
FBPase-1
Pyruvate Carboxylase
PEPCK
\
I
Oxaloacetate Figure 1-4-12. Gluconeogenesis and glycolysis.
Each of the four enzymes unique to gluconeogenesis also catalyzes an irreversible reaction, but in the opposite direction from the corresponding enzyme in glycolysis. To bypass the pyruvate kinase reaction, two enzymes are required: pyruvate carboxylase and phosphoenolpyruvate carboxykinase (PEPCK). 1. Pyruvate carboxylase, an enzyme located in the mitochondria, catalyzes the carboxylation
of pyruvate to oxaloacetate, the first step in gluconeogenesis (Figure I-4-13). Acetyl-CoA is an allosteric activator that must be present for the enzyme to function. Biotin serves as a carrier of the "activated carboxyl" group derived from bicarbonate. ATP hydrolysis to ADP and Pi provides the energy needed to generate the "activated carboxyl" group.
COOH
I + C=O I CH 3
Pyruvate
Pyruvate Carboxylase
COOH
I
C=O
I
CH 2
I
COOH Oxaloacetate
Figure 1-4-13. The pyruvate carboxylase reaction.
2. Phosphoenolpyruvate carboxykinase (PEPCK) catalyzes the second step in gluconeogenesis (Figure 1-4-14). PEPCK is a cytosolic enzyme that phosphorylates and decarboxylates oxaloacetate to form phosphoenolpyruvate. The phosphate group is derived from GTP, which is energetically equivalent to ATP. Thus, to bypass the irreversible pyruvate
50
meClical
Carbohydrates
kinase reaction, two enzymes are required and the equivalent of 2 mols of ATP are consumed in converting pyruvate to phosphoenolpyruvate.
COOH
I
C=O
I
CH2
I
Phosphoenolpyruvate Carboxykinase
f"\
GTP
COOH
•
I C-O-® + CO 2
II
CH 2
GOP
COOH Oxaloacetate
Phosphoenolpyruvate Figure 1-4-14. The PEPCK reaction.
3. Fructose-I,6-bisphosphatase (FBPase-l) catalyzes the hydrolysis offructose-l,6-bisphosphate to fructose-6-phosphate and inorganic phosphate. This reaction bypasses the irreversible step in glycolysis catalyzed by PFK-1.
FBPase-l Fructose-l,6-bisphosphate + H 2 0
------~ ..~
fructose-6-phosphate + Pi
FBPase-l is a cytosolic enzyme that is activated by ATP and citrate and inhibited by AMP and fructose-2,6-bisphosphate. These same compounds alter the activity of the opposing enzyme, PFK-l, but in the opposite direction (see Table 1-4-2). Thus, glycolysis is inhibited when gluconeogenesis is occurring, and vice versa. 4. Glucose-6-phosphatase (G6Pase) catalyzes the last step in gluconeogenesis by removing the phosphate from glucose-6-phosphate and releasing free glucose. G6Pase Glucose-6-phosphate + H 2 0
------~ ..~
glucose + Pi
Clinical Correlate A deficiency in glucose-6phosphatase results in von Gierke disease, which is characterized by low serum glucose and high serum lactate. The elevated lactate results from both a compensatory increase in liver glycolysis and a decreased ability to use lactate as a substrate for gluconeogenesis.
This reaction bypasses the irreversible hexokinase step in glycolysis. G6Pase is associated with the endoplasmic reticulum and is found only in liver, kidney, and intestinal epithelium. The absence of G6Pase in skeletal muscle accounts for the fact that muscle glycogen cannot serve as a source of blood glucose. C. Overall reaction of gluconeogenesis. The conversion of pyruvate to glucose via gluconeogenesis is shown below. For every mol of glucose synthesized, six ATP equivalents are required. Four ATP equivalents are required to convert pyruvate to phosphoenolpyruvate, and two are required to reverse the 3-phosphoglycerate kinase step in glycolysis. The NADH is used to reverse the step catalyzed by glyceraldehyde-3-phosphate dehydrogenase.
2 pyruvate + 4 ATP + 2 GTP + 2 NADH
--7
glucose + 4 ADP + 2 GDP + 6 Pi + 2 NAD+
The ATP required for gluconeogenesis is derived from the oxidation of fatty acids. It should be noted that the reaction may begin with lactate rather than pyruvate because the lactate dehydrogenase reaction is reversible. KAPLA~.
meulCa
I
51
Biochemistry
I Blood I ~
Glucose
ILiver I
Glucose-6-phosphate
t t ..
. .. ...
Pyruvate
I Muscle I
Glycogen
Glycogen
Lactate
Lactate
. .. ollIE
, Glucose-6-phosphate
tt ... Pyruvate
~
I Blood I Lactate
""'-
Figure 1-4-15. The Cori cycle.
D. Precursors for gluconeogenesis. Any compound that can be converted to an intermediate in glycolysis or the citric acid cycle can serve as a precursor for gluconeogenesis. 1. Lactate. The function of the Cori cycle is to conserve glucose by recycling lactate
formed from anaerobic glycolysis in red blood cells and skeletal muscle. Lactate is released from these tissues into the blood and is taken up by the liver. It is then reconverted to glucose via gluconeogenesis to provide more glucose for energy. The recycling process is illustrated in Figure 1-4-15. 2. Alanine. Skeletal muscle releases large amounts of alanine formed by the transamination of pyruvate. The alanine is taken up by the liver and is reconverted to pyruvate, which is used for glucose synthesis. This recycling is known as the alanine cycle. The alanine cycle provides a means of conserving carbohydrate. Note that neither the alanine cycle nor the Cori cycle result in the net synthesis of glucose. 3. Glucogenic amino acids. All of the common amino acids except lysine and leucine are glucogenic, i.e., they can be degraded to intermediates in either glycolysis or the TCA cycle and thus can serve as precursors for glucose synthesis. The nitrogen arising from these amino acids is disposed of as urea. Lysine and leucine are strictly ketogenic and cannot be converted to glucose. 4. Glycerol. The hydrolysis of triacylglycerols in adipose tissue produces glycerol that is
In a Nutshell
released into the blood. The liver takes up glycerol and converts it to glycerol-3 phosphate, which can be oxidized to dihydroxyacetone phosphate, a gluconeogenic intermediate.
Enzyme
Activators Inhibitors
Pyruvate carboxylase
Acetyl-CoA
Phosphoeno~
ADP ADP
pyruvate carboxykinase Fructose-l,6ATP bisphosphatase Citrate Glucagon Epinephrine
AMP Fructose-2,6bisphosphate
Glucose-6phosphatase
Glucose
52
meCtical
5. Odd-numbered fatty acids. The oxidation of odd-numbered fatty acids produces one molecule of propionyl-CoA from the ffi-end. Propionyl-CoA can be converted to succinylCoA, an intermediate in the TCA cycle, and then to glucose. In contrast, degradation of even-numbered fatty acids produces only acetyl-CoA, which is not a precursor of glucose. 6. Fructose. Fructose (from dietary sucrose) can be phosphorylated to fructose-I-phosphate and cleaved to glyceraldehyde and dihydroxyacetone phosphate (DHAP), a glucogenic intermediate. Glyceraldehyde can be converted to glucogenic intermediates either by reduction to glycerol or by phosphorylation to glyceraldehyde-3-phosphate. 7. Galactose. Galactose can be phosphorylated by the liver to galactose-I-phosphate and then converted to glucose-6-phosphate by a series of reactions discussed below.
Carbohydrates
E. Regulation of gluconeogenesis. Gluconeogenesis is tightly regulated in order to maintain blood glucose at a normal level. Regulation is accomplished by three methods: substrate availability, enzymatic control, and hormonal control. l. Substrate availability. Under conditions of fasting, the primary substrates for gluconeo-
genesis are amino acids derived from protein degradation. The oxidation of fatty acids provides the energy required. All of these processes are coordinated by hormonal control. 2. Enzymatic control. The enzymes that are regulated are unique to gluconeogenesis. The opposing enzymes of glycolysis and gluconeogenesis at the irreversible steps in these pathways are regulated reciprocially so that when one is active the other is inactive. This prevents futile cycling of substrate by ensuring that glycolysis and gluconeogenesis are not occurring at the same time. a. Pyruvate carboxylase is activated by acetyl-CoA. The opposing enzyme in glycolysis, pyruvate kinase, is inhibited by acetyl-CoA. b. Fructose-l,6-bisphosphatase is activated by ATP and citrate and is inhibited by AMP and fructose-2,6-bisphosphate. The opposing enzyme in glycolysis, PFK-l, is inhi-bited by ATP and citrate and is activated by AMP and fructose-2,6-bisphosphate. c. Glucose-6-phosphatase and the opposing enzyme glucokinase are both regulated by
substrate availability. Both enzymes have high Km values and are not saturated under the conditions in the cell. Therefore, as glucose-6-phosphate and glucose concentrations increase, the activities of glucose-6-phosphatase and glucokinase increase, respectively. 3. Hormonal control. The major hormones involved in regulating blood glucose levels are glucagon and insulin, which have opposing effects. Glucagon promotes glucose synthesis and release into the blood, and insulin promotes glucose uptake and storage. Both of these effects are mediated by intracellular concentrations of cAMP. Cellular cAMP levels increase in response to glucagon and decrease in response to insulin. cAMP activates protein kinase-A. The active form of the protein kinase phosphorylates a subset of enzymes and alters their activities. Under conditions of low blood glucose, the secretion of glucagon initiates several responses that lead to restoring blood glucose levels. Responses to elevated glucagon include: a. Inhibition of pyruvate kinase. Phosphorylation of this enzyme leads to its inactivation, thereby decreasing the amount of glucose consumption by glycolysis. b. Decreased concentration of fructose-2,6-bisphosphate. The degradation of fructose2,6-bisphosphate is stimulated by glucagon. Therefore, its inhibitory effect on FBPase1 and its stimulatory effect on PFK-l are both relieved, resulting in increased gluconeogenesis and decreased glycolysis. c. Increased synthesis of key enzymes. The synthesis of PEPCK, FBPase-l, and glucose-
6-phosphatase are increased by glucagon. This is a slower response, taking hours rather that minutes or seconds to occur. Synthesis of these enzymes is also induced by glucocorticoids and catecholamines. d. Increased protein degradation. During gluconeogenesis, proteolysis in skeletal muscle is increased, thus providing an increased supply of amino acids for glucose synthesis. e. Increased lipolysis. The release of fatty acids from adipose triglyceride is stimulated by any hormone that increases intracellular cAMP. Fatty acids are taken up by the liver and oxidized to supply the energy required for gluconeogenesis.
In a Nutshell Increased glucagon ---+ increased cAMP ---+ increased protein kinase-A activity ---+ phosphorylation ---+ decreased pyruvate kinase activity ---+ increased gluconeogenesis
In a Nutshell Increased insulin ---+ decreased cAMP ---+ increased protein phosphatase activity ---+ dephosphorylation ---+ increased F-2, 6-P2 ---+ increased glycolysis
Clinical Correlate Ethanol-induced hypoglycemia is due to the oxidation of ethanol by the liver, leading to the accumulation of excessive NADH and a deficit of NAD+. This prevents the oxidation of lactate to pyruvate, a-glycerol-P to dihydroxyacetone phosphate, and malate to oxaloacetate. Gluconeogenesis therefore fails due to inadequate prescursors, resulting in hypoglycemia.
KAPLAlf _ I meillea
53
Biochemistry
GLYCOGENESIS AND GLYCOGENOLYSIS Glycogen is a highly branched polymer containing glucose molecules linked by a-1,4 glycosidic bonds, with a-1,6 glycosidic bonds between the two glucose molecules at the branch points. Branching increases the solubility of the molecule and facilitates breakdown of glycogen. At the core of the glycogen particle is the protein glycogenin, which serves as the initial primer in the synthesis of glycogen. Glycogenin is not only the primer for the first glucose molecule; it is also the catalyst for the synthesis of the first eight glucose residues of the glycogen molecule. The synthesis and degradation of glycogen occur mainly in the liver and skeletal muscle. The liver may store up to 10% of its wet weight as glycogen. All of the synthesis and degradation occurs at the ends of the branch points. A. Functions. Glycogen is the storage form for glucose in animal tissues. The function of glycogen in skeletal muscle differs from that in the liver.
Mnemonic The well-"red" person is slow, but complete: red muscle fibers are slow, but completely oxidize fuel (TCA cycle).
1. Skeletal muscle degrades glycogen and rapidly metabolizes glucose via glycolysis. This process generates ATP required for muscle contraction. Thus, the function of glycogen in muscle is to provide energy for contraction. In white ("fast") muscle fibers, glucose is released from glycogen and metabolized by glycolysis, with lactate being the major end product. In red ("slow") muscle fibers, pyruvate is completely oxidized by the TeA cycle and oxidative phosphorylation. 2. Liver uses glycogen mainly to regulate blood glucose levels. In response to hypoglycemia, liver glycogen is degraded, and glucose is released into the blood. However, liver glycogen stores become depleted after approximately 12 hours of fasting. In response to hyperglycemia, glucose is removed from the blood and stored as liver glycogen. The pathways of glycogenesis and glycogenolysis are shown in Figure 1-4-16.
y
UDP
Glycogen
UDP-glu
PFl
Glu-1-P
Gll.p
()
Glucose (blood) Figure 1-4-16. Overview of glycogen metabolism.
B. Key enzymes in glycogenolysis. Glycogen degradation occurs at the ends of the branches, where glucose-1-P units are sequentially released by glycogen phosphorylase, the most
54
KAPLAlfdme leaI
Carbohydrates
important enzyme in glycogenolysis. Total degradation requires an additional "debranching" enzyme system. 1. Glycogen phosphorylase cleaves a-I,4 glycosidic bonds by the addition of inorganic
phosphate, a process known as "phosphorolysis': This reaction is the rate-limiting step in glycogenolysis and is regulated both allosterically and hormonally. The glycogen phosphorylase reaction is shown below, where n is the number of glucose units in glycogen. glycogen phosphorylase (Glucose)n
------------.~
P'~
(Glucose)n_l + Glucose-I-P
1
Glycogen phosphorylase will remove glucose units until it gets to within 4-5 glucose units of a branch point, when it no longer binds efficiently to the partially degraded glycogen. 2. Debranching enzymes. The complete degradation of glycogen requires two additional enzymes that make up the "debranching system" (Figure 1-4-17). a[1--t4] chain
Ja·1,6-glucosidase +
o Figure 1-4-17. The glycogen debranching enzymes.
a. a-[1,4] --7 a-[1,4] glucan transferase removes three or four glucose units from a branch point and transfers them to the end of another chain. In this reaction, one a-I,4 bond is being cleaved, and another is being formed. The elongated chain now becomes a substrate for glycogen phosphorylase. b. a-I,6 glucosidase removes the single glucose unit remaining at the branch point and releases it as free glucose.
In a Nutshell
C. Key enzymes in glycogen synthesis. As shown in Figure 1-4-16, the synthesis of glycogen
begins with glucose phosphorylation to glucose-6-phosphate. This reaction is catalyzed by glucokinase in the liver and by hexokinase in other tissues. Glucose-6-phosphate is rapidly and reversibly converted to glucose-I-phosphate by phosphoglucomutase. Before glucose can be added to the glycogen polymer, it must be "activated" or energized. This is achieved by the formation ofUDP-glucose, which serves as the donor of glucose to a glycogen primer. Most monosaccharides are activated by reacting with UTP to form a UDP-sugar. 1. Formation of UDP-glucose. The phosphate group of glucose-I-phosphate reacts with
UTP to form UDP-glucose and pyrophosphate (PPi). Thus, one of the phosphate groups in UDP-glucose is derived from glucose-I-phosphate and the other from UTP, as shown
Enzyme
Activator Inhibitor
Muscle AMP ATP glycogen Ca2+ Glucose-Gphosphorylase Epinephrine phosphate Insulin Glucagon Glucose Liver glycogen Epinephrine Insulin phosphorylase Glycogen synthase
Glucose Insulin
Glucagon Epinephrine
KAPLA~. I meulca
55
Biochemistry
Clinical Correlate Glycogenesis is coupled to the influx of K+ in the cells. Insulin and glucose are therefore given to treat hyperkalemia (high serum K+), inducing glycogenesis and causing an influx of K+ into the cells.
below. The reaction is catalyzed by UDP-glucose pyrophosphorylase. The equilibrium of this reaction is "pulled" toward UDP-glucose formation by the hydrolysis of pyrophosphate to inorganic phosphate. UDP-glucose pyrophosphorylase Glu-1-P + Uridine-P-P-P
..
UDP-Glu + PP j
The linkage between glucose and UDP is a high-energy bond, making it a suitable donor in many biosynthetic reactions. 2. Elongation of glycogen chains. To be active, glycogen synthase requires an existing glycogen chain serving as a primer. If the chain has been totally degraded, then glycogenin, the protein found at the core of the glycogen particle, serves as a primer for glycogen synthesis and accepts the initial glucose residue. Glycogen synthase catalyzes the transfer of glucose from UDP-glucose to the end of a chain. The linkage created is an o,-1,4-glycosidic bond. This is the rate-limiting step in glycogen synthesis and is therefore the site of regulation. glycogen synthase .. (Glucose)n+l + UDP (Glucose)n + UDP-glucose
3. Branching enzyme. After approximately 10 glucose units have been added, a branch point is created by 0,-[1,4] 0,-[1,6] glucan transferase. Forming a branch point involves breaking an 0,-1,4 linkage and creating an 0,-1,6 linkage. The two shorter chains that are produced can now be elongated by glycogen synthase. There are always at least four glucose molecules between branch points. D. Coordinate regulation of glycogenesis and glycogenolysis. Glycogen phosphorylase and glycogen synthase are regulated in a reciprocal manner, such that when one of these enzymes is active, the other is inactive. The primary mode of regulation for both enzymes is hormonal and is mediated by phosphorylation/dephosphorylation. In addition, both glycogen synthase and phosphorylase activities can be affected allosterically.
56
meClical
------~~~-
-~~~
Epinephrine
Glucagon (liver cell)
ADENYLATE CYCLASE
..
"
0
& liver cells)
- . ---= ,R ADENYLATE '
ATP
GLYCOGEN PHOSPHORYLASE KINASE
cAMP-DEPENDENT PROTEIN KINASE
I
CYCI,ASE active
cAMP-
Phosphodiesterase active
Glucose
0(
0(
Glucose i-Phosphate
t
GLYCOGEN PHOSPHORYLASE
a active
Glycogen
5Ie CD; A,"'l
gO
~
.....
*Reactions catalyzed by PHOSPHOPROTEIN PHOSPHATASE Figure 1-4-18. Cascade for activating glycogenolysis.
*
..go ~
{
i
Biochemistry
1. Glycogen phosphorylase. A comprehensive diagram describing the regulation of this
In a Nutshell Hormone (glucagon and epinephrine)
~
G-protein
~
ieAMP
~
Activates PKA
I
Phosphorylates glycogen synthase
~
\
Phosp horylates phosphorylase kinase
~
Inactive Phosphorylates (no glycogenesis) glycogen phosphorylase
~
Active (iglycogenolysis)
enzyme is shown in Figure 1-4-18. Phosphorylation of a specific serine side chain activates the enzyme, resulting in glycogen degradation. The activation of phosphorylase is initiated by the binding of glucagon to liver cell receptors or by the binding of epinephrine to muscle receptors. Both of these hormones increase the intracellular synthesis of cAMP, resulting in the activation of a cAMP-dependent protein kinase (protein kinase A). A single molecule of hormone can generate many molecules of cAMP; each molecule of cAMPdependent protein kinase can phosphorylate (and activate) many molecules of phosphorylase kinase; each molecule of phosphorylase kinase can phosphorylate (and activate) many molecules of glycogen phosphorylase; and each molecule of glycogen phosphorylase can release many molecules of glucose-I-phosphate from glycogen. This "cascade" system amplifies the response initiated by the binding of a few hormone molecules by generating millions of molecules of glucose-I-phosphate. It is noteworthy that phosphorylase kinase can also be activated directly (without phosphorylation) by binding calcium. This is particularly important in skeletal muscle, where the coupling of excitation with contraction is mediated by calcium. Thus, the same regulatory molecule that activates contraction also activates glycogenolysis, which provides the energy for contraction. The active (phospho) form of glycogen phosphorylase can be allosterically inhibited by glucose and ATP, whereas the inactive (dephospho) form can be activated allosterically by AMP. Thus, although covalent modification of these enzymes is the primary mode of regulation, the activity of the phospho- and dephospho- forms can be fine-tuned by the accumulation of intracellular metabolites that act as allosteric effectors. 2. Glycogen synthase. The same signals that activate glycogen phosphorylase inactivate glycogen synthase. Glucagon and epinephrine (via cAMP-dependent protein kinase) stimulate the phosphorylation and inactivation of glycogen synthase. The coordinate regulation of these enzymes prevents futile cycling of substrate that would exist if both enzymes were active at the same time. The inactive (phosphorylated) form of glycogen synthase in muscle can be allosterically activated by glucose-6-phosphate. Many texts refer to glycogen synthase-1 and glycogen synthase-D. The D form is the inactive (phospho) enzyme, and the 1 form is the active (dephospho) form. E. Glycogen storage diseases. A number of enzyme deficiencies have been identified that result in the accumulation of an abnormal type or quantity of glycogen in tissues. Table 1-4-4 lists the major types of glycogen storage disease, the deficient enzyme, and the cardinal clinical feature of each type.
58
me&ical
Carbohydrates
Table 1-4-4. Glycogen storage diseases. Type
Deficient Enzyme
Cardinal Clinical Feature
von Gierke Pompe
Glucose-6-phosphatase a-I, 4-glucosidase
III
Cori
Glycogen debranching
IV
Andersen (amylopectinosis)
Branching enzyme
Severe hypoglycemia Cardiomegaly, muscle weakness, death by 2 years Mild hypoglycemia, liver enlargement Infantile hypotonia, cirrhosis, death by 2 years
McArdle
Muscle glycogen phosphorylase
Hers disease
Hepatic glycogen phosphorylase Muscle phosphofructokinase Hepatic phosphorylase kinase
I II
V VI
VII VIII
Muscle cramps and weakness on exercise Hypoglycemia, cirrhosis Muscle cramps No neuromuscular symptoms, hypoglycemia
It is clear from Table I -4-4 that the clinical consequences of an enzyme deficiency depend on
which enzyme is missing. For example, in type I deficiency, the absence of glucose-6phosphatase, impairs the ability of the liver to release free glucose by glycogenolysis, resulting in severe hypoglycemia. Other consequences include increased uric acid levels due to increased pentose phosphates, increased purine synthesis, and increased purine degradation; acidosis due to the accumulation of lactate; elevated serum lipids due to fat degradation in adipose; and growth retardation due to accelerated protein degradation. In type III deficiency, the absence of debranching enzyme only partially impairs glycogenolysis, resulting in mild hypoglycemia. Glycogen structure is normal in all of the types except III and Iv.
HEXOSE MONOPHOSPHATE SHUNT This pathway, also known as the pentose phosphate pathway, provides an alternative route for the oxidation of glucose. The products of the pathway are CO 2 , pentose phosphates, and NADPH. The shunt branches off of glycolysis at glucose-6-phosphate and re-enters at fructose6-phosphate (Figure 1-4-19). The hexose monophosphate (HMP) shunt is present in the cytosol of all cells. Unlike glycolysis, this pathway neither consumes nor produces ATP. A. Functions. This pathway supplies the cell with NADPH and pentoses. 1. NADPH. Almost all of the NADPH required in reductive biosynthetic processes, such as
the synthesis of cholesterol, fatty acids, and steroid hormones, comes from the hexose monophosphate shunt. Tissues that synthesize large amounts of these compounds have high levels of the NADPH-producing enzymes in the pathway. Red blood cells require large amounts of NADPH to maintain the reduced form of glutathione. Reduced glutathione helps prevent hemolysis by neutralizing the effects of strong oxidizing agents such as superoxide and hydrogen peroxide. Neutrophils, macrophages, monocytes, and other phagocytosing cells require large quantities of NADPH to generate superoxide. These cells use superoxide as a part of the "cidal" process for killing bacteria they engulf. NADPH oxidase reduces molecular oxygen to superoxide in these cells. A deficiency in either NADPH or NADPH oxidase can result in chronic infection.
Clinical Correlate Chronic granulomatous disease is caused by a defect in the NADPH oxidase complex, resulting in neutrophils that do not produce superoxide. Affected individuals therefore present with an inability to kill invading microbes that are engulfed.
meClical
59
Biochemistry
2. Pentoses. The synthesis of nucleotides and some coenzymes (NAD+, NADP+, FAD, CoA) requires ribose-5-phosphate, which is supplied by the HMP shunt. B. Pathway and key enzymes. As shown in Figure 1-4-19, the HMP shunt branches off glycolysis at glucose-6-phosphate. The two pathways equilibrate by having fructose-6-phosphate as a common intermediate. After the early steps in the pathway, which lead to NADPH and ribose-5-phosphate synthesis, a large number of intermediates (shown in brackets) allow excess pentoses to be reconverted to fructose-6-phosphate. The numbers at each reaction refer to the enzyme used. The reactions in the HMP shunt can be divided in two phasesthe oxidative and non oxidative phases. 1. The oxidative phase produces 2 mols of NADPH per glucose oxidized. This phase consists of three reactions starting with glucose-6-phosphate and resulting in ribulose-5phosphate. All of these reactions are essentially irreversible. In the first reaction, the carbon-1 of glucose-6-phosphate is oxidized to a cyclic acid (lactone), with the simultaneous production of NADPH (Figure 1-4-20). In the next reaction, the lactone of 6-phosphogluconate is hydrolyzed to the straight chain form by lactonase. In the last step of the oxidative phase, 6-phosphogluconate is oxidized and decarboxylated, with the formation ofNADPH, CO 2 , and ribulose-5-phosphate. Glucose
~
Glucose-6-P
I
Fructose-6-P
NADPH
NADPH
H2 0
~•
/ . 6-phosphoglucono-o-lactone
6-P-gluconate
2
CO 2
~
/
Ribulose-5-P
3 4
.....If-----~.~
Glyceraldehyde-3-P Erythrose-4-P Xylulose-5-P Fructose-6-P Sedoheptulose-7-P
5,6,7
.....E-----------___ • Ribose-5-P
1
1
Pyruvate
Nucleotide Synthesis
Figure 1-4-19. The hexose monophosphate shunt. (1. Glucose-6-phosphate dehydrogenase; 2. lactonase; 3. 6-phosphogluconate dehydrogenase; 4. pentose-P-isomerase; 5. pentose-P-epimerase; 6. transketolase; 7. transaldolase)
COOH
CH2-00~
~ OH
HO
OH
I
CH2 0@
NADPH
~
~ OH
0
0
H-C-OH
NADPH
I
~
HO-C-H
I
H-C-OH
HO
I
OH
H-C-OH
I
CH2 0@ Glucose-6-@
6-Phosphoglucono-1)-lactone
6-P-Gluconate
Ribulose-5-P
Figure 1-4-20. The oxidative phase of the hexose mono phosphate shunt.
60
meClical
Carbohydrates
2. The nonoxidative phase. All of these reactions are reversible. Ribulose-5-phosphate is isomerized to ribose-5-phosphate, the pentose required for nucleotide synthesis. The remaining reactions involve the transfer of Cz- and Crunits from one sugar to another. Intermediates having 3, 4, 5, 6, and 7 carbons are involved. The key enzymes in the transfer reactions are transketolase and transaldolase. Transketolase transfers C2 -units, using thiamine pyrophosphate as a Cz-carrier between donor and acceptor. Transal-dolase transfers C3 units. The major function of the non oxidative phase is to provide a pathway for recycling excess pentoses. This is particularly important in tissues that require larger amounts of NADPH than pentoses. The recycling is achieved by the formation of fructose-6-phosphate, a common intermediate in the HMP shunt and glycolysis. Fructose-6-phosphate can be isomerized back to glucose-6-phosphate and reused. For every 6 mols of glucose-6-phosphate used in the HMP shunt, 6 mols of CO 2 are produced and 5 mols of fructose-6-phosphate can be returned to glycolysis. C. Regulation of the HMP shunt. The rate-limiting step in the pathway is the initial reaction cat-
alyzed by glucose-6-phosphate dehydrogenase. The amount of this enzyme present in liver and adipose increases when the diet contains large amounts of carbohydrate, a condition that leads to fatty acid synthesis and an increased requirement for NADPH. Glucose-6-phosphate dehydrogenase is allosterically activated by NADP+ and inhibited by NADPH and palmitoyl-CoA.
FRUCTOSE METABOLISM Fructose is second to glucose as a dietary source of carbohydrates. It is mostly derived from the hydrolysis of sucrose in the brush border of the small intestine. The primary site of fructose metabolism is the liver. As the portal blood enters the liver, fructose is very efficiently removed and metabolized by the liver. The liver has three enzymes (fructokinase, aldolase B, and glyceraldehyde kinase) that convert fructose into triose phosphates, intermediates in glycolysis. Because these reactions bypass the rate-limiting step in glycolysis, fructose is metabolized to pyruvate and acetyl-CoA much more rapidly than is glucose. The enzymes of glycolysis, gluconeogenesis, and glycogenesis also allow dietary fructose to be converted to blood glucose or glycogen. The very rapid phosphorylation of fructose by fructokinase may result in a transient decrease in intracellular phosphate concentrations and a diminished ability to synthesize ATP. A. Pathway and key enzymes of fructose metabolism. The metabolism of fructose starts with the conversion to fructose-I-phosphate by fructokinase (Figure 1-4-21). Fructose-I-phosphate is split into two C3 fragments by aldolase B, producing dihydroxyacetone phosphate and glyceraldehyde. Glyceraldehyde can be phosphorylated to glyceraldehyde-3-phosphate by triose kinase. Alternatively, glyceraldehyde can be reduced to glycerol and used for gluconeogenesis or for triacylglycerol synthesis. Both dihydroxyacetone phosphate and glyceraldehyde-3phosphate are intermediates in glycolysis. They can be further degraded by glycolysis, or they be condensed to fructose-I,6-bisphosphate and used for gluconeogenesis or glycogenesis.
Note Transketolase is used to diagnose thiamine deficiency by measuring erythrocyte transketolase activity upon addition of thiamine pyrophosphate.
Clinical Correlate Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked recessive disorder causing t NADPH production -7 a hemolytic anemia. Microscopic examination of erythrocytes reveals the presence of "Heinz bodies," small, dark inclusion bodies of precipitated hemoglobin. Oxidizing agents such as sulfonamides, aspirin, and antimalarial and antituberculous drugs t the amount of superoxide and hydrogen peroxide in the blood. The lack of NADPH -7 a lack of reduced glutathione, which is needed to neutralize the toxic effects of these substances. These agents can therefore aggravate the hemolytic anemia.
In a Nutshell Hexose Monophosphate Shunt • Produces ribose-5phosphate for nucleotide synthesis • Reactions occur in cytoplasm • Produces NADPH for use in anabolic processes (e.g., fatty acid biosynthesis) • Does not produce or consume ATP
meClical
61
Biochemistry
Dihydroxyacetone-P Fructokinase Fructose
)I
Aldolase-8
Fructose-1-P
-----<
ATP
I\
Glyceraldehyde
NADH
~
Glycolysis
ATP Triose kinase
Clinical Correlate Hereditary fructose intolerance (HFI) results from a deficiency of aldolase B, the enzyme that cleaves fructoseI-phosphate to glyceraldehyde and dihydroxyacetone phosphate. This results in an accumulation of fructose-Iphosphate in the liver, which inhibits glycogen phosphorylase and aldolase. Glycogenolysis and gluconeogenesis are thereby both impaired, resulting in severe hypoglycemia and vomiting. Symptoms are reversed after removing fructose and sucrose from the diet.
Clinical Correlate Galactosemia is an autosomal recessive disease resulting from a deficiency in either galactokinase or galactose-Iphosphate uridyl transferase. In both deficiencies, galactose accumulates and is converted to galactitol in the nervous system (retardation) and lens of the eye (cataracts). In the uridyl transferase deficiency, galactose-I-phosphate accumulates in the liver, resulting in hepato-megaly. Treatment requires excluding galactose (and lactose) from the diet.
62
meclical
Glycerol Glyceraldehyde-3-P
Figure 1-4-21. Fructose metabolism by the liver.
B. Abnormalities in frnctose metabolism arise from deficiencies in fructokinase and aldolase B, enzymes unique to fructose catabolism. A deficiency in fructokinase results in essential fructosuria, a benign condition in which fructose appears in the blood and urine and is excreted intact. A deficiency in aldolase B results in hereditary fructose intolerance.
GALACTOSE METABOLISM The primary source of galactose is milk, which contains high amounts of lactose. The concentration of lactose is higher in human milk than in cow's milk, although the caloric intake is about the same. Lactose is hydrolyzed in the small intestine to glucose and galactose. The metabolism of galactose occurs almost entirely in the liver. Three enzymes (galactokinase, galI-P:glu-I-P uridyl transferase, and UDP-galactose-4-epimerase) are required to assimilate galactose into the central pathways of carbohydrate metabolism. A. Pathway and key enzymes of galactose metabolism. Galactose metabolism starts by phos-
phorylation to galactose-I-phosphate by galactokinase. All dietary galactose is phosphorylated in the liver (Figure 1-4-22). Galactose-I-phosphate is then exchanged for the glucose-Iphosphate moiety of UDP-glucose. This reaction is catalyzed by "uridyl transferase" and results in glucose-I-phosphate and UDP-galactose. Finally, UDP-galactose is recycled to UDP-glucose by UDP-galactose-4-epimerase. The overall effect of these three reactions is to convert dietary galactose into glucose-I-P. Through pathways already considered in this chapter, glucose-I-phosphate can be incorporated into glycogen or converted to glucose-6-phosphate. The glucose-6-phosphate can be hydrolyzed by glucose-6-phosphatase to release glucose into the blood, or it can be used by glycolysis to produce pyruvate.
Galactokinase Galactose
( ATP
'lp
,.
Uridyl. transferase Galactose-1-P
7 '\ ,.
UDP-Glu
Glucose-1-P
UDP-Gal
V
4-epimerase
Figure 1-4-22. Metabolism of galactose by liver.
Lipids
Lipids are biologically important compounds that are structurally and functionally diverse. They can be classified into six major groups: fatty acids, triacylglycerols, ketone bodies, cholesterol, phospholipids, and sphingolipids. Each class of lipids plays a specific role in either energy production, transport, and storage, or as a structural component of cell membranes. Numerous diseases, including obesity, diabetes, hyperiipoproteinemias, and sphingolipidoses, are characterized by abnormalities in lipid transport and/or metabolism. Other minor classes of lipids, including bile acids, fat-soluble vitamins, and eicosanoids play important roles in normal body function as well as in certain disease states. This chapter describes the major classes of lipids, their cellular functions, and the metabolic pathways that connect them.
CLASSIFICATION OF LIPIDS The major classes of lipids and their functions are listed in Table 1-5-1. A brief description of the major structural features of each class follows the table. Table 1-5-1. Major classes of lipids and their metabolic functions. Lipid
Function
Fatty acids
Metabolic fuel; building block for triacylglycerol, phospholipids, and sphingolipids
Triacylglycerols
Storage depot and major transport form for fatty acids
Ketone bodies
Soluble metabolic fuel for skeletal muscle, cardiac muscle, kidney, and brain
Cholesterol
Structural component of plasma membrane; precursor of bile acids, vitamin D, and steroid hormones
Phospholipids
Major building block of membranes; storage site for polyunsaturated fatty acids; signal transduction pathways
Sphingolipids
Structural component of membranes; surface antigens
A. Fatty acids are composed of a long hydrocarbon chain with a carboxyl group at one end. They are amphipathic molecules, containing both polar and nonpolar ends. Fatty acids can be described using two different numbering systems. The C-numbering system starts at the carboxyl end, and the co-numbering system starts at the methyl end. The a-carbon is adjacent to the carboxyl group. Fatty acids are frequently identified as either "saturated" or "unsaturated" depending upon the absence or presence of double bonds, respectively.
meClical
63
Biochemistry
1. Saturated fatty acids contain no double bonds. The most common saturated fatty acids
are palmitic and stearic acid. Their formulae and those of other fatty acids found in human tissues are listed Table 1-5-2. Table 1-5-2. Length and structure of common saturated fatty acids.
Fatty acid
Length
Structure
Acetic
C2
CH3-COOH
Propionic
C3
CH3-CH-COOH
Butyric
C4
CH3-(CH2)2-COOH
Lauric
C l2
CH3-(CH 2)1O-COOH
Myristic
C l4
CH3-(CH2)12-COOH
Palmitic
C I6
CH3-(CHJI4-COOH
Stearic
CH3-(CH2)16-COOH
Arachidic
CIS C20
Lignoceric
C24
CH3-(CH2)22-COOH
CH3-(CH 2 )IS-COOH
2. Unsaturated fatty acids contain one or more double bonds in the cis-configuration. a. Monounsaturated fatty acids contain one double bond. The most common monounsaturated fatty acid is the I8-carbon oleic acid, which has one double bond between carbons 9 and 10: CH 3-(CH 2h-CH=CH-(CH 2h-COOH.
Clinical Correlate A deficiency of essential fatty acids (linoleic and linolenic acids) is seen in patients on long-term intravenous hyperalimentation with no intravenous fat supplementation.
b. Polyunsaturated fatty acids contain two or more double bonds. (1) Linoleic acid is an I8-carbon (0-6 fatty acid with two double bonds. It is an essential fatty acid because it must be obtained from dietary sources.
(2) Linolenic acid is an I8-carbon (0-3 essential fatty acid with three double bonds. CH3-CH2-CH=CH-CHz-CH=CH-CHz-CH=CH-( CH2)7-COOH
(3) Arachidonic add is a 20-carbon (0-6 fatty acid with four double bonds. It can be synthesized by humans from linoleic acid via elongation and desaturation reactions. If linoleic acid is deficient in the diet, arachidonic acid becomes an essential fatty acid. B. Triacylglycerols (TAG) contain a glycerol backbone with three fatty acids linked as esters
(Figure 1-5-1). This is the most common storage form for fatty acids.
64
meClical
Lipids
o II CH 2-O-C-R
~
I
R'-C-O-CH
~
I
CH2-0-C-R" Glycerol
Fatty Acids
Figure 1-5-1. Triacylglycerol.
Removal of one fatty acid generates a diacylglycerol, which acts as a second messenger in the phosphatidylinositol signal transduction pathway. Removal of fatty acids from both ends of the triacylglycerol molecule results in 2-monoglyceride, the end product of TAG digestion in the small intestine. C. Ketone bodies are C4 acids that have either a keto or a hydroxyl group attached to the p-
carbon atom. The two major ketone bodies are acetoacetic acid and p-hydroxybutyric acid (Figures 1-5-2 and 1-5-3).
o II
0
II
CH 3-C-CH 2-C- OH Figure 1-5-2. Acetoacetic acid.
H
0
I II CH -C-CH -C- OH 3 I 2 OH
Clinical Correlate Arachidonic acid is the major precursor for prostaglandins, thromboxanes, and leukotrienes, which act as local hormones and play critical regulatory roles in human physiology. The biologic action of these compounds is different for each organ system. Platelet aggregation is controlled by the antagonistic effects of prostaglandins and thromboxanes; leukotrienes are important mediators of inflammation and allergic responses. A deficiency in arachidonic acid and an overproduction of eicosanoids from arachidonic acid both result in a diverse group of symptoms.
Clinical Correlate Ketone bodies are synthesized from fatty acids and amino acids in the liver during prolonged starvation and diabetic ketoacidosis. They are excreted in the urine, but p-hydroxybutyric acid will not show up on a urine ketone test. Patients with excess ketones present with a fruity breath odor.
Figure 1-5-3. I3-Hydroxybutyric acid.
D. Cholesterol and sterol derivatives contain a common steroid nucleus-a fused fourmember ring system that contains 19 carbon atoms (Figure 1-5-4). Cholesterol, a 27-carbon compound (Figure 1-5-5), is the precursor for vitamin D (C 27 ), bile acids (C24 ), adrenocortical hormones (C21 ), progesterone (C21 ), androgens (C I9 ), and estrogens (CIS).
meClical
65
Biochemistry
18
16 2 3
4
6
Figure 1-5-4. Steroid nucleus.
Clinical Correlate Respiratory distress syndrome (ROS) occurs in preterm newboms due to the inability of the premature lung to synthesize dipalmitoylphosphatidylcholine, the active component of pulmonary surfactant. This lipid, which is normally synthesized shortly prior to parturition, forms a film that lines the alveoli and reduces the surface tension of the aqueous layer, thereby preventing the alveoli from collapsing during exhalation. Symptoms at birth include hypoxia, acidosis, and pulmonary edema. The maturity of the fetal lung can be assessed prenatally by measuring the ratio of dipalmitoylphosphatidylcholine/ sphingomyelin in amniotic fluid. Glucocorticoids (dexamethasone) can be used to induce production of dipalmitoylphosphatidylcholine and develop the lungs more quickly.
66
KAPLA~.
meulCa
OH Figure 1-5-5. Cholesterol.
E. Phospholipids are amphipathic molecules consisting of two alcohols linked by a phosphodiester bridge. Diacylglycerol, the alcohol common to all of the phospholipids, is the nonpolar structural component of membranes. The second alcohol forms the polar head of phospholipids. Each class of phospholipids is distinguished by the polar head. Choline, ethanolamine, and serine are amino alcohols, whereas inositol is a polyol. The four most important glycerol-based phospholipids can all be represented by the structure shown in Figure 1-5-6, where the nature of X is unique for each phospholipid. The names of these phospholipids, the nature of X, and its structure are given in Table 1-5-3.
o o II
II
CH -O-C-R
I
2
1
R -C-O-C-H 2
I
0
II
CH2 - 0- P- 0---0 Polar Head I
I
I 0-
I
I
Phosphodiester Bridge Figure 1-5-6. Glycerol-based phospholipid.
I -------------------
Lipids
Table 1-5-3. The unique polar heads of selected glycerol-based phospholipids. Phospholipid
x
Structure
Phosphatidylethanolamine (cephalin)
Ethanolamine
HO-CHz-CHz-NH 3
Phosphatidylcholine (lecithin)
Choline
HO-CHz-CHz-N(CH 3h
Phosphatidylserine
Serine
HO-CHz-CH-NH 3 tOOH
HoH OH
Phosphatidylinositol
Inositol
OH
HH OH
In membranes, the polar head group faces the aqueous environment, and the fatty acid groups of diacylglycerol constitute the lipid bilayer. F. Sphingolipids and glycolipids contain ceramide as a common structural component. Ceramide is composed of sphingosine, a long-chain amino alcohol with a saturated fatty acid linked to the amino group (Figure 1-5-7). The classes of sphingolipids and glycolipids can be differentiated on the basis of the X-group that is esterified to the terminal hydroxyl group of ceramide (Table 1-5-4).
Sphingosine OH
I
CH3 -(0-' 1'2 ) 12 -CH-CH-CH-CH-CH -01--1)(\ I 2 \C)
NH
[c=o I
Fatty Acid
~
Figure 1-5-7. Sphingolipids and glycolipids.
Table 1-5-4. The unique X-groups of selected spbingolipids and glycolipids. Sphingolipid or Glycolipid
X
Location
Sphingomyelin
Phosphocholine
Myelin sheath
Cerebrosides
Single hexose
Brain, peripheral nerve
Sulfatide
Galactose-SO 4
Nerve tissue
Globoside
Oligosaccharide
RBC membrane
Ganglioside
Oligosaccharide with
Ganglion cells
N -acetylneuraminic acid
IlAPLA~. I meulCa
67
Biochemistry
LIPOPROTEINS The metabolism of lipids frequently requires that a particular lipid be transported in the blood between different organs. Free fatty acids are transported by serum albumin, whereas the neutral lipids (triacylglycerol and cholesterol esters) are transported by lipoproteins.
Bridge to Pharmacology Fatty acids
t Bind strongly to serum albumin
A. Structure and composition. Ail lipoproteins consist of a hydrophilic shell and a hydrophobic core. The hydrophilic shell contains proteins, phospholipids, and unesterified cholesterolamphipathic molecules that interact favorably with both the aqueous environment and the inner core. The hydrophobic core contains the neutral lipids, triacylglycerols, and cholesterol esters, which are highly insoluble in water. A model for the structure of lipoproteins is shown in Figure 1-5-8.
Displace drugs that bind to albumin
phospholipid apoprotein cholesterol
Increase bioavailability of drug
Figure 1-5-8. Lipoprotein structure.
B.
Classes. The four major classes of lipoproteins in human serum can be separated by electrophoresis on the basis of their size and charge or by centrifugation on the basis of their density. A typical electrophoretogram is shown in Figure 1-5-9, and a typical centrifugal separation is shown in Figure 1-5-10.
HDL Density in g/mL Chylomicrons <1.006
c:
o
e
VLDL
~
'00 c:
C>
'E
VLDL
LDL
origin
Chylomicrons
"0
g/mL
LDL
1.006-1.063
HDL
1.063-1.210
e Figure 1-5-9. Lipoprotein electrophoresis.
68
meClical
0.95-1.006
Q)
Figure 1-5-10. Lipoprotein centrifugation.
Lipids
1. Chylomicrons are the least dense of the lipoproteins and do not migrate in an electric
field. They are formed in intestinal mucosa and transport dietary triacylglycerol (TAG) and cholesterol ester (CE). Chylomicrons are synthesized in the smooth ER of intestinal epithelial cells and secreted into the lymphatics. The TAGs in chylomicrons are hydrolyzed by lipoprotein lipase, an enzyme attached to the luminal surface of the vasculature of cardiac muscle, skeletal muscle, and adipose tissue. Chylomicrons contain several apoproteins, including apo B 48 , apo E, and apo C-II. Apo B48 is unique to chylomicrons; apo C-II activates lipoprotein lipase, resulting in fatty acid release to heart, skeletal muscle, and mammary glands. The presence of apo E facilitates the clearance of chylomicron remnants by the liver. Apo B48 is present in the nascent chylomicron; apo C-II and apo E are aquired from HDL following secretion. 2. Very low-density lipoproteins (VLDLs) are synthesized in the liver and transport TAG and CE. VLDLs are composed mainly of TAG, yet they are more enriched in CE than are chylomicrons. VLDLs contain apo B lOO , apo E, and apo C-IL Like chylomicrons, VLDLs are metabolized by lipoprotein lipase to produce remnants (intermediate-density lipoproteins [IDLs 1). These remnants can be further metabolized to particles of still lower density, or they can be internalized by the liver. 3. Low-density lipoproteins (LDLs) are generated from VLDLs and IDLs by the action of lipoprotein lipase, thus increasing the relative proportion of cholesterol esters in the neutral core. The major function of LDL is to transport cholesterol to extrahepatic tissues, where it is taken up by receptor-mediated endocytosis. The LDL particle retains onlyapo B lOO , and the uptake of LDL by cells is initiated by the interaction of apo BlOO with LDL receptors on the plasma membranes. 4. High-density lipoproteins (HDLs) are synthesized by the liver and are approximately 50% protein. When the particle is secreted by the liver, the core region is relatively empty. HDLs perform two major functions:
Clinical Correlate A deficiency in lipoprotein lipase will result in hyperchylomicronemia, or type I hyperiipoproteinemia.
Clinical Correlate Familial hypercholesterolemia (FH), or type II hyperiipoproteinemia, arises as a result of defective LDL receptors and is characterized by elevated LDL cholesterol. A positive correlation exists between elevated plasma concentration of LDL and coronary atherosclerosis.
a. Circulating reservoir for apoproteins. Members of the apo C and apo E families can be transferred back and forth between other lipoproteins. Newly synthesized chylomicrons and VLDL particles obtain some of their apoproteins from the HDL reservoir following secretion. b. Reverse cholesterol transport. HDLs are important in moving cholesterol from extrahepatic tissues to the liver. Elevated plasma levels ofHDL are associated with decreased incidence of coronary atherosclerosis. Cholesterol is taken up from the surface of cells by HDL, esterified to cholesterol esters, and ultimately returned to the liver either by uptake ofHDL particles by the liver or by the transfer of cholesterol esters to VLDL and chylomicron remnants followed by remnant uptake. Two proteins play important roles in reverse cholesterol transport: (1) Lecithin cholesterol acyl transferase (LCAT) is a plasma enzyme that esterifies HDL cholesterol. The fatty acid used for esterification comes from lecithin (phosphatidykholine). LCAT is activated by apo A-I, which is associated with HDL.
(2) Cholesterol ester transfer protein (apo D) is associated with HDL and facilitates the transfer of cholesterol esters to VLDL and chylomicron remnants in exchange for triacylglycerol.
In a Nutshell Apoprotein Function apo A
apo
B48
apo
B100
Reverse cholesterol transport Chylomicron clearance from serum LDL clearance from serum
apo C-II
Activation of lipoprotein lipase
apo D
Reverse cholesterol transport
KAPLA~.
meulCa
I
69
Biochemistry
C. Abnormalities of lipoprotein metabolism may result in either elevated or decreased plasma
concentrations of certain lipoproteins and associated lipids. 1. Hyperlipoproteinemias. Disorders of lipoprotein excess may be primary (hereditary) or secondary to a systemic illness such as diabetes, hypothyroidism, or extremely high saturated fat intake. Table 1-5-5 illustrates the different types of hyperlipoproteinemias, their mode of inheritance, the type of lipid and lipoproteins that accumulate, and the associated relative risk of atherosclerosis.
Table 1-5-5. Types of hyperlip oproteinemias. Type
Mode of Inheritance
1 IIa lIb
Autosomal recessive Autosomal dominant
III
?? Heterogeneous Heterogeneous
IV V
Increased Lipid and Lipoprotein Concentration
Atherosclerosis Relative Risk
TAG, chylomicrons, VLDL Cholesterol, LDL TAG, VLDL, LDL Cholesterol, TAG, VLDL TAG,VLDL TAG, VLDL, chylomicrons
+/+++ +++ ++ +/+/-
2. Hypolipoproteinemias. There are two major disorders originating from a deficit of lipoprotein. a. Abetalipoproteinemia is an autosomal recessive condition characterized by the absence of betalipop rote ins (apo B48 and apo BIQo). Chylomicrons and VLDLs are not formed, and lipid accumulates in intestinal cells and liver. Clinically, this results in ataxia, mental retardation, retinitis pigmentosa, and accumulation of acanthocytes in the blood. b. Familial alpha-lipoprotein deficiency (Tangier disease) is characterized by the absence of apo A. Serum levels of cholesterol and HDL are low, whereas triacylglyerol associated with chylomicion and VLDLs are elevated. Neurologic deterioration and hepatomegaly and large orange tonsils are the clinical sequelae.
FATTY ACID METABOLISM There are six major pathways of fatty acid and lipid metabolism. Fatty acids are synthesized from excess carbohydrate in liver and adipose tissue. They are stored as triacylglycerols in adipose tissue when nutrition is sufficient, and are mobilized from triacylglycerol and released into the blood during fasting or exercise. Most of the free fatty acids that are released from adipose tissue are carried by serum albumin to skeletal muscle, cardiac muscle, and liver, where they undergo P-oxidization to provide energy to the tissues. Cholesterol and ketones are synthesized from acetyl-CoA. Ketones are utilized as a metabolic fuel, and fatty acids are used to synthesize specialized products, such as phospholipids, sphingolipids, glycolipids, and prostaglandins. An overview of these pathways is outlined in Figure 1-5-11.
70
KAPLANct· •
me lea
I
--
----
------
---
Lipids
Carbohydrates -
Pyruvate
___~.I AcetYI_COA~ICitrateJ .#
l
/' /' Acetoacetyl-CoA
///////////
/' Oxidation for fuel __
L
()v!>I",
Oxaloacetate
\
TCAcyde
~-Hydroxy-~-methylglutaryl
(HMG)-CoA
-I
1 Lipolysis 1 ~ Triacylglycerols
===: I
Fatty acids 1
r.P~h:-o-s-p-:h""'o-:li:-p-:-id-:-S"'+ proteins_
Lipoproteins
ISphingolipids I IGlycosphingolipids I IProstaglandins I Figure 1-5-11. Interrelationship of pathways of fatty acid metabolism.
The pathways in Figure 1-5-11 that predominate at any time are determined largely by the insulin/glucagon ratio. An increase in the insulin/glucagon ratio (due to insulin secretion when blood glucose is high) favors lipid synthesis and storage, whereas a decrease in the insulin/glucagon ratio (due to glucagon secretion when blood glucose is low) favors fatty acid mobilization and l3-oxidation to generate energy. Many of these effects are mediated by the antagonistic effects of glucagon and insulin on the intracellular concentration of cAMP (glucagon increases cAMP and insulin decreases cAMP). Under conditions where excessive fatty acid oxidation is occurring and acetyl-CoA accumulates, ketone synthesis occurs as a means of converting acetyl-CoA into a soluble fuel that can be readily transported in the plasma. The key steps of these pathways, as well as the mechanism by which the pathways are regulated and coordinated, will be discussed separately. A. Fatty acid synthesis. In humans, fatty acids are synthesized from acetyl-CoA, bicarbonate, and NADPH. The reactions that occur are essentially a reversal of l3-oxidation, with two distinctions: the two processes use different enzymes and occur in different cellular compartments. Fatty acid synthesis occurs in the cytosol, whereas l3-oxidation occurs in mitochondria. Humans can synthesize all of the required fatty acids except linoleic acid and linolenic acid, which are therefore essential dietary requirements. Before fatty acid synthesis can begin, acetyl-CoA must be translocated from the mitochondria, where it is produced, to the cytosol, where it is utilized. Because the inner mitochondrial membrane is impermeable to acetyl-CoA, the citrate shuttle is used to carry acetyl-CoA from the mitochondrial matrix to the cytosol. The key steps of the citrate shuttle are shown in Figure 1-5-12.
KAPLAlf I med lea
71
---
Biochemistry
Inner mitochondrial membrane Mitochondrial matrix
pyruvate -
Cytosol
acetyl-co/citrate --t--+-..... citrate oxaloacetate \
\ )
~~
1~
oxaloretate ace.TI-coA -
fatty acids
malate t-NADPH
pyruvate,...-----t--+-- pyruvate
Figure 1-5-12. The citrate shuttle.
Citrate is formed in the mitochondria from oxaloacetate and acetyl-CoA and then transported into the cytosol. Once in the cytosol, citrate is cleaved by citrate lyase to form acetyl-CoA and oxaloacetate, which is converted through two sequential reactions to pyruvate. Pyruvate is returned to the mitochondria, where it is carboxylated to oxaloacetate to complete the shuttle. The citrate shuttle also produces NADPH, another factor required for fatty acid synthesis. About half of the NADPH for fatty acid synthesis is supplied by the pentose phosphate pathway. 1. Key enzymes in fatty acid synthesis
a. Acetyl-CoA carboxylase catalyzes the first step in fatty acid synthesis. The enzyme requires the presence of both biotin and bicarbonate for converting acetyl-CoA to malonyl-CoA (Figure 1-5-13). Malonyl-CoA is a three-carbon compound that serves as the donor of two-carbon units in the elongation of the fatty acid chain.
o
Acetyl-CoA 0 _ Carboxylase II II CH3 C- 5-CoA + HC03 + ATP • HOOC -CH2 - C -5 -CoA + ADP + Pi (Biotin) Acetyl-CoA
Malonyl-CoA
Figure 1-5-13. The conversion of acetyl-CoA to malonyl-CoA.
b. Fatty acid synthase (FAS) is a multienzyme complex that catalyzes all of the remaining reactions. It lengthens the fatty acyl-CoA being synthesized by the sequential addition of two-carbon units to the carboxyl end. After each addition, it reduces the product to a fully saturated acyl group. All of the reactions occur while the intermediates are covalently bound as thioesters to either acyl-carrier protein (ACP) or to the condensing enzyme (synthase). Each cycle adds a two-carbon unit and uses two molecules of NADPH to reduce the ketoacyl intermediate to a fully saturated fatty acid. Each cycle consists of the four sequential reactions shown in Figure 1-5-14.
72
iii8Cuca1 - - - _.._ - _ . _ - - - - - _. ._ - - - - - - _
..
__
..
_--
._--
Lipids
a
a
II
II
CH 3 -C -S -Synthase + HaaC -CH2 -C -S - ACP (1 )
Acetyl-S-Synthase
Malonyl-S-ACP
Acetoacetyl-S-ACP
t
r--NADPH
(2)
o II
NADPH
)
CH 3 -CH2 -CH2 -C -S - ACP ....."',...---""''-(4)
Butyryl-S-ACP
H
a
I
II
(3)
CH 3 -C =~ -C -S - ACP '"
co::
aH
a
I
II
CH 3 -CH-CH 2-C -S-ACP
H Crotonyl-S-ACP
[3-Hydroxybutyryl-S-ACP
Figure 1-5-14. The enzymatic actions of FAS.
At the end of the first cycle, butyryl-CoA is transferred onto the synthase so that the acyl carrier protein can be recharged with another molecule of malonyl-CoA and a new cycle can begin. Each cycle consists of the following four reactions: (1) Condensation of malonyl-CoA with fatty acyl-CoA to produce a ~-ketoacyl CoA intermediate.
(2) Reduction of ~-ketoacyl-CoA to reaction.
~-hydroxyacyl-CoA
in an NADPH-dependent
(3) Dehydration of ~-hydroxyacyl-CoA to produce enoyl-CoA with a double bond. (4) Reduction of the double bond by NADPH to produce a fatty acyl-CoA that has been lengthened by two carbons. This cyclic pattern is repeated until palmitoylCoA, the product of the FAS complex, is formed. 2. Elongation and desaturation reactions convert palmitate into a variety of fatty acids that are required for use by the normal cell. These reactions, which occur primarily in the endoplasmic reticulum, rely upon the use of malonyl-CoA for elongation. Elongation can also occur in the mitochondria, where acetyl-CoA, instead of malonyl-CoA, is used. Desaturation occurs in the endoplasmic reticulum and requires a multienzyme complex that contains cyt b s and cyt b s reductase. 3. Regulation of fatty acid synthesis depends on the availability of substrates and the activity of acetyl-CoA carboxylase, the enzyme that catalyzes the first step in the initial reaction converting acetyl-CoA to malonyl-CoA. This reaction is the rate-limiting step in fatty acid synthesis. Acetyl-CoA carboxylase is activated by citrate, insulin, and a high-carbohydrate, low-fat diet; it is inhibited by fatty acids, glucagon, and a high-fat diet. Acetyl-CoA carboxylase is inactivated by cAMP-dependent phosphorylation and activated by insulindependent dephosphorylation. The synthesis of both acetyl-CoA carboxylase and fatty acid synthase complex is induced by insulin. B. Fatty acid oxidation. Most fatty acid oxidation occurs in the mitochondria, although peroxisomes are important in the oxidation of very long-chain fatty acids and branched-chain fatty acids. A separate set of enzymes oxidizes fatty acids in peroxisomes.
In a Nutshell Fatty Acid Synthesis • Occurs in cytosol • Citrate shuttle (acetyl-CoA transport to cytoplasm, NADPH production) • Acetyl-CoA carboxylase: - first step/rate-limiting step - produces malonyl-CoA (C2 donor) - uses 1 ATP - activated by citrate, insulin - inhibited by palmitoylCoA, glucagon • Fatty acid synthase: - lengthens fatty acid chain by two carbons from carboxy terminus - reduces ketone to full saturation - uses 2 NADPH • Synthesis stops at C16 palmitoyl-CoA; needs microsomes from endoplasmic reticulum to elongate past C16 • Synthesis of palmitoyl-CoA requires 7 ATP and 14 NADPH KAPLA~.
meulCa
I
73
Biochemistry
1. Uptake and oxidation of fatty acids. The uptake and oxidation of fatty acids by cells can
be divided into three major stages: activation, the transfer of fatty acids into the mitochondria, and ~-oxidation of fatty acids. a. Activation. Fatty acids are converted to fatty acyl-CoA immediately upon entry into the cell. This reaction traps the fatty acid in the cell and generates a high-energy thioester bond with CoA-SH. The reaction is catalyzed by fatty acyl-CoA synthetase (thiolase) and is driven by the hydrolysis of pyrophosphate.
o
0 II
II
CH3-(CH2)n-C-OH + COA-SH + ATP
.. CH3-(CH2)n-C-S-CoA+AMP + P-P Fatty acyl-CoA Synthetase ,
I
2Pi
b. Transfer of fatty acids into mitochondria. Fatty acids having a chain length of C l2 or greater enter the mitochondria via the carnitine shuttle, which consists of two enzymes (i.e., carnitine-acyl transferase-land carnitine-acyl transferase-II) and one transporter (i.e., carnitine translocase).
Clinical Correlate
(1) Carnitine-acyl transferase-I (CAT-I) is associated with the outer surface of the inner mitochondrial membrane. It transfers the fatty acid from fatty acyl-CoA to
A deficiency in medium chain acyl dehydrogenase (MCAD) is the most common inborn error of fatty acid metabolism. Onset usually occurs in infancy. Symptoms include vomiting, lethargy, and hypo kinetic hypoglycemia. A deficiency in carnitine or CAT-l results in weakness, hypotonia, and hypo ketotic hypoglycemia
carnitine to form fatty acyl carnitine. (2) Carnitine translocase transports fatty acyl carnitine into the mitochondria and
transports free carnitine back out of the mitochondria. (3) Carnitine-acyl transferase-II (CAT-II) is associated with the inner surface of the inner mitochondrial membrane. It catalyzes the reformation of fatty acyl-CoA in the mitochondrial matrix. c. ~-oxidation of fatty acids involves the sequential removal of two-carbon fragments
from the carboxyl end. Each cycle of oxidation involves four reactions and generates one molecule each of acetyl-CoA, NADH, and FADH 2. The pathway is called ~ oxidation because the two oxidation steps that generate FADH2 and NADH both involve the ~-carbon atom. The key reactions are shown in Figure 1-5-15. (1) Dehydrogenation of the fatty acid forms a double bond between the a and ~ car-
bons in a reaction that generates FADH 2. This reaction is catalyzed by a family of fatty acyl-CoA dehydrogenases that differ in specificity for fatty acid chain length: long-chain acyl dehydrogenase, medium-chain acyl dehydrogenase, and shortchain acyl dehydrogenase. The complete oxidation of long-chain fatty acids requires all three dehydrogenases. (2) Hydration of the double bond produces ~-hydroxy-acyl-CoA.
74
KAPLAlfilme leaI
-------
----
----
Lipids
o II
FAD"
R -CH2 -CH2 -C -S -CoA
7:
2
H
0
Hp
I
II
l
R -C =C -C -S -CoA
I
(1 )
0
--.:::-.----+-. (2)
H Fatty acyl-CoA
II
R -CH -CH -C -S -CoA
I
2
OH
Enoyl-CoA
I3-Hydroxyacyl-CoA
(3)
o
0
II
II
R-C-S-CoA
+
CH3-C-S-CoA
CoA-SH
..J "-"'---'""'--
o II
~
NAD+ NADH
0 II
R -C -CH2 -C -S -eoA
(4)
Shorter Acyl-CoA
Acetyl-CoA
[3-Ketoacyl-CoA
Figure 1-5-15.13-0xidation of fatty acids.
(3) Dehydrogenation of f3-hydroxyacyl-CoA in an NAD+-dependent reaction generates 13-ketoacyl-CoA. (4) Thiolytic cleavage by the addition of CoA-SH to the f3-carbon releases acetylCoA and completes the cycle. The resultant acyl-CoA can start at step (1) and proceed through the cycle until it is completely degraded to acetyl-CoA units. d. Oxidation of fatty acids with an odd number of carbon atoms results in the production of one molecule of propionyl-CoA from the co-end of the fatty acid. This molecule is released during the final thiolytic cleavage cycle. Propionyl-CoA can be carboxylated to methylmalonyl-CoA and then converted to succinyl-CoA for entry into the TCA cycle for further metabolism. The oxidation of unsaturated fatty acids is also important because nearly 50% of human fatty acids are unsaturated. Unsaturated fatty acids in natural fat contain cis double bonds only, but the enzyme enoyl-CoA hydratase, which catalyzes the second reaction in the f3-oxidation cycle, acts only on trans double bonds. An auxiliary enzyme, cisll.3 -transll.2 enoyl-CoA isomerase, converts natural cis bonds to the trans configuration, allowing continued oxidation of the unsaturated fatty acid. 2. Energetics of f3-oxidation. Oxidation of palmitic acid (C 16 ) produces eight molecules of acetyl-CoA, seven molecules of NADH, and seven molecules of FADH 2. Further oxidation of acetyl-CoA by the TCA cycle and the electron transport chain results in the following stoichiometry for the oxidation of palmitic acid:
The net yield of usable energy resulting from the complete oxidation of one molecule of palmitic acid is 129 molecules of ATP. Because the respiratory quotient (RQ) is defined as moles of C02 produced divided by moles of O 2 consumed, the RQ for fatty acid oxidation is approximately 0.7. In contrast, the RQ for the complete oxidation of glucose is approximately 1.0.
In a Nutshell f3-0xidation of Fatty Acids • Occurs in mitochondria • Oxidizes f3-carbon atom • Activation uses 2 ATP per molecule • Carnitine transports fatty acid from the cytosol to the mitochondria - inhibited by malonyl CoA and insulin • Oxidation removes 2 carbons per cycle - 1 acetyl-CoA ~ TeA cycle - 1 FADH2 and 1 NADH ~5ATP
• Odd-carbon fatty acids - propionate (0) is carboxylated to methylmalonyl-CoA (C4) - methymalonyl-CoA + vitamin B12 ~ succinylCoA ~ TeA cycle • Unsaturated fatty acids - cis bonds ~ trans bonds, then oxidation continues
meClical
75
Biochemistry
Note Oxidation of fatty acids produces more energy than carbohydrate oxidation, with 9 kcal/g of fat versus 4 kcal/g of glucose.
3. Regulation of fatty acid oxidation is achieved by controlling the rate at which fatty acids enter the mitochondria. CAT-I is inhibited by malonyl-CoA, the first compound committed to fatty acid synthesis. This ensures that a futile cycle is not generated by simultaneous synthesis and oxidation of fatty acids. The rate of oxidation is also controlled by the rate at which fatty acids are released from triacylglycerol stores in adipose tissue. 4. Comparison of fatty acid synthesis and oxidation. The key differences between synthesis and oxidation offatty acids are summarized in Table 1-5-6.
Table 1-5-6. Comparison between synthesis and oxidation of fatty acids. Synthesis
~-Oxidation
Final product
Palmitate
Acetyl-CoA
Tissues involved
Adipose, liver
Muscle, liver
Subcellular localization
Cytoplasmic
Mitochondrial
Membrane transport
Citrate shuttle carries acetyl groups from mito matrix into cytosol
Carnitine shuttle carries fatty acids from cytosol into mito matrix
Cofactors
NADPH
NAD+,FAD
Effect of high insulin/ glucagon ratio
Pathway preferred
Pathway suppressed
Other regulators
Activated by citrate
Inhibited by malonyl-CoA
Rate-limiting enzyme
Acetyl-CoA carboxylase
CAT-I
Clinical Correlate Ketosis, the overproduction of ketones, occurs as a result of a high glucagon/insulin ratio during carbohydrate deficiency states, such as starvation, severe diabetes, and alcoholism. The acidic properties of the ketones lower the pH of the plasma, causing metabolic acidosis and decreased plasma bicarbonate levels.
C. Ketone body metabolism. The major ketone bodies are acetoacetatic and f3-hydroxybutyric acids, weak acids that dissociate to acetoacetate and f3-hydroxybutyrate at physiologic pH. Spontaneous decarboxylation of acetoacetate gives rise to acetone. These compounds are synthesized from acetyl-CoA by liver mitochondria when excessive amounts of fatty acids are being oxidized and glucose availability is limited. Ketone synthesis is inhibited when adequate carbohydrate is available. Ketones are used as fuel by extrahepatic tissues. 1. Ketone synthesis occurs in liver mitochondria via the reactions shown in Figure 1-5-16.
GoASH 2 Acetyl-GoA
Acetyl-GoA
-~~"---.. a
Acetoacetyl GoA
\...
a
• HMG-GoA
NADH
~-HYdroXYbutyrate ..(-J-,,---c Figure 1-5-16. Ketone synthesiS.
76
meCtical ---~----~.---~.------
b
~Acetyl-COA
Acetoacetate
Lipids
a. Condensation of three molecules of acetyl-CoA in two sequential reactions generates ~-hydroxy-~-methylglutaryl-CoA (HMG-CoA). Acetoacetyl-CoA is formed in the first reaction and acts as the substrate for the second. b. Cleavage of HMG-CoA produces acetoacetate and acetyl-CoA.
c. Reduction of acetoacetate to
~-hydroxybutyrate
consumes NADH.
2. Ketone use by extrahepatic tissues occurs in the mitochondria. Following the uptake of ketones, ~-hydroxybutyrate is oxidized back to acetoacetate. The fate of acetoacetate involves two sequential reactions as shown in Figure 1-5-17.
a
p-Hydroxybutyrate ( ' . . ) Acetoacetate --('-,;:::_.--) Acetoacetyl-GoA NAD+
Succinyl GoA
b
I/'
CoA-SH
r
2 Acetyl-GoA Figure 1-5-17. Ketone use.
a. Conversion of acetoacetate to acetoacetyl-CoA is catalyzed by an enzyme that transfers CoA-SH from succinyl-CoA to acetoacetate. The absence of this transferase in liver accounts for the inability of liver to use ketones as fuel. b. Thiolytic cleavage of acetoacetyl-CoA releases two molecules of acetyl-CoA. This reaction is catalyzed by thiolase, an enzyme of the ~-oxidation pathway. D. Triacylglycerol metabolism. Triacylglycerols are the most common storage and transport form for fatty acids derived from either dietary sources or de novo synthesis. The synthesis and degradation of triacylglycerols involves formation and hydrolysis of the ester bonds between fatty acids and the glycerol backbone. The conditions that promote lipogenesis are a highcarbohydrate diet and elevated insulin/glucagon ratio. Fasting, exercise, and a decreased insulin/glucagon ratio promote lipolysis.
Note
The fruity breath odor commonly seen in patients with ketosis is caused by the ventilation of acetone (produced by the decarboxylation of acetoacetate).
1. Triacylglycerol synthesis occurs primarily in liver and adipose tissue. Synthesis requires glyc-
erol phosphate, which is formed by the reduction of dihydroxyacetone phosphate (DHAP), an intermediate in glycolysis. Fatty acids are transferred from fatty acyl-CoA to carbons 1 and 2 of the glycerol backbone by fatty acyl transferase. Hydrolysis of the phosphate bond at carbon3 generates diacylglycerol, which is then esterified with a third fatty acid, producing triacylglycerol. A summary of triacylglycerol synthesis is shown in Figure 1-5-18.
meClical
77
Biochemistry
E
o
o
GHpH
I
GH2 0H
I
NADH \.
G=O
I
-",",,--~.
HG-OH
I
GH 20-®
II
--C -R FA-GoA \. --...-.....---.. H OH ------.. FA-GoA \.
GH2 -O-®
O-®
Glycerol Phosphate
Dihydroxyacetone-®
t
II 0 -C -R'
O-®Phosphatidic
Lysophosphatidic acid
I
o-ColI -R
t
o
glycolysis
o ~ -R
FA-GoA
o ~ -R'
~O(-_/~
t
II
o-c -R
®
o
II
glucose
acids
u
Triacylglycerol
t
II
O~_R II O-C -R' OH
Diacylglycerol
Figure 1-5-18. Triacylglycerol synthesis.
2. Triacylglycerol hydrolysis involves a family of lipases that differ in their localization and specificity. A summary of triacylglycerol hydrolysis is shown in Figure 1-5-19.
intestinal lumen (dietary) TAG intestinal lumen
jpa",..",
intestinal mucosal cell
llpas'
fatty acids + 2-monoglyceride
diffusion
lymphatics I
1 Iblood streaml endothelial lipoprotein lipase
I
+~------------~+~------~--~+ glycerol fatty acid chylomicron remnants
::c
~
t
glucose synthesis
I'We'1 bile Jnthesis
TAG synthesis sensitive lipase
Figure 1-5-19. Summary of triacylglycerol hydrolysis.
78
me leaI KAPLAlfd-
Lipids
a. Pancreatic lipase hydrolyzes dietary triacylglycerol in the small intestine. Hydrolysis occurs at positions 1 and 3, resulting in the release of two molecules of fatty acid and 2-monoglyceride. These compounds diffuse into the intestinal mucosal cells, where they are re-esterified to triacylglycerol and incorporated into chylomicrons. The chylomicrons are released into the lymphatics and enter the bloodstream. b. Lipoprotein lipase (LpL) is produced by the endothelial cells of the vasculature in adipose and muscle tissue. It hydrolyzes triacylglycerols in chylomicrons and VLDLs into free fatty acids and glycerol. The fatty acids are taken up by adipose and muscle tissue. In adipose tissue they are re-esterified into triacylglycerols for storage. In muscle, the free fatty acids are oxidized for energy. The glycerol produced by the action of lipoprotein lipase is taken up by liver. The chylomicron remnants, emiched in cholesterol, are taken up by the liver where the cholesterol can be converted to bile acids or repackaged into VLDLs. c. Hormone-sensitive lipase is found primarily in adipose tissue where it hydrolyzes the first fatty acid from triacylglycerol. This is the rate-limiting step in mobilization of fatty acids from adipose stores. The enzyme is activated by cAMP-dependent phosphorylation. A number of hormones, including epinephrine and norepinephrine, stimulate cAMP production in adipose tissue and initiate lipolysis. The fatty acids released from adipose are carried in the plasma bound to albumin. Glycerol is released and extracted by the liver, where it can be used for gluconeogenesis or resynthesis of triacylglycerol. The adipocyte cannot recycle glycerol due to the absence of glycerol kinase.
Brid~eto
Pharmacology
Gemfibrozil and clofibrate are cholesterol-lowering drugs that increase the activity of lipoprotein lipase. They are discussed in the Cardiovascular Pharmacology chapter in Organ Systems Book 1 (Volume III).
CHOLESTEROL METABOLISM There are two routes by which cholesterol is introduced into the body: It can originate from the diet, or it can be synthesized de novo by any nucleated cell. Cholesterol is an integral structural component of plasma membranes and serves as a precursor of vitamin D, bile acids, and steroid hormones. A. Cholesterol synthesis. The major site of cholesterol synthesis is the liver. The adrenal cortex, the ovaries, and the testes also produce significant amounts of cholesterol and use it for steroid hormone synthesis. The enzymes required to synthesize cholesterol are extramitochondrial and are localized in the cytosol and the endoplasmic reticulum. The substrates required for cholesterol synthesis are acetyl-CoA, NADPH, ATP, and Oz. The overall equation for cholesterol synthesis is:
18 acetyl-CoA + 18 NADPH + 18 ATP + 4 Oz
~
cholesterol (CZ7) + 18 NADP+ + 18 ADP + 18 Pi + 9 COz
1. Stages of cholesterol synthesis. The synthetic pathway occurs in four stages. a. Mevalonic acid synthesis. The first stage of cholesterol synthesis is the sequential condensation of three molecules of acetyl-CoA to produce HMG-CoA, which is then reduced to mevalonic acid. 2NADPH 3 acetyl-CoA ----,l.--~.~HMG-CoA ------..".".-=--l.~mevalonic acid HMG-CoA reductase The key enzyme in the overall pathway is HMG-CoA reductase. This enzyme reduces HMG-CoA to mevalonic acid in a reaction that requires two molecules of NADPH. This is the rate-limiting step in cholesterol synthesis and is therefore the site at which KAPLAlf I medlea
79
Biochemistry
Bridge to Pharmacology Lovastatin and pravastatin are cholesterol-lowering drugs that block the action of HMG-CoA reductase, the ratelimiting step in cholesterol synthesis. These drugs are discussed in the Cardiovascular Pharmacology chapter in Organ Systems Book 1 (Volume III).
synthesis is controlled. The synthesis of HMG-CoA involves the same steps as were described for ketone synthesis with two exceptions: synthesis of HMG-CoA in the cytosol and mitochondria require different sets of enzymes, and the cytosolic HMGCoA pool used for cholesterol synthesis does not mix with the mitochondrial pool used for ketone synthesis. b. Synthesis of activated isoprene units. The second stage of cholesterol synthesis is the conversion of mevalonic acid (C 6 ) into activated isoprene units (Cs ) that are designed to condense with one another (Figure 1-5-20). Two types of activated isoprene units are synthesized: isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DPP). Synthesis of an activated isoprene unit requires three molecules of ATP. These compounds have many synthetic uses; they are substrates for dolichol, ubiquinone, and fat-soluble vitamin synthesis.
Isopentenyl Pyrophosphate
3,3 Dimethylallyl Pyrophosphate
Figure 1-5-20. Activated isoprene units.
c. Formation of squalene. In the third stage, squalene, a C30 linear compound, is formed by condensation reactions that use six activated isoprene units. Squalene is generated via three condensation reactions (Figure 1-5-21): (1) Condensation of two Cs units
IPP + DPP -7 geranyl pyrophosphate + PPi (2) Condensation of Cs and C lO units IPP + geranyl-PP -7 farnesyl pyrophosphate + PPi (3) Condensation of two CIS units farnesyl-PP + PP-farnesyl-7 squalene + PPi
Figure 1-5-21. Squalene.
d. Conversion of squalene to cholesterol. The fourth and final stage of cholesterol synthesis involves the cyclization of squalene to form lanosterol, which is converted via a number of reactions to cholesterol (Figure 1-5-22).
80
meClical
Lipids
Lanosterol
Cholesterol
Figure 1-5-22. Conversion of squalene to cholesterol.
2. Cholesterol ester hydrolysis and formation. Approximately 70% of the cholesterol found in humans exists as cholesterol ester. The most common fatty acid found esterified to the 3-hydroxyl group of the A ring of cholesterol is oleic acid. a. Hydrolysis of cholesterol esters (1) Pancreatic cholesterol esterase hydrolyzes dietary cholesterol esters in the intestinal lumen. Re-esterification occurs after diffusion into the intestinal mucosal cell but prior to incorporation into chylomicrons. (2) Intracellular cholesterol esterases are found in all tissues but are in highest concentrations in liver and steroid hormone-producing glands. b. Synthesis of cholesterol esters. Two enzymes contribute to the synthesis of cholesterol esters. (1) Lecithin cholesterol acyl transferase (LCAT), found in the plasma, participates in reverse cholesterol transport. After HDL acquires cholesterol from extrahepatic tissues, it is esterified by LCAI. The fatty acid used for esterification comes from the 2-position of phosphatidylcholine. (2) Acyl cholesterol acyl transferase (ACAT), found inside the cell, is involved in cholesterol storage. Esterification involves the transfer of a fatty acid from fatty acyl-CoA to cholesterol. 3. Regulation of cholesterol synthesis. Cholesterol synthesis is highly regulated. Diets high in fat and carbohydrate stimulate HMG-CoA reductase, the rate-limiting enzyme in the pathway. The activity is suppressed by high dietary cholesterol and by fasting, which limits the available acetyl-CoA and NADPH required for synthesis. HMG-CoA is also under hormonal control: it is stimulated by insulin and thyroxine and inhibited by glucagon. Finally, cholesterol is constantly recycled between hepatic and extrahepatic tissues, either via the enterohepatic bile circulation or from cholesterol-rich chylomicron remnants, IDLs, and LDLs. These lipoproteins bind to specific receptors on cell membranes and are internalized and hydrolyzed, yielding free cholesterol. This increase in free cholesterol in the cell has two major regulatory effects: it suppresses the synthesis of LDL receptors ("down regulation"), thereby decreasing additional uptake of LDL-cholesterol from plasma, and it suppresses the synthesis of HMG-CoA reductase, thus decreasing the de novo synthesis of cholesterol by the cells.
Mnemonic lCAT is involved in the leaving of cholesterol via HDL; ACAT is involved in the accumulation of cholesterol in cells.
KAPLAN· . I meiIlea
81
Biochemistry
Bridge to Pharmacology Cholestyramine and colestipol are cholesterol-lowering drugs that bind bile acids in the intestine and promote their excretion. This increases the production of bile acids from cholesterol and ultimately lowers LDL cholesterol. These drugs are discussed in the Cardiovascular Pharmacology chapter in Organ Systems Book 1 (Volume III).
B. Cholesterol derivatives. Cholesterol is the precursor for bile acid and steroid hormone synthesis. 1. Bile acids are 24-carbon compounds derived from cholesterol. Synthesis occurs in the
liver and involves four reactions, each of which makes bile acids more amphipathic and more suitable for their roles in lipid emulsification. Bile acids are the major excreted form of cholesterol. a. Side chain cleavage of cholesterol releases a three-carbon fragment and results in a C24 compound in which the terminal carbon of the side chain has been oxidized to an acid. b. Conjugation of the side chain carboxyl group with either glycine or taurine adds a more acidic group and ensures complete ionization at physiologic pH. c. Reduction of the double bond in the ring system uses NADH as a source of reducing power. d. Hydroxylation at carbons 7 and 12 is catalyzed by microsomal mixed-function hydroxylases. These reactions require both O 2 and NADPH. An example of a bile acid (cholic acid) and its conjugated derivative (taurocholic acid) are shown in Figure I-5-23. The term "bile salt" indicates that at physiologic pH, the side chain group is negatively charged and is associated with a counterion. 2. Steroid hormones are derived from cholesterol in the adrenal cortex, the ovaries, and the testes. The structures of the major steroid hormones are shown in Figure I-5-24. Steroid hormone synthesis involves two reactions that are common to all pathways and numerous additional reactions that have tissue and cell specificity.
H
I
C-N-CH CH
II
o
HO H
H Cholic acid
Taurocholic acid
Figure 1-5-23. Cholic acid and taurocholic acid.
82
meClical
2
2
-so 3 H
Lipids
Adrenal Cortical Steroids
Cortisol
Aldosterone
Gonadal Steroids
OH
o Progesterone
OH
HO
Testosterone
17~- Estradiol
Figure 1-5-24. Major steroid hormones.
a. Common synthetic reactions. The initial reaction in the synthesis of all steroid hormones is cleavage of the side chain to generate pregnenolone, a C21 intermediate. Pregnenolone is converted to progesterone by the action of 3-~-hydroxysteroid dehydrogenase (3-~-HSD). Both pregnenolone and progesterone are C21 intermediates in the synthesis of all steroid hormones. The rate-limiting step in steroid hormone synthesis is the initial cleavage of the side chain. The enzyme 20-22 desmolase is located in the mitochondria, and its activity is increased in response to hormone binding to membrane receptors. In cells that synthesize glucocorticoids, ACTH stimulates desmolase activity; in mineralocorticoid synthesis, the activity is stimulated by angiotensin II; in androgen and estrogen synthesis, the activity is stimulated by LH. b. Tissue-specific synthetic reactions include the following four types of reactions. (1) Hydroxylation reactions can occur at various positions on the steroid nucleus. Cortisol synthesis by the adrenal cortex requires hydroxylation at carbons 11, 17, and 21, whereas aldosterone synthesis requires hydroxylation at carbons 11, 18, and 21. (2) Side chain cleavage by 17-20 desmolase removes the remainder of the side chain and converts the steroid to a C 19 androgen. (3) 5-a-reductase reduces the double bond in testosterone to form dihydrotestosterone (DHT). This enzyme is present in tissues that use DHT as the major androgen. (4) Aromatase removes the methyl group that extends up between the A and Brings of the steroid nucleus and makes the A ring aromatic. This enzyme is present in tissues that convert androgens to estrogens.
Clinical Correlate The most common cause of congenital adrenal hyperplasia is an inherited deficiency in 21-hydroxylase, leading to decreased cortisol and aldosterone and increased adrenal androgens. ACTH levels are elevated, and patients present with salt wasting and virilization.
KAPLA~. I meulCa
83
Biochemistry
PHOSPHOLIPIDS Phospholipids are the major building blocks of membranes. They also participate in signal transduction pathways and serve as reservoirs for polyunsaturated fatty acids needed for eicosanoid synthesis. A. Synthesis. The synthesis of phosphatidylethanolamine (PE) will be used to illustrate the synthetic strategy used to form these compounds. The two major substrates required for PE synthesis are activated ethanolamine and diacylglycerol. Activation of ethanolamine occurs in a two-step reaction. Free ethanolamine is first phosphorylated and then condensed with cytidine triphosphate to generate CDP-ethanolamine (Figure 1-5-25). The formation of phosphatidylethanolamine involves the transfer of P-ethanolamine from CDP-ethanolamine to the free hydroxyl group of diacylglycerol (Figure 1-5-26).
ATP Ethanolamine
ADP
_\......::::.._...L~__•
Cytidine-P-P-P Ethanolamine-P
P-P
_\.....:::..._L...::....._. CDP-ethanolamine
Figure 1-5-25. Activation of ethanolamine.
o
II O-C-O-R
o II
cytidine-P-P-ethanolamine + DAG ~R'-C-O CMP
0 {
o -PII I o
0 -ethanolamine
Figure 1-5-26. Formation of phosphatidylethanolamine.
In a Nutshell Phospholipid Synthesis • ATP phosphorylates ethanolamine • CTP activates phosphoethanolamine • CDP-ethanolamine combines with diacylglycerol to form phosphatidyl-ethanolamine
84
iiieilical
B. Interconversion of phosphatidylethanolamine (PE), phosphatidylserine (PS), and phosphatidylcholine (PC). Three types of reactions allow interconversion between these three classes of phospholipids. 1. Polar head group exchange. The ethanolamine moiety of phosphatidylethanolamine can undergo an exchange with free serine, resulting in phosphatidylserine. 2. Decarboxylation of phosphatidylserine results in phosphatidylethanolamine. 3. Methylation of phosphatidylethanolamine in three consecutive reactions results in phosphatidylcholine. S-adenosylmethionine (SAM) is used as a methylating agent. These interconversions are illustrated in Figure 1-5-27.
Upids
Phophatidylethanolamine
Phosphatidylserine
Phosphatidylcholine
Figure 1-5-27. Interconversion of PE, PS, and PC.
C. Phosphatidylinositol synthesis uses a variation of the above pathway in which the diacyl-
glycerol moiety is activated by the formation of CDP-diacylglycerol. DAG-phosphate is subsequently transferred from CDP-DAG to one of the hydroxyl groups of inositol.
SPHINGOLIPIDS AND GLYCOLIPIDS This group of lipids is classified into five major categories: sphingomyelin, cerebrosides, sulfatides, globosides, and gangliosides. All five classes are categorized as sphingolipids, containing ceramide (N-acyl-sphingosine). Additionally, all of the classes except sphingomyelin are glycolipids due to the presence of carbohydrate. A. Synthesis of sphingolipids and glycolipids occurs in two major steps. The first step is the synthesis of the ceramide core. The common ceramide core is synthesized from three precursors: palmitoyl-CoA, serine, and a long-chain fatty acyl-CoA. All classes of sphingolipids and glycolipids are formed by the transfer of groups from their activated carriers to a hydroxyl group on the terminal carbon of ceramide (see Figure 1-5-7). Activated carriers used in sphingolipid and glycolipid synthesis include UDP-sugars, CDP-choline, phosphoadenosine phosphosulfate (PAPS), and CMP-N-acetylneuraminic acid (CMP-NANA). B. Classes of sphingolipids and glycolipids (see Table 1-5-4) 1. Sphingomyelin is a major component of membranes of the central nervous system. It is
the only sphingolipid that contains phosphate. The transfer of phosphocholine from UDP-choline to ceramide forms sphingomyelin. 2. Cerebrosides and sulfatides. Cerebrosides contain either glucose or galactose. The addition of sulfate to galactocerebroside generates a sulfatide. Synthesis requires UDP-glu, UDP-gal, and PAPS as "active sulfate:' 3. Globosides. The addition of two or more sugars to ceramide results in globosides. The sugars may be glucose, galactose, or N-acetylgalactosamine. These compounds are important constituents of red blood cell membranes. 4. Gangliosides. Glycolipids containing neuraminic acid, the most common form of sialic acid, are classified as gangliosides. These lipids are found in very high concentration in ganglion cells of the central nervous system. C. Sphingolipidoses (Table 1-5-7)
~1caI
85
Biochemistry
Table 1-5-7. Common sphingolipid disorders. Disease
Mode of Inheritance
Mechanism of Disease
Characteristics
Gaucher
Autosomal recessive
Deficiency of
Hepatosplenomegaly Neurologic deficits Mental retardation
~-glucocerebrosidase
t Glucocerebrosides in brain, liver, spleen, bone marrow Fabry
X-linked recessive
Deficiency of a-galactosidase t Ceramide trihexoside
Renal failure Telangiectasias Skin rash Pain in lower extremities
Tay-Sachs
Autosomal recessive
Deficiency of hexosaminidase A t GMz gangliosides
Mental retardation, blindness, muscular weakness Cherry red spot on macula Death by age 3 Common in Ashkenazic Jews
Deficiency of sphingomyelinase
Mental retardation Hepatosplenomegaly Neurologic deficits Foam cells in bone marrow Cherry red spot in 40% of cases Death by age 3
Niemann-Pick Autosomal recessive
t Sphingomyelin and cholesterol in reticuloendothelial tissues
Farber
Autosomal recessive
Deficiency of ceramidase t Ceramide
Hoarseness, dermatitis Skeletal deformations Mental retardation Hepatomegaly
PROSTAGLANDINS, THROMBOXANES, AND LEUKOTRIENES These compounds, collectively known as the eicosanoids, are derived from arachidonic acid and play crucial regulatory roles in human physiology. They bind to cell surface receptors and act as autocrine and paracrine hormones. They exert their effects at very low concentrations, have extremely short half-lives, and have many diverse functions. A. Prostaglandins are 20-carbon hydroxy fatty acids containing a five-membered ring. Prostacyclin, PGlz, is the major prostaglandin and is synthesized by endothelial cells. It promotes vasodilatation of the coronary arteries and antagonizes platelet aggregation. B. Thromboxanes are 20-carbon hydroxy fatty acids with a six-membered ring containing an
oxygen atom. Thromboxane A2 is the major thromboxane. It antagonizes prostacyclin, leading to platelet aggregation and vasoconstriction. It is synthesized primarily by platelets. C. Leukotrienes contain no ring. They play a major role in inflammatory responses and
chemotaxis. The slow-reacting substance of anaphylaxis (SRS-A) is a combination of leukotrienes that acts as a potent smooth muscle constrictor.
86
meClical
Lipids
D. Synthesis of prostaglandins, thromboxanes, and leukotrienes. Arachidonic acid (AA) is the major precursor of these compounds. AA is stored in membrane phospholipids, where it is esterified to carbon-2 of the glycerol backbone. The release of AA from the membrane is catalyzed by the action of phospholipase Az. The major enzymes involved in eicosanoid synthesis and their functions are summarized in Table 1-5-8. Linoleic acid, an omega-6 fatty acid, is the dietary precursor of arachidonic acid, which is used to synthesize all of the series-2 eicosanoids (PGI 2, T~, etc.). Linolenic acid, an omega-3 fatty acid, is the dietary precursor of eicosapentaenoic acid, which is used to synthesize the series-3 eicosanoids. The most important eicosanoid in this series is TXA3, which is synthesized by platelets and antagonizes the effects of T~.
Table 1-5-8. Key enzymes in eicosanoid metabolism. Enzyme
Action
Phospholipase A2
Releases arachidonic acid from membrane stores; inhibited by glucocorticoids (e.g., cortisone)
Cyclooxygenase
Catalyzes initial step in the pathway that converts arachidonic acid to prostaglandins and thromboxanes; inhibited by nonsteroidal antiinflammatory drugs
5-Lipoxygenase
Catalyzes the initial step in the pathway that converts arachidonic acid to leukotrienes
I KAPLAlf medlea
87
Amino Acid Metabolism One of the major functions of the amino acid pool is to provide a source of building blocks for protein synthesis. Humans can synthesize only 10 of the 20 amino acids found in proteins. The remainder are termed the "essential" amino acids and must be supplied by dietary protein. Both the quantity and the composition of the amino acid pool in cells remain remarkably constant under a wide variety of conditions. Processes that contribute to the pool of amino acids include degradation of body protein, digestion and absorption of dietary protein, and the de novo synthesis of nonessential amino acids. Processes that remove amino acids from the pool include the synthesis of body protein, the oxidation of excess amino acids to CO2 and H20, and the synthesis of a large number of specialized products, including heme, neurotransmitters, purines, pyrimidines, and catecholamines. This chapter reviews protein digestion and absorption, pathways for synthesis of nonessential amino acids, mechanisms for disposing of a-amino groups and the "remnant" carbon skeletons, and the use of amino acids as precursors for a large number of specialized products.
ESSENTIAL AMINO ACIDS An essential amino acid is one that cannot be synthesized in adequate amounts to meet the needs of the cell and therefore must be supplied by dietary protein. There are 10 essential amino acids (Table 1-6-1). Two of these (arginine and histidine) are essential only in infants and children. Humans are unable to synthesize the aromatic ring system in amino acids, the branched chain amino acids, or the basic amino acids. Table 1-6-1. Essential amino acids. Arginine* Histidine* Isoleucine Leucine Lysine
Methionine Phenylalanine Threonine Tryptophan Valine
*Essential only in early childhood
Mnemonic In sentence form: Any help in leaming these little molecules proves truly valuable (arg, his, ile, leu, thr, Iys, met, phe,
A. The amino acid pool. There are approximately 100 grams of free amino acids in the body, of which nearly 50% is glutamine and alanine. Approximately 10% of the total pool consists of essential amino acids. The major drain on the amino acid pool is protein synthesis, with 200-300 grams of protein synthesized per day. In anabolic states, when insulin is acting on liver and muscle, this rate is increased. Additionally, specific amino acids are removed from the pool to support the synthesis of specialized compounds, including heme,
trp, val)
In name form: Pvt. Tim Hall, U.s. Army (phe, val, thr, trp, ile, met, his, arg, leu, Iys) KAPLA~. I meulca
89
Biochemistry
neurotransmitters, creatine, polyamines, carnitine, and nucleotides. Therefore, an exogenous protein source is required to replenish and maintain the amino acid pool. The recommended protein requirement for a healthy adult is 0.8 g/kg body weight/day. B. Digestion of dietary protein. Protein digestion starts in the stomach, where the acidic gastric juice denatures the protein and activates pepsin. Proteins are hydrolyzed by pepsin to a mixture of large peptides. Further degradation occurs in the small intestine by the pancreatic proteases. These enzymes (trypsin, chymotrypsin, elastase, carboxypeptidases) are secreted as inactive precursors and are activated in the small intestine. Activation is initiated by enteropeptidase, an intestinal enzyme that converts inactive trypsinogen to trypsin. Trypsin, in turn, activates the other pancreatic proteases. These enzymes continue the hydrolysis of dietary protein, producing a mixture of free amino acids, dipeptides, and tripeptides. C. Absorption of amino acids. Specific transport systems absorb amino acids and small peptides into the epithelial cells where the dipeptides and tripeptides are hydrolyzed to free amino acids before they leave the cell. The transport systems for amino acids in the intestinal cells are similar to those for glucose, where transport across the luminal membrane is Na+ -dependent and transport across the contraluminal membrane is Na+ independent. Several different carriers have been identified on the basis of their specificity. Genetic deficiencies in each of these have been reported. Hartnup disease and cystinuria are clinical problems arising from faulty transport mechanisms. 1. Hartnup disease is a rare autosomal recessive disorder characterized by the excretion of large quantities of neutral amino acids in the urine. The clinical symptoms of this disease can be attributed to the loss of tryptophan, a precursor of nicotinamide, in the urine. Similar symptoms are seen in pellagra, a condition caused by niacin or nicotinamide deficiency. Up to 50% of nicotinamide is normally supplied by the metabolism of tryptophan.
Mnemonic Cystinuria results from an inability to reabsorb COAL in the renal tubules: cystine, omithine, arginine, and lysine.
Note Pyridoxal phosphate is a derivative of pyridoxine (vitamin 86 ) and acts as a coenzyme for all transaminases.
90
meCtical
2. Cystinuria is one of the most common amino acidurias. It is an autosomal recessive disease caused by a defect in the transport protein for lysine, arginine, cystine, and ornithine, resulting in their excretion in the urine. The low solubility of cystine leads to the precipitation and formation of kidney stones.
AMINO ACID DEGRADATION The catabolism of amino acids will be reviewed in two parts: the disposal of the a-amino group and the disposal of the carbon skeletons. Many of these reactions require the actions of pyridoxal phosphate. A. Disposal of a-amino groups. The degradation of amino acids usually begins with removal of the a-amino group. Approximately 85% of the amino nitrogen ultimately gets excreted as urea. The two most important reactions in the flow of nitrogen from amino acids to urea are transaminations and the oxidative deamination of glutamate. All of the amino acids except lysine and threonine have specific transaminases that are involved in the disposal of the a-amino group. 1. Transaminases are a family of enzymes that transfer the a-amino group from an amino acid to an acceptor, an a-keto acid. Pyridoxal phosphate (PLP) acts as a transient carrier in the reaction (Figure 1-6-1). Transaminases are specific for the amino acid but are nonspecific for the acceptor. Most transaminases use a-ketoglutarate as an acceptor, providing a mechanism for funneling the amino groups from many amino acids into a common pool of glutamate.
Amino Acid Metabolism
2. Fate of glutamate. Two routes for disposal of the a-amino group of glutamate exist in the liver. It may be released as ammonia or transferred to oxaloacetate.
Glutamate
Amino acid N~
N~
I R -CH -COOH)( E",-PLP
R -C -COOH II
o
E",-PLP I NH2
I HOOC -CH, -CH, -CH -COOH
)C
HOOC -CH -CH -C -COOH 2 2 II 0
a-Ketoacid
a-Ketoglutarate
Figure 1-6-1. Transfer of a-amino groups from amino acids to glutamate.
a. Oxidative deamination of glutamate. This reaction is catalyzed by glutamate dehydrogenase, a mitochondrial enzyme that releases an ammonium ion from glutamate, making it available for urea synthesis.
Glutamate Dehydrogenase Glutamate + NAD+ ...
• a-Ketoglutarate + NADH + NH/
b. Transamination to oxaloacetate. Some of the a-amino groups that have been collected in glutamate are transferred to oxaloacetate to form aspartate. Aspartate, in turn, acts as an amino group donor in the synthesis of urea. This reaction occurs mainly in the cytosol of liver, and is catalyzed by aspartate transaminase (AST), also known as glutamate:oxaloacetate transaminase.
Aspartate Transaminase • Glutamate + Oxaloacetate ...
a-Ketoglutarate + Aspartate
3. Urea synthesis. Urea synthesis occurs only in the liver. Urea contains two amino groups that are linked by a carbonyl group. One amino group comes from ammonia and the other is donated by aspartate. The carbonyl group comes from bicarbonate. The synthesis of one mol of urea requires five enzymes and 3 mols of ATP.
NH/ + HC0 3- + Aspartate + 3 ATP ...... Urea + Fumarate + 2 ADP + AMP + 2 Pi + PP i a. Reactions and enzymes of the urea cycle. The first two steps in the urea cycle occur in the mitochondria, and the remaining steps occur in the cytosol. An overview of the urea cycle is shown in Figure 1-6-2, with a brief description of the enzymes and the reactions. KAPLAlf _ I meillea
91
Biochemistry
--------~----------------------------------------------------------------------------------
Mitochondrial Matrix
NH: + HCO"3 + 2 ATP
I
Ca"'amoyl phosphale syolhelase I
r
Carbamoyl phosphate
Omllhloe I,"osca"'amylase
Om"hloe + -
-
-
-
-
I
Citrulline
I
Cytosol
I
I
:
:
Citrulline Arginosuccinate synthetase
~spartate ATP MP+ PPj
Arginosuccinate
~osuccloale lyase Fumarate
!
TCAcycle
Arginine
A Urea
Arginase
Ornithine -
-
-
-
Figure 1-6-2. The urea cycle.
In a Nutshell
(1) Carbamoyl phosphate synthetase I (CPS-I) catalyzes the condensation of
ammonia and bicarbonate to form carbamoyl phosphate. The energy for creating the high-energy bond in carbamoyl phosphate is supplied by 2 mols of ATP. This is the rate-limiting step in urea synthesis. The activity of CPS- I is allosterically activated by N-acetylglutamate (NAG), a compound formed when glutamate accumulates in the mitochondria. This occurs when the diet is high in protein. The synthesis of NAG is activated by arginine. Carbamoyl phosphate synthetase II is a cytosolic enzyme that participates in pyrimidine synthesis. It uses glutamine as a donor of amino groups.
High protein diet
J, Glutamate accumulation
J, Increase in NAG
J, CPS-I activated
(2) Ornithine transcarbamoylase (OTCase) transfers the carbamoyl group from carbamoyl phosphate to ornithine, resulting in citrulline. Citrulline is then transported across the inner mitochondrial membrane into the cytosol, where the remaining reactions in the urea cycle occur. (3) Argininosuccinate synthetase condenses citrulline with aspartate to form argininosuccinate. The a-amino group of aspartate is linked directly to citrulline in this reaction. The energy for synthesizing arginosuccinate is provided by ATP hydrolysis to AMP and PPi.
92
KAPLAlfdme leaI
-
-----------
-------
Amino Acid Metabolism
(4) Argininosuccinate lyase cleaves argmmosuccinate to form argmme and
fumarate. All of the aspartate molecule except the a-amino group is released as fumarate; the a-amino group becomes a part of the arginine side chain. (5) Arginase releases urea from the side chain of arginine. The other product is ornithine, which is transported back into the mitochondria for participation in another cycle of urea synthesis. The urea is excreted in the urine. Note that urea contains two amino groups, one from aspartate and the other from ammonia. b. Abnormalities in the urea cycle. Inherited deficiencies have been reported for each of the enzymes of the urea cycle. These can be distinguished from one another on the basis of the products excreted (Table 1-6-2). Ammonia accumulates in all of the deficiencies but is most pronounced in deficiencies of CPS-I and OTCase and at least pronounced in an arginase deficiency.
Note Arginase is found only in the brain, liver, and kidney.
Table 1-6-2. Defects in urea cycle enzymes. Defective enzyme
Condition
Metabolites Accumulated
Carbamoyl-P synthetase Ornithine transcarbamoylase Argininosuccinate synthetase Argininosuccinate lyase Arginase
Type I hyperammonemia Type II hyperammonemia Citrullinemia Argininosuccinic aciduria lIyperargininemia
Ammonia, glutamine, alanine Ammonia,glutamine,orotate Citrulline Argininosuccinate Arginine
4. Alanine. Skeletal muscle uses alanine as a carrier for transporting a-amino groups to the
liver, where urea synthesis occurs. As shown in Figure 1-6-3, the amino groups that have been collected in glutamate are subsequently transferred to pyruvate with the formation of alanine. This reaction is catalyzed by alanine aminotransferase (also known as glutamate:pyruvate transaminase). Skeletal muscle releases large amounts of alanine into the circulation. Alanine is taken up by the liver, where the reverse reaction occurs. This cycle allows amino groups from skeletal muscle to be transferred to the hepatic pool of glutamate. The alanine aminotransferases of both skeletal muscle and liver are cytosolic enzymes. Liver recycles pyruvate by using it for gluconeogenesis.
Amino acids a-Ketoacids
X
Muscle a-Ketoglutarate
Glutamate
X
In a Nutshell • Amino groups in muscle are transferred to pyruvate to form alanine. • Alanine is picked up by liver, where it is converted back to pyruvate. • Liver uses pyruvate for gluconeogenesis and amino groups for urea synthesis.
Liver
Alanine -+---11-~ Alanine
PY"Nate
Pyruvate
t
~
a-Ketoglutarate
X
Glutamate _
Urea
Glucose..,I-+-- Glucose
Figure 1-6-3. Alanine as a carrier of a-amino groups from muscle to liver.
5. Glutamine. All tissues produce some free ammonia that can be "detoxified" by the formation of glutamine. This reaction is important in extrahepatic tissues, where urea synthesis does not occur, and it is of particular importance in the brain, where the toxic effects of ammonia are severe.
Glutamate + NlI4 + + ATP
Glutamine synthetase ..
Glutamine + ADP + Pi KAPLAN"dme leaI
93
Biochemistry
Skeletal muscle and brain release large amounts of glutamine into the circulation, with most of the glutamine being taken up by the kidney and the liver. The nitrogen is released from glutamine as ammonium ions in two sequential reactions catalyzed by glutaminase and glutamate dehydrogenase (Figure 1-6-4). Both of these reactions occur in mitochondria. In liver, the ammonia is incorporated into urea; in kidney, it is excreted as ammonium ion. Ammoniagenesis in kidney is an important mechanism for titrating protons (60% of H + is excreted through NH4+). The activity of glutaminase is markedly increased in states of prolonged acidosis. In prolonged fasting and starvation, the a-ketoglutarate in this reaction is an important substrate for renal gluconeogenesis.
Glutamine
Glutamate dehydrogenase
Glutaminase
-_'),.----'~
NHt
Glutamate
----=--::::------o:o--~,
NAO~
::O(P)H
a-Ketoglutarate
JHt
Figure 1-6-4. Glutamine as a carrier of amino groups.
In a Nutshell • Strictly ketogenic: leu, Iys • Both ketogenic and glucogenic: ile, phe, tyr, trp • Strictly glucogenic: everything else
94
mectical
B. Disposal of carbon skeletons. Carbon skeletons are the "remnants" of amino acids after the amino groups have been removed. The carbon skeletons can be oxidized to C02 and H20, with the generation of energy, or they can be used to synthesize either glucose or ketones. As shown in Figure 1-6- 5, all of the amino acids can be degraded to seven common metabolites: acetyl-CoA, acetoacetyl-CoA, pyruvate, oxaloacetate, fumarate, succinyl-CoA, a-ketoglutarate, and propionyl-CoA (which is converted to succinyl-CoA). The ketogenic amino acids (leucine and lysine) are degraded to acetyl-CoA or acetoacetyl-CoA, both of which can be converted to ketone bodies. Four amino acids are both ketogenic and glucogenic (isoleucine, phenylalanine, tyrosine, and tryptophan). The remaining amino acids are strictly glucogenic.
Amino Acid Metabolism
~
Glycine, Alanine, Cysteine, Serine, Threonine, Tryptophan
Leucine, 'so'.u';".
Asp"ag;". Aspartate
I___~~
-----.;.~ pyruvate
1 _ _ _ _ _... ~
Acetyl-CoA .....e----- Acetoacetyl-CoA .....i------- Leucine Lysine Phenylalanine Tryptophan Tyrosine
Oxaloacetate
Citrate
Tyrosine~
Proline a-Ketoglutarate __ Glutamate - - Arginine Histidine Glutamine
Phenylal:::J .... Fumarate
Succinyl-CoA
t'--______
Propionyl-CoA .....i------- Isoleucine Methionine Threonine Valine
Figure 1-6-5. Metabolic intermediates from amino acids.
C. Degradation of branched-chain amino acids. Liver has little, if any, transaminase activity for valine, isoleucine, and leucine. Therefore, in contrast to the other amino acids, the degradation of the branched-chain amino acids starts in skeletal muscle, where transaminase activity is high. The first two reactions in the degradation of these three amino acids are catalyzed by common enzymes (Figure 1-6-6). Branched-chain amino acid transaminase (BCAA transaminase) transfers the a-amino group to a-ketoglutarate to form glutamate and a-keto acids corresponding to the carbon skeletons valine, isoleucine, and leucine. This enzyme is present in high concentrations in skeletal muscle and very low concentrations in the liver. In the next step, the a-keto acids are decarboxylated by a single branched-chain ketoacid dehydrogenase (BCKA-DH), resulting in branched-chain acylCoA analogs. The products of the BCKA-DH reaction proceed along different pathways. The end products for the degradation of each amino acid are shown in Figure 1-6-6. The end products of branched-chain amino acid degradation are used by nerve tissue for the synthesis of lipid.
Clinical Correlate Maple syrup urine disease results from an autosomal recessive deficiency of branchedchain ketoacid dehydrogenase. Affected children have elevated plasma and urine levels of the branched-chain amino acids leucine, valine, and isoleucine, as well as elevated levels of their corresponding a-keto acids and a-hydroxyacids. Clinically, the urine has an odor of maple syrup or burnt sugar; if untreated, brain darnage and death occur by the end of the first year.
meclical
95
Biochemistry
Valine, Isoleucine, Leucine
1
BCM "",samlnase
Branched-chain ketoacid analogs
CO'1
BCKA-dehydwgenase
Branched-chain acyl-CoA analogs
/
I
Val
lie
~
Leu
~
/
Succinyl-CoA
~
Propionyl-CoA Acetyl-CoA
Acetoacetyl-CoA
Figure 1-6-6. Degradation of branched-chain amino acids.
The BCKA-DH is a multienzyme complex structurally homologous to pyruvate dehydrogenase and a-ketoglutarate dehydrogenase. All three catalyze the oxidative decarboxylation of a-ketoacids, and they are composed of three distinct enzymes that require the actions of five coenzymes (NAD+, FAD, CoA, thiamine-PP, and lipoic acid). They are all located in the mitochondria of most cells. D. Assimilation of propionyl-CoA into the TeA cycle. Propionyl-CoA results from the degradation of isoleucine and methionine and from the ill-end of odd-chain fatty acids. The pathway for converting propionyl-CoA into succinyl-CoA is shown in Figure 1-6-7. A deficiency in either propionyl-CoA carboxylase or methylmalonyl-CoA mutase results in organic aciduria. This condition is usually seen in children who present with signs of acidosis. Chromatographic analysis of blood and urine are an important part of the diagnosis. Treatment protocols include measures to counteract the acidosis, followed by restriction of dietary protein. Individuals excreting excessive amounts of organic acids are at risk for developing a secondary carnitine deficiency, leading to impaired fatty acid oxidation. These secondary effects can be prevented by supplementation with L-carnitine. Odd-chain fatty acids
ISOI~
7n,neb'Otin
Propionyl-CoA + HC0 3-
I
Threonine
vitamin B"
~Methylmalonyl-CoA
(
~
) Succinyl-CoA
Methylmalonyl-CoA mutase
ATP ADP + Pi Propionyl-CoA carboxylase
Figure 1-6-7. Conversion of propionyl-CoA to succinyl-CoA.
96
metlical
Amino Acid Metabolism
1. Propionic aciduria results from a deficiency of biotin, propionyl-CoA carboxylase, holo-
carboxylase synthase, or the enzyme that covalently attaches biotin to all carboxylases. In the latter case, additional organic acids accumulate. 2. Methylmalonic aciduria results from a deficiency in vitamin B12 or a defect in methylmalonyl-CoA mutase. Some patients respond favorably to megadoses of vitamin B12 .
SYNTHESIS OF NONESSENTIAL AMINO ACIDS The pathways for amino acid synthesis are complex. All of the nonessential amino acids are synthesized from intermediates in glycolysis or the TCA cycle, from essential amino acids, or from interorgan pathways. Only the key concepts of these pathways will be reviewed. A. Synthesis from intermediates in glycolysis or the TCA cycle. Eight of the nonessential amino acids can be synthesized from intermediates in glycolysis or from the TCA cycle intermediates. This is illustrated in Figure 1-6-8. The transamination of pyruvate, oxaloacetate, and a-ketoglutarate give rise to alanine, aspartate, and glutamate, respectively. The addition of an amide group to the side chains of aspartate and glutamate results in asparagine and glutamine. Phosphoglycerate is a precursor of serine and glycine. Glycolysis
TCA cycle
Glucose ----. Phosphoglycerate ---+- Pyruvate --+ a-Ketoglutarate - - Oxaloacetate
~
~
Serine
~
Alanine
Aspartate
/\..
{-
/\.. GlYCine Cysteine
~
Glutamate
Proline Glutamine Asparagine
Figure 1-6-8. Precursors for the nonessential amino acids.
B. Synthesis from essential amino acids. Phenylalanine is the precursor for tyrosine, and methionine provides the sulfur for cysteine synthesis. Therefore, if either phenylalanine or methionine is deficient in the diet, tyrosine and cysteine also become essential amino acids. This situation may occur transiently in premature babies. The enzyme systems for synthesizing tyrosine and cysteine are developed late in gestation. 1. Tyrosine. The conversion of phenylalanine to tyrosine is catalyzed by phenylalanine
hydroxylase (Figure 1-6-9). This enzyme requires 02 and tetrahydrobiopterin (THB). During the hydroxylation reaction, THB is oxidized to dihydrobiopterin (DHB). For the synthesis of tyrosine to continue, DHB must be reduced back to THE. The regeneration of THB requires NADPH and dihydrobiopterin reductase. Phenylalanine hydroxylase
Phenylalanine
--7-:::;:;O-7-::::-..
""'\:::-----~)
02
K
THB
NADP+
Tyrosine
DHB
D;hydrob;opterio reductase
NADPH
Clinical Correlate Phenylketonuria (PKU) results from either a deficiency of phenylalanine hydroxylase or dihydrobiopterin reductase. There is therefore a buildup of phenylalanine, phenyl pyruvate, phenylacetate, and phenyllactate in both plasma and urine, and tyrosine becomes an essential amino acid. Clinically, there is a musty body odor and mental retardation. Treatment is to remove phenylalanine from the diet (including products containing NutraSweet®, a dipeptide containing phenylalanine and aspartic acid). If the deficient enzyme in PKU is dihydrobiopterin reductase, the ability to synthesize catecholamines and serotonin is also impaired.
Figure 1-6-9. Hydroxylation of phenylalanine to tyrosine. KAPLA~.
meulCa
I
97
Biochemistry
2. Cysteine. Serine and methionine are required for the synthesis of cysteine. Key steps in the pathway are shown in Figure 1-6-10. The sulfur atom in cysteine originates in dietary methionine, and the remainder of the cysteine molecule is derived from serine. Methionine is first converted to homocysteine through several steps. Cystathionine synthase, an enzyme requiring pyridoxal phosphate, condenses homocysteine with serine to form an adduct of the two amino acids. Cystathionase then cleaves the adduct so that the sulfur atom is attached to serine, generating cysteine. Excess homocysteine can be converted back to methionine by the addition of a methyl group from tetrahydrofolate. Methionine synthase is the only enzyme in human biochemistry known to use THF as a methylating agent. This is also one of the two reactions in humans that requires vitamin Bl2.
/~
! Methionine
Serine
\
___\..:..0.-_ _ _• Cystathionine
Homocysteine
Cystathionine synthase Vitamin B6
H20 \.
• Cysteine + a-Ketobutyrate + NH/
Cystathionase Vitamin B6
Vitamin B12 CH 3 -THF THF Methionine synthase Figure 1-6-10. Synthesis of cysteine from methionine and serine.
Clinical Correlate Epidemologic studies suggest that elevated plasma homocysteine is a risk for coronary heart disease that is independent of the risk associated with elevated plasma cholesterol.
a. Homocystinuria is characterized by excretion of large amounts of homocystine in the urine. It is most frequently seen in children who present with failure to thrive and visual problems due to displacement of the lens. Homocystinuria may be either acquired or inherited. A deficiency in pyridoxine, folate, or vitamin Bl2, or an inherited defect in either cystathionine synthetase or methionine synthase all result in the accumulation of homocysteine, which is readily oxidized to its disulfide form, homocystine. Cystathionine synthase requires pyridoxal phosphate (the activated form of vitamin B6) as a cofactor, and methionine synthase requires coenzymes derived from both folate and Bl2. b. Cystathioninuria results from a deficiency in pyridoxine or from a genetic defect in cystathionase. Large amounts of cystathionine are found in the urine and blood. C. Interorgan synthesis of arginine. The synthesis of arginine in humans is dependent on
cooperation between the intestinal mucosa and the kidney. The first two enzymes of the urea cycle are found in intestinal cells, and the third and fourth enzymes of the cycle are found in the kidney. Only liver has all of the enzymes. Intestinal cells synthesize citrulline and release it into the blood. Citrulline is extracted by the kidney and converted to arginine. The kidney has low levels of arginase activity, thus arginine accumulates; however, it does not accumulate in liver due to the high level of arginase activity in the urea cycle.
SPECIALIZED PRODUCTS DERIVED FROM AMINO ACIDS The synthesis of many of the specialized products, especially the biogenic amines, uses three types of reactions: decarboxylation, hydroxylation, and methylation. Decarboxylation reactions require pyridoxal phosphate; most of the hydroxylations require tetrahydrobiopterin (THB) as a reductant; the methylation reactions require S-adenosylmethionine as a methylating agent. Other specialized products derived from amino acids are melanin, creatine, heme, and nitric oxide.
98
KAPLAlfdme leaI
Amino Acid Metabolism
A. S-adenosylmethionine (SAM). Almost all methylation reactions require SAM as a methylating agent. The methyl transfer potential of SAM is much higher than that of methyl-THE SAM is synthesized by the condensation of methionine and ATP (Figure 1-6-11). A high-energy bond attaches the sulfur atom to the methyl group.
eaOH I
H2N -CH
I
CH 2
Mg
+
2+
ATP
I
CH2
I
CH 3 -S
High-Energy Bond
:Y
Methionine
o SAM
OH methyl transferase
r
OH
:-CH,
S-adenosyl homocystein e
Figure 1-6-11. Synthesis and use of S-adenosylmethionine (SAM).
B. Histamine. Decarboxylation of histidine results in histamine, an important mediator of allergic and inflammatory responses. Histamine is synthesized in mast cells of connective tissue near blood vessel (Figure 1-6-12). Histidine Decarboxylase Histidine - - - - - - -.....~ Histamine + CO 2 Pyridoxal-P
Figure 1-6-12. Synthesis of histamine. C. y-Aminobutyric acid (GABA). Decarboxylation of glutamate results in GABA, an important
inhibitory neurotransmitter (Figure 1-6-13). Glutamate Decarboxylase Glutamate _ _ _ _ _ _ _ _....... y-Aminobutyric acid (GABA) + CO2 Pyridoxal-P
Figure 1-6-13. Synthesis of "t"aminobutyric acid.
D. Serotonin and melatonin. Hydroxylation of the aromatic ring of tryptophan followed by its decarboxylation results in serotonin, a potent vasoconstrictor and stimulator of smooth muscle contraction. As shown in Figure 1-6-14, tryptophan hydroxylase requires 02 and tetrahydrobiopterin (THB). Dihydrobiopterin reductase and NADPH are required to regenerate THB. The end product of serotonin degradation is 5-hydroxyindoleacetate (5-HI). In the pineal gland, serotonin can be converted to melatonin by sequential acetylation and methylation reactions.
Clinical Correlate Parkinson disease results from a decrease of dopamine in the substantia nigra. It is found in approximately 1% of the U.s. population above the age of 55. Symptoms include tremors, postural instability, rigidity, and bradykinesia. The symptoms are treated with L-dopa and carbidopa; the latter selectively inhibits the aromatic acid decarboxylase outside of the central nervous system, but it cannot cross the blood-brain barrier and does not inhibit the conversion of L-dopa to dopamine.
KAPLAlf I me illea
99
Biochemistry
02 \. Tryptophan
r
THB
Tryptophan hydroxylase
"*"")'
DHB
Aromatic amino acid decarboxylase • 5-0H-Tryptophan -_~,......-----~. Serotonin
CO2
Figure 1-6-14. Synthesis of serotonin.
E. Catecholamines, melanin, and thyroxine are all derived from tyrosine.
1. Catecholamines act as neurotransmitters when synthesized by the brain and act as hormones when produced by the adrenal medulla. The pathway for synthesis is the same in both tissues (Figure 1-6-15). It includes hydroxylation, decarboxylation, and methylation reactions. Tyrosine hydroxylase and dopamine-~-hydroxylase have different cofactor requirements.
02 Tyrosine \ . hydroxylase Tyrosine
-7
tDHB
THB
Clinical Correlate Neoplastic transformation of enterochromaffin cells results in carcinoid tumors that secrete excessive serotonin, and high levels of s-hydroxyindole acetate are excreted in the urine.
Note There is only one difference in position between T3 and T4 :
T3: X = H T4 :
x= I
Bridge to Pharmacology The ability of nitroglycerin and other nitrates to relieve pain associated with angina is due, at least in part, to the spontaneous formation of NO from these compounds.
100
maC-ical
•
Aromatic acid 02 Dopamine-~Phenylethanolamine-Ndecarboxylase \.. hydroxylase methyl transferase (PNMT) ""'"'-_ _ _~. Norepinephrine • Epinephrine DOPA • Dopamine __ ?' "") Cu+ CO2 Ascorbate SAM S-Adenosylhomocysteine
"Y
Figure 1-6-15. Catecholamine synthesis.
Catecholamines are rapidly degraded by two enzymes that are widely distributed in many tissues: catechol-O-methyl transferase (COMT) and monoamine oxidase (MAO). 2. Melanins are the pigments of skin and hair that are formed in melanocytes. The initial reaction is catalyzed by tyrosine hydroxylase. The isozyme present in melanocytes, also known as tyrosinase, requires copper and ascorbate as cofactors. It hydroxylates tyrosine at two positions, creating a very reactive molecule that polymerizes and gives rise to a series of compounds collectively known as "melanins:' Some forms of albinism result from a deficiency in tyrosine hydroxylase. 3. Thyroxine synthesis occurs in the follicle cells of the thyroid. Synthesis requires the tyrosine-rich protein, thyroglobulin, and the uptake of iodide. The iodide must be oxidized to 1+ before it can be incorporated into tyrosine side chains. The introduction of one molecule of 1+ gives monoiodinated tyrosine (MIT), whereas introduction of two molecules ofI+ produces diiodinated tyrosine (DIT). Covalent cross-linking of two DIT molecules results in tetraiodothyronine (T4), whereas cross-linking of MIT and DIT produces tri-iodothyronine (T 3)' Stimulation by thyroid-stimulating hormone (TSH) results in excision and release of T 3 and T 4. F. Nitric oxide, also known as "endothelium-derived relaxing factor," is synthesized from arginine in endothelial cells of small blood vessels. Nitric oxide diffuses into the smooth muscle cells, where its direct effect is to stimulate cyclic GMP synthesis. cGMP activates a cascade of events resulting in relaxation of smooth muscle. Nitric oxide is synthesized from arginine by the enzyme nitric oxide synthase. This enzyme requires 02 and NADPH. The reaction catalyzed by NO synthase is shown in Figure 1-6-16. Its synthesis is stimulated by calcium ions. The regeneration of tetrahydrobiopterin requires NADPH.
Amino Acid Metabolism
EB Ca2 + Arginine + O2
NO synthase
;=-
NADPH
~.
Nitric oxide + ornithine
NADP+
Figure 1-6-16. Synthesis of nitric oxide.
Nitric oxide is also synthesized on nerve cells where it functions as an excitatory molecule and in macrophages where it is a potent toxin. Nitric oxide synthesis in endothelial and nerve cells is stimulated by calcium; synthesis in macrophages is stimulated by lipopolysaccharides and cytokines. G. Creatine synthesis requires arginine, glycine, and S-adenosylmethionine (Figure 1-6-17). Creatine phosphate is a storage form for high-energy phosphate in muscle. It can be used to rapidly regenerate ATP from ADP by the enzyme creatine phosphokinase (CPK).
Glycine amidinotransferase Arginine + Glycine \ Guanidinoacetic acid Ornithine
Methyl transferase
;=-
SAM
"=').
Creatine' .-----
CPK
)
S-Adenosylhomocysteine ATP
• Creatine phosphate ADP
Figure 1-6-17. Synthesis of creatine and creatine phosphate.
Both creatine and creatine phosphate spontaneously cyclize to form creatinine, which is excreted in urine. Under normal circumstances, the amount of creatinine excreted is constant and is directly proportional to muscle mass. Blood levels of creatinine are used clinically to assess kidney function or to estimate muscle mass. The amount of creatinine in a 24-hour urine specimen can also be used to validate the completeness of a 24-hour specimen. H. Heme synthesis requires the assembly of a porphyrin ring, which is derived entirely from glycine and succinyl-CoA (Figure 1-6-18). The initial step in the synthesis is catalyzed by L1-aminolevulinic acid synthase (L1-ALA synthase), an enzyme that requires pyridoxal phosphate. This is the rate-limiting step in heme synthesis and is inhibited by heme, the product of the pathway. Condensation of 2 mols of L1-ALA produces a porphobilinogen, the first intermediate in the pathway with a pyrrole ring. Condensation of four molecules of porphobilinogen gives a linear pyrrole, which can be cyclized to produce a porphyrinogen. Cyclization is catalyzed by uroporphyrinogen I synthase, but formation of the isomer that leads to heme requires another protein, uroporphyrinogen III cosynthase. The immediate precursor to heme is protoporphyrin IX. Insertion of iron by the enzyme heme synthase, also known as ferrochelatase, results in heme.
Clinical Correlate Porphyria refers to any abnormality in the pathway of heme synthesis. If the block is early in the pathway, the intermediates that build up are excreted in the urine; if the block is late in the pathway, they are excreted in the urine and feces and accumulate in the skin. Lead poisoning can be considered an acquired porphyria because it inhibits ALA dehydratase and heme synthase (ferrochelatase).
iiieCtical
101
Biochemistry
Glycine Succinyl-CoA
ALA synthase
ALA dehydratase 1 - - - - - - L'l-Aminolevulinate ;. Porphobilinogen
Uroporphyrinogen-I synthase ------;;.~
Uroporphyrinogen-III
Uro-III cosynthase
Protoporphyrin IX
Heme synthase (ferrochetolase)
Heme Figure 1-6-18. Heme synthesis.
Heme degradation begins in the reticuloendothelial celis, where heme oxygenase opens the ring system to give the linear pyrrole, biliverdin, and carbon monoxide (Figure 1-6-19). This is the only reaction in human biochemistry that generates carbon monoxide. Biliverdin is reduced to bilirubin, which is further metabolized in the liver. The addition of either one or two molecules of glucuronate to bilirubin greatly increases its solubility. The major forms of heme that are excreted are stercobilin (feces) and urobilin (urine). Free bilirubin is known as "unconjugated" or "indirect" bilirubin, whereas bilirubin glucuronide is known as "conjugated" or "direct" bilirubin.
Clinical Correlate Hyperbilirubinemia can result from massive hemolysis, a block in the catabolism of heme, bile obstruction, or liver damage. Whatever the cause, patients will present with jaundice.
102
meClical
Biliverdin reductase
Heme oxygenase Heme
, ,J
02
NADPH
Biliverdin
,
NADPH
J
UDP-glucuronyl transferase Bilirubin ........... ~ J Bilirubin diglucuronide UDPglucuronate
UDP
Figure 1-6-19. Degradation of heme.
Summary of Metabolism
Fuels burned by the body include sugars, fatty acids, ketones, and amino acids. Each fuel has a unique storage form, transport form, and intracellular metabolites. These three forms can be interconverted via separate synthetic and degradative pathways, thus allowing fuel to be stored or mobilized independently. The pathways for storage and mobilization are regulated in a reciprocal fashion, avoiding futile cycles created by simultaneous synthesis and degradation. This chapter reviews the major storage forms of energy, the types of fuels used by each organ, the hormones that regulate fuel metabolism, and the transitions that occur in going from a well fed state to an overnight fast and finally to a state of prolonged fasting.
PATHWAYS OF FUEL METABOLISM Each metabolic fuel has three primary forms: a storage form, a transport form, and unique intracellular intermediates. The relationships among these different forms of each fuel are shown in Figure 1-7-1.
I _ Triglycerides
,.-_--,
~. d~"----
~ooe~ Bodies
Glycogen
pyruvate ......f----------',
Fatty
_L_A_Ci_dS--,~
GilT I ._--.. ~
y Acet ; CoA
I
Amino . Acids
~
I~proteins
I
TCA Cycle ......f------------'
~
I
Electron Transport and ------.. Oxidative Phosphorylation
ATP
Figure 1-7-1. Summary of fuel metabolism.
A. Relationship between storage and transport forms. Fatty acids, glucose, and amino acids serve as the transport forms of triglycerides, glycogen, and proteins, respectively. The transport forms are found in highest concentration in the blood. They can either be released or taken up by cells, depending on the nutritional status of the organism. The formation of ketone bodies provides an overflow pathway for excess acetyl-CoA. When fatty acid oxidation is producing acetyl-CoA faster than it can be used, the excess acetyl-CoA is converted to KAPLAlf
-
med lea
I
103
Biochemistry
In a Nutshell Separate pathways for reversible processes prevent the futile cycling of opposing pathways.
ketones. The ketones can then enter the blood and be taken up by other tissues and used as fuel. The pathways by which storage forms of fuel are converted to transport forms and vice versa are unique and have been reviewed in detail in other chapters. For example, the incorporation of fatty acids into triglyceride and the release of fatty acids from triglyceride occur by different pathways rather than by the reversal of a common pathway. The same relationship exists for glycogen synthesis and degradation and for protein synthesis and degradation. These different and opposing pathways between storage and transport forms of fuel are usually regulated in a reciprocal manner, ensuring that when one pathway is in operation, the other is dormant. B. Relationship between transport forms and intracellular metabolites. Inside the cell, each of the fuels is converted to one or more characteristic intracellular metabolites. For example, amino acids are degraded to glycolytic or TCA intermediates, glucose is degraded to pyruvate, and fatty acids are oxidized to acetyl-CoA (Figure 1-7-2). Opposing but separate pathways are also present in cells, allowing these fuel-specific intermediates to be converted to their corresponding transport forms and released into the blood. A more detailed metabolic map of these interconversions is shown in Figure 1-7-3. Once again, the opposing pathways are tightly regulated so that intermediates are not being synthesized and degraded simultaneously. As shown in Figure 1-7-2, all of the metabolic fuels are eventually degraded to acetyl-CoA, which is oxidized to C02 and H20 by common pathways. The energy for synthesizing most of the cellular ATP comes from the TCA cycle, the electron-transport chain, and oxidative phosphorylation. C. Transitions between metabolic fuels. Certain transitions among the various fuels are permissible and others are nonpermissible. Both carbohydrates and proteins can be converted to fatty acids. Carbohydrate can be used for the synthesis of the nonessential amino acids and protein. However, acetyl-CoA cannot be converted to pyruvate and, therefore, cannot Glycogen (liver and muscle)
Ribose 5-Phosphate
~
Glucose
HEXOSE MONOPHOSPHATE SHUNT
~__In_te_rc_on_ve_rs_io_n_of_-, 3,4,5,6,& 7
Glucose - - - - . Glucose 6-P hosPhate -
1 I
Carbon Sugars
NADPH
GLYCOLYSIS
i/
Pyruvate
GIYOOgen/ Amino
~~'\
I
____ Vitamin 0
Acetyl CoA - - - - - - - - - - Cholesterol--Steroid Hormones ---Bile Acids
Fatty Acids Ketone Bodies
ATP
1
Ketogenic Amino Acids
Figure 1-7-2. Relationship of carbohydrate, fat, and amino acid metabolism.
104
me'lieal
Summary of Metabolism
act as a precursor for carbohydrate or protein synthesis. The reaction catalyzed by pyruvate dehydrogenase (pyruvate to acetyl-CoA) is an irreversible reaction, and there is no opposing enzyme in human tissues that will get around this irreversible step. Therefore, the conversion of fat to carbohydrate and protein is considered a nonpermissible transition. D. Regulation of fuel metabolism. The pathways that are operational in fuel metabolism depend on the nutritional status of the organism. Shifts between storage and mobilization of a particular fuel, as well as shifts between the type of fuel being used, are very pronounced in going from the well fed state to an overnight fast and finally to a prolonged state of starvation. The shifting metabolic patterns are regulated mainly by the insulin/glucagon ratio. Insulin is an anabolic hormone that promotes fuel storage_Its action is opposed by a number of hormones, including glucagon, epinephrine, cortisol, and growth hormone. The major function of glucagon is to respond rapidly to decreased blood glucose levels by promoting the synthesis and release of glucose into the circulation. 1. Well fed state. Immediately after a meal, the blood glucose level rises and stimulates the release of insulin. The three major target tissues for insulin are liver, muscle, and adipose tissue. Insulin promotes glycogen synthesis in liver and muscle. After the glycogen stores are filled, liver converts excess glucose to fatty acids and triglycerides (Figure 1-7-3). Insulin also promotes triglyceride synthesis in adipose tissue and protein synthesis in muscle. Following a meal, most of the energy needs of the liver are met by the oxidation of excess amino acids.
Ribulose 5-P04 Nucleotides+-Ribost 5-P04
Glucose 1-P04
NADPH~
!- -
==x.:::
L-UDP-GIUCOSe
6-P-Gluconolactone
-
Galactose 1-P04 UDP-Galactose
----------------jJGl!L~ugC~0~S~EJI I rl I
GIUCOS16-Po4...
-Fructost6-P04----1 MANNOSE
! !
FRUCTOSE
Fructose 1-P04
Fructose 1,6-bis-P0 4'-...... ~
/
'\..
Glyceraldehyde
Glyceraldehyde 3-1' 0 4 - - Di~YdrO~ • I ace one 4 • PhosPhoenr pyruvate
Glycerol 3-P04 ~ GLYCEROL I ~ FATTY Fatty AcidCOA. ACID
Lactate +----+- Pyruvate
!
Acetyl-CoA
~
NH3yC02 ASPARTATE
oxaloacetate
Carbamoyl P04
I
V
I
--------Acetoacetate~ LEUCINE
Citra\te
Argininosuccinate )
ur~
i
CoA
a-Ketoglutarate
Arginine
Glutamate
Meth~malonyl-
Ornithine
\
ALANINE SERINE CYSTEINE GLYCINE
• M~~~YI-
/ Fumarae t
Citrulline
HMP shunt activity varies with the body's need for reducing power (NADPH). Activity increases during the well fed state because of the need for NADPH for fatty acid or cholesterol synthesis.
IGAlACTOS' I
IGLYCr'" I
NAD~-P-GIUConat'
Note
Succinyl-Co
~~~~~~________
°t
~
PropionylCoA r---.JC::::==i-_Acetyl CoA FATTY ACYL
od~~!ber
Figure 1-7-3. Inter-relationships of metabolism.
mectical
105
Biochemistry
Note HMP shunt activity decreases with an overn ight fast as gluconeogenesis and ketone body formation begin.
2. Overnight fast. Glucagon and epinephrine levels rise during an overnight fast. These hormones stimulate the release of glucose from the liver and fatty acids from adipose tissue. In liver, glycogen degradation and the release of glucose into blood are stimulated. Hepatic gluconeogenesis is also stimulated, but the response is slower than that of glycogenolysis (Figure 1-7-4). The release of fatty acids from adipose tissue is stimulated by both glucagon and epinephrine. The ATP required for gluconeogenesis is supplied by oxidation of fatty acids. The carbon skeletons for glucose synthesis are derived primarily from amino acids that are released from skeletal muscle.
""C
Q)
/
Exogenous glucose
Protein sparing. Brain adapts to ketone bodies using 2/3 ketone bodies and 1/3 glucose as its energy source.
(J)
:J Q) (J)
o (.)
:J
a
. Llve~ glycogen
/"_" 'i.,•...../----1'.------ ......•. / --- ............... . .. ' ......\ Gluconeogenesis 10 hours
20 hours
2 days
24 days
40 days
Time fasting Figure 1-7-4. Source of blood glucose during fasting.
Note HMP shunt activity is almost nonexistent during the prolonged fasting or starvation state.
3. Prolonged fast (starvation). Levels of glucagon and epinephrine are markedly elevated during starvation. Lipolysis is brisk, resulting in excess acetyl-CoA that is used for ketone synthesis. Levels of both lipids and ketones are therefore increased in the blood. Muscle uses fatty acids as the major fuel and the brain adapts to using ketones for some of its energy. After 1-2 weeks of fasting, the brain derives approximately two thirds of its energy from ketones and one third from glucose. The shift from glucose to ketones as the major fuel diminishes the amount of protein that must be degraded to support gluconeogenesis (Figure 1-7-4). There is no "energy-storage form" for protein because each protein has a specific function in the cell. Therefore, the shift from using glucose to ketones during starvation spares protein. Red blood cells and renal medullary cells that have few, if any, mitochondria continue to be dependent on glucose for their energy.
ENERGY STORAGE AND UTILIZATION Fats are much more energy rich than carbohydrates, proteins, or ketones. Complete combustion of fat results in 9 kcal/g compared with 4 kcal/g derived from carbohydrate, protein, and ketones. The storage capacity and pathways for use of fuels varies with different organs and with the nutritional status of the organism as a whole. A. Storage. Most carbohydrate storage occurs in skeletal muscle and liver. Muscle glycogen accounts for approximately two thirds of the carbohydrate storage. A small fraction of the total carbohydrate is found as glucose in the circulation. Fats are stored in adipose tissue, which comprises anywhere from one fourth to one third of the human body weight. Proteins are found in all body tissues where, on the average, they account for three fourths of the
106
meClical
Summary of Metabolism
tissue mass. Degradation of more than approximately one third of the protein in the body is incompatible with life. Therefore, protein sparing by shifting patterns of fuel use is essential to survival during prolonged fasting. B. Utilization. Patterns of fuel use depend both on the metabolic state (well fed versus fasting)
and on the tissue being studied. Regardless of which fuel is used, they are all degraded to acetyl-CoA, which is oxidized by common pathways to C02 and H20. The fact that all metabolic fuels give rise to a common intermediate (acetyl-CoA) provides a mechanism for establishing priorities in fuel use. 1. Priorities. The fasting state promotes fat use and inhibits carbohydrate and protein use.
In the fasting state, gluconeogenesis, proteolysis, and lipolysis are all activated. The amino acids are supplying carbon skeletons for glucose synthesis and the oxidation of fatty acids to acetyl-CoA provides the energy for driving glucose synthesis. The accumulation of acetyl-CoA inhibits pyruvate dehydrogenase, the enzyme that irreversibly converts pyruvate to acetyl-CoA. When pyruvate dehydrogenase is inhibited, the ability to use carbohydrate and protein as sources of fuel is decreased. Under these conditions, pyruvate (derived from either carbohydrate or amino acid precursors) can be diverted away from oxidation and toward gluconeogenesis. Thus, when fat is being used as a metabolic fuel, there is no need to oxidize carbohydrate or protein.
In a Nutshell The increase in acetyl-CoA leads to a decrease in the activity of pyruvate dehydrogenase, which in turn leads to a decrease in the use of carbohydrates and proteins.
2. Organ specificity. Different organs use different fuels. The organ-specific patterns of fuel
use in the well fed and fasting states are summarized in Table 1-7 -1. Table 1-7-1. Preferred fuels in the well fed and fasting states. Organ
Postfeeding
Fasting
Skeletal muscle Cardiac muscle Brain Kidney cortex Kidney medulla Liver Adipose tissue Red blood cells
Glucose Glucose and fatty acids Glucose Fatty acids Glucose Glucose, amino acids Glucose Glucose
Fatty acids, ketones Fatty acids, ketones Ketones, glucose Fatty acids Glucose Fatty acids Fatty acids Glucose
a. Skeletal muscle. The main fuels of skeletal muscle are glucose and free fatty acids. Due to the enormous bulk, skeletal muscle is the body's major consumer of fuel. After a meal, glucose is used to replenish the glycogen stores. In the post-prandial state, elevated levels of insulin promote the uptake of glucose and amino acids by muscle. Excess amino acids are oxidized for energy, and excess glucose is broken down through glycolysis. If the muscle is anaerobic due to intense contraction, the production of pyruvate by glycolysis may exceed the capacity of the citric acid cycle to carry out terminal oxidation. In this case, lactic acid accumulates. Pyruvate is converted to lactate so that the NAD+ needed by glyceraldehyde-3-phosphate can be regenerated. In the fasting state, muscle uses fatty acids and ketones as the primary fuel. Any available glucose is spared for use by brain and red blood cells. b. Cardiac muscle. After a meal, glucose and fatty acids are the major fuels consumed by heart muscle. After a brief period of fasting, fatty acids are used, and after a longer fast, ketones are used. Thus, cardiac muscle behaves much like skeletal muscle in terms of fuel use, except it has a much higher oxidative capacity and many more mitochondria.
In a Nutshell • Glucose and fatty acids are the main fuels in skeletal muscle. • Cardiac muscle uses glucose, fatty acids, and ketone bodies for fuel. • The brain uses glucose for fuel and will resort to ketone bodies during prolonged fasting only if it's desperate. KAPLA~. I meulca
107
Biochemistry
c. Brain. Glucose is the primary fuel for brain. Fatty acids cannot cross the blood-brain barrier and are therefore not used at all. Between meals, brain relies on blood glucose supplied by either hepatic glycogenolysis or gluconeogenesis. Only in prolonged fasts does the brain gain the capacity to use ketones for energy, and even then ketones supply only approximately two thirds of the fuel supply. The remaining one third of the fuel continues to be supplied by glucose.
In a Nutshell The kidney isn't picky: it'll use whatever is available for fuel.
d. Kidney. The kidney is unique in that it utilizes virtually all fuels: fatty acids, glucose, lactate, amino acids, citrate, glycerol, and ketones. The renal cortex relies primarily on fatty acids and to a lesser extent on ketones but will also use lactate, amino acids, and glycerol. The renal medulla preferentially uses glucose. During states of fasting, the rate of gluconeogenesis by the kidney is increased. e. Liver. The two major roles of liver in fuel metabolism are to maintain a constant level of blood glucose under a wide range of conditions and to synthesize ketones when excess fatty acids are being oxidized. After a meal, the glucose concentration in the portal blood is elevated. The liver extracts excess glucose and returns the concentration in the blood to normal. The extracted glucose is used by the liver to replenish its glycogen stores, and any glucose that remains is then converted to acetyl-CoA and used for fatty acid synthesis. The increase in insulin following a meal stimulates both glycogen synthesis and fatty acid synthesis in liver. The fatty acids are converted to triglycerides and are released into the blood as VLDLs. In the well fed state, the liver derives most of its energy from the oxidation of excess amino acids. Between meals and during prolonged fasts, the liver releases glucose into the blood. The increase in glucagon during fasting promotes both glycogen degradation and gluconeogenesis. Lactate, glycerol, and amino acids provide carbon skeletons for glucose synthesis. f. Adipose tissue. After a meal, the elevated insulin stimulates glucose uptake by adipose tissue. Insulin also stimulates fatty acid release from VLDL and chylomicron triglyceride. Lipoprotein lipase, an enzyme found in the capillary bed of adipose tissue, is activated by insulin. The fatty acids that are released from lipoproteins are taken up by adipose tissue and re-esterified to triglyceride for storage. Insulin is also very effective in suppressing the release of fatty acids from adipose tissue. During fasting, the increase in glucagon and epinephrine activates hormone-sensitive lipase in fat cells, allowing fatty acids to be released into the circulation.
HORMONAL REGULATION OF METABOLISM The hormones that regulate fuel metabolism can be divided into two major groups: anabolic hormones that promote storage and catabolic hormones that promote mobilization. A. Hormones promoting fuel storage. In humans, insulin is the only hormone that promotes fuel storage. Insulin is produced by the ~-cells in the islets of Langerhans in the pancreas. The release of insulin from the ~-cells is stimulated by an increase in the concentration of blood glucose. B. Hormones promoting fuel mobilization. The action of insulin is antagonized by a number
of hormones that are collectively referred to as "catabolic hormones:' These hormones and their sites of synthesis are listed in Table 1-7-2. They all increase the rate at which fatty acids, glucose, and amino acids are released from their storage forms.
108
meClical
----~.--~~
-------~~--
Summary of Metabolism
Table 1-7-2. Fuel-mobilizing hormones. Hormone
Site of Synthesis
Glucagon Epinephrine Norepinephrine Cortisol Growth hormone *
Alpha cells of pancreas Adrenal medulla Adrenal medulla Adrenal cortex Anterior lobe of pituitary
*Growth hormone increases gluconeogenesis in liver and increases liver glycogen.
C. Mechanisms of hormone action. Hormones mediate the transfer of information from one
group of cells to another. There are two major types of mechanisms by which informational transfer occurs, depending on where the hormone exerts its effect. 1. Hormones acting at the plasma membrane of cells. The binding of hormones by cell surface receptors initiates a chain of events that results in the phosphorylation of specific intracellular proteins. There are several intermediate steps that occur between hormone binding and protein phosphorylation. Most of these hormones generate "second messengers" (cAMP, cGMP, Ca2+, diacylglycerol) inside the cell that stimulate specific protein kinases. An example is shown in Figure 1-7-5. In this case, the hormone stimulates adenylate cyclase to synthesize cAMP. The synthesis of cAMP requires interaction between three types of proteins: hormone receptors, G-proteins that bind GTP or GDP, and adenylate cyclase. The Gprotein acts as a communication link between the receptor and adenylate cyclase. When the receptor binds hormone, this information is transmitted to adenylate cyclase via the G-protein, and cAMP synthesis begins. (The G-protein must bind GTP in order to communicate with adenylate cyclase. The hydrolysis of GTP to GDP will terminate the communication.) The increased cAMP activates a protein kinase that then phosphorylates a few specific enzymes in the cell. The activity of the phosphorylated enzyme may be either increased or decreased. The enzyme activity can be restored to its original level by removing the phosphate group, a reaction catalyzed by a family of protein phosphatases. Extracellular
Hormone
Intracellular
Reor,or G-Protein
1
Adenylate Cyclase
ATP (
i
Inactive Protein Kinase
cAMP
Enzyme-OH Active Protein Kinase (
y
p. I
Protein Phosphatase
Enzyme-O-P03 (Altered activity)
Plasma Membrane
Figure 1-7-5. Mechanism of peptide hormones that activate adenylate cyclase.
meCtical
109
Biochemistry
2. Hormones that act in the nucleus. The other major site where hormones exert their effects is in the nucleus of cells, where the hormone-receptor complex binds to DNA and alters the rate of gene expression. Steroid hormones, thyroid hormones, and 1,25-dihydroxycalciferol (activated vitamin D) all bind to specific receptors and alter the rate of mRNA synthesis. Binding of the hormone-receptor complex to "enhancer" sequences in DNA results in increased mRNA synthesis, whereas binding to "silencer" sequences results in decreased mRNA synthesis. The mechanism by which steroid hormones stimulate the transcription of a particular gene is illustrated in Figure 1-7-6. The enhancer region in the DNA alone has no stimulatory effect on transcription. However, when the hormone-receptor complex binds to the enhancer region, transcription of a specific coding sequence is stimulated.
I"
••
DNA
-----1 Enhancer
Promoter
H
Coding Sequence
1-1---
(!) Hormone-Receptor Complex
DN"----1
E5'
Pmmote'
\
ICod;ng Sequence I
'fVVVV\J\
' , , ____ ®____ / / /
mRNArnthes;s Protein synthesis
Figure 1-7-6. Hormonal stimulation of gene expression.
D. Mechanisms of specific hormones that regulate fuel metabolism. The hormones primarily responsible for fuel mobilization are glucagon, catecholamines (epinephrine and norepinephrine), and cortisol. The only hormone that promotes fuel storage is insulin. A brief description of the mechanism for each of these hormones and how they coordinate the various pathways of carbohydrate, fat, and protein metabolism is discussed below.
In a Nutshell
1. Hormones that activate adenylate cyclase. Three of the four hormones that mobilize fuel II!'
Glucagon, epinephrine:~ and norepinephrine all increase cAMP.
110
mellical
(glucagon, epinephrine, and norepinephrine) bind to cell surface receptors and activate adenylate cyclase, resulting in the synthesis of cAMP and the subsequent effects previously described in Figure 1-7-5. a. Glucagon release is stimulated by low blood glucose and by elevated levels of epinephrine and several amino acids, particularly alanine and arginine. The primary target for glucagon is the liver, where it stimulates glycogenolysis and gluconeogenesis and inhibits glycolysis. It also activates lipolysis and the release of fatty acids from adipose tissue. The binding of glucagon to receptors in these tissues results in the phosphorylation of a number of enzymes by cAMP-dependent protein kinase. The enzymes that are phosphorylated in response to glucagon are listed in Table 1-7-3, together with the pathway they participate in and the effect that phosphorylation has on the enzyme.
Summary of Metabolism
Table 1-7-3. Effect of phosphorylation on key enzymes in carbohydrates and lipid metabolism. Pathway
Effect of Phosphorylation
Glycogen phosphorylase
Glycogenolysis
Activation
Enzyme Carbohydrate metabolism Glycogen synthase
Glycogenesis
Inhibition
Pyruvate kinase
Glycolysis
Inhibition
Pyruvate dehydrogenase
Links glycolysis with TCA cycle
Inhibition
Phosphofructokinase-2
Synthesis of F-2,6-Pz*
Inhibition
Fructose-2,6-bisphosphatase Degradation of F-2,6-P z
Activation
Lipid metabolism Hormone-sensitive lipase
Lipolysis
Activation
Acetyl-CoA carboxylase
Fatty acid synthesis
Inhibition
HMG-CoA synthase
Cholesterol synthesis
Inhibition
•
*Fructose-Z,6-bisphosphate is both an allosteric activator of glycolysis and an inhibitor of gluconeogenesis.
b. Epinephrine and norepinephrine are released from the adrenal medulla in response to hypoglycemia. These hormones have two major types of receptors, ex and ~. When the ~ receptors are occupied, adenylate cyclase is activated and cAMP levels are increased. Glycogenolysis in cardiac and skeletal muscle and lipolysis in adipose tissue are all increased by cAMP-dependent mechanisms. Binding of epinephrine to ex receptors on liver cells results in other second messengers (diacylglycerol and calcium) and stimulation of other protein kinases, ultimately resulting in the activation of glycogenolysis and gluconeogenesis. Epinephrine also increases the heart rate and the force of heart contraction, stimulates contraction of bronchial smooth muscle, and increases blood pressure. 2. Insulin lowers cAMP levels. Insulin antagonizes the effects of glucagon by mechanisms that are not entirely understood. For example, glucagon promotes phosphorylation of the intracellular proteins described previously, and insulin promotes dephosphorylation of these same proteins. In liver, insulin activates cAMP phosphodiesterase, the enzyme that degrades cAMP. As cAMP levels in cells drop, protein phosphatases begin to shift the equilibrium from the phospho- to the dephospho- forms of these enzymes.
cAMP+HzO
cAMP phosphodiesterase
- - - - - - - - - - - - - - - - : I.. ~
5'AMP
(±linsulin
3. Hormones that modulate gene expression. Steroid and thyroid hormones exert their effects by altering the rate of mRNA synthesis for specific proteins or sets of proteins. Glucagon and insulin can also alter the rate of mRNA synthesis for key regulatory enzymes in glycolysis and gluconeogenesis (discussed below).
KAPLAlf I meillea
111
Biochemistry
a. Cortisol functions mainly to increase de novo synthesis of glucose. Cortisol is synthesized and secreted by the adrenal cortex. Its synthesis is stimulated by ACTH, a hormone released from the anterior pituitary in times of stress. Cortisol has three major target tissues: liver, adipose tissue, and skeletal muscle. The enzymes whose synthesis is induced by cortisol are summarized in Table 1-7-4. Cortisol results in increased lipolysis and proteolysis in adipose tissue and muscle, respectively. The synthesis of glucose from amino acid precursors is increased in liver, as are the glycogen stores. Glucose use is decreased in both muscle and adipose tissue. b. Thyroid hormones (T3 and T4) also exert their action in the nucleus by altering the rate of gene expression. Some of the metabolic effects of thyroid hormones are increased oxygen consumption, lowering of blood cholesterol, hyperglycemia, and thermogenesis. Receptors for the thyroid hormones are found in virtually all cells of the body, and the interaction of hormone with receptor stimulates numerous pathways of protein, lipid, and carbohydrate metabolism.
In a Nutshell
c. Glucagon and insulin can also alter the rate of gene expression. The mechanism by which glucagon alters gene expression involves cAMP-dependent phosphorylation of nuclear proteins that interact with the DNA. The mechanism for insulin is unclear, although its effects are clearly antagonistic to the effects of glucagon. Glucagon increases mRNA synthesis for enzymes that are specific for gluconeogenesis (PEPCK, FBPase-I, and glucose-6-phosphatase) and represses the synthesis for key glycolytic enzymes (glucokinase, PFK-l, and pyruvate kinase). Insulin stimulates the synthesis of mRNA for the key glycolytic enzymes and represses mRNA synthesis for gluconeogenic enzymes.
Glucagon
· t
PEPCK
·t ·t
FBPase-1 Glucose-6-phosphatase
J- Glucokinase • J- PFK-l • J- Pyruvate ki nase
112
Table 1-7-4. Induction of enzyme synthesis by cortisol. Tissue and enzyme
Pathway
Consequence
Liver FBPase-l PEPCK
Gluconeogenesis Gluconeogenesis
Increased glucose release Increased glycogen stored Increased glucose release
Adipose tissue Hormone-sensitive
Lipolysis
Increased release of fatty acids (fuel for gluconeogenesis)
Skeletal muscle Proteases
Protein degradation
Increased amino acid release (substrate for gluconeogenesis)
meclical ----
- - - - -----------------------------
---
SECTION II
Molecular Biology
---
~~~------~
..
---.~~~--~~~~~-
Nucleic Acids The nucleic acids DNA and RNA are the informational macromolecules of the cell. The building blocks for nucleic acids are nucleotides, which are arranged in a specific linear sequence and are linked together by phosphodiester bonds between the 3'-OH of one sugar and the 5' phosphate ester of the adjacent sugar. All of the information that specifies the properties and functions of a cell is programmed into the nucleotide sequence of DNA. DNA normally exists as a double helix. The helix is stabilized by noncovalent interactions between the purine and pyrimidine bases in opposite strands of the DNA duplex. This chapter reviews the chemical structure and the nomenclature of the DNA and RNA building blocks, the types of interactions that stabilize the secondary structure of nucleic acids, the conformations of DNA, and the metabolism of the purine and pyrimidine bases. Disease states associated with purine and pyrimidine metabolism are also reviewed.
In a Nutshell
NUCLEIC ACID STRUCTURE Nucleic acids are polymers of nucleotides covalently linked to one another. The primary structure of nucleic acids refers to the sequence of the nucleotides in DNA or RNA. Higher orders of structure are stabilized by noncovalent interactions between purine and pyrimidine bases.
A. Chemical structure of nudeotides. The nucleotides are the building blocks of nucleic acids. As shown in Figure II-I-I, nucleotides consist of three components: a nitrogenous base, a pentose, and a phosphate group. The linkage of the nitrogenous base to the pentose generates a nucleoside. The addition of a phosphate group to the pentose generates a nucleotide. The genetic information is carried in the sequence of the nitrogenous bases, and the sugar and phosphate groups form the backbone of the polynucleotide chain.
Nucleotide • Nitrogenous base • Pentose • Phosphate(s) Nucleoside • Nitrogenous base • Pentose
1. Nitrogenous base. Nucleic acids contain two types of nitrogenous bases: purines and
pyrimidines (Figure II -1-1). a. Purines contain two rings, both with nitrogen atoms. There are two types of purines found in nucleic acids: adenine (A) and guanine (G). b. Pyrimidines contain a single nitrogen-containing ring. The three types of pyrimidines found in nucleic acids are cytosine (C), thymine (T), and uracil (U). Thymine is found only in DNA, and uracil is found only in RNA.
Note Important nucleotide bonds often refer to the pentose carbons: • 5'-(
phosphate
2. Pentose sugar. RNA contains ribose, and DNA contains deoxyribose. Deoxyribose differs from ribose in that there is a hydrogen atom instead of a hydroxyl group attached to the carbon-2. The carbon atoms of the pentoses in the nucleic acids are numbered with primes. For example, the pentose in DNA is 2'-deoxyribose.
• 3'-( hydroxyl
3. Phosphate groups form the linkages between nucleotides in nucleic acids. The phosphate group is esterified to the 5' carbon of the pentose. In nucleic acids, phosphodiester bonds
• 1'-( glycosidic bond to base
OH on RNA and 2'-( H on DNA
• 2'-(
I KAPLAlf medlea
115
Molecular Biology
are formed between adjacent nucleotides. There are three types of phosphodiester linkages found in nucleic acids. a. 3'-5' phospho diester linkage is the most common linkage and forms the backbone of both DNA and RNA molecules. b. 2'-5' phospho diester linkage is involved in RNA splicing.
Pyrimidines
Purines
0
o
HNC)rH HN~CH' N&H JZ ~1 :1 ~16 N N
o
H
I
H Adenine (6-aminopurine)
Guanine (2-amino-6-oxypurine)
Nucleoside
N
H
I
H Uracil (2,4-dioxypyrimidine)
Cytosine (2-oxy-4aminopyrimidine)
:x
Also,
61
o
H
I
H Thymine (5,6-methyluracil)
0
cytidine H and ...... N deoxycytidine I
I
O-?-.......N
Also, adenosine and deoxyadenosine
0
H
H
5'CH 2 0H
o 4,V"~1' H
H
3'
H
2'
H
bH 6H e.g., URI DINE
e.g., GUANOSINE
e.g., DEOXYTHYMIDINE
Nucleotide
H
II
e.g., guanylic acid (GMP)
HO-P-OH
I o
4'
(Also, adenylic acid AMP (5'-AMP) R Adenosine-5' -phosphate Adenosine monophosphate l' Adenosine ribonucleotide H
5'~IH2 0 4'
H
5'CH 2 0H
H
3'
OH
2'
H
OH
R
~
H
H
3'
o
H
2'
H
H
I
HO-P-OH
II
o
Figure 11-1-1. Nucleic acid structure.
116
meclical
l'
Depending on R, uridylic acid Thymidylic acid (TMP) Deoxycytidylic acid 3'-D CMP Deoxycytidine-3'-phosphate cytosine-3'deoxyribonucleotide may be formed
Nucleic Acids
c. 5'-5' phosphodiester linkage is found in the cap structure at the 5' end of eukaryotic
messenger RNA.
B. DNA and RNA are polymers of nucleotides. 1. Phospho diester linkage. Nucleotides are linked together by phosphodiester bonds formed between the 3' hydroxyl group on one sugar and the 5' phosphate group of the adjacent nucleotide (Figure II -1-2). The specificity of the nucleotide at a particular posi-
tion is determined by the complementary base in the template strand.
2. Polarity. Polynudeotides have polarity. At one end of the polymer, the ribose has a free 3' hydroxyl group, and on the other end the ribose has a 5' phosphate group, .. OH 3'. i.e., 5' p
5'pp 5'pp
G>
~
:r
(Q
3'
Sugar
rot 3
"0
3'OH
a CD
o I
0
II
II
II
0
0
0
I
0
!e-
+
iil :l
a.
I
0- P - 0 - P - 0 - P -05- - CH
3'
rot
PPI
3
"C
t•
~
r
!e-
iil
:l
a.
Phosphodiester bond
2
Sugar
3' OH
5'
5'
Figure 11-1-2. Phosphodiester linkage in DNA and RNA.
C. Major differences in DNA and RNA. DNA and RNA differ in both structure and function.
In a Nutshell
1. Pentose. DNA contains 2' deoxyribose, whereas RNA contains ribose.
2. Nitrogenous bases. DNA contains A, T, G, and C, whereas RNA contains A, U, G, and C. 3. Number of strands. DNA is double stranded, whereas RNA is single stranded. 4. Function. DNA is the repository of genetic information, whereas RNA represents "working copies" of the DNA that are used in the transfer of genetic information from DNA sequences to protein sequences.
DNA • H at pentose 2'-( ("deoxy") • Bases are A, T, G, and ( • Double stranded
RNA • OH at pentose 2'-( ("ribo") • Bases are A, U, G, and C • Single stranded
I KAPLAlr me d lea 117
Molecular Biology
Note
D. Nomenclature and conventions
Glycosidic bond connects pentose l'-Cto base; phosphodiester bond connects one pentose to another pentose.
1. Nomenclature of nitrogenous bases, nucleosides, and nucleotides: The terminology that
distinguishes a free nitrogenous base from a base attached to a pentose (nucleoside), and a base attached to a ribose-S'-phosphate (nucleotide) is summarized in Table II-I-I. 2. Linkage between nitrogenous base and sugar. In purine nucleosides and nucleotides, the nitrogen-9 of the ring system is linked to the l' -carbon of the sugar. In pyrimidine nucleosides and nucleotides, the nitrogen -1 of the ring is linked to the I' -carbon of the sugar (see Figure II-I-I). Table II-I-I. Nomenclature of bases, nucleosides, and nucleotides. Base
(Deoxy) Ribonucleoside*
(Deoxy) Ribonucleotide*
Adenine (A) Guanine (G) Cytosine (C) Thymine (T)t Uracil (U)t
(Deoxy) (Deoxy) (Deoxy) (Deoxy) Uridine
(Deoxy) adenylate (Deoxy) guanylate (Deoxy) cytidylate (Deoxy) thymidylate Uridylate
adenosine guanosine cytidine thymidine
*Nomenclature for deoxyribonucleosides and deoxyribonucleotides is indicated in parentheses. tThymine is found only in DNA, whereas uracil is found only in RNA.
3. Conventions for writing nucleic acid sequences. The nucleotide sequence is represented by the single letter codes corresponding to the bases (A, C, G, T, U). Unless otherwise specified, the orientation is written in the direction of synthesis (5' to 3'). ACCTG If polarity (directionality) is being emphasized, the numbers may be added to the beginning and the end of the letter sequence. 5' ACCTG 3' If the presence of the phosphate groups is being emphasized, the structure may be written as follows. In the first structure below, there is a free hydroxyl group on the 3' end. In the second structure, there is a phosphate at the 3' end.
Note 5' pApCpCpTpG-OH 3' Nuc1eases cut phosphodiester bonds. Exonuc1eases remove terminal nuc1eotides only, whereas endonuc1eases cut between internal nuc1eotides.
5' ApCpCpTpGp 3' The presence of a 5' triphosphate and a 3' hydroxyl group is indicated by either of the following structures. If a phosphate group is not shown at the 3' end, as in the first sequence, it is assumed that there is a free hydroxyl group. In the second structure, the hydroxyl group is drawn in. 5' pppApCpCpTpG 3' 5' pppApCpCpTpG-OH 3'
118
meClical
Nucleic Acids
E. Secondary structure of nucleic acids. The secondary structure of DNA refers to its doublestranded duplex structure. Although RNA is almost always a single-stranded molecule, it can bend back on itself to form regions of double-stranded secondary structure.
In a Nutshell 10 structure = nucleotide sequence
1. Base pairing. The double-stranded structure is stabilized by base pairing between purines
20 structure = double helix, which can form between any antiparaliel and complementary sequences:
and pyrimidines. Complementary bases that pair with one another are G and C (in both DNA and RNA), A and T (in DNA), and A and U (in RNA). 2. Antiparallel strands. As shown in Figure 11-1-3, the two strands of DNA are always oriented in an antiparallel fashion, where one strand runs in the 3' to 5' direction and the other runs in the 5' to 3' direction.
5'
• Double-stranded DNA • Inverted complementary sequences within an RNA
3'
• RNA and DNA
3'
5'
Figure 11-1-3. Double-stranded DNA.
3. Stabilizing forces. The two strands are held together by two types of forces: hydrogen bonding and base stacking. a. Hydrogen bonding between base pairs. A-T and A-U base pairs are stabilized by two hydrogen bonds, and the G-C pair is stabilized by three hydrogen bonds (Figure 11-1-4). Because of the extra hydrogen bond, G-C base pairs provide more stability to the DNA duplex structure than do A-Tor A-U pairs.
liN
b
Cytosine
H
/N
?
c~
HO--r=O
H
fN
0 -
~'i--r~ OH
H
-...::::::
O==j--OH 0
H
£ . N~N~HHOo~
Guanine
I
I
H
c(
I
•• H
I
H N/ "
... O
A N ....... H· N I H
I
HH ~ OH
(3 H-BONDS)
H
b
Thymine
CH,
.-t . . o=iT "I
I
?
H N H-<
C~O¥"N
I
.......N y N " Q C H ,
~N'•••• H
A
N.b (2
~'i--r~ OH
I
Adeninex: ........ N
HO-j=O
o
,.........H·
OH
H
•••• 0_.....
H 0
~-BONDS)
H
H OH
H H
H
Figure 11-1-4. Hydrogen bonding between base pairs.
b. Base stacking interactions. The ring structures of the purines and pyrimidines are stacked over one another in the interior of the double helical structure. Hydrophobic interactions between adjacent purine and pyrimidine rings add stability to the double helix. The base stacking interactions are interrupted by a number of intercalating KAPLA~.
meulca
I
119
Molecular Biology
agents, such as actinomycin D, which have been shown to "slide" in between neighboring base pairs in DNA. These agents prevent DNA from serving as an effective template, thus inhibiting replication (DNA -7 DNA) and transcription (DNA -7 mRNA).
Note Localized "melting" is needed to initiate DNA replication and RNA transcription. DNA sequences needed to initiate DNA replication or RNA transcription are usually A-T rich.
4. Destabilization of the double helix. Double-helical DNA can be denatured by conditions that disrupt hydrogen bonding and hydrophobic interactions, resulting in the "melting" of the double helix into two single strands that separate from one another. No covalent bonds are broken in this process. Some conditions that promote denaturation are: a. Changes in pH. Addition of sodium hydroxide leads to the ionization of protons associated with the nitrogen atoms in the purine and pyrimidine rings. Ionization disrupts the hydrogen bonds that hold complementary bases together. b. High temperatures. Temperatures above 80-90°C result in the "melting" of the double helix. c. Chemicals. Both formamide and urea interfere with hydrogen bonding between bases.
TOPOLOGY OF NUCLEIC ACIDS Double-stranded DNA may be either linear or circular. Most DNA forms a right-handed, antiparallel helix.
In a Nutshell • B DNA is the common, right-handed, antiparallel helical DNA with approximately 10.5 base pairs per helical turn. • Z DNA is a left-handed helical DNA that occurs occasionally within a B DNA chromosome.
A. Conformations of linear DNA. Linear DNA is the form of double-stranded DNA found in most eukaryotic chromosomes. Three conformations have been identified. 1. B DNA is the most common form of DNA. It is the classic Watson-Crick right-handed antiparallel helical structure of DNA in which the bases are stacked upon one another and are perpendicular to the axis of the helix. The helix contains two grooves-a major and a minor groove-that provide sites where DNA-protein interactions occur. 2. Z DNA is a rare form of DNA that is found in G-C rich sequences and in DNA sequences that have long tracts of alternating purines and pyrimidines. In contrast to B DNA, this form of DNA forms a left-handed antiparallel helix. The biologic function is unknown. 3. A DNA is a form of DNA in which the bases are not perfectly perpendicular to the helical axis but are tilted about 20 degrees away from the axis. This type of DNA is the anhydrous form of B DNA. Like B DNA, it is a right-handed antiparallel helix. This type of structure is found in RNA-DNA hybrids.
B. Circular DNA has no ends. This is an advantage because circular DNA is resistant to exonucleases. Mitochondrial DNA and the DNA of most prokaryotes and some viruses are closed circular structures. Circular DNA may exist in a relaxed form (no supercoils), or it may be converted to more-compact structures by supercoiling.
In a Nutshell Negative supercoils stabilize partially unwound DNA, promoting replication and transcription. Both circular prokaryotic chromosomes and linear eUkaryotic chromosomes contain negative supercoils.
1. Supercoiling. One of the important properties of closed circular DNA is that it can form supercoils, which are important for DNA packaging. The supercoils may be either positive or negative. a. Negative supercoiling twists the DNA in the opposite direction from the clockwise turns of the right-handed double helix. DNA is usually negatively supercoiled, the form required for most biologic reactions. b. Positive supercoiling adds torsional pressure and allows the DNA to be wound more tightly. In positive supercoils, the DNA is twisted in the same direction as the intrinsic winding of the double helix. 2. Topoisomerases are enzymes that relieve the tension caused by supercoils in replicating DNA. These enzymes make transient breaks in the DNA by cutting and resealing phosphodiester bonds in the DNA strands.
120
meClical
Nucleic Acids
PURINE AND PYRIMIDINE METABOLISM A. Synthesis of nudeotides. Nucleotides are synthesized by either salvage pathways or by the
pathway for de novo synthesis. In salvage pathways, the nucleosides and the nitrogenous bases that are released by the degradation of nucleic acids are salvaged and reutilized. In the pathway for de novo synthesis, the starting materials are more elemental precursors, such as amino acids, ammonia, bicarbonate, and ribose-S' -phosphate. Tetrahydrofolate is an important coenzyme in purine and pyrimidine synthesis, acting as a donor of Cl fragments in the de novo assembly of the nitrogenous ring systems. In the adult, the salvage pathway is the major route for synthesis, and the de novo pathway is used primarily by rapidly dividing cells. Deoxyribonucleotides are synthesized by the reduction of ribonucleoside diphosphates. This reaction is catalyzed by ribonucleotide reductase and requires thioredoxin and NADPH as sources of reducing power. 1. Synthesis of purines. As shown in Figure II-1-S, the purine ring system is synthesized
from amino acids, bicarbonate, and Cl fragments carried bytetrahydrofolate. The purine ring is attached to ribose throughout the assembly. A parent purine nucleotide, IMP, gives rise to both AMP and GMP. The synthesis of purines is subject to feedback inhibition by GMP and AMP.
CO 2- 6 ---------- .. - - Glycine ~C"i-.5 7 N ,,' Asparate - 1 N , ~ I : II Ca - - Folate Folate-2 C~ ~C~ / ~N"'i 4: N / 3 : __ 9~
C-":'
f
Note Deoxynucleotide synthesis inhibitors are used as antineoplastic agents. • 5-Fluorouracil inhibits thymidylate synthetase. • Hydroxyurea inhibits ribonucleotide reductase. These drugs are discussed in the Pharmacology section of General Principles Book 2 (Volume II).
1
Glutamine
Glutamine
Figure 11-1-5. Origin of atoms in the purine ring system.
2. Synthesis of pyrimidines. In contrast to purines, the pyrimidine ring is completely assembled before it is attached to ribose-S' phosphate. As shown in Figure II -1-6, the precursors for the pyrimidine ring are carbamoyl phosphate and aspartate. The parent nucleotide in the pyrimidine pathway is orotidylate (OMP). Both UTP and CTP are derived from OMP. Thymidine nucleotides (required only for DNA synthesis) are synthesized by methylation of dUMP in a reaction that uses Cl-tetrahydrofolate as a Cl donor. Pyrimidine biosynthesis is inhibited by CTP and UMP.
In a Nutshell Purines are assembled while attached to ribose-5' phosphate; the pyrimidine ring is completed before it is attached to ribose-5' phosphate.
:- -4" --- ---:
,yC,C5: I: II: -- Aspartate O=C' C, 3
From carbamoyl phosphate [
N,
I
2 ~N/6 :, , .JI ',_________ 1
Figure 11-1-6. Origin of atoms in the pyrimidine ring.
KAPLA~.
I
meulC8
121
Molecular Biology
B. Degradation of nudeotides. The degradation of nucleotides starts with the removal of the
phosphate group and the pentose, yielding free purine and pyrimidine bases. The amino groups attached to the ring system are removed as ammonia by the action of adenosine deaminase and guanine deaminase. 1. Degradation of purines. The purine ring system cannot be opened up and degraded.
Therefore, the strategy is to make the ring as soluble as possible so that it can be excreted. The end product of purine degradation is uric acid. 2. Degradation of pyrimidines. In contrast to purines, the pyrimidine ring can be opened and partially degraded. Thymidine is degraded to butyrate, whereas uracil and cytosine are degraded to ~-alanine. C. Disease states are associated with defects in purine and pyrimidine metabolism. There are a
number of clinical conditions that arise from abnormalities in the degradation of purine nucleotides. 1. Gout results from the excessive production of uric acid. Elevated levels of uric acid can
occur secondary to other diseases that are characterized by high turnover of nucleic acids (i.e., polycythemia and leukemia). In gout, the joints become inflamed because of the precipitation of uric acid crystals. Kidney disease is also seen because of accumulation of uric acid in the tubules. The disease affects mostly males and is frequently treated with allo-purinol, an inhibitor of xanthine oxidase. Xanthine oxidase catalyzes the sequential oxidation of hypoxanthine to xanthine to uric acid. 2. Lesch-Nyhan syndrome arises from a deficiency in the enzyme hypoxanthine-guanine phosphoribosyl transferase (HGPRT). This enzyme is a part of the salvage pathway for purines. A deficiency leads to the inability to recycle purines and an overproduction of uric acid. Individuals with Lesch-Nyhan syndrome are mentally retarded, have hyperuricemia, suffer from gout, and have compulsive self-destructive behaviors. The basis for the involvement of the central nervous system is unknown. 3. Severe combined immunodeficiency disease (SCID). A deficiency in adenosine deaminase, an enzyme in the salvage pathway for purines, results in defective development of T and B lymphocytes. Individuals with a deficiency in this enzyme must live in a sterile environment to survive. Large amounts of dATP accumulate in red blood cells. This compound allosterically inhibits ribonucleotide reductase, an enzyme essential for DNA synthesis.
122
meClical
The Nucleus, the Cell Cycle, and Meiosis Most of the cellular events originate in the nucleus. In eukaryotic cells, the nuclear compartment is defined by the nuclear envelope, containing pores that allow macromolecules to pass in and out of the nucleus. The reproduction of cells involves duplication of cellular contents followed by cell division, or mitosis. The process of cell division occupies a small part of the total cell cycle. Most of the cell cycle is spent in interphase, a period of growth and preparation for cell division. Meiosis is a special type of cell division that produces sperm and ova, each of which contains half of the original complement of chromosomes. Each of the gametes produced by meiosis is genetically distinct from one another and from the parent cell. This chapter reviews the structure and function of the cell nucleus, the events occurring in interphase and mitosis, and the reductive cell division that occurs during meiosis.
NUCLEUS The nucleus of the cell serves as a reservoir of genetic information. A. Function. Three cellular functions are carried out in the nucleus. 1. DNA synthesis and repair. The process of DNA replication is both rapid and accurate.
The nucleus contains all of the enzymes and proteins required for DNA synthesis. Additionally, there are several proofreading and repair mechanisms that correct mistakes that are made spontaneously or by environmental insult. 2. RNA synthesis. Transcription of DNA into RNA occurs in the nucleus of eukaryotic cells by three distinct RNA polymerases, each synthesizing a different class of RNA. 3. RNA processing. In eukaryotic cells, RNA is synthesized as a precursor that is converted to mature RNA in the nucleus by a number of steps collectively known as "processing". B. Structure. The nucleus is the most conspicuous organelle in eukaryotic cells. It contains
almost all of the cellular DNA, and microscopy reveals the following structural features. 1. Nuclear envelope. The nucleus is separated from the cytoplasm by a double membrane (inner and outer). The outer membrane is continuous with the rough endoplasmic reticulum and, therefore, is a part of the endomembranous system. The inner and outer membranes form two concentric rings and are separated by a perinuclear compartment. 2. Nuclear lamin. The inner surface of the nuclear envelope is lined by an electron-dense layer containing three major proteins. This network of proteins plays an important role in the structural organization of the nucleus by providing connections between the inner nuclear membrane and the chromatin.
In a Nutshell Nuclear lamin proteins are important in nuclear disassembly and reassembly during mitosis and meiosis.
KAPLAN'dme leaI
123
Molecular Biology
3. Nuclear pores. The inner and outer nuclear membranes are fused together at the pores, providing channels of communication between the nucleus and the cytosol. Water, ions, amino acids, and small proteins can freely pass through the pores. The pores are associated with proteins that are required for transport of large macromolecular complexes into and out of the nucleus. The number of nuclear pores is usually fIxed in a particular cell type but may vary at times in relation to the transcriptional activity in the cell. 4. Chromatin. The chromosomes and chromatin are composed of DNA that is associated with histones, a family of positively charged proteins. 5. Nucleolus. The nucleolus is a very dense region containing large amounts of RNA and functioning as the site of ribosome assembly. The nucleolus is associated with the nuclear organizer region (NOR) on the chromosome. The NOR of the DNA contains many copies of the genes for ribosomal RNA. Electron microscopy reveals three distinct zones in the nucleolus. The periphery of the nucleolus has a granular zone that contains ribosomal precursor particles in various stages of assembly. The central region has a fIbrillar zone containing ribonuclear protein fIbrils. The DNA in the NOR region of the chromosome is a pale-staining region of the nucleolus.
CELL CYCLE The cell cycle begins when a cell comes into existence and ends when the cell divides into two daughter cells. The cell cycle can be divided into two major components: interphase and cell division (Figure II -2-1).
Go
In a Nutshell • Cells perform their differentiated functions while in G1 (or Go). • Mitochondria and centrioles, which contain DNA, divide during S phase. • During G2, each chromosome consists of two sister chromatids, connected at the centromere.
124
meclical
Ctk = Cytokinesis M = Mitosis Interphase
Figure 11-2-1. The cell cycle.
A. Interphase is the period of the cell cycle that precedes mitosis. It can be subdivided into three parts (G b S, and G2) based on discrete events occurring during interphase. l. Gl phase (Gap phase) is a period of cellular growth that precedes DNA synthesis. In most
cells, Gl lasts approximately 12 hours. During this time, lipids, carbohydrates, and proteins are synthesized. In some cells, Gl may be very long. For example, in muscle and nerve cells, Gl is so long that it seems the cells may have completely stopped cycling. Such resting cells are said to be in a special Gl state called Go.
---------
The Nucleus, the Cell Cycle, and Meiosis
2. S phase (synthesis phase) usually lasts for 6-8 hours and includes the entire period of DNA synthesis and chromosomal replication. The rate of RNA synthesis increases, and the cell prepares for mitosis. 3. G2 phase lasts between 3 and 4 hours and resembles the Gl phase in terms of cellular activity, except that the cell is now tetraploid (diploid X 2), whereas in the Gl phase it was diploid. B. Mitosis is the nuclear division of the cell, resulting in the reduction of the chromosome
complement from the tetraploid to the diploid number found in each daughter nucleus. Cytokinesis is the division of the cytoplasm, resulting in the enclosure of each daughter nucleus within a separate cell. As shown in Figure 11-2-2, mitosis is divided into six phases.
NUcl~::::us
Mitotic Spindle
Preprophase
Prophase
Metaphase
Telophase (Cytokinesis)
Late Anaphase
Early Anaphase
Figure 11-2-2. Phases of mitosis.
1. Preprophase. The chromosomes condense into recognizable thread-like structures in the
nucleus. A pair of centrioles (barrel-like structures) are visible in the cytoplasm. 2. Prophase. During prophase, the two copies of each chromosome are separated lengthwise into two single chromosomes, called chromatids. The main structural component of the mitotic apparatus is the mitotic spindle, which begins to form near the end of prophase. When the centrioles begin to separate, bundles of microtubules assemble between them, creating a spindle. At the end of prophase, the nuclear envelope begins to rupture. 3. Metaphase. The nuclear envelope and the nucleolus disappear during metaphase. The spindle moves into the region formerly occupied by the nucleus. The chromosomes move toward the midpoint of the spindle, and each chromosome attaches to bundles of spindle microtubules. 4. Early anaphase. The chromatids begin to split longitudinally and start migrating toward the poles of the cell. Once the chromatids split, they are referred to as chromosomes. 5. Late anaphase. The chromosomes aggregate at the poles, and a cleavage furrow begins to form, marking the beginning of cytokinesis.
In a Nutshell Until anaphase, each chromosome contains two sister chromatids. After anaphase, each chromatid is a separate chromosome. KAPLAlf I medlea
125
Molecular Biology
Note • Cells entering meiosis I are called primary gametocytes (spermatocytes or oocytes); they have the same DNA content as a cell entering mitosis. • Cells entering meiosis II are called secondary gametocytes; they contain 23 chromosomes, each consisting of two sister chromatids.
6. Telophase. A nucleolus forms, and nuclear envelopes appear around each group of daughter chromosomes. The condensed chromatin expands again and begins to reappear. The cytoplasm divides by deepening the cleavage furrow until it forms two daughter cells, thus completing cytokinesis.
MEIOSIS Meiosis is the type of cell division that occurs in sperm and ova and reduces the chromosome number by half. It occurs before maturation of the gametes. Genetic recombination also occurs in meiosis and involves the exchange of segments of chromosomes, resulting in a mixing of allelic linkages into new combinations. This is one of the ways in which deleterious mutations are introduced into the chromosome. As shown in Table II-2-1, meiosis involves two complete cell divisions, each resembling the mitotic division previously described. There is no DNA replication during either of the two meiotic divisions. DNA replication occurs before the first meiotic division. Table 11-2-1. Summary of the stages in meiosis. Meiotic Division I
Meiotic Division II
Prophase I Metaphase I Anaphase I Telophase I
Prophase II Metaphase II Anaphase II Telophase II
A. First meiotic division. The six stages of the first meiotic division are illustrated in Figure II-2-3 (steps A-F). 1. Meiotic prophase occurs in three stages: A, B, and C. a. Stage A. The chromosomes condense into visible threads, and pairing of homologous chromosomes occurs. The pairing is precise, except for the X-Y chromosome combination in males. The centro meres of homologous chromosomes do not pair. b. Stage B. Homologous chromosome pairing is complete, and four chromatids appear in each pair; this is a tetrad.
Note Recombination occurs between the chromatids within a tetrad; it changes allelic linkages but not gene sequence.
c. Stage C. This is the recombination, or cross-over, stage where the interchange of chromatid segments between two paired homologous chromosomes can occur. The point of exchange has an X-like appearance and is called a chiasma. At the chiasma, the chromosome pairs are held together, and at this time large segments of genes are exchanged between homologous chromosomes. 2. Meiotic metaphase I (stage D). Paired chromosomes line up on the mitotic spindle. The two chromosomes of each homologous pair form connections with microtubules leading to opposite ends of the cell.
In a Nutshell During meiosis II, sister chromatids of the 23 chromosomes separate. The final cells resulting from meiosis II are spermatids and ova (plus polar body).
126
meClical
3. Meiotic anaphase I (stage E). Both chromatids migrate toward the same end of the cell. 4. Meiotic telophase I (stage F). Each daughter cell gets one member of each chromosome pair, for a total of 23 double-stranded chromosomes.
B. Second meiotic division. This is shown in Figure II-2-3, step G. The steps are similar to those in a mitotic division, except that no DNA synthesis occurs before this division. The 23 chromosomes divide at the centromere, and each of the newly formed daughter germ cells receives 23 chromatids. Therefore, each germ cell now has a haploid number of chromosomes and half the amount of DNA of a diploid somatic cell.
The Nucleus, the Cell Cycle, and Meiosis
A
B
c
o
First meiotic division
G
Second meiotic division
Figure 11-2-3. First and second meiotic divisions.
meClical
127
.--_._---
DNA Replication and Repair
Genetic information is transmitted from parent to progeny by replication of parental DNA. The process of replication requires a number of proteins. Some participate as enzymes in the polymerization of nucleotide; others are responsible for unwinding the double-stranded DNA helix, holding it apart at the point of replication and preventing it from tangling. Maintaining the stability of the genome depends on a number of repair systems that correct occasional mistakes made during replication or that occur after replication due to environmental insult. This chapter reviews the basic concepts underlying DNA replication, the proteins and enzymes involved in replication, and some of the mechanisms that have evolved for repairing DNA. Inhibitors of DNA replication used as chemotherapeutic agents are reviewed, and some clinical abnormalities associated with DNA repair are also discussed.
DNA REPLICATION Most of the detailed information about DNA replication has been obtained from in vitro studies with Escherichia coli DNA. Although DNA replication in eukaryotic systems is more complex, the same basic concepts and mechanisms are involved. A. General concepts. The purpose of DNA replication is to create two daughter DNA molecules that are identical to the parental DNA. This is achieved by semi-conservative replication (Figure II -3-1). 1. Semi-conservative replication uses each of the parental strands of DNA as a template for directing the synthesis of one new daughter DNA molecule. 2. Base-pairing is the process by which each nucleotide in the parental strand is recognized and the complementary base is incorporated in the newly synthesized strand. As shown in Figure II-3-1, adenine (A) always base pairs with thymine (T), and guanine (G) always base pairs with cytosine (C).
Daughter DNAs
5'-GTTACG-3' 5'-GTTACG-3' 3'-CAATGC-5' - - -... 3'-CAATGC-5
L
+
I strands~
5'-GTTACG-3' 3'-CAATGC-5'
NeW'y synthesized
Figure 11-3-1. Semiconservative replication.
meClical
129
Molecular Biology
B. Enzymes involved in DNA replication. The properties of the E. coli enzymes required for
DNA replication are described below. 1. DNA polymerase I (Kornberg enzyme). The polymerization of nucleotides is catalyzed by DNA polymerase I, which also has exonuclease activities that function in proofreading and repair mechanisms.
In a Nutshell All DNA polymerases (prokaryotic, eukaryotic, and viral): • Must synthesize 5' to 3' • Must use an antiparallel template • Require a nucleotide (or short nucleic acid sequence) with a free 3'_ OH as a primer • Are associated with proofreading enzymes
In a Nutshell In both prokaryotes and eukaryotes, each replication fork requires: • Primase • DNA polymerases • Helicase • SSBs
• Ligase
a. Requirements for polymerization. DNA polymerase I requires all four deoxyribonucleotides (dATP, dTTP, dCTP, and dGTP) and Mg2+ for activity. Additional requirements are a DNA template (either single- or double-stranded DNA) and a primer with a free 3'-OH group that can react with the first nucleotide. The primer is subsequently erased, and the gaps are filled in by the polymerase. Chain elongation proceeds in the direction of 5' to 3'. b. Proofreading function (3' to 5' exonuclease activity). Occasionally polymerases add a nucleotide to the 3'-OH end that cannot hydrogen bond to the corresponding base in the template strand. Correct hydrogen bonding is required for polymerization to continue. Thus, the polymerase stops and removes the unpaired base from the 3' end so that polymerization can begin again. c. Repair function (5' to 3' exonuclease activity). The main function of the 5' to 3' exonuclease activity is to erase the nucleotides in the primer. 2. DNA polymerase II and III. There are two additional DNA polymerases in E. coli. The properties of DNA polymerase III are similar to those of DNA polymerase I. DNA polymerase III is a part of a multiprotein complex and is the major replicating enzyme in E. coli. The function of DNA polymerase II is unknown. 3. DNA ligase. This enzyme catalyzes the formation of a phospho diester bond between the 3' -OH of one fragment of DNA and the 5' -monophosphate group of an adjacent DNA fragment. These fragments are synthesized as a discontinuous strand in the DNA duplex. The formation of the phospho diester bond is an endergonic reaction and requires the input of energy that is supplied by NAD+ in bacteria and by ATP in animal cells and viruses. 4. Primase. The primer molecule that is required by DNA polymerase is a short strand of RNA (4-10 bases) that is complementary to the template strands of DNA. The primer is synthesized by a specific RNA polymerase known as primase. The growing end of the RNA primer is a free 3' -OH group. The primase does not require a primer for initiation of polynucleotide synthesis. 5. Helicases. Unwinding of the two strands in the DNA helix must occur before DNA replication can begin. This process requires energy (ATP) and enzymes known as helicases that force the two parental strands of DNA to separate at the replication fork. 6. Single-strand DNA binding (SSB) proteins. The single strands of DNA resulting from the action of helicase are prevented from reannealing by binding to SSB proteins. These proteins also protect the single-stranded DNA from cleavage by nucleases. 7. DNA topoisomerases. These enzymes produce a number of "swivel" points in the DNA molecule that relieve the strain induced by the replication fork. These enzymes cut and reseal the DNA. There are two major classes of topoisomerases: class I and II. a. Class I topoisomerases relax superhelical DNA in front of the replication fork by creating a transient nick in one of the strands. Class I topoisomerases do not require ATP. b. Class II topoisomerases introduce negative supercoils in the DNA molecule. This process requires ATP and involves transient breaking and resealing of both strands of DNA.
130
iiieClical --------~.---------
DNA Replication and Repair
c. Gyrase is the class II topoisomerase used by E. coli to promote DNA helix unwinding during replication. C. Events occurring at the replication fork. As the two strands of parental DNA unwind, a
fork-type structure is formed that is referred to as the "replication fork" (Figure II-3-2). As DNA synthesis proceeds along the DNA duplex, the replication fork continues to move. The synthesis of one of the daughter strands of DNA occurs continuously (the leading strand) whereas the other strand (the lagging strand) is made in short fragments (Okazaki fragments) that are then joined together.
5'
3'
Helicase
In a Nutshell 5'
Figure 11-3-2. Events at the replication fork.
l. Unwinding of parental DNA. At the site of replication, the two parental strands do not
completely separate but are unwound in a localized region known as the replication fork. The replication fork can move in either direction from the origin of replication (ori). Unwinding of the helix at the replication fork is accomplished by helicase, and the separation of the single strands is maintained by the binding of several molecules of singlestrand binding proteins. 2. Synthesis of leading strand. At the replication fork, one strand is synthesized continuously in the 5' to 3' direction as the parental DNA duplex molecule unwinds. Thus, the leading strand is complementary to the parental strand that runs in the 3' to 5' direction. 3. Synthesis of the lagging strand. The lagging strand is also synthesized in the 5' to 3' direction, but the synthesis occurs discontinuously, producing small fragments (approximately 1,000-2,000 bases) known as Okazaki fragments. These fragments are later joined by DNA ligase to form a continuous lagging strand. 4. RNA primers. There is no known DNA polymerase that can initiate the polymerization of a deoxyribonucleotide chain. Thus, the synthesis of both the leading strand and each of the Okazaki fragments in the lagging strand starts with a short RNA primer (approximately 10 bases). The primer is complementary and antiparallel to the 5' to 3' parental strand. The RNA primers are synthesized by a protein complex containing both singlestrand binding proteins and primase. This complex binds near the replication fork and moves along the lagging strand as it is opened up by helicase. The 3' OR of the last
Both prokaryotic and eukaryotic DNA synthesis is bidirectional: • DNA replication begins at an "ori" sequence in the DNA. • Two replication forks form at each ori site and move in opposite directions.
• E coli DNA contains a single ori site, whereas eukaryotic chromosomes each contain many ori sites.
In a Nutshell In both prokaryotes and eukaryotes, DNA replication is semidiscontinuous: • The leading strand is made continuously. • The lagging strand is made in discontinuous Okazaki fragments and then joined.
meClical
131
Molecular Biology
ribonucleotide in the primer serves as the site at which the first deoxyribonucleotide is added by DNA polymerase. Elongation of the DNA fragment occurs until it approaches another RNA primer. 5. Conversion of Okazaki fragments to a continuous strand. The precursor fragments are eventually joined to form a continuous strand that contains no RNA. This is accomplished by two sequential reactions. When DNA polymerase III approaches another RNA primer, it dissociates and DNA polymerase I enters. DNA polymerase I removes (erases) the ribonucleotides one at a time from the 5' end (5' to 3' exonuclease activity) and adds complementary deoxyribonucleotides to fill in the gaps. Finally, DNA ligase forms a phosphodiester bond between two adjacent DNA fragments. D. Inhibitors of DNA replication. The synthesis of DNA is inhibited by a number of compounds, most of which are either analogs of purines, pyrimidines, or folic acid. These compounds are frequently used as chemotherapeutic agents because of their ability to decrease the rate of division of rapidly growing cancer cells. l. Purine analogs. The most commonly used purine analog inhibitors are 6-mercapto-
purine, 8-azaguanine, and 6-thioguanine.
Note A nucleotide analog lacking a 3'-( OH will terminate elongation when it is inserted; e.g., cytosine arabinoside or other "dideoxynucleotides."
2. Pyrimidine analogs. Analogs such as S-fluorodeoxyuridine and S-bromodeoxyuridine inhibit thymidylate synthase, an enzyme critical for DNA synthesis. Cytosine arabinoside is an analog of cytosine nucleosides in which the sugar moiety is altered. Insertion of this analog into a DNA chain stops elongation of the chain. 3. Folic acid analogs. The synthesis of both purines and pyrimidines requires folic acid as a carrier of Cl fragments. The transfer of a Cl fragment from tetrahydrofolic acid to an acceptor results in the oxidation of tetrahydrofolic acid to dihydrofolic acid. In order to recycle the coenzyme, the cell requires NADPH and dihdyrofolic acid reductase. There are a number of folic acid analogs, such as methotrexate and aminopterin, that specifically act as powerful competitive inhibitors of dihydrofolic acid reductase.
DNA REPAIR The structure of DNA can be altered in a number of ways. Incorrect bases may be inserted during replication, or changes can result from exposure to ultraviolet radiation or chemicals found in the environment. Several repair systems have evolved that correct many of these changes. A. General terminology and definitions l. Mutation is a heritable change in the nucleotide sequence of DNA.
2. Mutagen is a chemical that alters the structure of a base in DNA. 3. Point mutation is a change in a single nucleotide. There are two types of point mutations: transitions and transversions. a. Transition is the change of one purine for another purine or of one pyrimidine for another pyrimidine. Transitions occur either from mispairing of bases during DNA replication or from chemical insult. For example, nitrous oxide converts cytosine to uracil by the removal of the amino group on the cytosine ring. b. Transversion is the exchange of a purine for a pyrimidine or vice versa. B. Types of DNA repair. Many of the mistakes occurring during replication are corrected by
the proofreading (3' to 5' exonuclease) activity of DNA polymerases. Additional types of repair mechanisms exist, which correct alterations that occur because of chemical or environmental insult.
132
meClical
DNA Replication and Repair
1. Nucleotide excision-repair mechanism of UV-damaged DNA. Ultraviolet light induces the formation of dimers between adjacent pyrimidines in DNA Cusually between adjacent thymines). The formation of pyrimidine dimers prevents DNA replication and normal gene expression. As shown in Figure II-3-3, four steps are involved in repairing this damage.
a. Incision. A UV-specific endonuclease recognizes the damaged DNA and makes a nick in the phospho diester backbone several bases away on each side of the dimer.
In a Nutshell Nucleotide excision repair removes a UV dimer and replaces it with normal nucleotides.
b. Removal. A helicase in the same enzyme complex removes the oligonucleotide. c. Polymerization. DNA polymerase fills in the gap by adding nucleotides, starting with the addition of the first nucleotide to the free 3' OR group created by the incision and moving in a 5' to 3' direction.
d. Ligation. DNA ligase forms a phosphodiester bond between the new DNA segment and the original DNA strand.
Thymine dimer~
I I II I I I I I I I rlu'.Jhl'l"'1MIIMI....I "-11 ....1'1..-1
I
t
Incision step Nicking by UV-specific endonuclease
fCl>\
~1'1"'1T"1~IIMI'I"'IT"I~llnl""nlIMI'I"'IT"I~IIMI'I"'IT"lrl
t
Removal by associated helicase
~ 5'-3' . . ,.1"T"1T"111....1'1T"1MII"""I"'IMil, " .1111111111111
I
DNA polymerase I
~t p synthesizes new DNA
1111111111111, t, ,1111111111111 Ligation by DNA ligase
I I 111111 111111 II 111111 111111 II Figure 11-3-3. Nucleotide excision-repair mechanism for UV-damaged DNA.
2. Base excision repair. The most common base transition is the deamination of cytosine to uracil in the DNA duplex. The deamination leaves an improper base pair between the two strands CU -G instead of C-G). The repair mechanism for this type of damage involves the following steps. a. Removal of the uracil base. A uracil-DNA glycosidase recognizes the mismatch and hydrolyzes the N-glycosidic bond between uracil and the deoxyribose moiety, leaving an apyrimidinic site CAP site) in the DNA strand. b. Cleavage of phosphodiester. A specific endonuclease recognizes the damage and nicks the phospho diester bonds adjacent to the missing base, thus releasing dexoyribose and
metlical
133
Molecular Biology
creating a gap. Endonucleases that cleave at apyrimidinic sites (or apurinic sites) belong to a family known as AP nucleases. c. Insertion of new cytosine nucleotide and ligation. DNA polymerase fills the gap, and the nick is sealed by DNA ligase.
In a Nutshell • An autosomal recessive deficiency in nucleotide excison repair results in xeroderma pigmentosa. • An autosomal recessive deficiency in base excision repair results in ataxia telangiectasia.
114
iiieilical
C. Diseases associated with DNA repair. Because repair mechanisms play such an important role in mutation surveillance and prevention, inherited defects that alter the activities of the repair enzymes can lead to dramatic increases in frequency of mutations. Several autosomal recessive diseases, such as xeroderma pigmentosa, ataxia telangiectasia, Bloom syndrome, and Fanconi anemia, are associated with either documented or suspected defects in DNA repair mechanisms. All of these diseases occur with high frequency and are associated with a predisposition to malignancy. 1. Xeroderma pigmentosa is an autosomal recessive trait characterized by extreme sensitivity to sunlight, skin changes, and a predisposition to malignancy. The disease results from a defective excision-repair mechanism for UV-damaged DNA. 2. Ataxia telangiectasia is an autosomal recessive disorder, characterized by hypersensitivity to ionizing radiation, degenerative ataxia, dilated blood vessels, chromosome aberrations, and lymphomas. The disease results from a defect in AP endonuclease.
Transcription The process of making an RNA copy of DNA is called transcription and is catalyzed by the enzyme RNA polymerase. In any particular region of the DNA double helix, only one of the two DNA strands is transcribed into RNA. The RNA strand is always synthesized in a 5' to 3' direction, but from an antiparallel and complementary DNA template strand. The completed RNA is therefore antiparallel and complementary to the template or "anti-sense" DNA strand. The RNA is, however, parallel and identical to the "sense" strand of the DNA duplex (except that it uses uracil instead of thymine). Cells contain three types of RNA, each having a different function. Messenger RNA (mRNA) carries the information specifying the amino acid sequence of proteins. Transfer RNA (tRNA) and ribosomal RNA (rRNA) play important roles in protein synthesis. This chapter reviews the key structural features of the genes coding for the three different types of RNA. the transcriptional machinery, and the steps involved in the process of transcription.
STRUCTURE AND TRANSCRIPTION OF PROKARYOTIC GENES In prokaryotes, both the gene structure and the machinery for transcription are considerably simpler than in eukaryotic systems. A. DNA elements. Specific sequences in the DNA act as start and stop signals for transcription.
1. Bacterial promoter region. The region of DNA that binds RNA polymerase and allows transcription to be initiated is known as the promoter region. As shown in Figure 11-4-1, the promoter region contains a starting point at which transcription is initiated and two consensus sequences that are recognized by RNA polymerase. The sequences at which RNA polymerase bind are located at positions -lO and -35. By convention, the starting point is designated as +1. (Negative numbers are not transcribed and indicate that the nucleotide is upstream from the initiation site, i.e., on the 5' side of the starting site). a. Pribnow box. The Pribnow box is an A-T rich sequence (TATATT) located 10 base pairs upstream from the site at which transcription begins. This sequence is present in almost all promoters and is involved in the initial unwinding of DNA by RNA polymerase. b. Hexamer at -35 position. Another consensus sequence of six nucleotides is located 35 base pairs upstream from the start site for transcription. This TTGACA sequence is involved in the initial recognition of the promoter by RNA polymerase.
In a Nutshell Most E coli promoters contain two recognition sequences for RNA polymerase: • Pribnow sequence at -10 • -35 sequence
c. Start site. The first nucleotide transcribed into RNA is usually a purine (Pu), either A or G. The next two nucleotides (designated NN) can be any of the four nucleotides found in RNA (A, G, C, or U).
KAPLAlf _ I meillea
135
Molecular Biology
Promoter
Coding region
II -35
-10
+1
5' -",,'-..rTTmGU\AC:CA~-..ffjITAiTI RNA polymerase
Initiation of transcription
binding sites
Figure 11-4-1. Bacterial promoter.
2. Bacterial terminators. Termination of transcription involves the release of both the DNA template and the newly synthesized RNA from RNA polymerase. Bacterial RNA polymerase has two methods of termination. a. Rho-independent termination occurs when the newly synthesized RNA folds back on itself and forms a hairpin loop that is stabilized by hydrogen bonding between complementary bases. The hairpin loop must be followed by a run of 6-8 U residues that form weak bonds with the complementary run of 6-8 A residues in the DNA template (Figure II-4-2). These two structural features of the newly synthesized RNA promote dissociation of the RNA from the DNA template.
u C U
C G
G-C C-G C-G G-C G-C A A In a Nutshell Rho-independent termination requires a specific 2° helical stem to form in the newly transcribed RNA; rhodependent termination requires rho protein to move along the newly transcribed RNA and to "catch" the RNA polymerase. 136
meClical
5'-GCACCGCA
UUUUUUU-OH 3'
Figure 11-4-2. Structural features required for rho-independent termination.
b. Rho-dependent termination. Rho factor is a protein that terminates transcription. It binds to the newly formed RNA and moves toward the RNA polymerase that has paused at a termination site. Rho then displaces the RNA polymerase from the 3' -OH end of the RNA. Rho factor has ATPase activity that is RNA dependent, and it requires a polyribonucleotide that is greater than 50 bases long.
Transcription
B. Transcriptional machinery. In prokaryotic systems, all forms of RNA are synthesized by a
single RNA polymerase. 1. Structure of RNA polymerase. This multisubunit enzyme exists in two forms: a core enzyme and a holoenzyme. The core enzyme has four subunits (a2~W). It is capable of polymerizing ribonucleotides, but it does not recognize promoter regions in the DNA. The holoenzyme has an additional sigma subunit that allows the enzyme to recognize promoter sequences. 2. Requirements for RNA synthesis. The synthesis of RNA requires all four ribonucleotides (ATP, GTP, CTP, and UTP), a divalent cation (either Mg2+ or Mn2+), and a template. Double-stranded DNA is the preferred template, but single-stranded DNA can also be used. Synthesis occurs in the direction of 5' to 3', and each time a nucleotide is added to the 3'-OR end, pyrophosphate is released. RNA polymerase does not require a primer and cannot proofread and correct mistakes. 3. Function of RNA polymerase subunits. The a subunits are involved in binding to the consensus sequences in the DNA promoter region. The ~ subunit contains the active site that binds nucleotide triphosphates and forms the phosphodiester bond of the polyribonucleotide chain. The Wsubunit plays a role in the attachment of the enzyme to the DNA template. Sigma factor recognizes promoter sequences and provides the enzyme with specificity.
In a Nutshell RNA Synthesis • Requires an antiparaliel and complementary template • Occurs 5' to 3' • Is not proofread • Can be initiated de novo (no primer is required)
C. Steps involved in transcription. Transcription in prokaryotes involves three steps: initia-
tion, elongation, and termination. 1. Initiation. The sigma subunit of the holoenzyme recognizes consensus sequences in the
promoter, binds to DNA, and helps unwind the DNA double helix so that one strand can serve as a template. The initiating ribonucleotide triphosphate is usually a purine (either A or G). After the first few phospho diester bonds are formed, the sigma subunit dissociates from the holoenzyme, and the core enzyme begins elongation. 2. Elongation. The core enzyme moves along the template extending the RNA chain, and the region of local unwinding moves with it. As the enzyme leaves a region, the DNA duplex reforms, and RNA is displaced as a growing polynucleotide chain. Growth of the chain is always in the 5' to 3' direction. RNA polymerase moves along the DNA template strand in the 3' to 5' direction.
Note In prokaryotes, the processes of transcription and translation are coupled. Translation of mRNA starts before the completion of transcription. In these systems, almost all gene regulation occurs at the transcriptional level.
3. Termination. The DNA template contains stop signals for transcription, as described in paragraph A.2. D. Inhibitors of prokaryotic transcription. Many antibiotics exert their action by interfering with bacterial RNA or protein synthesis while having no effect on eukaryotic RNA and protein synthesis. 1. Rifampin inhibits initiation of RNA synthesis. 2. Actinomycin D binds to DNA and inhibits RNA synthesis by blocking movement of RNA polymerase along the template. 3. Streptolydigin binds to the
~
subunit of RNA polymerase and blocks elongation.
metlical
137
Molecular Biology
STRUCTURE AND TRANSCRIPTION OF EUKARYOTIC GENES Both the structure of eukaryotic genes and the mechanisms for transcription are more complex than in prokaryotic systems. A. Transcriptional machinery: three RNA polymerases. Each type of RNA is transcribed by a different RNA polymerase. The requirements of each of these enzymes are the same as for prokaryotic RNA polymerase. None of the RNA polymerases have the proofreading activities that DNA polymerases have. 1. RNA polymerase I is localized in the nucleolus and transcribes the genes for three types of ribosomal RNA: 28S, 18S, and 5.8S rRNA. rRNA is the most abundant RNA in the cell.
2. RNA polymerase II is found in the nucleoplasm, where it transcribes genes coding for proteins. The primary transcripts synthesized by RNA polymerase II are known as heterogeneous nuclear RNA (hnRNA), which are precursors for mRNA and snRNA (small nuclear RNAs). The snRNAs (UI-U5) are a part of the "spliceosome;' a complex involved in removing intron sequences from precursor RNA molecules. 3. RNA polymerase III is located in the nucleoplasm and transcribes the genes for transfer RNA (tRNA) and 5S rRNA. B. Structure and transcription of ribosomal RNA genes. The genes coding for rRNA are transcribed by RNA polymerase I in the nucleolus. The nucleolus contains large loops of DNA from several chromosomes, each containing a cluster of genes for rRNA. As shown in Figure 11-4-3, multiple copies of the genes for rRNA are tandemly arranged so that each gene is separated from the next by a spacer. The primary RNA transcript of each of these genes is a 45S RNA that serves as a precursor for 18S, 28S, and 5.8S rRNA. The primary transcript also contains spacer regions between each of the rRNAs. The spacer regions are removed by a series of endonucleolytic cleavages. Processing of the precursor rRNA results in equimolar amounts of each of three types of rRNA. After the processing shown in Figure 11-4-3, the rRNA species are modified by methylation of specific 2'-OH groups. This reaction is believed to confer stability on the rRNA molecules and protect them from endonucleolytic cleavage after incorporation into ribosomes. C. Genes coding for protein. RNA polymerase II is found in the nucleoplasm, where it transcribes the genes whose RNAs will be translated into proteins. RNA polymerase II cannot initiate transcription itself and is absolutely dependent on additional proteins, known as transcriptional factors, that act at promoter sites. The essential features of genes that are transcribed by RNA polymerase II are shown in Figure II -4-4 and are briefly discussed. 1. Start site. The initial nucleotide in position + 1 of the RNA transcript is usually A, flanked by pyrimidines.
2. Promoters. There are two common sequences in promoters that are used by RNA polymerase II.
138
iiieClical --------------
-------
Transcription
45S rRNA precursor
CI)
co
CI)
CI)
to
C\I
co
45S rRNA precursor
CI)
co
co
CI)
CI)
to
C\I
co
co
45S rRNA precursor
S'p
L...L~~
OH3 '
___. L . - _
CI)
CI)
CI)
to
C\I
cq
co
CD
co
o
Q.
Processing of the 45S rRNA precursor
(/J
Mature rRNA CI)
CI)
CI)
tri
C\I
co
co
co
Figure 11-4-3. Structure and transcription of ribosomal RNA genes.
Poly- A+ addition site
>c
~o
0·-
O"l
~
O"l
a::
-70
-25
~ ..c
..c
t;(
«
0
Exon 1
Intron 1
t
Exon 2
x
0
~ ~
1+1 c 0 '5>
AGGTAAGT
NCAGG
t
t
"0
til
U5 C
~
c
::> Ln
11 AATAAA
c 0 '5>
(ij
"0
+
~
til
U5 c ~
C O"l
'iii
«
:>. ~
C ::> M
Figure 11-4-4. Structure of a typical gene transcribed by RNA polymerase II.
a. TATA box (Hogness box). This sequence of base pairs, which is important in the initiation of transcription, is found in all eukaryotes. It is located approximately 25 base pairs upstream (-25) from the start point and is almost identical to the Pribnow box found in bacterial systems. TFIID, the critical transcription factor for RNA polymerase II, binds here. b. CAAT box. This sequence is usually found between positions -75 and -80, but it can KAPLAN"dme leaI
139
Molecular Biology
function at distances that vary considerably from the start point. Binding of transcription factors at this site may influence the formation of initiation complexes at other sites.
In a Nutshell RNA polymerase II initiation requires: • Specific transcription factors bound to enhancer sequences • General transcription factors bound to promotor sequences • Association of RNA polymerase II with transcription factors to form initiation complex
3. Regulatory regions. Sequences that either increase or decrease the rate at which transcription is initiated by RNA polymerase II exist at various places in the gene. Although they are usually located upstream from the start site, they may also be internal to the gene or downstream from the gene. Enhancer sequences bind transcription factors that increase the rate of transcription, whereas silencer sequences bind factors that decrease the rate of transcription. 4. Exon and introns. The segment(s) of the gene that are maintained in the mature mRNA and code for protein are known as exollS. Introns are the portions of the primary RNA transcript that are removed by splicing together the exons (Figure 11-4-5). The splicing usually occurs at a consensus sequence (GU ... AG) found at the boundaries between introns and exons (discussed in more detail below).
prima7rahnn:c~; Mature mRNA
5'
--l 5'
Exon 1
---1
H
Exon 1
Exon 2
H
Exon 3
H
I Exon 2 I Exon 3 I Exon
Exon 4
r--
3'
4}-- 3'
Figure 11-4-5. hnRNA and mature mRNA.
In a Nutshell RNA polymerase III initiation requires: • Transcription factors bound at intemal promotor sequence and at start site • Association of RNA polymerase III with transcription factors at start site to form initiation complex
Note In eukaryotes, because transcription and translation are not coupled, the primary transcript (hnRNA) is extensively modified in the nucleus, yielding mature mRNA that is then transported to the cytoplasm for translation into protein.
140
ineClical
D. Genes coding for tRNA and 5S rRNA. These genes are transcribed in the nucleoplasm by RNA polymerase III. The promoters for both the 5S rRNA and the tRNA genes are internal and are found downstream from the start site of transcription. l. 55 rRNA genes. The genes for this small rRNA are tandemly repeated in a single cluster
located far away from the genes for tRNA. These are the only rRNA genes that are transcribed outside the nucleolus. 2. tRNA genes. The genes for tRNA are clustered and are transcribed as larger precursor RNA molecules, which are processed by endonucleases. Internal promoters are found in two regions downstream from the start site. tRNA is subject to a number of posttranscriptional modifications, including modification of specific bases and the addition of the sequence -CCA to the 3' -OH of the tRNA.
PROCESSING OF EUKARYOTIC RNA The heterogeneous nuclear RNAs (hnRNAs), synthesized by RNA polymerase II, leave the nucleus as messenger RNAs (mRNAs). The processing of the hnRNA starts while transcription is still occurring and involves covalent modification of both the 5' and 3' ends, followed by cutting and splicing to eliminate the intervening sequences that separate the coding regions. A. 5' Capping. The 5' end of the RNA is "capped" shortly after the initiation of RNA synthesis. This process involves the addition of an "inverted" methylated guanosine molecule to the first nucleotide in the RNA transcript. The 7-methyl-guanosine is linked through a 5'-5' triphosphate linkage. The 5' cap plays an important role in the initiation of protein synthesis and protecting the mRNA chain from degradation. B. Polyadenylation of the 3'-OH end. Mature mRNA molecules have a poly-A tail that is
between 20 and 250 nucleotides long. The tail is added to hnRNA by the enzyme poly-A polymerase. A consensus sequence near the end of the gene provides a signal that initiates
Transcription
polyadenylation. Polyadenylation is believed to increase the stability of hmRNA. Not all mRNA molecules are polyadenylated: histone mRNAs, for example, have no poly-A tails. C. RNA splicing. hnRNA contains coding sequences (exons) that are separated from one another by intervening sequences (intrans). In the conversion ofhnRNA to mature mRNA, the introns are removed and the exons are spliced together. This process is illustrated in Figure 11-4-6. During the excision of introns, the 5' cap and the poly-A tail are not removed. The base sequence at the beginning of an intron is GU ... and at the end of an intron is ... AG. This consensus sequence defines the sites at which cutting and splicing occur. The intron is excised as a loop (lariat) of RNA that is degraded. After excision, ligation of the exons occurs. These reactions occur in the nucleus. STEP 1.
-0 Q)
'til
-0
co
!:;c
Ui c
~'rn
!:;c
Q)
Ui c
'til
co
co
Co
Q) l!)lo..
t
~'rn Q) C')lo..
Intron 1
Exon 1
Exon 2 AAUAAA
5' Cap AGGUAAGU
t
t
AGG
t
["'il
AAAn
HnRNA
t
2
STEP 2.
'(jj
+ «'co >'c Exon 1
0-0 a.. co
a..'(jj
~.... AAUAAA
.......""'"""'........ AG
« .Q b:g
DOl
Exon 2
5' Cap
+ c
[ii,1
AAAn
Formation of lariat
G
STEP 3. Exon 1
Exon 2
====;.;.1 AAUAAA leII AAAn
5'Cap
G
AG STEP 4.
Excision of lariat
Exon 1 Exon 2
5' Cap
........··.··, ••. ·\.. 1 AAUAAA
II
(mRNA) AAAn
Ligation of exons
AGG
plus
Lariat (degraded in nucleus) Figure 11-4-6. Processing of hnRNA. KAPLAtf _ I med lea
141
Protein Synthesis
Translation is the process by which the base sequence in mRNA is decoded into an amino acid sequence. All three types of RNA play different and essential roles in translation. The genetic code is defined as the relationship between the sequence of bases in DNA (or its RNA transcript) and the sequence of amino acids in proteins. mRNA is the template for protein synthesis and acts as a "working copy" of the gene in which the code words for each amino acid (codons) have been transcribed from DNA to mRNA. The tRNA has a three-base anticodon that hydrogen bonds with the complementary codon in mRNA thus aligning amino acids in the appropriate sequence prior to peptide bond formation. Ribosomes are complexes of protein and rRNA that serve as the molecular machines, coordinating the interactions between mRNA, tRNA enzymes, and protein factors required for protein synthesis. This chapter reviews the structure and function of the three types of RNA, the genetic code, the structure and function of ribosomes, and the events involved in protein synthesis. Commonly used antibiotics that inhibit protein synthesis are also reviewed.
ROLE OF RNA IN PROTEIN SYNTHESIS Each of the three major types of RNA plays an essential role in protein synthesis. A. Messenger RNA (mRNA) acts as the "working copy" of the gene coding for a protein. The mRNA carries the information from the genome in the nucleus to the cytosol where protein synthesis occurs. Messenger RNA is synthesized as an hnRNA precursor and is processed to mature mRNA in the nucleus. The mature mRNAs are capped at their 5' end with 7-methylguanosine attached through a triphosphate linkage to the first nucleotide in the mRNA. Most mRNAs also contain a poly-A tail attached to the 3' end. Messenger RNA constitutes approximately 5% of the total cellular RNA and has a shorter half-life than other types of RNA. The length of the mRNA is related to the size of the gene. The key structural features of mRNA are shown in Figure 11-5-1.
KAPLAN"iIme leaI
143
Molecular Biology
5' Untranslated region
Coding region or open reading frame
Poly-A+ signal
Poly-A+ tail
UGA 5' Cap - - AUG - - - - - - UAA - - - AAUAAA--- AAAn 3' UAG Start codon Stop codon (Methionine)
t
t
3' Untranslated region
Figure 11-5-1. Structure of eukaryotic mRNA.
B. Ribosomal RNA (rRNA). Ribosomal RNA is the most abundant form of RNA, comprising approximately 80% of the cellular RNA. Ribosomes, the machines for synthesizing protein, are complexes containing protein and rRNA. In prokaryotic systems, there are three forms of rRNA: 23S, 16S, and 5S rRNA, which vary in length from 120 to 3,700 nucleotides. Eukaryotic rRNA has four forms of rRNA: 28S, 18S, 5.8S, and 5S. In eukaryotic systems, all of the forms of rRNA except 5S rRNA are synthesized in the nucleolus. The precise function of rRNA is unclear, but it is necessary for the organization of a functional ribosome.
Note The 5' end of an RNA that has been cut out of a larger precursor RNA is a monophosphate; the 5' end of a precursor or unprocessed RNA is a triphosphate.
C. Transfer RNAs (tRNAs) are the adaptor molecules in protein synthesis. They have a threebase region (anticodon region) that recognizes and hydrogen bonds to the complementary codon in mRNA, which specifies a particular amino acid. The tRNAs react with amino acids at their 3' ends. Transfer RNAs are small, containing approximately 80 nucleotides. The key structural features of tRNA are shown in Figure 11-5-2 and are described briefly below. 3' Amino acid OH - - attachment site A
C C
Phosphorylated 5' terminus - - 5' P
A G···· C
nvC loop
"" ______________"Extra arm" (variable)
Figure 11-5-2. Structure of tRNA.
144
mectical ---
._---_.----- - - - - - -
Protein Synthesis
1. The 5' end of tRNA is a monophosphate rather than a triphosphate, and the base is usually G. 2. The 3' end of tRNA has the sequence CCA. The "activated amino acid" is covalently attached to the 3' OH of the terminal adenosine. The bond linking the amino acid to tRNA is a high-energy bond that provides energy for peptide bond formation, an endergonic reaction.
Note The CCA amino acid attachment site of tRNA is encoded in prokaryotes but is added posttranscriptionally in eukaryotes.
3. Unique structural features of tRNA include three loops and an "extra arm" created by internal hydrogen bond formation. The anticodon loop contains three bases that are antiparallel and complementary to the bases in the codon of mRNA. 4. A high degree of secondary structure is found in tRNA due to the bending back of the molecule on itself with the formation of internal base pairs that stabilize the secondary structure. About half of the nucleotides in tRNA are base paired to form double helices. 5. A large number of unusual bases are found in tRNA that are not found in other types of RNA. These are believed to be important in maintaining the characteristic secondary structure. Inosine, pseudouridine, dihydrouridine, ribothymidine, and methylated guanosine are found exclusively in tRNA.
THE GENETIC CODE The genetic code is the relationship between the sequence of bases in DNA (or its working RNA transcript) and the sequence of amino acids in proteins.The genetic code is read in triplets. The code words are almost (but not absolutely) universal. Human mitochondria have a few differences in codons. A. A codon is a group of three nitrogenous bases (base triplet) that represents an amino acid or signals the initiation or termination of protein synthesis. The codons in mRNA are antiparallel and complementary to the anticodons (recognition sites) found in tRNA. The codons in mRNA are shown in Figure II-5-3. There are 64 possible combinations of the four bases in mRNA, and thus the genetic code contains 64 codons. B. Amino acid codons. There are 61 triplets that specify 20 amino acids. (The remaining three codons are "stop" codons.) Because more than one codon can specify the same amino acid, the genetic code is said to be redundant or degenerate. Different co dons for the same amino acid usually differ in the third base. C. Stop codons. There are only three codons that do not specify an amino acid. These codons (UAA, UAG, UGA) act as termination signals during protein synthesis.
D. Start codon. AUG (which codes for methionine) and sometimes GUG are signals for the initiation of translation. In prokaryotic systems, polypeptide chains start with a modified amino acid, formylmethionine (fMet). Prokaryotes have a specific tRNA that carries fMet and recognizes the initiating AUG codon in mRNA. In eukaryotic systems, the AUG closest to the 5' end of the mRNA is the start signal for protein synthesis. Eukaryotes also have a specific initiating tRNA that carries fMet.
meilical
145
Molecular Biology
8econd base U U
C
UCUj
UUU} UUC Phe UCC UCA UUA} UUG Leu UCG
CUUj CUC
C CUA CUG
Ser
CCUj CCC Leu
CCA CCG
Pro
ACUj
AUU} lie AUC ACC A AUA ACA AUG fJ~1 ACG
Val
GCA GCG
G
UAU} UAC Tyr UAA Stop UAG Stop
UGU} UGC Cys UGA Stop UGG Trp
U C A G
CAU}H' CAC IS
CGUj CGC
U C A G
CGA CAA} Gin CAG CGG
Arg
Thr
U AAU} AGU} AAC Asn AGC Ser C A AGA} ~}LYS AGG Arg G
Ala
GAU} GAC Asp GGC GGA GAA} GAG Glu GGG
GUUj GCUj GCC
GUC G GUA GUG
A
GGUj Gly
U C A G
Figure 11-5-3. The genetic code.
PROKARYOTIC AND EUKARYOTIC RIBOSOME STRUCTURE The structure and function of ribosomes are very similar in prokaryotes and eukaryotes. A. Common features. E. coli and eukaryotic ribosomes share the following features. 1. Function. Ribosomes are the sites at which protein synthesis occurs.
2. Components. Protein and rRNA are the building blocks for ribosomes. Each of the forms of rRNA and most of the proteins are present in only one copy per ribosome.
Note In general. the small subunit is necessary for initiating protein synthesis; the large subunit catalyzes the elongation steps.
3. Subunits. As shown in Figure 11-5-4, ribosomes have two subunits, one large and one small. (Note that the Svedberg units [S] are not additive.)
8mall subunit
Prokaryotes: 308: 168 rRNA + 20 proteins --- Eukaryotes: 408: 188 rRNA + 30 proteins Prokaryotes: 508: 238 and 58 rRNA + 34 proteins ---Eukaryotes: 608: 288,5.88, and 58 rRNA + 40 proteins
Ribosome
Prokaryote ribosome: 308 + 508 = 708 Eukaryote ribosome: 408 + 608 = 808 Figure 11-5-4. Composition of ribosomes.
B. Differences in prokaryotic and eukaryotic ribosomes. As seen in Figure 11-5-4, eukaryotic ribosomes are larger than prokaryotic ribosomes. In prokaryotes, the 70S ribosome is made up of a large subunit (50S) and a small subunit (30S), whereas eukaryotes have an 80S ribosome containing a large subunit (60S) and a small subunit (40S). Eukaryotic ribosomes contain four forms of rRNA, whereas prokaryotes have only three forms. Other minor differences are found in the number of proteins found in both the large and small subunits of eukaryotic and prokaryotic systems.
146
meCtical
---~~~~~-
Protein Synthesis
C. Eukaryotic ribosome assembly. In eukaryotes, the large ribosomal subunit (60S) is assembled in the nucleolus, whereas the small subunit (40S) is assembled in the nucleus. The ribosomal proteins are synthesized in the cytoplasm and are transported into the nucleus, where they combine with the appropriate rRNA species to form the large and small ribosomal subunits. After assembly, the ribosome moves through the nuclear pores into the cytoplasm by an unknown mechanism. Because prokaryotes have no defined nucleus, all of these processes occur in the cytoplasm.
In a Nutshell
ACTIVATION OF AMINO ACIDS AND ATTACHMENT TO tRNA The formation of peptide bonds between amino acids is an endergonic process and therefore requires a source of energy. The energy is derived from ATP and is transferred to the bond that links the amino acid to the 3'-OH group of the tRNA molecule. Enzymes that "activate" the carboxyl group of amino acids are known as aminoacyl-tRNA synthetases. These enzymes are highly specific for both the amino acid and the tRNA. There is a specific enzyme for each amino acid. As shown in Figure 11-5-5, the attachment of the amino acid to the tRNA occurs in a twostep process. R I
Step I
I
0
II
NH2-CH-C-AMP+tRNA R I
Sum
I
0
II
ATP+NH 2 -CH-COOH - - - - - NH2-CH-C-AMP+PPj R
Step 2
R
Each tRNA must be "charged" with the correct amino acid by a separate tRNA synthetase.
R I
0
II
- NH 2-CH-C-tRNA+AMP R I
0
II
NH 2-CH-COOH+ATP+tRNA - - NH 2-CH-C-tRNA+AMP+PPj
Figure 11-5-5. Formation of aminoacyl-tRNA.
The AGO for this reaction is close to zero, but in the cell, the overall reaction is highly exergonic and essentially irreversible because the high-energy bond in the pyrophosphate product is rapidly hydrolyzed by pyrophosphatases.
STEPS INVOLVED IN TRANSLATION The process of translating the genetic code found in mRNA into a specific sequence of amino acids in a protein involves three steps: initiation, elongation, and termination. Protein synthesis occurs in the direction of amino terminal to carboxy terminal, and the mRNA is read from the 5' end to the 3' end. A. Initiation of protein synthesis. Initiation of protein synthesis requires special tRNA molecules and the formation of an initiation complex. 1. Initiating tRNA molecules. The codon AUG in mRNA usually signals the beginning of protein synthesis. AUG is the codon for methionine. a. Prokaryotes. The initial methionine residue has a formyl group attached to it (fMet). The initiating tRNA is known as tRNAfMet. The tRNA that carries methionine to any other position is known as tRNAMet. b. Eukaryotes. The initiating methionine has no formyl group. The initiating tRNA is known as tRNAiMet, whereas the tRNA involved in elongation of the protein is known simply as tRNAMet. KAPLAN" . ._
me lea
I
147
Molecular Biology
2. Formation of initiation complex. The assembly of the 70S initiation complex found in prokaryotes is a stepwise process involving the formation of an intermediate 30S complex.
In a Nutshell In prokaryotes, the initiating AUG is defined by its position near a Shine-Oalgarno sequence. Therefore, prokaryotic mRNAs may contain multiple genes ("polycistronic"). Because each gene in the mRNA begins with a Shine-Oalgarno + AUG sequence, each will be independently translated by ribosomes. In eukaryotes, the ribosomal small subunit (with tRNAMet + e1F-2 + GTP bound) must begin each time at the 5' cap, then scan the mRNA for the first AUG to initiate, where it is joined by the large subunit. Eukaryotic mRNAs are typically monocistronic (one gene per mRNA).
a. Assembly of the 30S complex. Formation of the 30S complex requires mRNA, the 30S ribosomal subunit, three initiation factors (IF-I, IF-2, and IF-3), GTP, and tRNAtMet. The mRNA contains the start codon (AUG or GUG) that recognizes tRNAtMet. There is a special sequence of bases upstream from the AUG codon called the ShineDalgarno sequence. This sequence of bases binds with the 16S rRNA in the 30S ribosomal subunit. The binding of the mRNA to the 30S ribosomal subunit requires the transient help of IF-3. After mRNA binds to the 30S ribosomal subunit, IF-3 dissociates. The complex between mRNA and the 30S ribosomal subunit then binds IF-2, GTP, and tRNAtMet to produce an active 30S initiation complex. This reaction requires IF-I. b. Assembly of the 70S initiation complex occurs by the interaction of the 50S ribosomal subunit with the 30S complex. The formation of the 70S complex results in the hydrolysis of GTP to GDP and Pi and the dissociation of both IF-l and IF-2. The structure of the 70S initiation complex is shown in Figure 11-5-6. The association of the ribosomal subunits creates two important sites for protein synthesis within the ribosome, the A site and the P site. (1) The aminoacyl site (A site) binds the incoming tRNA molecule carrying an activated amino acid. (2) The peptidyl site (P site) is the site on the ribosome at which tRNAtMet initially binds. After formation of the first peptide bond, the P site is occupied by the growing peptide chain. The tRNAtMet recognizes two sites: the P site on the ribosome and the start site (AUG) on the mRNA. B. Elongation of the protein. This process is a three-step cycle that is illustrated in Figure II-5-6.
Each step is described below.
----,TT"'"""Trl~,.,.---
----,TT"'"""Trl.,..,.,.---3'
3'
Delivery of activated tRNAArg
P site
•
A site
P site
A site
70S Initiation complex Peptide bond formation by peptidyl transferase
-rl...--
mRNA 5' --r..,-".c"....
P site
..
tI
----,TT"'"""Trl.,..,.,.--- 3' Translocation
r
Empty A site
r
UAC
P site
Uncharged tRNA
Figure 11-5-6. Elongation phase of protein synthesis in bacteria.
148
mellical
A site
Protein Synthesis
1. Binding of aminoacyl-tRNA to the A site. The A site will always contain the next amino acid to be added to the peptide chain. The specific aminoacyl-tRNA that comes into the A site is determined by the mRNA codon that is positioned above the A site. Thus, in Figure II-5-6, tRNAArg is delivered to the A site because CGC codes for Arg (see Figure 11-5-3). The delivery of the aminoacyl-tRNA to the A site requires elongation factor EF-Tu and the hydrolysis of GTP to GDP and Pi. GDP remains associated with EF-Tu until it is displaced by another elongation factor, EF-Ts. The new Tu-Ts complex is dissociated by the binding of a second GTP to give GTP-Tu complex.
2. Peptide bond formation. Formation of a peptide bond between the amino acid (or peptide) in the P site and the amino acid in the A site is catalyzed by peptidyl transferase, which is an integral part of the 50S ribosomal subunit. This reaction results in the release of the amino acid from the tRNA in the P site. The resulting peptide is bound to the tRNA in the A site. 3. Translocation. In order for elongation to continue, translocation has to occur. This involves three movements. First, the uncharged tRNA leaves the P site. Next, the peptidyl tRNA moves from the A site to the P site. Finally, the mRNA moves a distance of three nucleotides to bring a new codon into a position above the empty A site. The movement of mRNA requires an elongation factor known as translocase (EF-G). Hydrolysis of GTP is required to release EF-G from the ribosome. At some point during elongation of the peptide chain, the formyl group is removed from the initial methionine residue. C. Termination of protein synthesis. When anyone of the three stop codons is encountered,
elongation is terminated. Cells do not have tRNAs with anticodons that are complementary to stop codons. Release of the peptide from the ribosome requires a protein known as a release factor (RF) that binds to the stop codon. Hydrolysis of the peptidyl-tRNA bond requires an enzyme, peptidyl-tRNA hydrolase, and GTP, which is hydrolyzed to GDP and Pi' The polypeptide leaves the ribosome, the ribosome dissociates into its 30S and 50S subunits, and the mRNA is released.
Note During peptide bond formation, the amino group of the amino acid bound to the A site tRNA is bound to the a-carboxy group of the amino acid bound to the Psite tRNA.
In a Nutshell Elongation is catalyzed by the large subunit: • Charged tRNA binds to the A site (requires GTP hydrolysis) • Peptide bond formation • Translocation (requires GTP hydrolysis)
INHIBITORS OF PROTEIN SYNTHESIS Several antibiotics recognize differences between prokaryotic and eukaryotic protein synthesis and can be used to inhibit one independent of the other. Additionally, some bacterial toxins inhibit protein synthesis in animal cells. Table II -5-1 lists several inhibitors of protein synthesis.
Table II-5-l. Inhibitors of protein synthesis. Inhibitor
Prokaryote or Eukaryote Step/Site of Action
Tetracycline
Prokaryotes
Streptomycin Erythromycin Chloramphenicol Puromycin
Prokaryotes Prokaryotes Prokaryotes Both
Cycloheximide Sparsomycin
Eukaryotes Eukaryotes
Ricin Eukaryotes Diphtheria toxin Eukaryotes Pseudomonas toxin Eukaryotes
Initiation; prevents binding of aminoacyl-tRNA to ribosome Initiation; causes misreading of code Translocation Ribosomal peptidyl transferase Elongation; binds to A site and prematurely terminates chain growthl Ribosomal peptidyl transferase . Initiation; inhibits formation of initiation complex Initiation; binds to 60S subunit Translocation; inactivation ofEF-2 Translocation; inactivation ofEF-2
KAPLI~. I meulca
149
Regulation of Ciene Expression
Regulation of gene expression is an essential feature in maintaining the functional integrity of a cell. Regulation of a gene may occur in a variety of ways; some are positive, whereas others are negative. Regulation of gene expression in prokaryotes almost always involves either initiation or termination of transcription. In eUkaryotes, transcription is more complicated than in prokaryotes, and, therefore, there are more possible sites for regulation. In both prokaryotes and eukaryotes, transcriptional regulation is usually achieved by the interaction of proteins with specific sequences in the DNA, resulting in either an increase or a decrease in the rate of transcription. All of the cells in eukaryotic organisms contain the same genome, yet different types of cells contain unique complements of mRNAs and proteins. Therefore, mechanisms for specifying cell-specific transcription exists in eukaryotes but not in prokaryotes. In this chapter, the basic mechanisms for regulating transcription in both prokaryotes and eukaryotes are summarized. A few selected examples of gene regulation are discussed that illustrate different mechanisms of transcriptional control.
REGULATION OF TRANSCRIPTION IN PROKARYOTES The regulation of gene expression in prokaryotes is usually achieved by regulating the rate at which transcription is initiated. The examples that will be considered are the positive and negative control of the lactose (lac) operon in E. coli. A. Operon concept. In bacteria, a set of structural genes and a regulatory region constitute an operon. The structural genes code for a group of proteins required for a particular metabolic function. The regulatory region is upstream (to the 5' side) of the structural genes. The structural genes in an operon are coordinately regulated, i.e., the expression of all the structural genes is controlled by the same regulatory region in the DNA. B. Description of the lac operon. The arrangement of the structural and regulatory genes in the lac operon of E. coli is shown in Figure 11-6-1. The regulatory gene (i) codes for a repressor that can interact with the operator sequence (0). The operator sequence is situated adjacent to the three structural genes (Z, Y, and A) that code for three enzymes concerned with lactose metabolism (B-galactosidase, permease, and transacetylase). The expression of these three genes is regulated by the operator sequence. RNA polymerase binds at the promoter site (P).
1. Negative regulation of the lac operon. In the absence of lactose, the repressor protein binds to the operator sequence and blocks the movement of RNA polymerase along the template, thus inhibiting transcription (Figure II -6-1A). When lactose is present, it induces transcription by the following mechanism: Lactose is converted to 1,6-allolactose, a molecule that binds to the repressor and changes its conformation so that it no longer binds to the operator region. Thus, the repressor is released and the three structural genes are transcribed as a single mRNA that codes for all three proteins (Figure II-6-1B).
Note Each structural gene in the polycistronic lac mRNA has a Shine-Dalgarno sequence to define its initiating AUG.
Note The lac repressor is made constitutively, i.e., whether or not lactose is present.
meclical
151
Molecular Biology
Messenger RNA coding for more than one protein is known as a polycistronic mRNA and is found only in prokaryotic systems. In this model of negative regulation of an operon, a protein acts as the repressor and lactose (or l,6-allolactose) acts as the inducer of transcription.
In a Nutshell Full transcription of the lac operon requires: • Absence of the repressor (negative regulator) • Presence of the activator (positive regulator)
2. Positive regulation of the lac operon. The function of ~-galactosidase in lactose metabolism is to cleave lactose to glucose and galactose. The galactose is ultimately converted to glucose by other enzymes. Therefore, if the bacteria has both glucose and lactose in the growth medium, there is no reason to activate the lac operon. When glucose is low, the lac operon is activated, and the bacteria begin to use lactose to generate glucose. The effects of glucose are mediated by cAMP. When glucose is low, cAMP concentration is high and vice versa. When cAMP increases, it binds to a protein known as CAP (catabolite activator protein). The CAP-cAMP complex activates transcription of the lac operon by binding to the promoter region and allowing RNA polymerase to initiate transcription. Thus, the CAP-cAMP complex is a positive regulator of the lac operon.
A. In the absence of lactose Regulatory region
Control region
Structural genes jrj----------------------------~
p
01
z
y
A
! Repressor mRNA
t
Repressor binds to 0 and structural genes cannot be transcribed
Repressor
B. In the presence of lactose Regulatory region
Control region
p
! t
Structural genes
jrj-----------------------------,
o
z
y
A
!
.-
Repressor mRNA
Beta-galactosidase, permease, transacetylase polycistronic mRNA
Irll
Repressor-Inducer complex
Repressor + Inducer
The repressor cannot bind to 0 because it is bound to the inducer and so structural genes are transcribed.
Figure 11-6-1. Negative control of the lac operon.
152
iiieClical
Regulation of Gene Expression
PACKAGING OF EUKARYOTIC DNA The DNA molecule in eukaryotes is associated with histones. The DNA-histone complex is known as chromatin and is organized into discrete units of higher structure in the eukaryotic chromosome. A. Eukaryotic chromosomes contain two specialized structures that are required for replication and segregation during mitosis. 1. Telomeres are G-rich, block-like structures located at the end of eukaryotic chromosome
arms. They are essential for the completion of DNA replication. 2. Centromeres are the chromosomal sites where the two daughter chromatids attach during mitosis. Centromeres are essential for aligning the DNA molecule on the mitotic spindle during mitosis. They are required for segregation and stability of the mitotic apparatus. The centromeres attach to the spindle fibers and are responsible for movement during both mitosis and meiosis.
Note Telomeres protect the ends of the linear DNA molecules from being degraded by exonucleases and are needed to complete replication.
B. Chromatin composition. Chromatin is composed oflinear double-stranded DNA and five types of histones (HI, H2A, H2B, H3, and H4). Histones have a high density of positive charge that interacts with negatively charged phosphate groups of DNA. Histones contain a large number of side chains that are modified by methylation, acetylation, or phosphorylation after the protein is translated. C. Chromatin organization. There are various levels of organization that chromatin undergoes
during packaging.
Note
1. Nudeosomes. Electron micrographs of chromosomes show long fibers that are 10 nm
Highly transcribed regions of DNA contain fewer nucleosomes than less transcribed regions.
in diameter and contain discrete bead-like structures equally spaced along the lO-nm fiber. The bead-like particles are DNA-histone complexes known as nucleosomes, which are connected to one another by linear regions of DNA. The core of the nucleosome contains approximately 140 base pairs of DNA wrapped twice around eight histones (two each of H2A, H2B, H3, and H4). Approximately 160 base pairs of linear DNA connect adjacent nucleosomes. Nucleosomes constitute the first level of packaging of DNA. 2. Solenoid fibers. Histone HI binds to the linear DNA between nucleosomes. Chromatin that contains HI forms solenoid-like fibers, with six nucleosomes per turn of the helix. The solenoid fibers constitute the second level of packaging of eukaryotic DNA. A still higher level of organization occurs when the solenoid fibers are organized into loops of greater than 20 kilobases. D. Chromatin and gene regulation. Chromatin can be organized into two classes based on their genetic activity. 1. Heterochromatin contains DNA that is genetically inactive and highly condensed. The
regions of DNA that condense in early prophase are known as heterochromatin. Most of these regions are located near the centromere, and, although they are not transcribed, they playa role in pairing and segregation of homologous chromosomes. Heterochromatin is found in the 30-nm solenoid fibers folded into looped domains. 2. Euchromatin makes up most of the genome, and about 10% of euchromatin contains genes that are actively transcribed. This active euchromatin is made up of lO-nm fibers of nucleosomes connected to one another by linear DNA.
I KAPLAlf medlea
153
Molecular Biology
In a Nutshell
REGULATION OF EUKARYOTIC GENE EXPRESSION
The major eukaryotic gene regulation mechanisms occur in the nucleus, including:
Eukaryotic gene expression is much more complex than that of prokaryotes and can occur at several levels. Although regulation of mRNA transcription initiation appears to be the most common type of gene regulation in eukaryotes, several other levels of control also exist. Alternative processing of mRNA primary transcripts into different mature mRNAs provides an important mechanism for cell-type specific gene expression. Within the cytoplasm, both the stability of the mRNA and the initiation of translation can be regulated. Other examples are also mentioned.
• Regulation of transcription initiation • Alternative mRNA processing • DNA modifications or rearrangements
Note Regulatory proteins (transcription factors) exert their effects in trans, i.e., they can diffuse through the nucleoplasm to affect any and all genes that contain their recognition sequences (enhancers, silencers).
A. Initiation of eukaryotic mRNA transcription 1. Description. As with prokaryotes, the rate of mRNA transcription is regulated by the interaction of regulatory proteins that bind to DNA sequences near the promoter and modulate the rate at which the initiation complex can form on the promoter. In eukaryotes, general transcription factors (including TFIID and TFIIB) must bind to the promoter to allow RNA polymerase II to bind and form the initiation complex. Specific transcription factors bind to regulatory DNA sequences, often called enhancer or silencer sequences, and modulate the formation of the initiation complex, thus regulating the rate of transcription. 2. Transcription factors. Transcription factors are proteins that bind to regulatory DNA sequences and to other transcription factors or to RNA polymerase II in order to regulate initiation of transcription. Typically, transcription factors contain at least two recognizable domains, a DNA-binding domain and an activation domain. a. The DNA-binding domain binds to a specific sequence in the promoter, enhancer, or silencer. Several types of DNA-binding domain motifs have been characterized and have been used to define certain families of transcription factors. Families based on DNA-binding domains include "zinc fingers" (seen on steroid hormone receptors), and "homeodomain" (seen on some transcription factors involved in development). b. The activation domain allows the transcription factor to bind to another transcription factor or to RNA polymerase II to stabilize the formation of the initiation complex. These are less well characterized. c. Some transcription factors must dimerize in order to form functional DNA-binding domains and functional activation domains. These include the "helix-loop-helix" family and "leucine zipper" family. Within each family, partners may form heterodimers or homodimers, creating dimeric combinations with a variety of DNA sequence specificity and a variety of activating or inhibiting abilities. Because different cells can express different partners within each family, this greatly increases the possible range of gene regulation. The genes that code for fos and jun, two transcription factors important in regulating cell proliferation, are members of the "leucine zipper" family. When expressed abnormally (or overexpressed), these two genes can contribute to transformation of the cell; therefore, fos and jun are both proto-oncogenes.
Note DNA sequences (promoters, enhancers, silencers) exert their effects in cis, i.e., they can affect only the gene to which they are attached.
3. Enhancer and silencer sequences. These are DNA sequences to which the specific transcription factors bind to regulate transcription. Enhancer sequences contain binding sites for specific transcription factors that increase transcription. Enhancers are functional both upstream and downstream of the promoter and in either orientation. Silencers contain binding sites for specific transcription factors that inhibit transcription. B. Regulation by specific transcription factors. Each gene contains a variety of enhancer and
silencer sequences in its regulatory region. Each enhancer or silencer sequence may be recognized by a different combination of specific transcription factors. The exact combination
154
iile&ical
Regulation of Gene Expression
of specific transcription factors available (and active) in a particular cell at a particular time determines which genes will be transcribed at what rates. 1. Regulating transcription factor function. Because specific transcription factors are pro-
teins, their expression can be cell-type specific. Additionally, hormones can regulate the activity of specific transcription factors. 2. Examples
Note
a. Thyroid receptor (T3R) is localized in the nucleus. Besides its DNA-binding and activation domains, it contains a thyroid-binding domain at its C-terminus. This receptor is found in many tissues, but it is expressed in very high levels in the anterior pituitary, where it increases transcription of the growth hormone gene. The effects of thyroid hormone on the anterior pituitary are shown in Figure 11-6-2. Thyroid hormone activates growth hormone transcription. T3 (or T 4) enters the cell and moves into the nucleus, where it binds to its receptor. The T3R complex undergoes a conformational change that allows it to bind to specific enhancer sequences located upstream from the growth hormone gene. In the nucleus, the rate of transcription is regulated by RNA polymerase II, resulting in increased mRNA for growth hormone. Translation of mRNA in the cytosol results in increased growth hormone synthesis. The steroid hormones exert their effects by a similar mechanism. The DNA-binding domain of thyroid hormones and steroid hormones contains "zinc fingers;' a structural motif that binds to DNA.
_....,t""-_AAAn HnRNA
Steroid and thyroid hormone receptors are hormoneactivated specific transcription factors that allow these hormones to change gene expression.
•
Processing
1
Growth 5'Cap - - - AAAn hormone mRNA Transport to cytoplasm
Cytoplasm
Growth 5'Cap --:---- AAAn hormone mRNA Translation •
•
!
Growth hormones
Secreted growth hormone
Figure 11-6-2. Activation of growth hormone transcription by thyroid hormone. KAPLA~. I meulca
155
Molecular Biology
b. CREB is a specific transcription factor found in many cell types that is active only when cAMP levels rise in the cell. The cAMP-dependent protein kinase phosphorylates CREB, enabling it to bind to its enhancer sequence in various genes and activate their transcription. In hepatocytes, CREB affects the transcription of some of the key enzymes in gluconeogenesis. c. AP-l is a family of transcription factors. Members include the fos-jun complex consisting of one molecule of fos bound to one molecule of jun. Fos and jun are proteins encoded by proto-oncogenes; mutations in these genes have been associated with a wide variety of tumors. A range of cellular stimuli, including growth factors, phorbol esters, and neurotransmitters, regulate the activity of the fos-jun complex. The dimerization of these proteins is highly specific and occurs through a domain on the proteins known as the "leucine zipper." This domain consists of repeating leucine residues occurring at every seven amino acids in a region of a-helical structure.
Note
C. Alternative mRNA processing
Alternative mRNA processing allows different proteins to be synthesized from the same gene and pre-mRNA.
1. mRNA processing. Eukaryotic mRNA primary transcripts are extensively processed before the mature mRNA is transported into the cytoplasm. On each mRNA the 5' end is capped, the 3' end is cleaved to allow addition of polyadenosine, and the introns are spliced out. The presence of the sequence AAUAAA in the mRNA signals a 3' cleavage/polyadenosine addition site, and splice donor (GU) and splice acceptor (AG) sequences define splicing patterns.
2. Cell-type specific gene regulation. Alternative use of such signals allows the formation of different mRNAs from transcripts of the same gene. The alternative mRNAs are translated into different proteins. This is often seen in the production of different proteins in different cell types produced from the same gene. 3. Example. The calcitonin gene contains exons for both calcitonin, a hormone that regulates blood calcium and phosphate levels, and CGRP, a protein that regulates neural receptor expression. In thyroid C cells (stromal cells located between the follicles in the thyroid gland), this primary gene transcript is cleaved in front of the CGRP exon and spliced to form an mRNA containing the calcitonin exon. In neural cells, a cleavage signal after the CGRP exon is used and the calcitonin exon is spliced out, leaving an mRNA containing the CGRP exon. D. Regulation of initiation of translation
Note Regulation of gene expression can also occur in the cytoplasm via: • Regulation of translation initiation • Regulation of mRNA stability
1. Initiation of eukaryotic translation requires the small ribosomal subunit, charged initiator tRNA (tRNAiMet), GTP, and several initiation factors. The two important initiation factors are eIF-2 and eIF-4.
a. eIF-2, GTP, and tRNAiMet form a complex and bind to the small (40S) ribosomal subunit, forming a pre-initiation complex. b. The cap-binding protein subunit of eIF-4 recognizes the 7-methyl-guanosine "cap" at the 5' end of eukaryotic mRNA and allows the pre-initiation complex to bind. c. The pre-initiation complex scans down the mRNA until it encounters the first AUG in the appropriate sequence; GTP is hydrolyzed to GTP, the large ribosomal subunit joins the complex, and the initiation factors leave. Translation continues much as in prokaryotes. 2. Some viruses, such as polio virus, ensure preferential translation of viral mRNAs by cleaving the eIF-4 cap-binding subunit but providing a cap-independent alternative recognition site for the pre-initiation complex (called a "ribosomal landing pad").
156
meClical
Regulation of Gene Expression
3. Initiation of translation can also be regulated by proteins that bind to sequences on the mRNA. a. Ferritin is a cytoplasmic Fe2+-binding protein expressed in hepatocytes only when cytoplasmic Fe2+ levels are high. Ferritin sequesters the Fe2+, preventing it from being toxic to the cell. b. Ferritin mRNA contains three "IRE" sequences between the 5' cap and the first AUG. The hepatocyte also makes an IRE-binding protein that binds to the IRE sequence and prevents the pre-initiation complex from scanning from the cap to the AUG; this inhibits the translation of ferritin.
Note Certain sequences found near the 3' end of some mRNAs decrease mRNA stability. Regulatory proteins can reversibly mask these destabilizing sequences, increasing protein synthesis.
c. As Fe z+ levels rise in the cell, iron binds the IRE-binding protein and changes its con-
formation. The Fe2+ -IRE-binding protein complex cannot bind to the IRE, so ferritin is translated. E. The level of packing of the DNA can also affect transcription. 1. Condensed DNA is not accessible to transcription factors or RNA polymerases and so is not transcribed. The level of packing of the DNA can be regulated by the frequency of methylation of cytosines found in the sequence 5' CG 3'. Such methylation inhibits the binding of specific transcription factors to their enhancer sequences and promotes higher levels of packing of the DNA. Different methylation patterns are found in different cells; the regulation of these patterns is not clear. 2. Transient modification of histones, such as acetylation or binding of ubiquitin (which may target them for degradation by proteases), is associated with unpackaging the DNA before transcription. F. Regulation of 5S rRNA gene (Xenopus). Regulation of rRNA transcription is much less common than the regulation of mRNA transcription but does occur in Xenopus oocytes. The
5S rRNA genes are tandemly repeated and organized in clusters. These genes have an internal promoter and are transcribed by RNA polymerase III. 1. Xenopus has two types of gene clusters for 5S rRNA: One gene cluster code for the somat-
ic-type 5S rRNA and the other cluster codes for the oocyte 5S rRNA. Both types of genes are present in all cells. Although the gene types differ from each other at only six positions in the 120 base-pair coding region, they are transcribed at very different rates. The somatic gene population constitutes 2% of 5S rRNA genes and accounts for more than 95% of the 5S rRNA synthesized in somatic cells. In the oocyte, almost all of the 5S rRNA is transcribed from the oocyte gene cluster. 2. The differential transcription of the two 5S rRNA genes can be accounted for by different interactions between the promoter and a transcription factor, TFIIIA. TFIIIA binds to the internal promoter, signaling RNA polymerase to initiate transcription. TFIIIA has a greater affinity for somatic 5S rRNA genes than for the oocyte 5S rRNA genes. In fact, the binding of TFIIIA to oocyte 5S rRNA genes is prevented in regions of the chromosome that contain histone HI. Early in oogenesis, there are very high levels of TFIIIA (101Z molecules/oocyte), and under these conditions all internal promoters of the 5S rRNA genes (both somatic and oocyte) bind to TFIIIA, activating transcription. As the 5S rRNA gene is expressed and the level of 5S rRNA increases in the nucleus, the 5S rRNA begins to bind TFIIIA and deplete the transcription factor, thus decreasing transcription. Therefore, the 5S rRNA regulates its own synthesis.
meClical
157
Genetic Engineering
Genetic engineering, also known as recombinant DNA technology, provides a means of analyzing and altering genes and proteins. Additionally, this technology can provide a source of specific proteins in almost unlimited quantities and has many applications in clinical medicine. Genetic engineering depends on having an array of tools for analyzing genes and proteins, including enzymes that can cut, join, and replicate genes. This chapter reviews the procedures and related techniques of genetic engineering and indicates how these procedures can be applied to clinical medicine.
TOOLS USED IN RECOMBINANT DNA TECHNOLOGY A. Enzymes that modify nucleic acids. Many enzymes that alter the structure of nucleic acids are used in genetic engineering. 1. Nucleases constitute a family of enzymes that hydrolyze phospho diester bonds. They are classified either as ribonucleases or deoxyribonucleases, depending on whether they hydrolyze RNA or DNA. Both ribonucleases and deoxyribonucleases can be further classified as endonucleases (if they cleave internal phosphodiester bonds) or as exonucleases (if they cleave terminal phosphodiester bonds, either at the 5' or 3' end of the chain). 2. Restriction endonucleases are enzymes that recognize specific double-stranded sequences in DNA and cleave the DNA at or near the recognition or "restriction" site. These enzymes are powerful tools in recombinant DNA technology, allowing specific genes to be excised from the genome. Many restriction endonucleases have been isolated from bacterial sources. Isochizomers are restriction endonucleases from two different sources that recognize the same DNA sequence. Most restriction nucleases recognize sites consisting of four to eight base pairs. The sequences in the two strands of the recognition site are palindromes, having the same 5' to 3' sequence in both strands. Two examples of restriction endonucleases are shown in Figure 11-7-1.
!
t
5'-GGCG-3' 3'-CCGG-5'
t
!
feoRI
5'-G + 3'-CTTAA-5'
!
Haelll
5'-MTTC-3' G-5'
The location of restriction sites along a DNA helix depends upon its nucleotide sequence: • Use of a restriction enzyme on mUltiple samples of the same sequence will always generate the same pattern of fragment sizes.
!
5'-GMTTC-3' 3'-CTTMG-5'
Note
5'-GG-3' + 5'-CC-3' 3'-CC-5' 3'-GG-5'
Figure 11-7-1. Examples of restriction endonucleases.
• A mutation or difference in the DNA sequence can change the presence or absence of a restriction site, thereby changing the sizes of the resulting fragments. KAPLA~.
meulCa
I
159
Molecular Biology
a. EcoRI recognizes a specific six-base-pair sequence in double-stranded DNA and cleaves one site in each strand, as indicated by the arrows in Figure II-7-1, producing staggered cuts that leave short single-stranded tails at the two ends of each fragment. Ends of this type are known as sticky ends because each tail can form complementary base pairs with the tail of any other fragment produced by EeoR!. b. HaeIII recognizes a specific four-base-pair sequence in double-stranded DNA and cleaves both strands at positions opposite one another, producing blunt ends with no unpaired tails. 3. Reverse transcriptase is an enzyme found in retroviruses whose genome is composed of RNA rather than DNA. This enzyme is an RNA-dependent DNA polymerase that can synthesize a single strand of DNA using a complementary RNA strand as a template. It is used in recombinant DNA technology to construct synthetic DNA molecules known as cDNA (complementary DNA) by copying the corresponding mRNA. 4. DNA and RNA polymerases are used to synthesize a particular DNA or RNA, respectively. Unlike RNA polymerase, DNA polymerase requires a primer (a 3' -OH group at the end of an oligonucleotide chain) to initiate synthesis. 5. DNA ligase forms a phosphodiester bond between two DNA fragments. This is an essential step in creating recombinant DNA molecules. 6. SI nuclease acts exclusively on single-stranded polynucleotides or single-stranded regions of double-stranded polynucleotides. Double-stranded regions are resistant to its action. 7. Terminal deoxynucleotidyl transferase catalyzes the addition of deoxynucleotides to the 3'-OH end of the DNA molecule. It does not require a template (Figure II-7-2). Most restriction endonucleases produce complementary "sticky" ends. However, DNA fragments that have "blunt" ends can be joined by using terminal deoxynucleotide transferase to add complementary homopolymer tails. Thus, two molecules can be joined if poly( dA) tails are put on one molecule and poly( dT) tails are put on a second molecule.
5 ' - - - - - - - - 3' 3' 5'
tI
Terminal deoxynucleotidyl transferase dTTPP
5'-------TTTT3' 3'TTTT 5'
In a Nutshell
Figure 11-7-2. Terminal deoxynucleotide transferase reaction.
To radioactively label the 5' end of a nucleic acid:
8. Alkaline phosphatase removes the S'-phosphate group from either single-stranded or double-stranded DNA or RNA to give a 5' -OH group.
• Remove existing 5' phosphate with alkaline phosphatase.
9. Polynucleotide kinase catalyzes the transfer of the terminal phosphate group of ATP to a 5' -OH group in either DNA or RNA. The physiologic function of this enzyme is unknown. However, it is useful in radiolabeling nucleic acids, a procedure used in determining the base sequence of polynucleotides. Because naturally occurring nucleic acids usually contain 5' phosphate rather than 5' OH, labeling with polynucleotides can be accomplished only after the S'-phosphate group is removed with alkaline phosphatase.
• Use radioactive ATP and poly-nucleotide kinase to replace it with radioactive phosphate. 160
meClical
10. Eco RI methylase catalyzes the methylation of the adenine (A) residue in the EeoR! recognition sequence, thereby protecting the DNA sequence from cleavage by BeoR!.
Genetic Engineering
B. Oligonucleotides. Short DNA molecules, usually 16 to 40 base pairs, can be chemically synthesized from nucleotide building blocks. Two specific uses of these oligonucleotides are discussed below. 1. Hybridization screening probes. Radiolabeled oligonucleotides can be used in
hybridization experiments to screen cells for specific DNA clones. Oligonucleotides with base sequences complementary to different parts of the gene of interest are synthesized. Colonies of cells that hybridize with two different oligonucleotide probes are considered to be strong candidates for containing the desired gene. 2. Detection of specific mutations in genes. The knowledge of either the protein sequence or the DNA sequence of a particular gene allows synthesis of specific oligonucleotides that will hybridize with specific regions in the gene. A mismatch of a single base can result in the formation of unstable hybrids. The shorter the oligonucleotide, the more sensitive the probe to base changes in the gene.
TECHNIQUES AND APPLICATIONS IN MOLECULAR BIOLOGY A. Gel electrophoresis is very useful in recombinant DNA technology for separating fragments resulting from cleaving DNA with restriction endonucleases. Electrophoresis permits the separation of DNA (or RNA) molecules by measuring the rate at which they move in an electric field. DNA molecules have a negative charge because of the phosphate groups. In an electric field, these molecules move toward the positive pole at a rate that is dependent upon their size. Smaller DNA molecules move more rapidly than do larger molecules. 1. Types of gels. Two types of gels are typically used for separating DNA.
a. Polyacrylamide gels are used to separate small single-stranded DNA fragments ranging from about 10 to 500 nucleotides.
In a Nutshell Probes (in a single-stranded form) will hybridize with any homologous sequence in the (denatured) genomic DNA. • Long probes can be made from known genes or cDNAs. Minor sequence differences, such as allelic differences, or sometimes even the difference between a mouse and a human version of a gene, will not prevent hybrid formation. • Short oligonucleotide probes are more sensitive to differences in nucleotide sequence.
b. Agarose gels are used to separate double-stranded DNA fragments ranging from approximately 300 to 20,000 base pairs in length. 2. Applications a. Separation of DNA on the basis of size. In the experiment shown in Figure II -7 -3, a 5-kilobase (kb) DNA molecule was digested with two different restriction endonucleases (RE). Digestion with RE-A results in two fragments of the same size (2.5 kb), whereas digestion with RE-B results in three fragments of different sizes (2.5 kb, 1.5 kb, and 1 kb). After digestion, the fragments are separated by electrophoresis on an agarose gel. Molecular weight markers (MW) of different sizes ranging from 0.7 kb to 5 kb and a sample of undigested DNA (5 kb) are also submitted to electrophoresis. The position of DNA fragments in the gel is detected by staining the gel with ethidium bromide, a dye that binds to DNA and can be visualized as a fluorescent band when the gel is illuminated with UV light. Note that the pattern of electrophoresis of the DNA fragments differs between RE-A and RE-B. With RE-A, only one band is detected because the enzyme cuts the 5-kb DNA into two pieces of equal size.
meclical
161
Molecular Biology
7
(5 kb)
Sample DNA
Res'dct;on Enzyme
,,\es.,;cllon Enzyme B
~(2.5kb)
~(2.5kb)
~(2.5kb)
~
(1.5kb) (1 kb)
2 DNA fragments
3 DNA fragments
MW UC RE-A RE-B kb 5
- pole
2.5 2
Electrical field
0.7
+ pole
UC = uncut DNA
Figure 11-7-3. Restriction enzyme digestion and agarose gel electrophoresis.
b. Separation of DNA molecules on the basis of shape. Gel electrophoresis can distinguish between different configurations of a DNA molecule. Supercoiled DNA is more compact and migrates faster than open circular DNA and linear DNA of the same mass.
B. Hybridization. In molecular biology, hybridization is defined as the complementary pairing of an RNA and a DNA strand, or of two different DNA strands, to form a stable doublestranded molecule. 1. Definitions and principles of hybridization are illustrated in Figure II -7 -4. The breaking of hydrogen bonds between two complementary nucleotide strands is defined as denaturation. Conditions promoting denaturation are high temperatures or treatment of DNA with high salt, alkali, urea, or formamide. The temperature at which the double-stranded DNA molecule denatures into single-stranded DNA is defined as the melting temperature (Tm). In addition to solution conditions of ionic strength, pH, etc., the Tm is dependent upon the relative number of A-T (or A-U) and G-C base pairs in a given DNA or DNA-RNA hybrid. Because G-C base pairs have three hydrogen bonds, they are more stable than the A-T and A-U base pairs with only two hydrogen bonds. Thus, the higher the number of G-C base pairs in a given DNA molecule, the higher the Tm. The Tmis also dependent upon the number of mismatched base pairs: The greater the number of mismatches, the less stable the hybrid and the lower the Tm. Renaturation or annealing between two separated complementary strands occurs upon the cooling of the heatdenatured DNA or by the removal of agents that promote denaturation.
162
meclical ------------------
Genetic Engineering
~ ~ ~
Double-stranded DNA
~aturat;o" ~ ~
~ ~ ~ ~
Initial base pairing
Single-stranded DNA
Figure 11-7-4. Denaturation and renaturation.
2. Applications. The principles of hybridization are used in numerous techniques, including Southern blotting, Northern blotting, and in situ hybridization. a. Southern blotting is used to detect DNA fragments in an agarose gel by hybridization with a specific radiolabeled oligonucleotide probe. The technique is illustrated in Figure II-7-5 and involves the following steps:
A.
B.
* Isolate genomic DNA
* Restriction
C.
* Agarose gel
electrophoresis
digestion
kb MW 27
Long DNA fragments
DNA fragments 0.5 Genomic DNA
Short DNA fragments
DNA fragments Agarose gel
D.
E.
* Denature gel in alkali * Blot-transfer onto
* Hybridize with
F.
* Autoradiography
radioactive probe * Wash blot
nitrocellulose * Bake nitrocellulose
Singlestranded -+-----+- DNA fragments ...
Nitrocellulose filter
Washed nitrocellulose filter
Figure 11-7-5. Southern blotting.
-
Photographic film
I KAPLAlf me d lea
163
Molecular Biology
Note A Southern blot of two samples of DNA exposed to the same restriction enzyme and probe may reveal different fragments (in size and/or number). Such a difference is due to a sequence difference that has affected the position of a restriction site and is called a restriction fragment length polymorphism (RFLP).
In a Nutshell Northern blots are often used to detect which cell types express mRNA from a particular gene.
Bridge to Physiology In situ hybridization can detect the chromosomal location of a gene, or it can detect the cells in an intact tissue that express that gene.
164
meClical
(1) Cleavage of genomic DNA by treatment with a specific endonuclease. The fragments are separated according to size by agarose gel electrophoresis. Because the sample used in the figure was genomic DNA, thousands of fragments were produced. When submitted to electrophoresis, the digested DNA appears as a continuous smear of fragments from the top to the bottom of the gel. (2) Denaturation of the DNA fragments is achieved by treatment with alkali. The gel is then placed on a buffer-saturated filter paper, covered with a sheet of nitrocellulose, and overlaid with dry filter paper. (3) Immobilization on nitrocellulose. The filter paper draws buffer out of the gel. The buffer carries single-stranded DNA with it, and when the DNA comes in contact with the nitrocellulose filter, it binds to the nitrocellulose and is immobilized. (4) Detection of a specific DNA fragment by hybridization. The filter is dried and incubated with a solution containing a radioactive DNA probe that is complementary to the sequence of the DNA of interest. The radioactive probe and the DNA on the filter are allowed to renature under conditions that promote hybridization. Under these conditions, only the DNA that is complementary to the radioactive oligonucleotide probe will be recognized by the probe. The filter is washed and dried, and the region of hybridization is visualized by autoradiography. Southern blotting is a very sensitive method and can detect DNA sequences present in a single copy per genome. b. Northern blotting is a technique similar to Southern blotting, but it is used to determine the size and abundance of mRNA for a specific gene in a sample of total cellular RNA. Figure II -7 -6 uses the total RNA from liver to test for the mRNA expression for albumin. The total RNA includes rRNA, tRNA, and mRNA. Because mRNA contains poly-A tails, it can be isolated from the other types of RNA by hybridizing it to an oligo d(T) column. The mRNA is removed from the column by heat denaturation and is run on a denaturing agarose gel containing formamide. The mRNA is then transferred onto nitrocellulose filter paper. The filter is baked and hybridized with a singlestranded radioactive probe. The filter is then washed, and the position of the mRNA for albumin is identified by autoradiography. By use of marker RNA molecules of known size, the size of the specific mRNA can be determined. c. In situ hybridization can be used to detect the distribution of a specific mRNA in tissue sections. The radioactive nucleic acid probe is incubated directly with the tissue. After hybridization, it is possible to determine exactly which population of cells in the tissue expresses the specific mRNA of interest. This technique can also be used to detect the position of a specific DNA sequence on a chromosome. C. Cloning vectors. Cloning vectors are DNA molecules that have inserts of foreign DNA incorporated into their genome. There are two important features of cloning vectors: They possess sites at which the foreign DNA can be inserted without disrupting its function, and they replicate in the host cell independently of the host cell chromosome. Two of the most commonly used cloning vectors are plasmids, which are routinely used for cloning short DNA fragments (fewer than 5-10 kilobases), and bacteriophages, which are used for cloning larger DNA fragments (up to 20 kilobases).
Genetic Engineering
A.
* Prepare liver total RNA
B.
* Isolate poly-A+ RNA
using oligo d(T) column • mRNA with poly· (A) tail
IIIIIII
C.
* Agarose-formaldehyde
gel electrophoresis rRNA poly A+
An
IIIIIII An • rRNA (288, 188)
I II III
288
-
188
-
• tRNA
+
D.
+ Agarose-formaldehyde gel
rRNA poly A+
* Blot-transfer onto
nitrocellulose * Bake nitrocellulose * Hybridize with
radioactive probe (albumin cDNA or oligonucleotide) * Wash blot * Autoradiography
288 -
c::=I
188 -
c::=I
-
....~- Albumin mRNA
Photographic film Figure 11-7-6. Northern blotting.
1. Plasmids
a. Plasmids are small, circular, double-stranded DNA molecules (2-10 kilobases) that replicate in bacteria. Multiple copies of plasmid DNA can be found in bacterial cells. The important features of a plasmid cloning vector are shown in Figure 11-7-7. They contain an origin of replication (ori) that permits autonomous replication, one or more genes that confer specific antibiotic resistance, and sites for restriction endonucleases that can be used for inserting specific DNA fragments. b. Polylinker DNA, containing many overlapping sites for restriction endonucleases, can also be inserted into the plasmid (Figure 11-7-8). The advantage of adding polylinker DNA is that it can provide unique sites that can be used for inserting other foreign pieces of DNA. In principle, there is no limit on the size of foreign DNA that can be inserted into the plasmid, but larger molecules do not multiply as well as smaller ones.
KAPLAlf I meillea
165
Molecular Biology
Pvull
~ .....
Q)
I:: Q)
III
0>
(')
'S.
Q)
EcoRI
I::
ell
U5
Pvull
s·
u
'iii ~
§
'u
!
!
'6.
(!l
CD (/) iii'
Neal
iii ~
(') (!l
E
«
EcoRI
Bgnl
San Figure 11-7-7. Important features of a plasmid cloning vector.
BamHI
I
Hind/II
I
I
I
S'GGATCCCGGGAAGCTI3' 3'CCTAGGGCCCAAGCTIS'
I
Smal
I
Figure 11-7-8. Polylinker DNA.
Note Transformation has two definitions. It can refer to the introduction of exogenous DNA into a bacterium, or it can refer to the process by which an animal cell becomes a cancer cell.
166
meCfical
c. The cloning of a DNA fragment into a plasmid involves cleaving the plasmid with a restriction endonuclease (such as EeoR!) that results in sticky ends. If the DNA fragment to be cloned also has EeoR! sticky ends, it can be joined to the plasmid by DNA ligase.
d. The plasmid, containing foreign DNA, is introduced into the host bacterium by a process called transformation. Bacterial membranes are made permeable to plasmids by treatment with CaCho The efficiency of transformation is low (0.001 %). Transformed bacteria can be selected by growing them on a medium containing antibiotic. Only the bacteria that contain plasmids with the antibiotic resistance gene will grow under these conditions.
--------~--~----
Genetic Engineering
2. Bacteriophages (phages) a. Phages are bacterial viruses with a relatively large and linear DNA molecule (40-50 kilobases) enclosed in a shell of protein. The phage genome codes for the coat proteins and a number of other specific viral proteins. The structure of the protein coat imposes a physical limitation on the size of the DNA that can be enclosed in the virus (about 50 kilobases). Consequently, there is a limit to the size of foreign DNA that can be inserted into this type of cloning vector. Genetic engineering has tried to overcome this problem by replacing parts of the viral DNA that do not contain essential viral proteins with foreign DNA. b. Lambda phages that replicate in E. coli are most commonly used as cloning vectors. They have a genome of approximately 50 kilobases. However, they can be reduced to 30 kilobases by elimination of nonessential genes, thus providing room for insertion of up to 20 kilobases of foreign DNA. If the recombinant DNA is too small, the phage is typically not viable. Infection of E. coli is initiated by adsorption of lambda onto the surface of E. coli. The phage DNA enters the bacterium and converts it into a "phagesynthesizing factory" that eventually lyses and releases approximately 106 phages that can infect other bacteria. Not all phages are lytic; however, only lytic phages are used as cloning vectors.
Note Plasmid or bacteriophage vectors can be used to express human genes in bacteria; this is a source of human insulin used to treat diabetics.
D. Host cell for cloning vectors. Cloning vectors are usually transformed into a prokaryotic host cell, with E. coli usually being the host of choice. E. coli grows quickly, with a dividing time of approximately 20 minutes. This makes E. coli an ideal choice for a cloning vector. The growth curve of E. coli has three distinct phases. In the lag phase, the bacteria are adjusting to their environment and are activating their replication machinery. In the log phase, exponential growth is occurring. With each cell division per generation, the number of bacteria is doubled. Transformations are performed at this stage of growth. In the stationary phase, the nutrients in the medium become scarce, and the replication machinery slows down.
CONSTRUCTION OF DNA LIBRARIES The purpose of cloning is to isolate a particular gene in large quantities. The most common approach to this problem is to construct a set of recombinant DNA clones from a source that contains the gene or DNA sequence of interest. A collection of clones containing all of the sequences found in the original source is known as a DNA library. There are two approaches to constructing a library. One approach starts with the total population of mRNA of a given cell type, synthesizes complementary DNA (cDNA) copies of the mRNA, and inserts the cDNA into cloning vectors, thereby producing a cDNA library. The other approach is to start with digested genomic DNA and insert the fragments into bacteriophage cloning vectors, producing a genomic library. A. cDNA libraries. A cDNA library is a collection of recombinant vectors that together contain a complete copy of all of the messenger RNAs in a particular cell. There are five steps involved in constructing a cDNA library: isolation of the total mRNA population from a cell, synthesis of cDNA using mRNA as a template, introducing the cDNA library into a cloning vector, transforming the cDNA library into E. coli, and screening the cDNA library for specific cDNA clones. The chief advantage to a cDNA library versus a genomic library is that the cDNA clones do not have introns or other noncoding sequences found in genomic DNA.
In a Nutshell A cDNA library represents the genes expressed in a particular cell type; a genomic library contains all of the genes present in the DNA.
1. Preparation of mRNA. The cell or tissue type used as a source of mRNA must contain the
specific mRNA of interest. For example, reticulocytes are a good source for mRNA that codes for (1,- and l3-globin proteins. Once a cell type has been identified, the total RNA population (rRNA, mRNA, and tRNA) is isolated from the cells. mRNA usually constitutes <5% of the total RNA population. Because most mRNA molecules contain poly-A+ KAPLAN· . I medlea 167
Molecular Biology
tails, the total RNA can be passed through a column coated with oligo d(T). The poly d(T) column will retain the mRNA on the column while allowing the other RNA populations to pass through the column. The mRNA can then be removed from the column using a low-salt solution. 2. Synthesis of cDNA from mRNA. The ability to make a DNA copy from an RNA template relies on reverse transcriptase and a primer, oligo d(T), which anneals with the poly-A+ tail of mRNA (Figure II-7-9). In the presence of all four deoxyribonucleotides, reverse transcriptase synthesizes a strand of DNA that is complementary to the mRNA. The resulting RNA-DNA heteroduplex is treated with NaOH to hydrolyze the RNA strand. The DNA strand is then used as a template for DNA polymerase I to synthesize doublestranded DNA. The primer for synthesis of the second strand is provided by reverse transcriptase, which makes a hairpin loop ending with a 3' -OH group. The double-stranded DNA is treated with Sl nuclease, which removes the hairpin loop and single-stranded staggered ends, to create a blunt-ended cDNA duplex. 3. Introduction of the cDNA library into a cloning vector. In order to form recombinant DNA between the cDNA and the plasmid (or phage) DNA, both must have "compatible" restriction endonuclease ends. For example, if BeaRI is used to create sticky ends, the cDNA must have BeaRI sites only at its ends. As shown in Figure II-7-9, internal BeaR! sites are methylated, making them insensitive to cleavage. To ensure that BeaR! sites are present at the ends of the cDNA, linker DNA containing restriction endonuclease sites are added to each end. Both the plasmid cloning vector and cDNA are treated with BeaR! to generate "compatible" sticky ends that, when mixed, will anneal with one another and can be covalently linked by the action of DNA ligase to generate the cDNA library. 4. Transforming the cDNA library into B. coli. The cDNA library is introduced into competent B. coli that have been made partially permeable. These bacteria are grown in a medium containing an antibiotic. Only those bacteria with plasmids will grow in the presence of antibiotics. 5. Screening the cDNA library for specific cDNA clones. Frequently, the most difficult part of gene cloning is the identification of the bacterial colonies that contain a specific DNA fragment of interest. Two approaches are used to screen for specific clones. In one method, in situ hybridization with a DNA probe identifies bacterial colonies containing a particular cDNA. In the second method, antibodies can be used to identify the ability of a clone to express a specific protein.
Note In situ hybridization identifies colonies containing DNA fragments complementary to the probe; these are not necessarily complete genes.
168
meclical
a. In situ colony hybridization screening is illustrated in Figure II-7-10. The bacterial colonies to be screened are blotted with a piece of nitrocellulose filter paper. Some of the bacteria in each colony will adhere to the filter, producing a replica. The petri dish still contains the original colonies and serves as a master reference plate. The filter is treated with alkali to lyse the cells and to separate the two strands of DNA. After neutralization and treatment with protease to remove protein, the filter is incubated with a radiolabeled DNA probe containing part of the sequence of the gene of interest. The colony that gives a positive autoradiographic signal can be picked from the master reference plate. If some sequence information is available on the protein encoded by the DNA of interest, it is possible to deduce a sequence that can be used for constructing an oligonucleotide probe. Due to redundancy in the third position of the genetic code, there are a number of possible mRNA sequences that code for the same
----------
Genetic Engineering
3 1AAAAA _ _ _ _ _ _ _ _ _ _ 51
!
3 0H 1
51 TTTTT 3 1AAAM
~~ 51
Hairpin loop first strand of cDNA
Treatment with NaOH to remove mRNA template
! 5 1 TTTTT
mRNA
Oligo d(T) primer Reverse transcriptase +4 dNTPs + Mg2+
3 0H 1
tI
~
First strand of cDNA synthesized
DNA polymerase I
+4 dNTPs + Mg2+ Second strand of cDNA synthesized
5 1 TTTTT
~ S1 nuclease Blunt-ended cDNA
!
~._.CORI Methylase
Il2ill EcoRI site
CH3
CH3
I
I•
t
I
Methylation of EcoRI sites within the cDNA
EcoRI linker
CH3
CH3
LI
•
Linker DNA ligated to cDNA
Cut linkers with EcoRI and ligate the cDNA with EcoRI cut plasmid cloning vector
Figure 11-7-9. Construction of cDNA library.
peptide, and there are several oligonucleotides that can be constructed as probes. This is illustrated in Figure II -7 -11, where five of the six amino acids in the peptide shown have degenerate genetic codes in the third base of the codon. The oligonucleotide probes can be made radioactive by using polynucleotide kinase and y_ 32 p_ATP.
KAPLA~. I meulCa 169
Molecular Biology
COIO~ Master reference plate
W
1. Transform competent bacteria with cDNA library and grow on agar plates with antibiotic
2. Replica plate onto nitrocellulose filter
Nitrocellulose filter replica 3. Lyse bacteria with NaOH Neutralize Proteinase K treatment Wash and bake filter 4. Hybridize filter with radioactive probe Wash and autoradiograph 5. Pick up positive colony from master reference plate Autoradiograph Figure 11-7-10. Colony hybridization screening.
Gin -
Pro -
Met -
His -
Lys - Lys
A
A C C A A CAG-CCG-AUG-CAU-AAG-AAG U Figure 11-7-11. Sequence of degenerate oligonucleotides based on amino acid sequence.
Note Expression vectors must be used if production of the actual protein is desired.
170
meclical
b. Screening by expression of a specific protein. If an antibody is available that recognizes the protein encoded by a particular gene, it can be labeled and used to find the clone that is producing the protein. In this method of screening, the cDNA is inserted in a special type of cloning vector called an expression vector (Figure 11-7-12). The expression vector has a special promoter, the lac Z promoter, and a small fragment of the l3-galactosidase cloned into it.
Genetic Engineering
lacZ
Fragment of /3-galactosidase gene cDNA insert
Transcription
Figure 11-7-12. Lac Z expression vector.
Bacteria are transformed with this vector that contains the cDNA library and are plated. Under certain conditions, the lac Z promoter is activated, and the small fragment of the ~-galactosidase gene and the entire insert of cDNA is transcribed into "fusion" mRNA, which codes for a "fusion" protein. To find the desired fusion protein, replicas are made on nitrocellulose fIlters. The bacterial colonies on the fIlters are lysed with chloroform. The filter is incubated with antibody to the protein of interest. The fIlter is washed to remove unbound antibody and is incubated with 125I-Iabeled protein A, which binds to the antibody. After autoradiography, the positive colony can be isolated from the master reference plate. B. Genomic libraries. A genomic library is a large collection of recombinant vectors that have been constructed in such a way that, collectively, they contain a complete collection of all the DNA sequences in the entire genome. In contrast to cDNA libraries, genomic libraries contain both introns and exollS. 1. Construction of genomic libraries. Genomic DNA is isolated from a cell and fragmented with a restriction endonuclease into managable sizes (ranging from 500 bases to 18 kilobas-
es). The size of fragments is critical because in making a library, it is desirable to obtain the entire gene coding for a particular protein in a single restriction fragment. The 18- to 20kilobase restriction fragments are isolated from the rest of the fragments by centrifugation on a sucrose density gradient or by gel electrophoresis. These large fragments are methylated with EcoRI methylase to prevent EcoRI sites within the fragments from being cleaved. Linker DNA with sites for EcoRI are then ligated to the ends of the 18- to 20-kilobase fragments. These fragments are cut with EcoRI, yielding sticky ends that anneal with compatible cohesive EcoRI ends of lambda phage cloning vector. The cloning vector is joined to the genomic inserts by DNA ligase. The phage is then packaged, and bacteria are infected with phage that replicates lytically in the bacteria. 2. Screening genomic libraries. The best way to find a particular gene is to screen bacterial clones by using a single-stranded radioactive cDNA probe. The technique is similar to in situ colony hybridization screening.
KAPLA~.
meulCa
I 171
Molecular Biology
DNA SEQUENCING DNA sequencing allows a rapid and reliable determination of the order of nucleotides in isolated DNA fragments by reducing the DNA to four sets oflabeled fragments. The reactions that generate the fragments are base specific, so the length of the fragment corresponds to the position in the DNA where the specific base occurs. A. Sanger single-stranded DNA sequencing is based on the in vitro synthesis of DNA carried out in the presence of chain-terminating nucleotides (dideoxynucleotides). The steps involved can be described in three phases: the preparation of single-stranded DNA, the enzymatic synthesis of four sets of base-specific fragments, and the analysis of the fragments by gel electrophoresis. 1. Preparation of single-stranded DNA. For sequencing purposes, it is desirable to have
large quantities of single-stranded DNA. The use of M13 bacteriophage as a cloning vector makes this possible. The M13 phage has a circular single-stranded genome that has a double-stranded replicative form. Double-stranded DNA is inserted into the doublestranded replicative form of M13 DNA using the standard techniques for recombinant DNA. Host bacteria are then transformed with the double-stranded recombinant DNA, and the new phages produced in the bacteria will contain only one of the complementary strands. 2. Enzymatic synthesis of DNA in the presence of terminating nucleotides. The singlestranded DNA is used as a template for directing the synthesis of the complementary strand by DNA polymerase 1. DNA pol I also requires the four deoxynucleotides and a primer to which nucleotides are added. The synthesis is carried out in four separate tubes, each containing a single-stranded DNA template, a primer, all four deoxynucleotides, and a small amount of a dideoxy analog of one of the nucleotides. When DNA pol I incorporates the radiolabeled dideoxy analog (instead of the corresponding deoxynucleotide), chain elongation stops. For example, one tube will contain dideoxy ATP, another dideoxy CTP, etc. Thus, four sets of fragments are generated that correspond to the positions of these nucleotides in the DNA.
Note The smallest fragment is the 5' nucleotide. The next largest contains the first two nucleotides, etc. So the sequence is read from the bottom of the gel up.
In a Nutshell peR is a very powerful amplification method that uses repeated cycles of DNA synthesis.
172
meClical
3. Analysis of radiolabeled fragments by gel electrophoresis. The fragments are heated to 100°C to separate the strands and are run on a denaturing polyacrylamide gel. The four sets of fragments are run side by side on the gel, and the positions of the radiolabeled fragments are identified by radioautography. Because small fragments migrate faster in the gel, the sequence is reconstructed by reading the gel from bottom to top.
OTHER METHODS A. Polymerase chain reaction (PCR). This is a technique in which a short sequence of either DNA or RNA can be amplified by more than 10 6 times within a few hours. PCR allows very small amounts of DNA or RNA to be analyzed without cloning and without the need for Southern or Northern blotting. The procedure is illustrated in Figure II-7-13. The DNA to be amplified is flanked by two short oligonucleotide primers that hybridize to opposite strands of the target sequence. Synthesis of the DNA target sequence is achieved by the addition of Taq polymerase, which is heat stable, and the four deoxynucleotides. The primers are oriented in such a way that at the end of each cycle, the two new strands of DNA are complementary, and together they constitute a new copy of the target sequence. Repeated cycles of heat denaturation, hybridization with primers, and polymerization by Taq polymerase results in the exponential amplification of the target sequence. Within a few hours, millions of copies of the starting sequence can be generated.
Genetic Engineering
fill:UfI.(:I,I;IUll
t
Heat to 94°C
III i 1111111111 11111111111111
!
Add primers Anneal at 50°C
11111111111111 I III III i 111111
!
dNTPs and Taq Polymerase Polymerization at 72°C
11111111111111
~ ~
11111111111111
~
Completion of cycle 1 .
l!if;!IHli';iHf!m:II:I!I!!liil +
III:li:t!,'iI2Iilli:1111!i~li;1
t
Repeat cycle again Figure 11-7-13. Polymerase chain reaction.
B. Western blotting. This procedure is used to identify a specific protein that may be present
in very small concentrations in a complex mixture of proteins. As shown in Figure 11-7-14, the protein mixture is separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). The proteins are immobilized by transferring them to a nitrocellulose filter. The filters are incubated with antibody to the protein of interest (the antigen). Excess antibody is removed by washing the filter, and the antibody-protein complex is identified by incubating the filters with radiolabeled Protein A, which binds to the antibody. The presence of the protein of interest is identified by autoradiography.
Clinical Correlate Western blots are used to confirm the presence of anti-HIV antibodies in the serum of infected patients.
C. Shuttle vectors. The unique feature of a shuttle vector is that it can replicate in two different
organisms. These vectors, carrying a specific gene, are replicated in one organism (usually E. coli) and are then transfected into eukaryotic cells, where synthesis of protein encoded by
the specific gene occurs. Shuttle vectors are engineered to consist of the following components: a bacterial origin of replication (ori), a mammalian ori, a poly-A+ tail, antibiotic resistance genes, and a mammalian promoter.
meClical
173
Molecular Biology
A.
* Prepare cellular protein
B.
extracts
C.
* SOS-polyacrylamide gel
electrophoresis (S OS-PAG E)
* Blot-transfer onto
nitrocellulose * Block nitrocellulose
with milk * Incubate with
antibody against protein of interest
Ab-Ag complex
D. * Wash nitrocellulose * Incubate with
E.
* Wash nitrocellulose * Autoradiography
1251-Protein A sepharose kO MW Extract
200
1 -
~Protein
of interest
14
Photographic film Figure 11-7-14. Western blotting.
174
meclical
--~
SECTION III
Cell Biology
- - - -
------------
Overview of Cell Types
Cells are separated from their environment by a plasma membrane (and sometimes a cell wall). The function of the plasma membrane is to control the passage of molecules into and out of the cell. There are two basic categories of cells: prokaryotes and eukaryotes. Prokaryotic cells (bacteria) are relatively small and lack a nucleus, whereas eukaryotic cells (fungi, animal, and plant cells) are larger and have a well defined nucleus separated from the cytoplasm by a double membrane structure. This chapter reviews the major structural components of prokaryotic and eukaryotic cells, the properties of the plasma membrane that surrounds all cells, and the mechanisms for transporting molecules across the plasma membrane.
STRUCTURAL FEATURES OF PROKARYOTIC CELLS Prokaryotic cells (bacteria) are relatively small (1-10 J..lm long) and consist of a plasma membrane that surrounds a simple internal cytoplasmic compartment containing DNA, RNA, and all of the enzymes and small molecules required for cell maintenance and reproduction. The plasma membrane is usually surrounded by a rigid protective cell wall. In contrast to eukaryotic cells, prokaryotes do not contain subcellular membrane-bound organelles. A. Cell wall. The thick rigid structure that surrounds the plasma membrane may range in thickness from 15 to 100 nm and is composed oflipids, proteins, and polysaccharides. The cell may be coated with a capsule, which is typically a polysaccharide consisting of repeating units of two or three monosaccharides and is usually attached to phospholipids in the membrane. B. Plasma membrane. The plasma membrane controls the movement of materials in and out
of cells. All naturally occurring membranes consist of an amphipathic bilayer composed of lipids and membrane proteins. C. Nucleoid. The DNA of prokaryotic cells is found in a region of the cytosol known as the nucleoid. This region is equivalent to the nucleus in eukaryotic cells, but it is not separated from the cytoplasm by a membrane. D. Cytoplasm. The total internal compartment of prokaryotic cells is defined as the cytoplasm.
E. Flagella. The outer surface of many bacteria is coated with flagella, which are thread-like structures that allow the bacteria to move rapidly.
STRUCTURAL FEATURES OF EUKARYOTIC CELLS Eukaryotic cells are considerably larger than prokaryotes and have subcellular compartments that are defined by networks of internal membrane structure. The linear dimensions of eukaryotic cells generally range from 10-100 /lm. The structure of a typical eukaryotic cell is shown in Figure III-I-I. KAPLAlf _ I meillea
177
Cell Biology
--~---------------------------------------------------------------------------------
Nucleolus
Lysosome Golgi apparatus
-+-=---"'----!t-- Nucleus
Rough endoplasmic reticulum (RER)
Smooth endoplasmic reticulum (SER)
Figure 111-1-1. Eukaryotic cell structure.
A. Plasma membrane. As in prokaryotes, the plasma membrane separates the cell from its extracellular environment and is primarily concerned with controlling the movement of molecules into and out of the cell.
Note Topologically, the lumen of any of the endomembranous system organelles or vesicles is equivalent to the outside of the cell.
B. Endomembranous system. In eukaryotes, an extensive membrane system exists, including the plasma membrane, the smooth and rough endoplasmic reticula, Golgi apparatus, endosomes, lysosomes, and secretory vesicles. The endomembranous system transfers macromolecules and membrane components from one region of the cell to another and transfers macromolecules to and from the cell's extracellular environment. The specific functions for the various members of the endomembranous system are discussed in Chapter 4, Subcellular Organelles, in this section. C. Mitochondria. Most of the energy metabolism in eukaryotic cells occurs in mitochondria.
They contain two separate membrane systems and are found in varying numbers in different cell types. D. Nucleus. The nucleus contains two major components.
Note Molecules less than 40 kD in size can diffuse freely between the nucleoplasm and the cytoplasm through the nuclear pores.
178
meClical
1. The nuclear envelope consists of a double membrane structure with nuclear pores that allow molecules to move between the cytoplasm and the nucleoplasm. The outer membrane is continuous with the rough endoplasmic reticulum.
2. The nucleolus is a dense region in the nucleus with a high content of RNA. It is the site of ribosomal RNA synthesis and ribosomal assembly.
Overview of Cell Types
E. The cytoplasm (cytomatrix) is a colloidal substance within the plasma membrane of the cell but outside of the nucleus. The organelles contained within the cytoplasm are discussed in Chapter 4, Subcellular Organelles, of this section.
STRUCTURE AND FUNCTION OF THE PLASMA MEMBRANE Biologic membranes are bilayers that are approximately 7.5 nm in width and are assembled from a mixture of lipids and proteins. The ratio of lipid to protein is different in various membranes of the cell. The content of protein is proportional to the number of functions performed by the membrane, with the lowest content being found in myelin, which functions as a simple insulator ofaxons. The inner mitochondrial membrane, which is very active in electron transport and oxidative phosphorylation, has the highest protein content. A. Composition of plasma membrane. The plasma membrane of cells is composed of approximately equal proportions of lipid and protein. 1. Lipids. The lipids found in the plasma membrane are phospholipids, unesterified choles-
terol, and glycolipids. All of the lipid components are amphipathic, having polar head groups that interact with the aqueous environment. The hydrophobic tails interact with one another to form the interior of the bilayer. The fatty acids of the phospholipids, sphingolipids, and glycolipids form the hydrophobic tails. a. Phospholipids are the major building blocks of all biologic membranes, comprising between 50 and 60% of the total membrane lipid. The phospholipids found in animal plasma membranes include phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, and sphingomyelin (also a glycolipid-see below). b. Cholesterol is a major component of plasma membranes, comprising between 15 and 25% of the total lipid. The cholesterol is always in the unesterified form. e. Glycolipids make up the remainder of the plasma membrane lipids. Although glyco-
lipids usually make up less than 100/0 of the total lipid in the plasma membrane, they are very important in cell-cell and cell matrix interactions. 2. Proteins. The dynamic functions of the membrane are carried out by protein. Plasma membrane proteins, which are frequently glycoproteins, include hormone receptors, transport proteins, ion channels, and enzymes. There are two basic types of membrane proteins: integral and peripheral proteins. a. Integral membrane proteins are embedded in the lipid bilayer and cannot be removed without disrupting the bilayer. They span the lipid bilayer one or more times, and their association with the membrane is stabilized by hydrophobic interactions. The protein domain that spans the lipid bilayer is usually an a-helix composed of approximately 20 amino acids. Detergents are required to solubilize integral membrane proteins. b. Peripheral membrane proteins are loosely associated with the membrane and can be removed by alterations in the pH, by an increase in ionic strength, or by other conditions that interfere with ionic interactions. They are bound to the membrane by interaction with the polar head groups of phospholipids or with exposed regions of other membrane proteins. B. Properties of the lipid bilayer. The driving force for formation of lipid bilayers is the hydrophobic interaction between the fatty acid chains of the lipid components.
Note A subset of peripheral membrane proteins contains fatty acids or prenyl groups covalently bound to an amino acid. These "tails" anchor the protein to the membrane. Examples include the src tyrosine kinase and the ras G protein. KAPLA~. I meulca
179
Cell Biology
1. Structure. The bilayer consists of two leaflets held together by hydrophobic interactions
between the fatty acids in each leaflet (Figure III-I-2). The polar head groups of the outer leaflet interact with the aqueous environment outside the cell, whereas those of the inner leaflet interact with the cytosol.
Intrinsic
t- Hydrophilic e~ Phospholipid Ir- Hydrophobic ~
Figure 111-1-2. The structure of biologic membranes.
2. Asymmetry. Lipids, proteins, and carbohydrates are all asymmetrically distributed across the lipid bilayer. The asymmetry of the two sides of the membrane allows each side to be functionally distinct. a. Phospholipid asymmetry. The choline-containing lipids (phosphatidylcholine and sphingomyelin) are enriched in the outer leaflet, whereas amine-containing phospholipids (phosphatidylserine and phosphatidylethanolamine) are found primarily in the inner leaflet.
In a Nutshell All membrane carbohydrates are attached to lipids or proteins and are exposed to the "exterior" of the cell.
Bridge to Physiology Increasing the proportion of unsaturated fatty acids or, to a lesser degree, shorter-chain fatty acids increases membrane fluidity. Cholesterol decreases fluidity somewhat but prevents actual freezing; it always increases mechanical stability.
180
iiieClical
b. Carbohydrate asymmetry. The carbohydrate portions of both glycoproteins and glycolipids are found on the exterior of the plasma membrane, where they may function in holding adjacent cells together. c. Protein asymmetry. Proteins are not randomly inserted in membranes. Some proteins have their N-terminus outside the cell, whereas others have their N-terminus on the cytosolic side of the membrane. However all molecules of a specific protein are always inserted in the membrane with the same orientation. 3. Fluidity. The fluidity of the plasma membrane is influenced by the content of cholesterol and by the nature of the fatty acids found in the phospholipids. The higher the cholesterol content, the more tightly the phospholipids of the bilayer are packed, resulting in a membrane that has high rigidity and low fluidity. Note, however, that cholesterol prevents actual freezing of the membrane. Rigidity is also increased by long-chain saturated fatty acids that pack more tightly than unsaturated fatty acids or short-chain fatty acids. The effect of fatty acid composition on rigidity is demonstrated by the fact that the melting temperature (Tm) of membranes is lowered by increasing the proportion of either unsaturated fatty acids or shortchain fatty acids. 4. Mobility. Phospholipids move laterally within the membrane at very high rates. Some integral membrane proteins can also move laterally within the plane of the membrane, whereas the movement of others is restricted by interaction with other proteins either in the cytosol or outside the cell.
- - -
----------------------------
Overview of Cell Types
TRANSPORT ACROSS THE PLASMA MEMBRANE The plasma membrane is a selective barrier that maintains distinct internal and external environments by controlling the passage of molecules into and out of the cell. Several mechanisms are used for the transport of molecules across the membrane. A. Osmosis. Water moves across a cell membrane from a compartment with a lower solute concentration to a compartment with a higher solute concentration. The movement of water requires no expenditure of energy. Osmotic pressure is defined as the force that would be required to prevent the movement of water between compartments.
B. Passive transport. The movement of molecules across a membrane from a region of higher concentration to a region of lower concentration is termed "passive transport" because it requires no external source of energy. There are two types of passive transport: simple diffusion and facilitated diffusion. 1. Simple diffusion. Small uncharged molecules such as oxygen and carbon dioxide can pass through the lipid bilayer by simple diffusion from a region of higher concentration to a region of lower concentration; ions can move through open ion-selective protein channels via simple diffusion.
2. Facilitated diffusion. Some molecules have very low permeability because of their size or polar nature, and they require protein carriers to move from a region of higher concentration to a region of lower concentration. The carrier-mediated movement down a concentration gradient is termed "facilitated diffusion:' All of the transport proteins are integral membrane proteins that span the membrane multiple times. For example, the glucose transporters contain 12 membrane-spanning domains. C. Active transport. The movement of molecules across a membrane from a region oflow concentration to a region of high concentration requires both a carrier protein and the expenditure of energy. The hydrolysis of ATP by an ATPase is directly coupled to this transport, and the free energy released in hydrolysis is used to move ions up an electrical or concentration gradient. This process is called "active transport:' and it is fully reversible. Three examples of proteins in active transport are the Na+K+ -ATPases (which pump Na+ out and K+ into the cell), Ca2+-ATPases (which pump Ca2 + out of cells, or in muscle, from cytosol into the sarcoplasmic reticulum), and the H+ -ATPases (which acidify lysosomes). 1. Cotransport. Cotransport is a form of active transport in which cells import molecules such as glucose or amino acids against a Na+ or H+ gradient. The movement of the ion across a membrane and down a concentration gradient is coupled to transport of the other molecule up a gradient. Ifboth molecules move in the same direction, this is known as symport. For example, glucose and Na+ move from the intestinal lumen across the apical surface of brush border cells via the glucose-Na+ symport protein. If the movement is in opposite directions, it is called antiport. For example, cardiac muscle cells decrease the frequency of contractions by exporting Ca2+ and importing Na+. D. Signal transduction. Some macromolecules do not need to cross the plasma membrane to affect the cell's biologic functions. The extracellular binding to the appropriate membrane receptor triggers a cascade of intracellular events. The binding of an agonist such as a hormone to its receptor causes a conformational change in the receptor. The receptor then interacts with a protein known as a stimulatory G protein (Gs ). Gs is composed of three subunits, (alpha, beta, and gamma) and the alpha subunit contains a molecule of GDP. The agonist-receptor complex triggers an exchange of bound GDP for GTP on Gs' and this dissociates alpha-GTP from beta and gamma. The alpha-GTP activates an intracellular effector protein such as adenylate cyclase. This transduces the signal created by the binding of the agonist to its membrane receptor. The GTP bound to alpha is hydrolyzed back to GDP, which deactivates the adenylate cyclase and returns the G protein to its unstimulated state.
In a Nutshell Simple diffusion is not saturable. Facilitated transport requires specific binding sites for the substrate and therefore is saturable and competitively inhibited.
Clinical Correlate Cystic fibrosis is caused by a defect in the cystic fibrosis transmembrane conductance regulator (CFTR) channel, a cAMP-activated chloride channel. This results in altered chloride permeability in epithelial cells.
Note There is a family of receptors that interact with the G protein. They are all glycosylated integral membrane proteins that have seven transmembrane segments. An example of this class of protei n is the betaadrenergic receptor for the hormone epinephrine. KAPUlf I meillea
181
Cell Biology
VESICULAR TRAFFIC AND THE PLASMA MEMBRANE A. Endocytosis. Movement of macromolecules from the outside of the cell into the cell by the active invagination of the plasma membrane is known as endocytosis. Endocytosis has been divided into three categories: receptor-mediated endocytosis, fluid-phase endocytosis (pinocytosis), and phagocytosis. All three classes require energy. 1. Receptor-mediated endocytosis. The molecule being internalized binds to a receptor on
the surface of the cell. The receptor-ligand complexes concentrate at clathrin-coated pits on the plasma membrane. These coated pits bud to form clathrin-coated vesicles. The vesicles lose their clathrin coats and fuse with early endosomes. The pH of the early endosomes is slightly acidic due to an ATP-driven proton pump, and this lowering of pH causes the dissociation of the ligands from the receptors. The dissociated ligands fuse with late endosomes or lysosomes for degradation, and the receptor vesicles (recycling vesicles) return to the plasma membrane. 2. Fluid-phase endocytosis. This process is also known as pinocytosis ("cellular drinking"), and it refers to the uptake of molecules that are in solution. Receptors are not involved and it is not a concentrating process.
Note Constitutive secretion is the "default" pathway for proteins entering the endomembranous system (by cotranslational import into the RER mediated by SRP). All other destinations (retention in RER or Golgi, delivery to Iysosomes or regulated secretory vesicles) require additional signals. In the absence of such signals, the protein will reach the plasma membrane or be secreted from the cell.
182
meClical
3. Phagocytosis. This process is known as "cellular eating" and is carried out by macrophages and neutrophils. B. Exocytosis. Movement of macromolecules out of the cell is achieved by exocytosis. There are
two types of exocytosis: regulated exocytosis and constitutive secretion. In both cases, the molecules that leave the cell are packaged into secretory vesicles. 1. Regulated exocytosis. The secretion of hormones requires a signal before the secretory
vesicle will fuse with the plasma membrane. The vesicles are coated with clathrin. 2. Constitutive secretion. Secretory vesicles that are not coated with clathrin are continuously fusing with the plasma membrane. These vesicles contain membrane proteins, membrane lipids, and plasma proteins.
Nucleus and Nucleolus
The nucleus of the cell contains DNA, RNA, and nuclear proteins. The nucleus is spherical in shape and is separated from the cytoplasm by a nuclear envelope consisting of two distinct lipid bilayers. The outer nuclear membrane is continuous with the endoplasmic membrane. The inner nuclear membrane is associated with the nuclear lamina, a network of proteins involved in the structural organization of the nucleus. The inner nuclear membrane also has contact sites for interacting with the chromatin and with newly synthesized RNA. The transport of molecules into and out of the nucleus is facilitated by pores in the nuclear envelope. The nucleolus is a dense organelle in the nucleus where ribosomal RNA synthesis and ribosome assembly occur. The functions of the nucleus are to synthesize DNA and repair mistakes made during synthesis and to synthesize RNA and to process it before transport to the cytosol. This chapter reviews the structure of the nucleus and the packaging of DNA into chromatin and the structure and function of the nucleolus.
NUCLEUS Eukaryotic cells have their DNA sequestered in the nucleus, a membrane-bound organelle that can be seen by light microscopy. The subnuclear components can be visualized by the electron microscope. A. Function. The nucleus is involved in both mitosis and meiosis. Several events required for cell division occur in the nucleus, including DNA replication and transcription of DNA into precursor RNA molecules (Figure 1II-2-l). All of the enzymes required for replication and repair of newly synthesized DNA, as well as for transcription and processing of precursor RNA molecules, are found in the nucleus. The synthesis and assembly of ribosomes occurs in a region of the nucleus known as the nucleolus. A detailed review of these processes is discussed in the first five chapters of Molecular Biology (Section II).
KAPLAN'dme leaI
183
Cell Biology
---
./
--
-
"" I
Nuclear pore
-+~-i
/
/
rRNA
/
•
•
DNA Replication and Repair
\
\ \
,,
\
~
I
(
·1 ,Ribosome
Ribosomal assembly
/ 0(
,,
\ \
,
mRNA
RNA Transcription and Processing
mRNA
+ + I
/
tRNA
DNA
.~
DNA
•
tRNA
/
/ /
Nucleus
"-
""
-..
- - ---
Cytoplasm
./ ."""
Figure 111-2-1. Functions of the nucleus.
B. Structure. The major structural features of the nucleus are the nuclear envelope, the nuclear lamina, the nuclear pores, and the nucleolus. 1. Nuclear envelope. The periphery of the nucleus is defined by a double membrane known as the nuclear envelope. Each of the nuclear membranes is composed of a distinct lipid bilayer that is approximately 6 nm thick. Thus, the nuclear envelope is thicker than the plasma membrane. The outer nuclear membrane is continuous with the endoplasmic reticulum. It is associated with ribosomes that are actively synthesizing proteins. The inner nuclear membrane is coated with a meshwork of fibrous proteins known as the nuclear lamina. The double membrane structure contains pores or channels through which most macromolecules must pass to enter or leave the nucleus.
Note Phosphorylation of the lamina during prophase of mitosis initiates nuclear disassembly into small vesicles.
2. Nuclear lamina. The nuclear lamina is a lattice-like network of proteins that play an important role in the structural organization of the nucleus. The lamina is composed of intermediate fllaments having a diameter of approximately 10 nm and containing three types of proteins known as lamins A, B, and C. The lamins contain specific sites that allow the chromatin to be connected to the inner membrane of the nuclear envelope. They are essential for the breakdown and reformation of the nuclear envelope that occurs during the cell cycle. 3. Nuclear pores. The presence of pores in the nuclear envelope provides a mechanism of communication between the cytosol and nucleus. Molecules such as water, ions, amino acids, and small proteins (e.g., ribosomal proteins) pass through the pores. The transport through pores is highly selective because nearly all of the proteins made in the cytosol are
184
mellical
Nucleus and Nucleolus
excluded from the nuclear compartment. The inner and outer membranes of the nuclear envelope are fused to form openings that are approximately 90 nm in diameter. The periphery of the pore is defined by a complex of proteins arranged in an octagonal pattern. 4. Nucleolus. The region in the nucleus where rRNA synthesis occurs and ribosomes are assembled is known as the nucleolus. With electron microscopy, three morphologically distinct zones can be observed. A granular zone found at the periphery of the nucleolus consists of ribosomal precursor particles in various stages of assembly. A centrally located fibrillar zone contains ribonuclear protein fibrils, and a pale-staining fibrillar center contains DNA that is not being transcribed. The size and shape of the nucleolus is dependent upon its activity. In cells synthesizing large amounts of protein, the nucleolus may occupy 20-25% of the total nuclear volume, whereas in resting cells the nucleolus may be almost invisible. The difference in the size of the nucleolus is primarily due to a difference in the size of the granular zone.
In a Nutshell The nucleolus is the site of RNA polymerase I-mediated transcription of rRNA and the site of large subunit ribosome assembly. rRNA is the most abundant RNA in the cell.
CHROMATIN Chromatin is a complex of DNA and proteins. The proteins can be classified as either histone proteins or nonhistone proteins. A. DNA (deoxyribonucleic acid) is a double-stranded helical molecule that carries the genetic information of the cell. 1. Structure. DNA is composed of four nitrogenous bases linked together by a deoxyribose
phosphate backbone. The four nitrogenous bases consist of two purines (adenosine and guanine) and two pyrimidines (cytosine and thymine). The nucleotides are linked via 3'-5' phosphodiester linkages. DNA exists in three conformations: B DNA, Z DNA, and A DNA. The differences in these three types of DNA are discussed in the first chapter of Molecular Biology (Section 11). The most common type is B DNA, a classic Watson-Crick double helix with major and minor grooves that serve as sites for DNA-protein interactions. 2. Histone proteins. The histones are positively charged proteins enriched with lysine and arginine residues. They have no enzyme activity but are involved in DNA packaging. There are five types of histones: HI, H2A, H2B, H3, and H4. The histones are modified post-translationally by phosphorylation, acetylation, and methylation. The histones are important in forming two types of structures in chromatin: nucleosomes and solenoid fibers (Figure III-2-2). a. Nucleosomes. Each nucleosome contains two copies each of histones H2A, H2B, H3, and H4 and approximately 150 base pairs of DNA. The histones form an octamer, which has DNA wrapped around it to give chromatin the appearance of "beads on a string" when examined by electron microscopy. The nucleosomes are the basic repeating units of the chromatin fiber, having a diameter of approximately 10 nm. Adjacent nucleosomes are linked to one another by approximately 60 base pairs of DNA. b. Solenoid fibers. Histone HI is involved in packaging long strings of nucleosomes into a helical, secondary chromatin structure known as a solenoid, which appears under the electron microscope as a thick 30-nm fiber. Each turn of the solenoid contains six nucleosomes (Figure 1II-2-2).
Note Some transcription factors increase RNA polymerase II-mediated mRNA transcription by displacing the nucleosomes in the gene's DNA.
3. Nonhistone proteins. The enzymes involved in nuclear functions such as replication, transcription, DNA repair, and regulation of chromatin function are known as the nonhistone proteins. They are acidic or neutral proteins. B. Chromatin organization. During the cell cycle, chromosomes go through orderly stages of
condensation and decondensation. Various stages in the condensation of DNA are shown in KAPLA~. I meulca
185
Cell Biology
Figure III-2-2. After formation of the nucleosomes and solenoid fibers, the solenoids are further packed into loops, each containing approximately 100,000 base pairs of DNA. The loops are the beginning of the knob-like thickenings called chromomeres that are observable under the microscope in early prophase as mitosis begins. The chromomeres further condense, as shown in Figure III-2-2, to eventually form the chromosome.
c
DNA
A. 2 nm
[
B. 10 nm
[
String of nucleosomes
C. 30 nm
[
6 Nucleosomes/turn solenoid fiber
o ~ E
1111111111111111111
(;
LL
c
~
D. 300 nm
Loops
E
e
x
..c
o
E. 700 nm
[QRV I I
F. 1,400 nm [
Chromatin
I
===_==
Chromosome
Figure 111-2-2. Chromatin organization.
Note
C. Types of chromatin. Chromatin inside a eukaryotic cell nucleus can be classified into two
major types based on its state of condensation: heterochromatin and euchromatin.
Almost the entire inactive X chromosome in each somatic cell in a woman is condensed into heterochromatin.
1. Heterochromatin is highly condensed (30-nm solenoid fibers or higher states of condensation) and is transcriptionally inactive. The amount of heterochromatin in a cell is related to the transcriptional activity of the cell. In a typical eukaryotic cell, approximately 10% of the chromatin is heterochromatin.
2. Euchromatin is a more extended form of DNA and is the potentially transcriptionally active form of chromatin. In a typical cell, euchromatin accounts for approximately 90% of the total chromatin, although only about 10% is in the 10-nm fiber of nucleosomes and is being actively transcribed.
186
iiie&ical
Subcellular Organelles Eukaryotic cells, when viewed with the electron microscope, contain a number of well defined subcellular compartments or organelles, each enclosed by a membrane system that separates them from the cytosol. The organelles of eukaryotic cells include the nucleus, mitochondria, endoplasmic reticulum, Golgi apparatus, Iysosomes, and peroxisomes. Additionally, a part of the endoplasmic reticulum is associated with ribosomes, which are actively engaged in protein synthesis. This chapter reviews the structure and function of each of these subcellular organelles as well as some clinical conditions arising from a specific enzyme or organelle deficiency.
RIBOSOMES Ribosomes are cytoplasmic organelles composed of ribosomal RNA and protein. They contain binding sites for all of the interacting molecules involved in protein synthesis. A. Structure. The mature 80S ribosome is a multienzyme complex of rRNA and protein consisting of a large (60S) and a small (40S) subunit. The ribosomes are assembled in the nucleus and are transported to the cytoplasm through the nuclear pores. 1. The large subunit contains three species of rRNA (28S, 5.8S, and 5S) and a set of approx-
imately 50 proteins. 2. The small subunit contains a set of approximately 30 specific proteins that are associated with an 18S species of rRNA. B. Assembly. The large ribosomal subunit is synthesized in the nuceolus, whereas the small subunit is synthesized in the nucleus. Each subunit is assembled from rRNA and ribosomal proteins from the cytoplasm. After assembly of the ribosomal subunits, the subunits pass through the nuclear pore into the cytoplasm where they combine to form a ribosome. C. Function. The ribosomes are the cellular machines used for protein synthesis. They can exist
either as free polysomes in the cytoplasm or as membrane-associated polysomes, which are attached to the rough endoplasmic reticulum. Polysomes consist of a single mRNA that is being translated by several ribosomes at the same time, all moving on the mRNA from the 5' end toward the 3' end (Figure III -3-1). The two ribosomal subunits associate on the mRNA, with the small subunit binding first. Subsequent binding of the large subunit is necessary before protein synthesis can begin. Individual ribosomes are spaced approximately 80 nucleotides apart along the mRNA molecule. Each ribosome is independently synthesizing a single polypeptide. 1. Free polysomes are the sites of synthesis for proteins destined for the nucleus, peroxi-
somes, or mitochondria. 2. Membrane-associated polysomes are the sites of synthesis of secretory and membrane proteins.
meClical
187
Cell Biology
@
+ 6 Start codon
t
Nascent polypeptide chain
!N _
~
~
N Mature polypeptide
Figure 111-3-1. Structure of a polysome.
ENDOPLASMIC RETICULUM More than 50% of the total membrane in eukaryotic cells is made up of endoplasmic reticulum. There are two types: rough endoplasmic reticulum and smooth endoplasmic reticulum.
Note Protein synthesis for cytosolic, mitochondrial, nuclear, and peroxisomal proteins is completed in the cytosol.
Note Proteins destined for the RER, SER, Goigi apparatus, Iysosomes, plasma membrane, or for secretion from the cell must finish translation on RERbound ribosomes.
188
meClical
A. Rough endoplasmic reticulum (RER). The RER is a single lipid bilayer continuous with the outer nuclear membrane. It is organized into stacks of large flattened sacs called cisternae that are studded with ribosomes on its cytoplasmic side, giving the organelle its rough appearance. The internal space of the cisternae is known as the luminal space. Sacs and tubules form an interconnected branched network that covers a large part of the cell. Three functions are associated with the RER: protein synthesis, translocation of membrane proteins, and cotranslational modification of polypeptides. Proteins that are destined for secretion, the plasma membrane, the Golgi apparatus, and lysosomes, are synthesized by the rough endoplasmic reticulum. The RER is very prominent in cells that are specialized in the synthesis of proteins destined for secretion (e.g., pancreatic acinar cells). 1. Protein synthesis (Figure III-3-2). All protein synthesis begins on free polysomes. The association of the two ribosomal subunits (Step A) occurs at the 5' end of the mRNA, with the small ribosomal subunit binding first. After binding of the large subunit, protein synthesis begins (Step B). The association of ribosomes with the RER requires signal peptides, signal recognition particles, and signal recognition particle receptors. The mRNAs of proteins synthesized by RER-associated polysomes contain nucleotide sequences coding for approximately 30 hydrophobic amino acids. As the signal peptide is released by the ribosome (Step B), it is recognized by dle signal recognition particle (Step C). The signal recognition particle (SRP) contains six protein subunits and a 7S RNA. The SRP binds to both the ribosome and the signal sequence of the peptide being synthesized, causing a brief pause in protein translation. During the pause, the SRP binds to the SRP receptor (SRPR or docking protein), an integral membrane protein of the endoplasmic reticulum (Step D). The
Subcellular Organelles
G
6)
(A)
~ 5'
(C)
(8)
5'
3'
~
8
N
5'
3'
Signal sequence
3'
SRP
(E)
(0)
5'
3'
3'
SSR RR
RER membrane SRPR SSR
3'
RR
RER luman
•• ~ • IP (H)
(I)
5'
-~r.....-...--I..----
N
5' - - - - - - - 3'
G
3'
I~I
I I
RR
C
V)
,;,.
ASn\3e. N Dolichol pyrophosphate lipid carrier
RR
0 0
RER lumen
N.J'C)_Asn~
Figure 111-3-2. Protein synthesis and the rough endoplasmic reticulum.
binding of SRP to its receptor leads to its displacement from the ribosome and to the insertion of the signal sequence into the RER membrane, events that allow protein synthesis to continue. The ribosome receptor (RR) is made up of two proteins of the RER membrane, ribophorins I and II (Step E). The signal sequence and the newly synthesized polypeptide chain enter the RER membrane where the signal sequence interacts with a protein known as the signal sequence receptor (SSR). 2. Cotranslational modifications. Several modifications occur as the protein is being synthesized. Signal peptidases (SP) located in the RER membrane remove the signal peptide and are degraded by intraluminal proteases (Step F). N-linked glycosylation occurs by the transfer of preformed mannose-rich oligosaccharides from a dolichollipid carrier to specific asparagine side chains within the nacent polypeptide (Steps G and H). Intramolecular disulfide bonds are formed by protein disulfide exchange enzyme. After completion of polypeptide synthesis, the ribosome disassembles and detaches from the RER membrane (Step I).
Note The initial step of N-linked glycosylation occurs during translation. All O-linked glycosylation steps are posttransiational.
3. Insertion of membrane proteins into the endoplasmic reticulum membrane. Many proteins are completely released into the RER after synthesis (Figure III-3-2, Step I). These include proteins that function in the lumen of the endoplasmic reticulum, proteins that are to be secreted, and proteins destined to other organelles such as the Golgi apparatus
meClical
189
Cell Biology
and lysosomes. However, some proteins are destined to be inserted and retained in the membrane. The retention of such proteins is facilitated by two types of signals, the insertion signal (or the start-transfer signal) and the halt transfer signal (also known as the stop-transfer signal). How these signals are used depends on the number of times a protein crosses the membrane and on the orientation of the protein within the membrane (Figure III-3-3).
Extracellular side
Type I
Type II
Type III
Intracellular side Figure 111-3-3. Types of integral membrane proteins.
a. Type I proteins cross the membrane one time and are oriented so that the N-terminus faces the luminal surface and the C-terminus faces the cytoplasmic surface. For these proteins, the N-terminal start-transfer peptide is followed by a hydrophobic stoptransfer sequence that terminates the insertion. The start-transfer N-terminal signal peptide is then cleaved, leaving behind a single-pass integral membrane protein with its C-terminus in the cytoplasm and its N-terminus in the lumen of the ER.
In a Nutshell N-Linked Glycosylation • Initial step occurs during translation. • Initial step transfers preformed oligosaccharide from dolicholphosphate onto Asn in Asn-X-Ser sequence. • Preformed oligosaccharide is trimmed in RER. • New sugars (in a pattern specific to each protein) are added in the Golgi.
190
meClical
b. Type II proteins also cross the membrane one time, but their orientation is such that the N-terminus is in the cytoplasm. For these proteins, the start-transfer peptide sequence (insertion peptide) is in the interior of the protein and does not undergo cleavage. The N-terminus is synthesized first and is exposed to the cytoplasmic surface of the membrane. The C-terminus is then looped out of the membrane and into the lumen. c. Type III proteins cross the membrane several times. They contain a series of alternating insertion (start-transfer) sequences and halt (stop-transfer) sequences, thereby allowing the protein to cross the membrane multiple times. The start- and stop-transfer sequences are hydrophobic runs of 20-30 amino acids that form an a-helix in the lipid bilayer. 4. Cotranslational modification of polypeptides. Most proteins synthesized on the endoplasmic reticulum become glycosylated upon entry into the lumen of the ER. On the other hand, proteins that are synthesized on free polysomes are usually not glycosylated. In animal cells, oligosaccharides are attached to the glycoprotein through glycosidic bonds that are either N-linked (attached to the amide group in an asparagine side chain) or 0linked (attached to the hydroxyl group of a serine, threonine, or hydroxylysine side chain). The early stages of N -linked glycoprotein synthesis are summarized below. a. Synthesis of preformed oligosaccharide. A mannose-rich oligosaccharide is assembled on a dolichol pyrophosphate lipid carrier located in the membrane of the ER. h. Transfer of oligosaccharide to protein. The enzyme oligosaccharide transferase trans-
Subcellular Organelles
fers the carbohydrate moiety from the dolichol carrier to an asparagine residue with the sequence Asn-X-Ser/Thr (where X can be any amino acid except proline or aspartate). The enzyme is located on the luminal side of the RER membrane. Before polypeptide synthesis is completed, one or two mannose residues and three glucose residues are trimmed from the oligosaccharide by specific glucosidases, all enzymes of the ER. e. Classes of N-linked oligosaccharides. In mature glycoproteins, three classes of
oligosaccharides can be found (Figure 1II-3-4). All three classes share a core region (Man3GlcNAc2), but they differ in the composition of the branches. The core region is added to the protein in the RER, whereas the unique terminal monosaccharides are added in the Golgi. (1) High-mannose type oligosaccharides retain 2-6 mannose residues linked to the core region. Proteins with high-mannose type carbohydrate chains remain in the RER and are not transferred to the Golgi.
(2) Complex oligosaccharides contain sialic acid, galactose, and glucosamine in the branches coming off the core region. These terminal monosaccharides are added in the Golgi.
(3) Hybrid oligosaccharides consist of a structure in which one branch retains some of the mannose residues and the other branch contains galactose and gIucosamine. d. Pathway of glycosylation. The exact pattern of glycosylation of a newly synthesized protein can be used to trace the pathway of a protein through the intracellular compartments. For example, the ~-subunit of the Na/K ATPase is glycosylated. The nascent ~-subunit polypeptide (38 kD) acquires three core oligosaccharides of the high-mannose type in the endoplasmic reticulum, increasing its molecular weight to 45 kD' As the 45-kD protein moves through the Golgi, the molecular weight increases to 55-60 kD and the post-translational modification is completed, yielding the mature ~-subunit.
SA Man
Man
Man
I
I
I
Man
Man
Man
'-./
I
Man
Man
"-Man /
SA
I
I
Gal
Gal
I
I
GlcNAc
GlcNAc
I
I
Man
Man +/-GlcNAc -
"-Man /
Gal
I GlcNAc Man
I
Man
Man +/-GlcNAc -
'\.
Man
/
I
I
I
GlcNAc
GlcNAc
GlcNAc
I
I
GlcNAc
I
I
Asn
+/-Fuc - - GlcNAc
I
High Mannose
L4iJ Complex
Man
"-/
I GlcNAc
I
I
Asn
I
Hybrid
Figure 111-3-4. Classification of N-linked oligosaccharides.
B. Smooth endoplasmic reticulum (SER). The SER is a network of membranous sacs, vesicles, and tubules continuous with the RER but free of ribosomes. The membrane contains enzymes involved in the biosynthesis of phospholipids, triglycerides, and sterols. Some of the functions of the SER are listed below. KAPLA~. I meulCa
191
Cell Biology
1. Detoxification reactions. Many compounds are extremely water insoluble and, when present in sufficient quantities, are toxic. One of the approaches to detoxification is to make these compounds (e.g., steroid hormones, alcohol, drugs, insecticides) more water soluble so that they can be excreted. Two types of reactions that are most important in increasing the solubility are hydroxylation and conjugation reactions.
Note Phase I hydroxylations can result in toxic intermediates, which can be harmful unless modified by a phase II conjugation.
a. Hydroxylation reactions. The addition of hydroxyl groups to compounds is achieved by a multienzyme complex found in the smooth endoplasmic reticulum. The complex requires molecular oxygen, NADPH, and a minature electron transport system for using the reducing equivalents in NADPH to reduce oxygen to a hydroxyl group. These hydroxylase complexes contain cytochrome P 450, a flavoprotein, and a nonheme iron protein, all components of the SER. b. Conjugation reactions. Other enzymes found in the SER can transfer polar groups (sulfate, glucuronic acid) from activated carriers (PAPS and UDP-glucuronic acid) to the toxic water-insoluble molecule. 2. Glycogen degradation and gluconeogenesis. Glycogen is degraded to glucose-lphosphate, which is then isomerized to glucose-6-phosphate. Glucose-6-phosphate is also the last cellular intermediate in the pathway of gluconeogenesis. For glucose to leave the cell, the phosphate group has to be removed by the enzyme glucose-6-phosphatase, an integral membrane protein of the SER. 3. Reactions in lipid metabolism. Lipolysis begins in the SER with the release of a fatty acid from triglyceride. The SER is also the site where lipoprotein particles are assembled. 4. The sarcoplasmic reticulum. The SER in striated (skeletal and cardiac) muscle is known as the sarcoplasmic reticulum, an organelle that is active in the sequesteration and release of calcium ions.
GOLGI APPARATUS The Golgi consists of disc-shaped smooth cisternae that are assembled in stacks (dictyosomes) having a diameter of approximately 1 !im (Figure III-3-5). Numerous small membrane-bound vesicles are associated with the edges of the stacks. The Golgi has two distinct faces. The cis (forming) face is associated with the RER. The trans (maturing) face is oriented toward the plasma membrane. The trans-most region is a network of tubular structures known as the trans-Golgi network (TGN). The major functions of the Golgi apparatus include post-translational modification and the sorting of newly synthesized proteins and lipids. A. Transfer of proteins from the RER to the Golgi. The carbohydrate component of glycoproteins are processed to give complex-type oligo saccharides (see Figure III-3-4) in the Golgi. Regions of the RER that are smooth in appearance are known as transitional elements. These regions bud off to form vesicles that contain proteins destined for the Golgi. The vesicles go to the cis face of the Golgi and fuse with the Golgi membrane, allowing secretory proteins and membrane proteins to enter the Golgi. The transfer of proteins from the RER to the Golgi is an energy-dependent process and can be blocked by inhibitors of oxidative phosphorylation. B. N-Hnked oligosaccharides are attached to an asparagine residue of proteins during the course of polypeptide synthesis. Further modification of the carbohydrate moiety occurs in the Golgi and is required to produce complex and hybrid oligosaccharide chains (see Figure III-3-4). The Golgi stack contains biochemically distinct compartments. For example, the cis sac contains a-mannosidase I, N-Ac-glucosamine phosphotransferase, and N-Ac-glucosaminidase; the
192
meClical
Subcellular Organelles
medial sac contains cx-mannosidase II, transferase I, transferase II, and fucosyl transferase; and the trans-most sac contains galactosyl transferase. Membrane vesicles transport the proteins across the Golgi from the cis face to the trans face. Some proteins remain in the Golgi; others will reach the trans-Golgi network and become secretory proteins, a part of the plasma membrane, or lysosomal proteins.
Membrane ---:,r---t->JI(,i vesicles
Rough Endoplasmic Reticulum
Figure 111-3-5. Goigi apparatus.
C. O-linked oligosaccharides are attached to the hydroxy group on the side chain of serine,
threonine, or hydroxylysine residues in proteins. In contrast to N-linked oligosaccharides, they are not assembled prior to transfer and there is no dolichollipid intermediate involved. The O-linked oligosaccharides are built up one monosaccharide at a time on the protein. D. Packing, concentration, and storage of secretory granules occurs in the trans-Golgi network. Secretory proteins are transferred as dilute solutions to condensing vacuoles located on the trans face of the Golgi, where they become concentrated into membrane-bound secretory granules or vesicles. The vesicles bud off the TGN and release their contents into the extracellular space via exocytosis. E. Modification of glycoproteins
In a Nutshell O-linked Glycosylation • Occurs in Golgi apparatus after translation is complete • Adds sugars to Ser or Thr • Adds sugars one at a time • Tends to be less complex than N-linked glycosylation
1. Phosphorylation of mannose in glycoproteins is a signal that targets proteins to the lyso-
somes. Lysosomes have receptors that recognize and bind proteins with mannose-6phosphates prior to uptake. The phosphate is added in a two-step sequence of reactions that are catalyzed by N-Ac-glucosamine phosphotransferase and N-Ac-glucosaminidase. The first enzyme transfers N-Ac-glucosamine-l-P from UDP-N-Ac-glucosamine to specific mannose residues in the oligosaccharide chain. The second enzyme removes N-Ac-glucosamine, leaving phosphate attached to the 6-position of mannose. 2. Sulfation of oligosaccharide chains of proteoglycans occurs in the Golgi.
meclical
193
Cell Biology
3. Limited proteolysis of precursor proteins, e.g., pro insulin is cleaved to insulin and C-peptide in the Golgi. F. Diseases associated with Golgi apparatus include I-cell disease and hyperproinsulinemia.
Note I-cell disease patients lack the enzyme necessary to create mannose-6-phosphate on lysosomal enzymes. Therefore, these enzymes follow the default (no signals needed) pathway of constitutive exocytosis and are secreted from the cell.
1. I-cell disease is a disease in which a whole family of enzymes is sent to the wrong destination. The cause of the disease is a deficiency in N-Ac-glucosamine phosphotransferase, which is one of the two enzymes required to convert specific mannose residues to mannose-6-phosphate in glycoproteins (hydrolases) destined for lysosomes. Individuals with this disease are characterized by having huge "inclusion bodies" in cells due to the accumulation of undegraded glycoconjugates in lysosomes. The lysosomes are missing the hydro lases that normally degrade these macromolecules. The missing enzymes are found in the plasma and other body fluids, where they have normal levels of activity. The absence of the mannose-6-phosphate on the hydrolases results in their secretion rather than their incorporation into lysosomes.
2. Hyperproinsulinemia is characterized by elevated levels of proinsulin in the serum resulting from a deficiency in the peptidase associated with the secretory granules that contain proinsulin. The clinical manifestations are similar to those seen in patients with n oninsulin -dependent diabetes.
LYSOSOMES The lysosomes are spherical membrane-enclosed organelles that are approximately 0.5 diameter and contain enzymes required for intracellular digestion.
~m
in
A. Types of lysosomes. Lysosomes are a heterogeneous population of organelles, whose contents depend upon the degradation stage of the material. 1. Primary lysosomes have not yet acquired the materials to be digested. They are formed by budding from the trans side of the Golgi. 2. Secondary lysosomes are formed by the fusion of the primary lysosome with the substrate to be degraded and have contents that are in various stages of degradation.
Clinical Correlate Lysosomal storage diseases are caused by a lack of lysosomal enzymes or transporters, resulting in an accumulation of toxic materials.
B. Hydrolytic enzymes. Approximately 60 hydrolytic enzymes have been identified in lysosomes. These include nucleases for degrading DNA and RNA, lipases for degrading lipids, glycosidases for degrading glycoconjugates (glycoproteins, proteoglycans, and glycolipids), proteases and peptidases for degrading protein, and a variety of phosphatases. The specific complement of enzymes varies significantly between different lysosomes. All of the lysosomal enzymes are acid hydrolases, with optimal activity at a pH of approximately 5.0. The requirement for an acidic environment prevents this class of enzymes from causing damage if accidentially released into the cytoplasm. The synthesis of the lysosomal hydrolases occurs in the RER; the hydrolases are transferred to the Golgi, where they are modified and packaged into lysosomes. The key modification reaction that targets these hydrolytic enzymes to lysosomes is the addition of phosphate to the 6-position of mannose residues of their oligosaccharide chains. C. Functions. The major fuction of lysosomes is to degrade macromolecules to their building
blocks. The material to be degraded may be either extracellular or intracellular. The degradation of intracellular materials such as membrane or organelles is known as autophagy. Extracellular materials are taken up by endocytosis. 1. Fluid-phase endocytosis. Many large molecules enter the cell by the active invagination of the plasma membrane, resulting in an endocytic vesicle that fuses with a lysosome.
194
meClical
Subcellular Organelles
2. Receptor-mediated endocytosis. Some extracellular molecules recognize receptors that are widely dispersed over the plasma membrane. The binding of a molecule (ligand) to its receptor causes the receptors to aggregate in special regions called clathrin-coated pits, which invaginate, allowing the receptor and its ligand to enter the cell as a coated vesicle. For example, receptor-mediated endocytosis is the process by which cells take up LDLcholesterol. The vesicle loses its coat and then fuses with another vesicle to form an endosome. Within the endosome, the LDL receptor becomes incorporated into a membrane vesicle that buds off and returns to the cell surface. The remaining part of the endosome fuses with a primary lysosome, forming a secondary lysosome. In the secondary lysosome, the cholesterol esters are hydrolyzed to form free cholesterol.
Note The decreased pH of the endosome typically causes the ligand (e.g., LDL) to dissociate from its receptor, allowing receptor recycling.
PEROXISOMES The peroxisomes are a heterogeneous group of small, spherical organelles with a single membrane and a diameter that ranges from approximately 0.15 to 0.5 ~m. They contain a number of enzymes that transfer hydrogen atoms from organic substrates (urate, D-amino acids, very long chain fatty acids) to molecular oxygen with the formation of hydrogen peroxide. Catalase, the major peroxisomal protein, degrades the hydrogen peroxide to water and oxygen. A. Functions. In addition to the synthesis and degradation of hydrogen peroxide, peroxisomes are important in a number of other metabolic activities. 1.
~-oxidation of very long chain fatty acids (>C24 ) starts in the peroxisome and proceeds until the carbon chain has been reduced to a length of approximately C lO . Oxidation of the residual C lO is completed in the mitochondria.
2. Phospholipid exchange reactions occur in the peroxisome. Phospholipids are synthesized by the endoplasmic reticulum and are imported into the peroxisome, where enzymes convert phosphatidylserine and phosphatidylethanolamine.
Note Proteins destined for import into peroxisomes are fully translated in the cytosol and contain a (-terminal amino acid sequence that directs them to the peroxisome import machinery.
3. Bile acid synthesis occurs in peroxisomes. B. Synthesis of peroxisomal enzymes occurs on polysomes. After translation, the enzymes are incorporated directly into peroxisomes. C. Peroxisomal deficiency. Several genetic diseases are associated with the impairment or absence of peroxisomes. These patients fail to oxidize very long chain fatty acids and accumulate bile acid precursors. The four most common disorders are Zellweger cerebro-hepato-renal syndrome, neonatal adrenoleukodystrophy, infantile Refsum disease, and hyperpipecolic acidemia.
Clinical Correlate Zellweger syndrome is caused by a lack of the machinery (proteins) needed to recognize and import the various peroxisomal enzymes.
MITOCHONDRIA Mitochondria are similar to bacteria in size and shape. They have a characteristic cigar shape, with a width of 0.5 ~m and a length that can vary from 1-10 ~m. They are found scattered throughout the cell. Liver cells contain 700-1,000 mitochondria per cell, each with a half-life of approximately 10 days. Mitochondria contain their own double-stranded circular DNA, and they make some of their own proteins. Like bacteria, mitochondria reproduce by dividing. A. Mitochondrial compartments. As shown in Figure III-3-6, mitochondria are defined by a double membrane.
meCtical
195
Cell Biology
Cristae -l-_-Outer membrane Inner membrane Intermembrane compartment
Figure 111-3-6. Structure of the mitochondrion.
1. The outer membrane is smooth, continuous, and permeable. It contains an abundance of porin, an integral membrane protein that forms channels in the outer membrane through which molecules ofless than 10 kD can pass. 2. The inner membrane is impermeable to most small ions (Na+, K+, H+) and small
Note The electron transport chain pumps protons into the intermembrane space, creating a proton (electrochemical) gradient. The protons move back into the matrix through the Fa channel of ATP synthase, releasing energy for ATP synthesis.
molecules (ATP, ADP, pyruvate). The impermeability is likely related to the high content of the lipid cardiolipin. The inner membrane has numerous infoldings, called cristae, that greatly increase the total surface area. The enzymes for electron transport and oxidative phosphorylation are imbedded in the inner membrane. The number of mitochondria and the number of cristae per mitochondrion are proportional to the metabolic activity of the cells in which they reside. For example, both cardiac tissue and kidney tubule cells require large amounts of ATP for their normal function. These cell types therefore have an abundance of mitochondria with a large number of closely packed cristae. 3. The intermembrane compartment is the space between the inner and outer membranes. It contains enzymes that use ATP to phosphorylate other nucleotides (creatine phosphokinase and adenylate kinase). 4. The matrix is the region enclosed by the inner membrane, which contains several different components: a. Dehydrogenases oxidize many of the substrates in the cell (pyruvate, amino acids, fatty acids), generating NADH and FADH2 for use by the electron transport chain and energy generation. b. Double-stranded circular DNA genome and the enzyme machinery necessary for its replication and expression are all located in the matrix. The human mitochondrial nucleotide sequence encodes a few of the mitochondrial proteins. Mitochondrial DNA is always inherited from the mother, resulting in the maternal transmission of diseases of energy metabolism.
Note Most proteins destined for the mitochondria are completely translated in the cytosol but contain N-terminal amino acid sequences that direct them to the mitochondrial import machinery. Import requires unfolding, ATP, a membrane potential, and refolding. 196
meClical
c. RNA, proteins, and ribosomes allow mitochondria to carry out protein synthesis. However, most mitochondrial proteins are synthesized in the cytoplasm and are transferred into the mitochondria. d. Intramitochondrial granules containing calcium and magnesium are found in the matrix. Their function is not known, but it is believed that they may represent a storage site for calcium. B. Mitochondrial function. The major function of the mitochondria is to synthesize ATP
(Figure I1I-3-7). Cellular oxidation of glucose starts in the cytoplasm, where it is converted to pyruvate by glycolysis, yielding two molecules of ATP per glucose. Pyruvate is transported into the mitochondrial matrix, where pyruvate dehydrogenase oxidizes it to acetyl-CoA, the substrate for the TCA cycle.
Subcellular Organelles
glucose
Glycolysis cytosol
-~--,,--:-----+-.
pyruvate
inner membrane
NAD+
Intermembrane compartment
(proton pumps)
Figure 111-3-7. Energy generation by the mitochondria.
meCtical
197
Cytoskeleton
The cytoskeleton provides a supportive network of tubules and filaments in the cytoplasm of eukaryotic cells. The cytoskeleton is a dynamic structure responsible for cellular movement changes in cell shape, and contraction of muscle cells. It provides the machinery for intracellular movement of organelles. It is composed of three types of supportive stuctures: microtubules, intermediate filaments, and microfilaments. This chapter reviews the structure and function of each of the cytoskeletal components.
MICROTUBULES Microtubules are polymers of tubulin that undergo rapid assembly and disassembly. They are found in the cytoplasmic matrix of all eukaryotic cells. Microtubules have been implicated in a large number of cell functions, including mitotic and meiotic chromosomal movement, transport of vesicles from one site to another within the cell, and ciliary and flagellar motility. A. Structure. The major component of microtubules is tubulin, a protein dimer composed of two different polypeptides, a-tubulin and /3-tubulin. When viewed by electron microscopy, microtubules are hollow cylinders with a diameter of approximately 24 nm. A crosssectional view shows that the wall of the cylinder is made up of 13 protofilaments, each consisting of an alignment of tubulin dimers. The individual protoffiaments are arranged such that the a- and /3-tubulin subunits alternate along the length of the protoffiament. The tubules have a diameter of approximately 24 nm, and the wall is 5-6 nm thick. B. Assembly. Polymerization of tubulin to form microtubules is accomplished by microtubule organizing centers (MTOC) and two types of accessory proteins: tau proteins and microtubule-associated proteins (MAPs). Microtubules grow from the organizing centers. Both tau and MAPs, when purified, induce polymerization of tubulin and become bound to newly formed microtubules. Assembly can occur spontaneously in vitro in the presence of MAPs, GTP, and calmodulin. When the incubation is carried out at 37°C, self-assembly occurs with the hydrolysis of one molecule of GTP per microtubule. Lowering the temperature to 4°C results in depolymerization. As long as an adequate concentration of GTP is present in the reaction, it is possible to polymerize and depolymerize the microtubules indefinitely. Calcium can block or reverse polymerization, suggesting that calcium may also modulate microtubule formation in the cell. C. Polarity. Microtubules have polarity (a plus and a minus end). The minus ends are oriented
toward the inside of the cell and associated with the microtubule organizing center. All of the assembly and disassembly occurs at the plus ends of the microtubules, which are oriented toward the periphery of the cell.
In a Nutshell Microtubules are hollow cylinders formed by long protofilaments of tubulin dimers.
Note Typically, the negative end of microtubules is found at the centrosome (or basal body of cilia and flagella).
KAPLAlf I meillea
199
Cell Biology
D. Movement associated with microtubules. There are three major types of movement that involve microtubules. 1. Chromosomal movement during meiosis and mitosis depends on the activity of microtubules. Microtubule assembly is an important event in spindle formation. 2. Intracellular vesicle and organelle transport requires microtubules. Two specific microtubule-dependent ATPases, kinesin and dynein, are involved in the force generation, with the microtubules playing a more passive role in intracellular transport. 3. Ciliary movement is produced by the cilia beating in S-shaped waves and is important in clearing mucus from the respiratory tract. Movement is produced by the axoneme, a complex structure composed of micro tubules and a variety of other proteins that allow the beating action to occur. The structure of the axoneme is shown in Figure III -4-1. a. In axonemes, there are two central micro tubules surrounded by a circle of nine peripheral microtubule doublets. The peripheral doublets are fused so that they share a common tubule wall and form two subtubules (A and B). Subtubule A is a complete microtubule, but subtubule B is only a partial subtubule. The central singlets are connected by a bridge that runs between them and a sheath that surrounds them. Subtubule A of each peripheral doublet is connected by a spoke to the sheath. Adjacent doublets are connected to one another by nexin links.
Spoke - / + - - -
Central singlet
membrane
sheath
In a Nutshell Dynein moves toward to negative end; this powers axoneme bending in cilia and flagella and vesicle movement toward the nucleus (centrosome) or away from the nerve terminal in axons (retrograde).
200
ineilical
Bridge Figure 111-4-1. Structure of the axoneme.
b. A pair of dynein arms is attached to each A subtubule. The arms bind to ATP and rearrange themselves so that a binding site for the B subtubule in the tip of the arm is exposed. The B tubule interacts with the binding site, causing the arm to snap back and movement to occur. Each cycle of a single dynein arm slides adjacent doublets 10 nm past each other.
Cytoskeleton
E. Diseases associated with microtubules. Two disease states involve malfunction of microtubules: Chediak-Higashi syndrome and bronchiectasis. l. Chediak-Higashi syndrome is characterized by a defect in the ability of microtubules to polymerize within leukocytes. This leads to a delay in the fusion of phagosomes with lysosomes, thus preventing phagocytosis of bacteria.
2. Bronchiectasis is caused by immotile cilia in the respiratory epithelia, resulting in the inability of cilia to remove inhaled bacteria.
F. Drugs affecting tubulin polymerization may either promote or inhibit polymerization; both groups inhibit microtubule function. 1. Inhibitors include colchicine (which binds to tubulin and blocks polymerization), vinblastin, and vincristine. 2. Promoters are taxol (causes free tubulin to assemble) and D 20 (increases polymerization).
Bridge to Pharmacology Colchicine stops cell division during metaphase.
INTERMEDIATE FILAMENTS These components of the cytoskeleton, with a diameter of 10 nm, are intermediate in thickness between microtubules and microfilaments. These rope-like filaments function primarily in structural roles. Intermediate filaments are classified into three types: keratin filaments, vimentin-containing filaments, and neurofilaments. These tough and durable filaments are found predominantly in those parts of the cell that are subjected to mechanical stress, where they function to maintain cell shape and the positioning of organelles within the cell.
A. Keratin filaments are made up of a family of 20 closely related proteins. They are found in epithelial tissue, where they strengthen the epithelium. B. Vimentin-containing filaments are found in nonepithelial cells such as fibroblasts, chondrocytes, endothelial cells, and macrophages. Vimentin can copolymerize with other proteins, some of which are cell specific. For example, the intermediate filament in fibroblasts is made up solely of vimentin; those of glial cells and astrocytes contain both vimentin and glial fibrillary acidic protein; those of some muscle cells contain vimentin and desmin.
Note Keratin filaments form the tonofilaments that connect desmosomes in epithelial cells.
C. Neurofilaments are found in most neurons of the central and peripheral nervous system,
where they extend along the length of the axon. They are the major cytoskeletal component of nerve cells.
MICROFILAMENTS These filaments have a diameter of 6 nm and are composed of actin. Each actin filament (F-actin) consits of two strands of actin twisted into a helical pattern with 13.5 molecules of globular actin (G-actin) per turn of the helix. The globular monomer of actin is stabilized by one molecule each of calcium and ATP. The polymerization of G-actin to give F-actin is accompanied by the hydrolysis of ATP to ADP. Microfilament polymerization is believed to be under the control of small fluctuations in the concentration of calcium ions and cAMP.
In a Nutshell Microfilaments are doublestranded helices of polymerized actin.
A. Actin-binding drugs can interfere with the polymerization-depolymerization cycle of micro filaments. B. Movement associated with microfilaments. Two types of movement are dependent upon micro filaments. Local movement takes advantage of the polymerization and depolymerization properties of microfilaments. Sliding filament movement is generated by the interaction of actin filaments with myosin filaments.
meCtical
201
Cell Biology
1. Cytochalasin B inhibits the assembly of actin fllaments by binding to one end of the fll-
ament and preventing the addition of actin molecules to the fllament. Processes such as endocytosis, phagocytosis, cytokinesis, and cytoplasmic and amoeboid movements are all inhibited by cytochalasin B. 2. Phallodin binds along the length of the actin fllament, preventing depolymerization.
In a Nutshell • Myofibers are large multinucleated skeletal muscle cells. • Myofibrils are composed of tandem arrays of sarcomeres, or clusters of thin or thick filaments; these are the contractile elements. • Myofilaments are the thin (actin) and thick (myosin) filaments that slide past one another during contraction.
Note During contraction, the Z lines approach one another and the I bands get smaller, but the A band does not change size.
C. Microfilaments and muscle contraction. Skeletal (striated) muscle consists of long, cylin-
drical muscle fibers. These large fibers are multinucleated and arise from the fusion of a large number of precursor cells (myoblasts). The cytoplasm of these fibers is divided into discrete units (myofibrils), which extend the entire length of the muscle fiber. 1. Myofibrils are the contractile elements of muscle cells and are surrounded by a large
number of mitochondria that supply the ATP required for contraction. All other cellular components that are not involved in contraction are pushed aside and are tucked in between the outermost myofibril and beneath the sarcolemma (the plasma membrane of muscle cells). The ultrastructure of a myofibril is shown in Figure III-4-2. a. The sarcomere is the repeating contractile unit in the myofibril. Sarcomeres are separated from one another by the Z line. The A band spans the width of the myosin thick fllaments, including the region where they overlap with the thin fllaments. The actin thin fllaments are connected to the Z line and extend toward the center of the sarcomere, where they overlap with myosin fllaments. Each A band is flanked by I bands, the region containing actin fllaments only. b. Myosin molecules are long fibrous structures composed of six subunits: two heavy chains and four light chains. Each myosin heavy chain consists of a globular head and a fibrous tail. The two fibrous tails of the heavy chains are twisted into a double helical structure, forming regions where myosin molecules interact to form filaments. The globular heads of the myosin molecule contain ATPase activity as well as sites for binding to actin fllaments. c. Tropomyosin and troponin are involved in the regulation of actin and myosin interaction.
2. Tropomyosin is a fllamentous protein containing two subunits. It lies in the grooves on either side of the F-actin fllament and mediates access to the site on actin monomers that bind to the myosin head. Tropomyosin is found in actin fllaments of both muscle and nonmuscle cells. 3. Troponin is a complex of three subunits: T, I, and C. Troponin T binds to tropomyosin and, together with troponin I, inhibits the interaction of actin and myosin. Troponin C has a binding site for Ca2+, and when calcium is bound, actin and myosin interaction is promoted. Troponin is found only in skeletal muscle cells. Tropomyosin and troponin have a fixed relationship with F-actin: one molecule of tropomyosin and one molecule of troponin bind per every seven actin monomers.
202
meClical
Cytoskeleton
Myofibril
Sarcomere
F-Actin filament Myosin filament
C~;Jj.;~
C=:~ent
G-Actin molecules
CJIL--__
Heavy Light meromyosin meromyosin Figure 111-4-2. Ultrastructure of a myofibril.
a. Accessory proteins of the myofibril. As described below, several other proteins are associated with the sarcomere. (1) a-Actinin binds and anchors actin filaments to the Z line.
Note
(2) Myomesin cross-links adjacent myosin filaments at the M line (the center of the sarcomere).
Desmin, an intermediate filament, aligns adjacent myofibrils in the myocyte cytoplasm, giving it the classic "striated" appearance.
(3) Desmin is found at the Z line, where it holds myofibrils in place. (4) Titin is a large fibrous protein that extends over half of the sarcomere. It has elastic properties and keeps the myosin thick ftlaments centered in the sarcomere. (5) Nebulin is a large fibrous protein attached to the Z line and extends the length of the thin ftlament. It stabilizes the highly ordered structure of the myofibril by regulating the assembly of the actin filaments. D. Actin-myosin interaction in skeletal muscle. In relaxed muscle, the actin ftlaments extend
approximately halfway over the myosin ftlament (see Figure III-4-2). During contraction, the actin ftlaments slide toward each other, past the myosin ftlaments, resulting in the shortening of the sarcomere, the myofibril, and the length of the muscle. This is known as the sliding filament model of muscle contraction. There is no change in the length of either types of filaments. The movement of myosin along the actin ftlament is ATP dependent. The myosin head binds ATP,
Note Smooth muscle contains actin filaments attached to the plasma membrane as well as myosin filaments, but the fibrils are not aligned. When the myosin slides along adjacent filaments, the cell contracts in all directions. KAPLAff I me illea
20J
Cell Biology
which is hydrolyzed to ADP and Pi by myosin ATPase. ADP and Pi remain bound to the ATPase site. The myosin head moves to an adjacent thin filament, and as it makes contact with the thin filament, it undergoes a conformational change and releases ADP and Pi. A second molecule of ATP binds to the myosin head, causing it to be released from the thin filament. Hydrolysis of ATP results in the myosin head resuming its original conformation. The myosin head is then ready for another cycle.
Bridge to Physiology • In skeletal and cardiac muscle, increased Ca 2+ binds to troponin, which shifts tropomyosin, allowing actin to bind myosin, thereby activating myosin ATPase activity. • In smooth muscle, increased Ca 2+ binds myosin light chain kinase, which then phosphorylates the myosin (or its light chain), thereby activating its ATPase activity and initiating contraction.
204
meClical
E. Troponin and tropomyosin in muscle contraction. Control of muscle contraction is provided by troponin, tropomyosin, and a change in intracellular calcium concentrations. When the calcium concentration is low (10- 7 M), troponin I and troponin T are strongly bound to tropomyosin, holding it in the actin groove so that it blocks the myosin binding site on the actin monomers. Troponin C is either loosely associated with tropomyosin or is bound to troponin I and troponin T. When calcium concentrations increase above 10-7 M in the cell, troponin C binds calcium and undergoes a change in conformation, forcing troponin I and troponin T to move. The movement exposes the myosin binding site on the actin, permitting interaction between the two filaments to occur. This, however, does not necessarily result in contraction. Contraction can result only if ATP is present. F. Control of intracellular calcium concentrations. Small membranous folds, known as
T-tubules, extend from the sarcolemma and surround each myofibril at the Z line. The T-tubules act as a communication system for the depolarization of the plasma membrane that occurs when a nervous stimulation signals the muscle to contract. Depolarization of the sarcolemma is relayed to the sarcoplasmic reticulum (SR), a sheath of flattened vesicles that surrounds the myofibrils and stores large quantities of calcium. Normally, extracellular calcium concentrations are high (10- 3 M), whereas those in the cytosol are low (10- 7 M). Upon depolarization, the calcium levels rise from 10-7 to greater than 10-5 M during contraction. The increase is due primarily to the movement of calcium ions through Ca2 + release channels in the membrane of the sarcoplasmic reticulum. The change in calcium concentration occurs rapidly and relieves the inhibition of myosin binding to actin. Once the stimulation of the nerve ceases, calcium is pumped back into the sarcoplasmic reticulum by the action of a SR-specific ATPase. The calcium is bound in the SR by calsequesterin, an acidic protein with a high density of aspartate and glutamate residues.
Cellular Adhesion and Extracellular Matrix The relationship between the cell and its environment is controlled by specialized macromolecular complexes that bind cells together to form tissues and organs. The plasma membrane of mammalian cells has specialized junctional complexes that allow cells to bind to neighboring cells or to the extracellular matrix, which provides a structural framework for the association of cells. This chapter reviews the basic structure of the different types of cell junctions and the extracellular matrix and the way that they all function in relating the cell to its environment.
CELL JUNCTIONS Cell junctions anchor cells to each other, seal boundaries between cells, and form channels for direct transport and communication between cells. Each of the three types of junctional complexes has a characteristic ultrastructure (Figure III-5-l) designed to perform a specific function. A. Anchoring junctions are present in all cell types but are most numerous in tissues that are subject to extreme mechanical stress, such as the epithelial cells of skin, intestine, and uterus. These junctions couple neighboring cells to one another through interactions that are mediated by the cytoskeleton. Anchoring junctions are found in both vertebrates and invertebrates and are important in both adhesion and cellular movement. There are two major types of anchoring junctions, based on the type of cytoskeletal element involved: adherens junctions and desmosomes. Adherens junctions connect groups of actin filaments in adjacent cells, whereas desmosomes connect intermediate filaments of adjacent cells.
meCtical
205
Cell Biology
-tt--- Microvilli
Apical surface
Plasma membrane Tight [ junction Adhesion ,-------' belt
§~~~~~~ Intermediate I 'Alf=IIlAI--filaments (keratin)
. .~It-IIt---
Hemidesmosome
Basal lamina
Figure 111-5-1. Cell junctions.
1. Adherens junctions can couple cells with other cells or with a component of the extra-
cellular matrix. The junctional complexes are composed of two major proteins: intracel-
lular attachment proteins (lAP) and transmembrane linker glycoproteins (TLG). As shown in Figure III-5-2, lAP has binding sites for both TLG and actin filaments. TLG spans the plasma membrane and interacts with another TLG from a neighboring cell or with the extracellular matrix.
Transmembrane linker -t----t-t------+-+--, glycoprotein
-I-+----+.,.-
Intracellular attachment proteins
+-_ _ __+_ Cytoskeletal element
Plasma membrane Extracellular matrix
Transmembrane - - - - - linker glycoprotein
Figure 111-5-2. Adherens junctions.
206
ii1e&ical
---~----
Cellular Adhesion and Extracellular Matrix
a. Cell-cell adhesion junctions form an "adhesion belt" (also known as the zonula adherens) that encircles each of the interacting cells (see Figure III -5-1). These junctions are found between cells in epithelial sheets and are located in the apical region of the cells. The adhesion belt contains contractile actin filaments. Contraction of the adhesion belt is responsible for many of the morphologic changes that occur in embryonic development. One of the characteristic features of cardiac muscle is that adjacent cells are joined by intercalated discs, which are composed of adhesion junctions. The discs are L-shaped structures that allow cardiac muscle cells to interdigitate with one another, forming fibers. b. Cell-matrix junctions connect cells and their actin filaments to the extracellular matrix. These junctions are also known as adhesion plaques and are important in some types of cellular movement. 2. Desmosomes are button-like structures (see Figure III-5-1) that bind to intermediate filaments, anchoring them in place. The type of intermediate filament attached to the desmosome depends on the cell type. For example, epithelial cell desmosomes are attached to keratin filaments, brain desmosomes are attached to vimentin filaments, and cardiac muscle cell desmosomes are attached to desmin filaments. When viewed in the electron microscope, desmosomes appear as dense plaques. These plaques, known as desmoplakins, are composed of intracellular attachment proteins. The intracellular attachment proteins bind to transmembrane linker proteins, known as desmogleins, which hold adjacent cells together. These points of attachment between cells are known as "spot welds;' and the interaction is mediated by calcium. Hemidesmosomes anchor the basal surface of epithelial cells to the extracellular matrix. B. Tight junctions form a physical barrier between adjacent cells whose plasma membranes come in direct contact with one another. 1. Structure. Tight junctions are composed of a network of membrane proteins that
form a belt-like structure that encircles epithelial cells along their apical surface (Figure III-5-3). The junction between cells is so tight that no extracellular space can be seen. 2. Function. Tight junctions prevent the movement of small molecules between the two cells. They also block the exchange of lipid molecules between the outer region of the two plasma membranes that are in direct contact.
Clinical Correlate Pemphigus is a potentially fatal autoimmune disease that affects the skin. Individuals with this disease produce antibodies against transmembrane linker glycoproteins. The antibodies bind to these proteins and disrupt the desmosome structure, resulting in severe blistering and leakage of body fluids into the loosened epithelia. Only the desmosomes in skin are affected, suggesti ng that there are tissue-specific isoforms of desmosomes.
KAPLAlf I medlea 207
Cell Biology
Apical surface Microvilli Plasma membrane Intercellular space tMf--
Tight junction
Tight junction protein 14 nm
CeliA
Cell B
CeliC
Cell D
____ Basal membrane
Basal lamina
Figure 111-5-3. Tight junctions.
C. Gap junctions, also known as communication junctions, attach adjacent cells in a way that
allows transfer of chemical and electrical signals. 1. Structure. The key structural component of gap junctions is the connexon, a hollow cylinder made up of transmembrane proteins (Figure III-S-4). Connexons of adjacent cells interact with one another to form a continuous channel that is open to the interior of both cells. Although connexons of neighboring cells are in direct contact, the plasma membranes of the two cells are separated by a slight gap of 2-4 nm.
Bridge to Physiology Increased intracellular Ca 2+ will close gap junctions. This prevents the death of one cell from killing its coupled neighbors.
208
2. Function. Gap junctions permit communication between cells by allowing small ions or water-soluble molecules to pass between cells. The phenomenon of cell coupling via gap junctions provides a mechanism for coordinating the activities of individual cells. Cells may be coupled both chemically and electrically. Gap junctions are prominent in nerve and brain cells, cardiac muscle, smooth muscle, and liver cells. In nerve cells, gap junctions set up direct electrical connections that fuse the two cells into a single electrical unit. This communication is maintained by the concentration of Ca2+ and cAMP levels. An increase in the cytosolic Ca2 + concentration decreases the permeability of gap junctions, whereas an increase in cAMP increases the ability of the cells to communicate.
meclical ~---~~--~~----~----~---
Cellular Adhesion and Extracellular Matrix
Connexon
2-4nm
7nm Figure 111-5-4. Gap junctions.
EXTRACELLULAR MATRIX The extracellular matrix provides a structural framework for the organization of cells into tissues and organs. Three major types of macromolecules make up extracellular matrix: proteoglycans, structural proteins, and adhesive proteins. A. Proteoglycans are composed of approximately 90-95% carbohydrate and 5-10% protein. 1. Structure. The carbohydrate components of proteoglycans are known as glycosamino-
glycans (GAGs). They are long linear polysaccharide chains made up of repeating disaccharide units. The polysaccharide chain is linked to protein through a linker oligosaccharide that is common to all proteoglycans. 2. Function. Proteoglycans form a hydrated gel in which the fibrous proteins are embedded. These molecules serve as excellent shock absorbers and lubricants. B. Structural proteins. The two major structural proteins are collagen and elastin, both of
which are fibrous proteins. 1. Collagen is composed of three polypeptide chains wound around one another to form a
triple helical structure. They are highly enriched in glycine and proline (every third residue is glycine) and contain hydroxylysine and hydroxyproline. There are at least 30 different collagen peptide chains. Types I-IV are of primary significance. Collagens I-III are fibrous forms of collagen. Collagen IV is assembled into a sheet-like meshwork and is located exclusively in the basal lamina. The major function of collagen is to strengthen and organize the extracellular matrix. 2. Elastin is the main component of elastic fibers. These fibers are also rich in glycine and proline. After secretion into the extracellular space, they are cross-linked with each other via desmosine and isodesmosine residues to provide a mesh structure. Their major function is to provide elasticity to tissues such as lungs and to large arteries leaving the heart. C. Adhesive proteins. The two major adhesive proteins found in the extracellular matrix are
fibronectin and laminin. 1. Fibronectin is a large fibrous protein consisting of peptides that are similar but not iden-
tical. These polypeptides are held together by disulfide bonds. Fibronectin is synthesized by fibroblasts, monocytes, and endothelial cells. It binds to both the cell and to several
Bridge to Physiology Vitamin C is required for the formation of hydroxyproline in collagen and for the formation of interchain hydrogen bonds that stabilize the triple helix.
In a Nutshell Fibronectin is necessary for the formation of fibroblast adhesion plaques and for fibroblast movement.
meclical
209
Cell Biology
other matrix macromolecules, thereby providing a linkage between the cell and the extracellular matrix. Fibronectin is found in several locations. a. Cell surface fibronectin appears to be transiently present on the cell surface. b. Plasma fibronectin increases blood clotting and promotes wound healing. c. Extramatrix fibronectin is highly insoluble and stabilizes cells within the matrix. 2. Laminin is the major glycoprotein in the basal lamina, where it forms continuous mats of polypeptide underlying all epithelial cell sheets. It is secreted by epithelial cells and is composed of a complex of three polypeptide chains arranged in the shape of a cross. The chains are held together by disulfide bonds. Laminin has numerous functional domains, each binding a different protein such as collagen IV, heparan sulfate, etc. Laminin mediates the attachment of cells to connective tissue.
210
meClical
SECTION IV
Genetics
Mendelian Inheritance
The simplest inheritance patterns depend upon the genotype of an individual at a single locus. Traits inherited in this manner are said to follow a mendelian inheritance pattern. The mode of inheritance of a trait within a family can help suggest a diagnosis, which can be confirmed with diagnostic tests. It can also provide information to relatives regarding the probability of their being affected with the same condition.
TERMINOLOGY A. In a mendelian sense, a gene is an inherited factor that determines a given genetic characteristic of an organism. An individual has two copies of most genes, although the copies may not be identical. Alternative expressions of the same gene are called alleles. The locus of a gene refers to its physical location on a chromosome. B. The genotype is the genetic constitution of an individual at a given locus. The phenotype is
the observable expression of a particular gene in an organism due to the interaction of the gene with other genes and the environment. An individual is homozygous when he possesses two copies of a similar allele of a gene pair (e.g., AA or aa). An individual is heterozygous when he has two different alleles of the gene (e.g., Aa). Hemizygous refers to the special case in which an individual normally has only a single copy of a gene, as in the case of X-linked genes in males. C. An allele is said to be dominant if the phenotype associated with it is expressed in heterozygotes. An allele is recessive if it requires the homozygous condition to be expressed. A carrier
is an individual who carries a deleterious allele, but does not express the phenotype. Incomplete dominance describes the condition in which two different alleles produce a blended effect in the heterozygote. The clearest examples of incomplete dominance occur in plants. When certain plants are heterozygous for red and white flower pigments, pink flowers are produced. For dominant diseases, penetrance can be defined quantitatively by determining the proportion of obligate gene carriers who express the phenotype. This frequency is given as a percent (i.e., polydactyly has a penetrance of 95%). Expressivity is the degree to which a particular effect is expressed by individuals. Pleiotropy is the diverse effects of a single gene on several different organ systems and functions. The same mutant allele that causes pleiotropic effects will show variable expressivity in different individuals because of the effects of other genes modifying its expression or environmental interactions.
In a Nutshell Gene: an inherited factor that determines a given genetic characteristic
Allele: alternative expression of a gene Locus: the physical location of a gene on a chromosome Genotype: the genetic constitution of an individual at a single locus Phenotype: the observable expression of the interaction of a genotype with the environment Homozygous: having two similar alleles at a locus Heterozygous: having two different alleles at a locus Hemizygous: having one gene at a locus, characteristic of X-linked genes in males
KAPLA~.
meulca
I
213
Genetics
D. Pedigree analysis is a method of recording family information to trace the passage of a gene through generations. Figure IV-l-l summarizes basic pedigree nomenclature.
Generation
II III IV
2
D 0
0
•• C)[J
®
•
3
Male
00
Dead
Female
0-0
Mating
Unknown sex
0=0
Consanguineous or incestuous mating
Affected
DO
Sibship
DO
Dizygous twins
Carrier of an autosomal recessive (optional) Carrier of an X-linked recessive (optional) Stillborn or abortion
Figure IV-1-1. Pedigree nomenclature.
AUTOSOMAL DOMINANT TRAITS A. Characteristics 1. Of the over 5,000 catalogued traits that exhibit Mendelian inheritance, over 50% are inherited in an autosomal dominant manner. Figure IV-1-2 illustrates a typical autosomal dominant inheritance pattern.
In a Nutshell Autosomal dominants affect both male and female children and generally do not skip generations because only one copy of the mutant allele is needed for expression of the trait.
Figure IV-1-2. Autosomal dominant inheritance pattern.
2. The phenotype can be expressed if a dominant allele is present in only one dose. In other words, only one mutant allele need be present for the disease to be expressed. 3. Deleterious autosomal dominants occur at very low frequencies, so affected individuals are almost always heterozygous for the trait.
214
meClical
Mendelian Inheritance
4. Affected parents can have either affected or normal children. The characteristic does not "skip" generations, unless there is reduced penetrance. 5. Because the trait is carried on an autosome rather than a sex chromosome, both male and female progeny can be affected. B. Diseases
1. Familial hypercholesterolemia is a condition characterized by increased serum cholesterolleading to premature atherosclerotic disease and myocardial infarctions early in life. Homozygotes for this disorder lack functional LDL receptors and cannot internalize LDL or IDL via receptor-mediated phagocytosis. Their plasma LDL-cholesterollevels are three to five times that of normals. Heterozygotes have about half the normal number of functional LDL receptors and their LDL-cholesterollevels are twice that of normals. The incidence of homozygotes is approximately 111,000,000, and the incidence of heterozygotes is 11500. 2. Huntington disease is an autosomal dominant of late onset that leads to neurological degeneration, emotional disturbances, cognitive decline, and chorea. It is caused by the loss of neurons in the neostriatum and cortex. The gene responsible has been mapped to chromosome 4 (4pI6.3). It codes for a 348 kD polypeptide and contains a CAG trinucleotide repeat. In normal individuals, this repeat is present 11 to 34 times. In individuals with Huntington disease, the repeat has expanded and is present between 37 and 86 times. The larger the number of repeats, the earlier the age of onset of the disease. The incidence is approximately 8/100,000. 3. Neurofibromatosis type I, or von Recklinghausen disease, is an autosomal dominant with high penetrance, but variable expressivity, that maps to the long arm of chromosome 17 (l7ql1.2). The disease has three major features: multiple neural tumors anywhere on or in the body, numerous pigmented cutaneous lesions (cafe-au-lait spots) and pigmented iris hamartomas (Lisch nodules). EM studies show that the tumors are the result of the proliferation of fibroblasts or Schwann cells in peripheral nerves, possibly due to ras inactivation. There is no treatment except for surgical resection of symptomatic tumors. The incidence is approximately 113,000. 4. Marfan syndrome is due to a defect in the gene for fibrillin located at 15q21.1; the major clinical findings involve the skeleton, cardiovascular system, and the eye. Affected individuals tend to be tail with long extremities and long, tapering appendages. Many spinal deformities are seen including kyphosis and scoliosis, and the joints may be hyperextensible. The most characteristic ocular change is bilateral subluxation of the lens, or ectopia lentis. Mitral valve prolapse and dilation of the ascending aorta due to cystic medial degeneration are common. The latter is the more important defect because the loss of medial support leads to dilation of the aortic valve ring and the root of the aorta, giving rise to aortic incompetence. Weakening of the media predisposes the aorta to an intimal tear, which can produce a dissecting aneurysm. The incidence of Marfan syndrome is approximately 1115,000.
AUTOSOMAL RECESSIVE TRAITS A. Characteristics 1. Autosomal recessives account for approximately 1800 of the 5000 mendelian traits identified. Figure IV-1-3 illustrates a typical autosomal recessive inheritance pattern, in this case due to a consanguineous mating.
Flashback to Biochemistry For more information on lipoprotein metabolism, see Lipids (Chapter 5) in Biochemistry (Section I).
In a Nutshell Huntington disease is caused by expansion of a CAG trinucleotide repeat on chromosome 4. It is inherited as an autosomal dominant.
Clinical Correlate Type II neurofibromatosis is much rarer than type I and is characterized by acoustic neuromas and cafe-au-Iait spots, but Lisch nodules are usually absent. The gene has been localized to chromosome 22.
Clinical Correlate Many diseases affecting genes that code for structural proteins (e.g., collagen: Ehlers-Danlos syndrome, or fibrillin: Marfan syndrome) are inherited as autosomal dominants.
Note Other important autosomal dominant conditions include: Ehlers-Danlos syndrome, Gilbert syndrome, polycystic kidney disease, osteogenesis imperfecta, and chondrodystrophic dwarfism.
meClical
215
Genetics
In a Nutshell Autosomal recessive disorders require two copies of the mutant allele for expression. Therefore, these diseases often skip generations; unaffected parents can produce affected sons or daughters. Figure IV-1-3. Autosomal recessive inheritance pattern.
2. Autosomal recessive traits require two doses of the mutant allele (homozygosity) for the phenotype to be expressed. 3. The hallmark of autosomal recessive inheritance is that unaffected parents can produce affected children of either sex. 4. Many autosomal recessive diseases are due to enzyme deficiencies. B. Diseases
1. Cystic fibrosis is an autosomal recessive disease caused by point mutations or small deletions in an integral membrane protein that functions as a chloride transporter, called the cystic fibrosis transmembrane conductance regulator (CFTR). The gene coding for this protein is located at 7q31.2.
a. Phenotypically, cystic fibrosis often presents with meconium ileus and is also characterized by deficiencies of pancreatic enzymes, pulmonary obstruction and infection leading to progressive pulmonary damage, bronchiectasis, cor pulmonale, and respiratory failure. Other abnormalities include cirrhosis of the liver, infertility, and elevated sodium and chloride concentrations in sweat.
In a Nutshell The majority of cases of cystic fibrosis are due to a deletion of three nucleotides coding for phenylalanine at position 508 in the CFTR.
Bridge to General Principles Refer to the Pathology chapter of the General Principles book for more information about Tay-Sachs disease and phenylketonuria.
216
meClical
b. Cystic fibrosis occurs at an incidence of 112,000 births in the Caucasian population; the carrier frequency is estimated at 1 in 25. Although many mutations within the gene could cause the phenotype, it is not practical or cost effective to sequence the entire region to screen for carriers. However, in the Caucasian population, the most frequent mutant allele causing cystic fibrosis is due to a small deletion at phenylalanine 508 in exon 10. It accounts for up to 70% of mutant cystic fibrosis alleles in Caucasian populations. An amplification of this region using the polymerase chain reaction (PCR) can be done, and the PCR products sequenced and compared with the normal sequence for this region. If comparison reveals the deletion, the donor of that template DNA would be classified as a carrier. If the mutation is not present, the probability that the donor of that DNA is a carrier of cystic fibrosis is greatly reduced, but still exists. Most diagnostic laboratories use this method to screen for between 4 and 10 of the most common mutations. Note that if a person belongs to a different ethnic group, PCR must be used to amplify the exons that contain the majority of the CF mutations within that particular ethnic group. 2. Tay-Sachs disease is an autosomal recessive disease caused by a deficiency of hexosaminidase A, which leads to the accumulation of ganglioside GM2 in neurons, producing a degenerative neurologic disease. Children appear normal at birth, but then begin to suffer from diminished responsiveness, deafness, blindness, loss of neurologic function, and seizures. Death usually occurs by 4 to 5 years of age. There is no therapy. The incidence of Tay-Sachs disease is highest among Ashkenazi Jews, in whom it occurs in approximately
Mendelian Inheritance
113,600 births. The carrier frequency in this population is estimated to be 1 in 30. Screening for carriers is inexpensive and measures hexosaminidase A activity in the blood. Cells obtained from amniocentesis can also be screened for hexosaminidase A activity. 3. Phenylketonuria is caused by a deficiency in the enzyme phenylalanine hydroxylase. Without this enzyme, phenylalanine is not converted to tyrosine, but is made into phenylketones. These phenylketones are excreted in urine and lead to the characteristic musty smell of the disorder. If phenylalanine is not restricted in the diet, the deficiency is characterized by severe mental retardation and microcephaly. Treatment consists of a diet low in phenylalanine and supplemented with tyrosine, which becomes an essential amino acid in these individuals. The incidence in those of European descent is approximately 1110,000.
X-LINKED RECESSIVE TRAITS A. Characteristics 1. X-linked recessive traits account for less than 10% of the 5,000 mendelian traits identified. Figure IV-1-4 illustrates a typical X-linked recessive inheritance pattern.
Clinical Correlate Newborns are routinely screened for phenylketonuria using the Guthrie test that measures the amount of phenylalanine in the blood. If a child with phenylketonuria is identified early, a special diet that restricts phenylalanine can prevent significant mental retardation.
Note Other important autosomal recessive conditions include: albinism, alkaptonuria, Gaucher disease, Hartnup disease, homocystinuria, maple syrup urine disease, sickle-cell anemia, thalassemia, Wilson disease, and xeroderma pigmentosum.
In a Nutshell
Figure IV-1-4. X-linked recessive inheritance pattern.
2. Since males are hemizygous for the X chromosome, the phenotype is expressed in males with only one dose of the gene. Females require two doses for the phenotype to be expressed. 3. A male with an X-linked recessive allele will pass it to all of his daughters, but to none of his sons. A carrier female who is heterozygous for the trait, if mated to a normal male, can have affected sons or normal sons and carrier daughters or homozygous normal daughters. There is a 50% chance the female will transmit the gene to each son or daughter. B. Diseases 1. Duchenne muscular dystrophy (DMD) is due to a mutation in an X-linked gene located at Xp21.2. The gene encodes the protein dystrophin. a. Two thirds of DMD cases each generation are familial and the remaining one third arise sporadically. The gene is 2.5 Mb long and has 78 exons.1t codes for a 3687 amino acid protein that contains 24 similar repeats of 109 amino acids each. Because of this similarity, new mutations are thought to arise because of the incorrect alignment of the repeats at meiotic synapsis, followed by crossover events that lead to deletion or additions. If the illegitimate recombination event results in a frameshift mutation that truncates dystrophin, DMD results. Interestingly, if the recombination event preserves the reading frame, Becker muscular dystrophy results.
X-linked recessive diseases usually affect males, who inherit the mutant allele from heterozygous (carrier) mothers. A male with an X-linked recessive will pass it to all of his daughters, but none of his sons. If his mate is homozygous dominant, the daughters will be carriers. A carrier female will pass the disease to half her sons and will pass the carrier tra~ to half her daughters.
Bridge to Musculoskeletal System For more information on Duchenne-type muscular dystrophy, refer to the Musculoskeletal Pathology chapter in Organ Systems Book 2 (Volume IV).
I KAPLAlf medlea
217
Genetics
Flashback to Biochemistry Refer back to Nucleic Acids (Chapter 1) in Molecular Biology (Section II) in this book for more information about Lesch-Nyhan syndrome.
Bridge to Heme/Lymph Hemophilia is discussed in greater detail in the Hematologic/Lymphoreticular Pathology chapter of Organ Systems Book 1 (Volume III).
Note Other important X-linked recessive conditions include: hemophilia A, hemophilia B, glucose-6-phosphate dehydrogenase deficiency, and colorblind ness.
b. DMD is characterized by onset of weakness in early childhood. Most affected children are confined to wheelchairs by age 10 and die from respiratory and cardiac complications of the muscle degeneration by age 20. The incidence is approximately 1/3,500. 2. Lesch-Nyhan syndrome results from a severe deficiency of hypoxanthine-guanine phosphoribosyltransferase (HGPRT), a key enzyme in the purine salvage pathway. It results in excessive uric acid production, mental retardation, spasticity, self-mutilation, and aggressive, destructive behavior. 3. Hemophilia A is caused by a deficiency of factor VIII that leads to the inability to clot blood normally. Affected individuals have prolonged bleeding times and suffer from easy bruising and hemorrhage. Treatment consists of the replacement of factor VIII by means of a concentrate prepared from pooled blood or by using recombinant DNA techniques. The incidence of hemophilia A is approximately 1110,000 in Caucasian males. 4. G6PD deficiency. Glucose-6-phosphate dehydrogenase deficiency is a defect in the first step of the hexose monophosphate shunt. The main purpose of this pathway is to produce ribose SP and NADPH. NADPH is used in a variety of biosynthetic reactions and to regenerate glutathione. Glutathione detoxifies oxidants produced during infection or by oxidant drugs, such as primaquine, dapsone, and sulfonamides. Its levels are reduced in individuals with G6PD deficiency because of their diminished capacity to generate NADPH. Consequently, oxidants are free to damage cells. RBCs are especially susceptible, and hemolytic anemia may result. Alleles for G6PD deficiency are common in many populations including ones in the Mediterranean, Mrica, and India. The deficiency is believed to have been selected for because it confers an advantage against infection with plasmodium falciparum.
X-LINKED DOMINANT TRAITS A. Characteristics 1. X-linked dominant diseases are very rare, with only a few known examples. Figure IV-l-S illustrates a typical X-linked dominant inheritance pattern.
In a Nutshell A pedigree showing X-linked dominant inheritance from an affected female can look like an autosomal dominant pedigree, but transmission from an affected male is to all of his daughters but none of his sons. Figure IV-1-S. X-linked dominant inheritance pattern.
2. An affected male parent passes the trait to all of his daughters, but to none of his sons. 3. An affected female parent can pass the trait to both sons and daughters. The inheritance pattern from an affected female looks like that of an autosomal dominant. 4. Without a very large pedigree or employing molecular techniques, an X-linked dominant cannot be distinguished from an autosomal dominant.
218
meClical
---~---~--
- - - - -
Mendelian Inheritance
B. Diseases
1. Hypophosphatemic rickets is an X-linked dominant condition causing abnormal regulation of vitamin D3 metabolism and defects in renal tubular phosphate transport. Symptoms include growth retardation, osteomalacia, and rickets.
NON MENDELIAN INHERITANCE PATTERNS A. Mitochondrial inheritance
1. Mitochondrial traits exhibit a matrilineal inheritance pattern because only the mother contributes mitochondrial DNA to progeny (Figure IV-1-6).
In a Nutshell Mitochondrial inheritance exhibits a matrilineal pattern because mitochondria are inherited only from the mother.
Figure IV-1-S. Mitochondrial inheritance pattern.
2. Mitochondria, the organelles involved in the generation of ATP energy through oxidative phosphorylation, contain their own double-stranded circular DNA. Mutations in mitochondrial DNA occur at a 1O-to-20-fold higher frequency than mutations in nuclear DNA. This is thought to be a result of exposure to oxygen free radicals and the lack of an efficient repair system. The mitochondrial DNA also replicates independently of the nuclear DNA, and the organelles segregate into daughter cells independently of nuclear DNA. If a cell contains both mutant and normal mitochondria, after mitosis, daughter cells can contain different numbers of the mutant mitochondria. This phenomenon is called heteroplasmy and helps explain the variable phenotype between different tissues in mitochondrial disease. 3. Mitochondrial diseases are often expressed as neuropathies and myopathies because muscle and brain are highly dependent upon oxidative phosphorylation. a. Leber hereditary optic neuropathy was the first disease discovered that followed a mitochondrial inheritance pattern. It is a relatively common cause of acute or subacute loss of central vision secondary to optic nerve degeneration, especially in young men. b. Myoclonic epilepsy with ragged-red muscle fibers (MERRF) is a syndrome characterized by myoclonus, seizures, cerebellar ataxia, and mitochondrial myopathy.
Clinical Correlate Mitochondrial diseases affect the tissues that are the most dependent on oxidative phosphorylation (heart, skeletal muscle, brain).
B. Multifactorial or quantitative inheritance 1. In multifactorial inheritance, the phenotype is determined by the contributions of many genes as well as the interaction of the genes with the environment. Each gene contributes only a small amount toward the phenotype, and it is the net quantitative effect of all the genes that produces the phenotype. When a certain genetic threshold is exceeded and there is exposure to environmental triggers, the disease develops. Diseases or conditions impacted by many genes are said to be polygenic.
meC:lical
219
Genetics
2. Multifactorial inheritance is complex and incompletely understood. Many disorders are associated with this pattern of inheritance, including pyloric stenosis, cleft lip, and cleft palate. C. Fragile X syndrome
1. Fragile X syndrome is clearly a genetic disease, but it fails to follow the patterns described for normal X-linked recessive or dominant mutations. Completely unaffected carrier males, called nonpenetrant transmitting males (NTM), may be identified in pedigrees. The male or female offspring from such a carrier male are completely normal, but the grandchildren from the carrier's daughter may be affected. Among these grandchildren, approximately 25% of the males will be affected, and about 25% of the males will be unaffected carriers. Around 25% of the females may have mild symptoms of the disease, and about 25% of the females will be unaffected carriers. Fifty percent of the grandchildren, both males and females, will be completely normal. The expression of the phenotype seems to depend on the position of the individual in a pedigree (Figure IV-l-7).
Mild Sx
Figure IV-1-7. Fragile X syndrome.
2. The gene responsible for fragile X, called fragile X mental retardation (FMR1) is located at Xq27.3 and appears to code for an RNA-binding protein. a. There is a short series of CGG repeats that are normally transcribed as part of the 5' untranslated region of the FMRl mRNA. In normals, the repeats are present in 6 to 50 copies. b. In an individual with fragile X syndrome, the trinucleotide sequence is present in hundreds to thousands of copies. As the number of CGG repeats expands, the promoter region upstream from the expanded CGG repeat is hypermethylated, preventing transcription of the gene. In fragile X individuals, no FMRl mRNA is detected in tissues such as brain and testes, tissues in which the level of FMRl mRNA is normally substantial. c. A female carrier has an intermediate number of repeats, greater than 50 but less than 230. At this level, the 5' end of FMRl is not hypermethylated and the gene is still transcribed. The gene in this carrier female is called a premutation and is also found in NTMs. What causes the premutation to undergo an expansion of the CGG repeats is not known.
220
meClical
Mendelian Inheritance
3. Fragile X affects approximately 111,250 males and 112,000 females in all ethnic groups. It is the most common form of inherited mental retardation. In addition to mental retardation, characteristic features in males include narrow faces, prominent ears and forehead, and large testes. Physical symptoms in affected females are milder. 4. Recently, it was demonstrated that affected males have the expanded eGG repeats in somatic cells, but not in germ cells. This observation led to the hypothesis that the zygote (46,XY) possesses only the premutation. Expansion to the full mutation occurs later in embryonic development (postzygotically), after the germ cell lineage has been set aside. No expansion occurs in the germ cell lineage, and the exact magnitude of the expansion in somatic cells is not the same in each cell.
In a Nutshell Fragile Xsyndrome is the most common inherited form of mental retardation. It is caused by expansion of a eGG repeat on the mutant X chromosome in the zygote, which turns off the transcription of an essential gene called FMR 1. Other diseases caused by trinucleotide expansions include Huntington disease, myotonic dystrophy, and spinocerebellar ataxia types 1 and 3.
KAPLAIf,,_
me lea
I 221
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chromosomal Abnormalities
Chromosomal abnormalities are not generally due to mutations in single genes, but are the result of structural alterations that can be seen under the light microscope. These alterations include the rearrangement of genetic material in a chromosome, or numerical abnormalities due to the gain or loss of a chromosome.
STANDARD CYTOGENETIC NOMENCLATURE A. The chromosomal constitution of an individual is described by a karyotype. The karyotype includes the total number of chromosomes, the sex chromosome constitution, and any abnormalities in number or morphology. A normal human karyotype is 46,XX for human females and 46,XY for human males. Karyotypes are performed when cells are entering mitosis because the DNA is condensed and can be easily observed when stained with dyes such as quinicine or Giemsa. B. Chromosomes can be classified based on the position of the centromere. A metacentric
chromosome has its centromere located at its center. A submetacentric chromosome has its centromere off-center, creating unequal arms. And an acrocentric chromosome has its centromere very near the end, creating a minute p arm and a long q arm. C. Each chromosome can be divided into three regions, the p, or short arm, the q, or long arm,
and the centromere (the primary constriction found in each chromosome). During meiosis or mitosis, the centromere is the point at which sister chromatids are held together. Each arm is further subdivided into regions by landmarks. Landmarks are consistent features that are useful to identify a given chromosome, such as the ends of the arms, the major bands seen in a specific stained chromosomal preparation, and the centromere. The area between landmarks is called a region. Regions are numbered consecutively from the centromere, and bands (both light and dark) are numbered consecutively within a region (Figure IV-2-l).
In a Nutshell The karyotype is the chromosomal constitution of the individual. It can be visualized by staining metaphase chromosomes.
meCtical
223
Genetics
3
3
p 2 1
q
2 3
Figure IV-2-1. Chromosome structure.
1. If Figure IV-2-1 represents the 17th chromosome, then 17q2S refers to the 17th chromo-
some, the long arm, the second region, band 5. Note that a period or similar division is not used between the region and the band. 2. Table IV-2-1 summarizes common symbols used in karyotype nomenclature.
Table IV-2-1. Symbols used in designating karyotypes. 1-22
X,Y (+) or (-) rep cen die inv p
q t
rob del ins dup ter
-7
mos
224
meClical
Autosome number The sex chromosomes When placed before an autosomal number, indicates that chromosome is extra or missing Reciprocal translocation Centromere Dicentric Inversion Short arm of the chromosome Long arm of the chromosome Translocation Robertsonian translocation Deletion Insertion Duplication Terminal or end (pter = end of the short arm; qter = end of the long arm) Break (no reunion, as in a terminal deletion) Break and join Separates chromosomes when the rearrangement involves more than one chromosome From-to Mosaic
Chromosomal Abnormalities
STRUCTURAL ABERRATIONS
In a Nutshell
Structural aberrations arise from the incorrect repair of breaks in chromosomes. Such breaks can be caused by viruses, chemicals, radiation, or other events. Although all cells experience chromosome breakage, in terms of human genetics, only aberrations arising within germ cells are important. Enzymes exist that can repair the breaks, but when multiple breaks occur simultaneously, mistakes can occur. The structural aberrations that can arise are grouped into three categories: deletions, inversions, or translocations.
There are three categories of structural aberrations caused by breakage of chromosomal DNA: deletions, inversions, and translocations.
A. Deletions 1. A deletion occurs when a chromosome loses a segment because of breakage. This results in partial monosomy for the affected region. If the deletion covers a large area, the affected individual will not be viable. Deletions are divided into two major categories: terminal deletions, in which the deletion removes one of the ends of a chromosome, or interstitial deletions, in which a central portion of the chromosome is lost (Figure IV-2-2).
A
A
, tc t ,B t B
Breakage
E
D
E
Partially monosomic for C and D
+
C D Degraded
Figure IV-2-2. An interstitial deletion.
2. A deletion is indicated by del with the chromosome number in parentheses followed by what is left of the chromosome (not what is deleted); e.g., 46, XY, del(l5) (pter ~ q22:) would be a male with 46 chromosomes, of which one of the 15 chromosomes has a deletion from within q22 to the qter. 3. Diseases a. Cri-du-chat (5p-) syndrome is caused by a deletion of the short arm of the fifth chromosome. It is characterized by severe mental retardation, a cat-like cry, microcephaly, hypertelorism, epicanthal folds, low-set ears, and micrognathia. Most cases are sporadic. b. DiGeorge syndrome is a hereditary absence of the thymus and parathyroid glands associated with abnormal development of the third and fourth pharyngeal pouches. It is caused by a partial monosomy of 22q 11 and is characterized by highly variable phenotypic expression in affected individuals. Severely affected patients are immunodeficient with T-cell levels between 10 and 20% of normal. Cardiac outflow tract abnormalities, abnormal facies, and hypoparathyroidism are associated features. c. Wilms tumor is usually due to a deletion of Ilp13. It is the most common malignant urinary tract neoplasm in childhood. Two-thirds of the cases are diagnosed by age 4. Primary treatment is surgical. d. Angelman and Prader-Willi syndromes are due to a deletion of 15q ll-q 13. Although the deletions causing both syndromes are identical, the phenotypes are very different. Individuals affected with Angelman syndrome (the so-called "happy puppet" syndrome) display a peculiar affect in that they are always smiling, but lack speech and are hyperactive, hypotonic, and severely mentally retarded. The face is dysmorphic, the
In a Nutshell Angelman and Prader-Willi syndromes are caused by the same deletion. In Prader-Willi syndrome, the deletion is inherited from the father, and in Angelman syndrome it is inherited from the mother. This is called imprinting, i.e., the differential expression of genetic material depending upon the parent from which it is inherited.
meCtical
225
Genetics
children suffer trom seizures, and they often walk with an ataxic, puppet-like gait. In contrast, individuals with Prader-Willi syndrome are obese, have small feet and hands, and are short in stature with dysmorphic features. They exhibit hyperphagia and other behavioral abnormalities in addition to mental retardation. The differences between the two presentations are due the parental origin of the deleted chromosome. This differential expression of genetic material, depending upon whether the DNA was originally of maternal or paternal origin, is called imprinting. Individuals with PraderWilli syndrome inherited the deletion from their fathers. In Angelman syndrome the deletion was inherited from the patients' mothers. The differences in expression are thought to be associated with differences in DNA methylation patterns that are responsible for regulation of genes at the level of transcription.
In a Nutshell Important conditions caused by deletions include cri-duchat syndrome, DiGeorge syndrome, Wilms tumor, Angelman syndrome, and Prader-Willi syndrome.
B. Inversions are rearrangements of the gene order within a single chromosome due to the incorrect repair of two breaks. The amount of chromosomal material remains the same, but recombination within the inverted region leads to unbalanced gametes. Inversions are classified with relation to whether or not the centromere is involved. An inversion in which the centromere is located outside of the inverted region is called a paracentric inversion. An inversion in which the centromere is located within the inverted region is called a pericentric inversion. 1. Paracentric inversions a. In a paracentric inversion, both breaks are on the same side of the centromere, so the overall shape of the chromosome is unchanged. If an individual inherits one normal chromosome and one inverted homologous chromosome, he or she will be phenotypically normal. These individuals are said to be heterozygous for the inversion. Problems only arise when the individual produces germ cells. b. During meiosis, recombination or crossing over always occurs between homologues. In an individual heterozygous for a paracentric inversion, if the crossovers occur outside the loop, there will not be any problems. However, a single crossover occurring within the loop (Figure IV-2-3) leads to the formation of an acentric fragment and an anaphase bridge formed by a dicentric chromatid. Formation of this anaphase bridge leads to the failure of meiosis. The cell does not progress any further in the production of germ cells, leading to reduced fertility. The severity of the effect is a function of the size of the inversion. The larger the inversion, the greater the risk that a recombination event will occur within the loop.
In a Nutshell If a single crossover occurs within a paracentric inversion, a dicentric bridge and an acentric fragment result. This terminates meiosis.
Metaphase Meiosis I
A
Anaphase Meiosis I
A
B
B
C
E
D
D
E
C
F
F Crossover is between C and D Figure IV-2-3. Paracentric inversion.
226
meclical
Chromosomal Abnormalities
2. Pericentric inversions a. Pericentric inversions have breakpoints on either side of the centromere. This changes the shape of the chromosome and the position of the centromere. Although heterozygotes for this inversion will usually be phenotypically normal, problems arise during germ cell production. b. If a crossover event occurs within the inverted segment, the chromatids undergoing the crossover will suffer from the duplication of material from one terminus and the deletion of material from the other. As with paracentric inversions, the larger the inversion, the higher the probability of the crossover occurring within the affected region (Figure IV-2-4).
Metaphase Meiosis I A
Anaphase Meiosis I
C
In a Nutshell If a single crossover occurs within a pericentric inversion, each chromatid will have one terminus duplicated and one deleted.
B B
C
A
D
D
E
E
DE Crossover is between Band C
Figure IV-2-4. Peri centric inversion.
c. Note that in the preceding examples, the crossover event occurs between two strands. It is possible, especially if the inversion is very large, that multiple crossover events involving three or even four strands will occur.
d. An inversion is indicated by the chromosome number in parentheses followed by the two breakpoints in parentheses. 46,XX, inv(5) (p12q23) would be a female with a pericentric inversion of chromosome 5 with breakpoints at bands 5p12 and 5q23. The more detailed representation of the karyotype would be 46,XX, inv( 5) (pter ~ p 12 :: q23 ~ p12 :: q23 ~ qter). C. Translocations involve the exchange of chromosomal material between two nonhomo-
logous chromosomes. Two types of translocations exist, reciprocal translocations and Robertsonian translocations. 1. Reciprocal translocations a. Reciprocal translocations result when two nonhomologous chromosomes exchange pieces. The breakpoint of a translocation is the region at which the two different chromosomes are joined. Phenotypically, a person who is heterozygous for a reciprocal translocation will appear normal because all the information is present; it is just in a novel order. Problems arise when gametic cells undergo meiosis, because now four chromosomes share homology. Using the light microscope, a configuration called a quadrivalent can be seen (Figure IV-2-5).
meCtical
227
Genetics
2
3
4
Pairing of a Reciprocal Translocation in Meiosis I
Figure IV-2-S. A quadrivalent.
b. Unlike inversions, crossing over is not as much of an issue with translocations, because recombination either produces nonviable gametes or merely switches alleles between homologous regions. c. During meiosis I, homologous chromosomes separate. However, the centromere is the structure that the cell uses to define a chromosome, so in actuality, homologous centromeres are separating. Under normal circumstances, if homologous centromeres separate, homologous chromosomes separate. In the case of a reciprocal translocation, nonhomologous material attached to a centromere confuses the issue. The major problem is how these chromosomes will segregate from each other during meiosis I. There are three possible patterns for segregation: alternate segregation, adjacent I segregation, and adjacent II segregation. (1) In alternate segregation, homologous centromeres separate such that one cell
contains two normal nonhomologous chromosomes, and the other contains both chromosomes involved in the reciprocal translocation. (2) In adjacent I segregation, homologous centromeres separate such that each cell contains a normal chromosome and a chromosome involved in the translocation. (3) In adjacent II segregation, the breakpoint of the translocation is so close to the centromere that the cell cannot identify the centromere. To our eyes, it seems that two homologous centromeres are placed in the same cell. Figure IV-2-6 summarizes these segregation patterns.
228
iiiE;&ical
Chromosomal Abnormalities
Products of Meiosis I A Iternate S egregation
L
2
Adjacent I S egregation
~
"~"
In a Nutshell
',' heterozygote
4
Different centro meres but duplications and deletions
Adjacent \I S egregation
~
~BalanCed 3 •• translocation
4
Normal
w
~ Homologous 2 centromeres . and duplications
~ and deletions
~L :
","-
-
-,
~
-
-,
If a reciprocal translocation undergoes adjacent I or adjacent II segregation, unbalanced gametes result.
-"~
Different centromeres but duplications and deletions
L
'. .1.... . " .~. .' ..
Homologous .. centro meres an d duplications an d deletions
4
Figure IV-2-6. Segregation patterns in reciprocal translocations.
d. The amount of alternate segregation is always equal to the amount of adjacent I segregation, since to the cell, they both involve separating homologous centromeres. The amount of adjacent II segregation depends upon how far the breakpoint is located from the centromere. If the breakpoint is very far from the centromere, the cell does not become confused, and only alternate and adjacent I segregation will be observed. If the breakpoint of a translocation is located very near the centromere, the cell becomes confused as to which centromere it is sending to which pole, and a significant amount of adjacent II segregation will occur. If the breakpoint involves the centromere, all forms of segregation are equally likely. e. In chronic myelogenous leukemia (CML), which causes overproduction of cells of the granulocytic series, a characteristic chromosomal abnormality called the Philadelphia (PhI) chromosome is present in the bone marrow cells in 95% of the cases. The Philadelphia chromosome usually is due to a reciprocal translocation between the long arms of chromosome 22 and chromosome 9. The breakpoint on chromosome 9 is located at q34 and occurs near a cellular oncogene called c-abZ. The translocation causes c-ab/ to move near an area on chromosome 22 called the breakage duster region. The juxtaposition of these two sequences leads to the production of a novel protein called P2IO, a tyrosine kinase thought to playa role in triggering the proliferation of CML cells.
Bridge to Heme/Lymph For more detailed information on chronic myelogenous leukemia, refer to the HematologicjLymphoreticular Pathology chapter of Organ Systems Book 1 (Volume III).
meClical
229
Genetics
2. Robertsonian translocations a. Robertsonian translocations involve any two acrocentric chromosomes that break near the centromeres and rejoin in a way that results in fusion of the q arms at the centromeres and loss of the p arms (Figure IV-2-7). There are three ways that the chromosome involved can segregate during meiosis I, and because both breaks occur at the centromere, all three types of segregation are equally frequent. Individuals who carry the Robertsonian translocations appear phenotypically normal, but experience a large number of spontaneous abortions due to the production of monosomic and trisomic embryos, which are usually nonviable.
In a Nutshell Robertsonian translocations are caused by fusion of the long arms of two acrocentric chromosomes. These translocations are most common between chromosome 14 and chromosome 21, or chromosome 21 and chromosome 22.
21 21 14
14
14/21
Figure IV-2-7. Formation of the Robertsonian translocation.
b. Down syndrome, or trisomy 21, is usually the result of a nondisjunction event during meiosis. However, approximately 4% of Down individuals actually are affected because of a translocation between chromosomes 14 and 21 or between chromosomes 22 and 21. The theoretical risk of a translocation heterozygote producing a Down offspring is 1/3. However, because 80% of trisomy 21 fetuses are spontaneously aborted, for every Down child born, 5 normal and 5 balanced translocation heterozygotes are seen. Figure IV-2-8 shows the consequences of the segregation of a Robertsonian translocation.
230
meClical
Chromosomal Abnormalities
Pairing of the Chromosomes in Meiosis I Metaphase
Possible Products at the End of Meiosis I
mW . 00 ;00 ~u~ 21 "21 'i'.
14
14/21
·I., '·"., ji:
Possible Products at the End of Meiosis II
Zygotes
i~ i~ 14
14
j:
i; ':
14
14
21
14
21
14/21
21
~
21
~
21
il 14/21
Figure IV-2-S. Consequences of a Robertsonian translocation.
3. Nomenclature for translocations
a. When the karyotype of a reciprocal translocation is written, the two chromosomes involved are listed in parentheses after t or rcp, followed by the breakpoints also in parentheses. For example, 46,XY, t(7; 9) (q31; q22) would be a male with a balanced translocation involving exchange of the segments distal to 7q31 and 9q22. The more detailed nomenclature would be 46,XY, t(7; 9) (7pter ~ 7q31 :: 9q22 ~ 9qter; 9pter ~ 9q22 :: 7q31 ~ 7qter). Alternatively, rcp can be used in place of t to be more specific. b. A Robertsonian translocation involves the loss of the short arms of two chromosomes and the centromere of one. This results in a reduction in the total number of
meClical
231
Genetics
chromosomes. 45,XX, t(l4q; 21q) would be a female with a Robertsonian translocation, with the derivative chromosome having the long arms of 14 and 21. The origin of the centromere is not indicated. A more detailed symbolism would be 45,XX, t( 14; 21) (l4qter ~ cen ~ 21qter). Alternatively, rob can be used in place of t to be more specific.
A BRIEF REVIEW OF OOGENESIS AND SPERMATOGENESIS In males and females, the products of each meiotic division have specific names. Figures IV-2-9 and IV-2-10 summarize the key stages of oogenesis (females) and spermatogenesis (males).
Bridge to General Principl~s For a more detailed discussion of spermatogenesis and oogenesis, refer to the first Embryology chapter (Gametogenesis) in General Principles Book 2 (Volume II).
A. In females, only one true egg, which contains most of the cytosol, is produced. The unequal division of cytoplasmic material is important because the zygote receives all of the initial cellular organelles, including the mitochondria, from the mother. Because the first polar body does not enter the second meiotic division, only three products of meiosis are shown for the female.
B. In males, the sperm fertilizes the ovum during the second meiotic division. While meiosis in the female is being completed, the sperm head rounds up and forms the male pronucleus. A female pronucleus and a polar body are produced at the end of the second meiotic division. When the male and female pronuclei reach each other, they fuse and form a zygote with the diploid number of chromosomes. DNA synthesis soon commences and the cell undergoes the mitotic divisions of embryogenesis.
Oogenesis
First Prophase
First Metaphase
Second Prophase
Second Metaphase
(jj~®-~~ Primary Oocyte
Second Telophase
,;§!:-(]J5
Secondary oocyte and polar body
Ovum and two polar bodies
Ovum and two polar bodies
Figure IV-2-9. Oogenesis.
First meiotic Second meiotic division division . ~ Primary ---. Secondary ---. S t·d ~ S Spermat ogonrum spermatocyte spermatocyte perma I perm
Spermatogenesis
Figure IV-2-10. Spermatogenesis.
232
meClical
Chromosomal Abnormalities
NONDISJUNCTION A. Definitions 1. The normal gametic constitution contains the haploid or n number of chromosomes. This refers to the fact that every normal gamete contains one copy of each chromosome, and hence one copy of every gene in the genome. 2. The normal somatic constitution of the cell is referred to as the diploid or 2n number. This refers to the fact that every somatic cell contains two copies of each chromosome and hence two copies of every gene in the human genome. 3. Nondisjunction is the failure of chromosomes to disjoin from each other during cell division. It can happen during either the division steps of meiosis or during mitosis. B. Timing of nondisjunction 1. The most common time for nondisjunction to occur is during meiosis 1. The mechanisms
of failure are not well understood; however, there is a strong correlation between increasing the incidence of nondisjunction and increasing maternal age. 2. If nondisjunction occurs during mitosis in the developing embryo, some of the cells will have the normal number of chromosomes, some will lack a chromosome, and some will have an extra chromosome. The cells that lost a copy of the chromosome usually die because monosomy is not well tolerated. The cells that gained a chromosome may live, producing a situation in which individual cells in the person's body will have two different karyotypes. This condition is called mosaicism, and the person is said to be a mosaic for that chromosome. 3. Nondisjunction during meiosis I is characterized by the failure of homologous chromosomes to separate. Figure IV-2-ll illustrates a failure during meiosis 1. 4. Nondisjunction during meiosis II is characterized by the failure of sister chromatids to separate. Figure IV-2-12 illustrates failures during meiosis II. 5. If certain conditions are met, it can be reliably determined in which meiotic division and in which parent the failure occurred. For an unambiguous determination, there must be a way to determine which chromosomes came from which parent and to distinguish between a parent's homologues. This can be accomplished if a restriction fragment length polymorphism (RFLP) or a staining polymorphism exists on the chromosome of interest very near the centromere. Centro meres exercise crossover suppression, so the RFLP or staining polymorphism will be a reliable marker for that chromosome. Assume that each parent has two different forms of the polymorphism and that they do not share forms with each other. If an AB mother and a CD father produce a ABC child, then nondisjunction occurred in meiosis I of the mother. She has two different forms of the polymorphism, and since the child has both of her forms, her homologues failed to disjoin. If the child born from the cross was BCC, the failure must have occurred in meiosis II of the male. The child has two forms from the male parent and they are both of the same form, so it can be concluded that sister chromatids failed to disjoin during meiosis II.
In a Nutshell If nondisjunction occurs in meiosis I, homologues fail to separate.
In a Nutshell If nondisjunction occurs in meiosis II, sister chromatids fail to disjoin.
Note A restriction fragment length polymorphism (RFLP) is a stable, inherited variation in a DNA sequence recognized by a restriction endonuclease. Each individual has a nearly unique pattern of RFLPs within his genome.
e. Results of nondisjunction 1. The term polyploidy is used to refer to the state in which there are extra sets of chromo-
somes in the cell (e.g., a triploid = 3n, a tetraploid = 4n). Euploidy refers to the condition in which the number of chromosomes is equal to some multiple of n. Hence, diploidy and triploidy are both euploid states. 2. Rarely, both triploid and tetraploid fetuses have been reported. Several triploid live births have also been recorded, but the infants do not survive very long.
meltical
233
Genetics
Metaphase of
;;Obt;;S~II~! ~ [:8 Metaphase I
..
J
2 copies of each gene on
Me~sisl / ~ . ··:~r:~~mmOT ~ro~~ase ~~c:~ t:::::::"::'~~!~~~~ =0 ' ~ ~:I;:;;: '"
t~;~~~':p~~ ~~c~~~~~~~s ~
Homologues pair with each other at the metaphase plate. During anaphase I, homologues fail to disjoin. At the end of meiosis I, one daughter cell has both homologues, and one cell lacks that chromosome.
(
)
~
(
)
J
0 copies of each gene on ~he example chromosomes 0 copies of each gene on ( the example chromosomes During metaphase II, each chromosome lines up individually at the metaphase plate. In anaphase II, sister chromatids are pulled to opposite poles.
Gametes
Figure IV-2-11. Nondisjunction during meiosis I.
2 copies of each gene on the example chromosomes
Metaphase of
Meiosis
Metaphase I I
S, G2 proPhase.
Me~sis ~
/.
:
~
~[~ J 0 copies of each gene on
~ ~ the(examPle Chromoso)mes t~;~~~':~~ ~~~~~~~~~~s ~
dJ: .: c::::=::::y11 ~
(dJ:
I
~
4 copies of each gene on the example chromosomes
2 copies of each gene on the example chromosomes
(~~ ~ ~
~~' ....--f1 I
'---V
I
Homologues pair with each other at ~ the metaphase plate. During 2 copies of each gene on 0 copies of each gene on anaphase I, homologues are pulled to the example chromosomes the example chromosomes . ( ) different poles. At the end of meiosis I, homologues will be in different cells. Dunng metaphase II, each chromosome lines up individually at the metaphase plate. In anaphase II, Gametes sister chromatids fail to disjoin and are pulled to the same pole. One gamete ends up with both chromosomes, and one does not get a chromosome.
Figure IV-2-12. Nondisjunction during meiosis II.
234
meClical
Chromosomal Abnormalities
3. Aneuploidy is the condition in which there is either an extra chromosome or a missing chromosome (e.g., trisomy or 47 chromosomes [2n + 1] chromosomes, or monosomy or 45 chromosomes). Aneuploidy is the most common type of chromosomal disorder, occurring in approximately 0.4% of live births. The incidence of autosomal aneuploidies is directly related to increasing maternal age. 4. Polyploid and aneuploid states most commonly arise from a nondisjunction event during meiosis I or meiosis II. 5. Autosomal trisomies. Although trisomy for any chromosome is possible, only three autosomal trisomies are compatible with postnatal survival, barring mosaicism. These are Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13). a. Trisomy 21 (47,XX, +21 or 47,XY, +21) is the most common of the chromosomal disorders and is a major cause of mental retardation. Of the individuals affected with trisomy 21, 95% are caused by nondisjunction during gametogenesis, 4% have a Robertsonian translocation that usually involves chromosome 14 or chromosome 22, and 1% are mosaics due to mitotic nondisjunction during embryogenesis. (1) The phenotype of Down children is recognizable at birth because of their dysmorphic features, including epicanthal folds, brachycephaly, flat nasal bridge, low-set ears, and short, broad hands with a single transverse palmar crease. Mental retardation is a prominent feature, with SO% having IQs between 25 and 50. Approximately 40% have congenital heart disease, most of which is due to septal defects. Down children also have an IS-20-fold increased risk of developing acute leukemia, and in patients over 35, pathologic changes in the brain are seen that are similar to those seen in Alzheimer disease. (2) The incidence of live-born trisomy 21 is approximately 1ISOO. In SO% of cases, the extra chromosome is of maternal origin and is associated with increasing maternal age. When the maternal age is greater than 45 years, the occurrence is 1 in 25 births. b. Trisomy 18 (47,XX, +IS or 47,XY, +lS) occurs in approximately 1IS,000 births. It is estimated that the rate of conception is much higher, but that 95% of these fetuses spontaneously abort. Ninety percent of the cases are due to nondisjunction and 10% are due to mosaicism. Individuals with Edwards syndrome suffer from intrauterine growth retardation; mental retardation; severe failure to thrive; short sternum; small pelvis; cardiac, renal, and intestinal defects; and rocker bottom feet. Most die before 1 year of age. e. Trisomy 13 (47,XX, +13 or 47,XY, +13) occurs in approximately 1125,000 births. Ninety percent of the cases are due to nondisjunction and 10% are due to an unbalanced translocation. Individuals with Patau syndrome suffer from mental retardation, microcephaly, abnormal brain development (arrhinencephaly, holoprosencephaly), cleft lip and palate, ocular colobomas, postaxial polydactyly, cardiac dextroposition, and ventricular septal defect. The defects are so severe that survival past 6 months is very rare.
6. Sex chromosome aneuploidy a. In mammals, the presence of the Y chromosome determines maleness. Males are the heterogametic sex, having two different types of sex chromosomes (an X chromosome and a Y chromosome) in their normal state. b. Females are the homogametic sex because they have two copies of the X chromosome. If levels of an enzyme produced by a gene located on the X chromosome are measured
Clini(al Correlate Potential chromosomal abnormalities in a fetus can be identified by amniocentesis and chorionic villus sampling (O/S). Amniocentesis is usually performed between the 16th and 18th week of gestation. A small amount of amniotic fluid is removed and the cells are analyzed by standard cytogenetic techniques, fluorescence in situ hybridization (FISH), and biochemical and DNA analysis. Amniocentesis can also provide information concerning neural tube defects. The risk of complications due to amniocentesis is approximately 0.5%. Chorionic villus sampling has similar diagnostic accuracy to amniocentesis; however, it can be carried out at 9 to 12 weeks of gestation. This allows the results to be available much earlier; however, the risk of inducing a spontaneous abortion is approximately 3%. CVS does not provide information concerning neural tube defects.
Clinical Correlate Ruorescence in situ Hybridization (FISH) In this technique, a DNA probe that is labeled with fluorescent molecules will recognize and bind to its complementary sequence on a metaphase chromosome. The results can then be observed using a fluorescent microscope. FISH is used for a number of different applications including aneuploidy detection, microdeletion detection, and determining structural abnormalities.
meClical
235
Genetics
In a Nutshell Females are mosaics for genes on the X chromosome because in each of their cells, one X chromosome is randomly inactivated, whereas the genes on the other X chromosome are expressed.
in males and females, they are found to be the same. This phenomenon is explained by the Lyon hypothesis. It states that during early embryogenesis in the female, a decision is made in each somatic cell to turn off most of one of the X chromosomes. In fact, if the embryo contains more than two X chromosomes, the extra ones will be inactivated until only one X chromosome remains active in a given cell line. This X inactivation equalizes the expression of X-linked genes between males and females. The inactive X is visible under a light microscope as a chromatin mass called a Barr body. Since X inactivation is a random event in mammals, if a female is heterozygous for an X-linked recessive trait, she will usually have a normal phenotype because approximately one half of her cells will express the normal allele. c. Examples of sex chromosome aneuploidy (1) Turner syndrome (45,X and variants) is due to the complete or partial mono-
somy of the X chromosome. It is characterized by short stature, primary amenorrhea, infertility, webbed neck, shield chest and often, coarctation of aorta. The incidence is approximately 1/6,000 female births. (2) Klinefelter syndrome (47,XXY and variants) was the first human sex chromosome abnormality reported. It is characterized by hypogonadism, testicular atrophy, azoospermia, and a eunuchoid body with a lack of male secondary sexual characteristics. It occurs in approximately 112,000 male births. (3) XYY syndrome (47,XYY and variants) is not associated with an obviously abnormal phenotype. Individuals with this syndrome may be excessively tall and have severe acne. In newborn screening programs without ascertainment bias, XYY individuals were found to have normal intelligence, but an increased risk of behavioral problems. Fertility of these individuals is normal. XYY syndrome occurs in approximately 1/1,000 live male births.
236
meClical
Linkage
The pattern of inheritance of individual genes depends on their locations on the same or on different chromosomes. Nonallelic genes located in close physical proximity to each other on the same chromosome will tend to be inherited in association with one another, rather than assorting independently of each other.
SVNTENV AND LINKAGE A. If different genes are located on the same chromosome, they are said to be syntenic. B. When genes are located in close proximity to each other on the same chromosome such that they do not assort independently during meiosis, they are said to be linked. If genes are linked, the chance that they will be inherited together is a function of the distance between the loci. During the formation of chiasmata in prophase of meiosis I, genetic material is exchanged between homologues. If two loci are very far apart, there is a large chance that the crossover event will happen between them, and one allele will be moved to the other homologue. If the loci are very close, it is unlikely that an exchange will occur between them.
e. In Figure IV-3-1, an individual is heterozygous at both the A locus and the B locus. Although
In a Nutshell Genes located on the same chromosome are syntenic. Genes located in close proximity to each other are linked and tend to be passed together.
the A locus and the B locus are located on the same chromosome, the alleles of this heterozygote can be arranged in two different ways. The arrangement of the alleles at different loci relative to each other is called the linkage phase. If the A and B alleles are on one chromosome, and a and b alleles are on the other chromosome, the combination can be written in a shorthand form as AB//ab. When the dominant alleles, A and B, are on the same chromosome, they are said to be in coupling or in the cis configuration. If the A and B alleles are on different chromosomes, as in Ab//aB, they are said to be in repulsion or in the trans configuration.
a
o
b
a
b
A
B
A
B
a
g A
b
t
Xi B
a
b
a A
B b
A
B
0
Figure IV-3-1. Recombination frequency between homologues during prophase of meiosis I.
meClical
237
Genetics
RECOMBINATION FREQUENCY A. If a person is a heterozygote at both the A and B loci, and they are not linked, then the gametes of the heterozygote will contain AB, aB, Ab, and ab in equal frequency.
B. If A and B are linked in the cis conformation, AB//ab, four types of gametes are still made. However, they will not occur in equal frequency; it is more likely AB or ab will be passed because a recombination event between the loci is not required.
In a Nutshell Recombination frequency is the frequency of crossover events between two loci. The closer the two loci are, the less likely it is that a crossover event will happen between them.
C. In this example, the chromosomes with AB or ab are called parental chromosomes or nonrecombinant chromosomes because they are in the same configuration as in the parents. Chromosomes having Ab or aB are called recombinant chromosomes because they are the products of a recombination event and carry a different allelic conformation from that of the parents.
D. Recombination frequency is the frequency of crossover events between two loci. It can be determined experimentally in creatures like fruit flies in which a statistically significant number of progeny can be produced from a known cross. In this case, recombination frequency is equal to the number of recombinant progeny divided by the total number of progeny. E. Human families produce a small number of progeny, so an accurate determination of recombination frequency between two loci cannot be made by the simple formula, . . al test use d to d etermme "f I' recombinants . Th e I0 d score (Z)'1S t h e stattstlc 1 two oCt are tot al progeny linked or unlinked in the human genome. Data from lod scores are additive between different families, so the problem of small sample size is eliminated. 1. The lod score is defined as the 10glO of the odds that the loci are linked at a certain e or recombination frequency, divided by the odds that they are unlinked. In other words:
LOD = log
10
P(linked at a certain distance) P (unlinked)
2. Calculation of the lod score is beyond the scope of this chapter, but some useful generalizations can be made. By convention, if the lod score is equal to 3, then the odds of link_age are 1,000:1, and by convention the loci are considered to be linked. A lod score of-2 (100: 1 odds against linkage) is taken to be proof of independent assortment. To determine if two loci are linked and at what recombination frequency, the lod scores for all recombination frequencies between 0 and 0.5 are calculated. The highest lod value over 3 is considered to be the actual recombination frequency between the two loci. E Centimorgans are the standard units of genetic distance. The number of centimorgans can be calculated by multiplying the recombination frequency between the two genes by 100. G. If A and Bare syntenic but very far apart, a recombination frequency of 0.5 is seen. In this case, even though the genes are physically located on the same chromosome, they are not linked. Keep in mind that all linked loci are syntenic, but not all syntenic loci are linked.
GENETIC DISTANCE VERSUS PHYSICAL DISTANCE A. The genetic distance between two loci is a measure of the frequency of recombination between the loci. The physical distance between two loci is equal to the number of base pairs between the loci. It can be estimated from genetic distance using the following relationship: 1 centimorgan = 1 megabase pair (1 X 106 base pairs).
238
ii1eilical
Linkage
B. This relationship assumes that all regions of a chromosome have an equal probability of
recombination events. While this is often the case, some very important exceptions exist. 1. Centromeres exert crossover suppression. This effect causes recombination events in the region of the centromere to occur at a much, much lower frequency than expected. Because of crossover suppression, two loci located near a centromere will behave as if they were very closely linked even though they might be physically far away from each other.
2. The pseudoautosomal region (PAR), located near the p termini of both the X and Y chromosomes, allows for the homologous pairing of the X and Y chromosomes during meiosis I in males. In males, a chiasma always forms in the pseudoautosomal region during meiosis I. If the genetic distances between two markers at either end of the region are measured in males, PAR would be estimated to be 50 cM long. In females, chiasmata can form anywhere along the X chromosomes, since all of the material is homologous. The genetic distance between two markers at either end of the PAR in females is estimated to be less than 4 cM long. The genetic distance obtained from females correlates more closely with the actual physical distance of 2.6 Mbp found between markers at either end of PAR. 3. An illegitimate crossover event is one that occurs between nonhomologous material. During meiosis I in a male, if an illegitimate crossover occurs in addition to the crossover in the pseudo autosomal region, it can give rise to XX males and XY females. The gene Sry (sex-determining region Y) is located very close to the pseudoautosomal region. Its product is thought to be a transcription factor necessary for the activation of other genes in the testicular differentiation pathway. If illegitimate recombination occurs, Sry can be moved to the X chromosome and replaced with X material. XX males are infertile because they lack other genes necessary for fertility that are located on the Y chromosome; however, they are phenotypically normal except that they have small testes. These disorders occur at a frequency of approximately 1 in 20,000 births.
LINKAGE ANALYSIS FOR THE DIAGNOSIS OF GENETIC DISORDERS A. A restriction fragment length polymorphism (RFLP) is a stable, inherited variation in a DNA sequence within the human genome that produces a difference in the presence of one or more restriction sites. When the human genome is digested with a given enzyme, the great majority of restriction sites for that enzyme are the same between individuals because most of the DNA sequences are the same. Allelic differences between genes affect only transcribed DNA, which accounts for between 1 and 10% of the 3 X 10 9 base pair human genome. Also, the actual number of base pair differences between two alleles of a gene is very small. However, some restriction site differences exist for each restriction enzyme, just as alleles exist for almost every gene. Since 90% of human DNA is not transcribed, most of the differences will occur within this region. To be termed an RFLP, that fraction exhibiting the polymorphism must be 1% or more of a population. B. An RFLP can be detected using Southern blots. If there is variation in the presence of
restriction sites in a specific region of a chromosome, a probe with homology to the region will be able to detect several different patterns on a Southern blot of genomic DNA. These patterns are called haplotypes, and they can be thought of as the allele equivalent for RFLPs; however, they cannot truly be called alleles because an allele is defined as an alternate expression of a gene. Haplotypes of the RFLPs act as codominant alleles, since the genetic information from both chromosomes is cut and run on the gel. So if a person is heterozygous, two different haplotypes will be seen.
Clinical Correlate RFLP analysis can also be used to determine paternity or to compare a forensic sample of DNA from a crime scene with the DNA of possible suspects.
C. In many cases, a deleterious trait has been mapped to a chromosomal region, but the specific gene sequence has not been identified. In addition, there are very large genes that have been isolated, such as neurofibromatosis type I, in which many different mutations can KAPLA~.
meulCa
I
239
Genetics
occur that will lead to the same phenotype. In this case, it is too expensive and timeconsuming to sequence the entire region in the individuals in question. In both of these instances, linkage analysis between the gene of interest and a closely linked RFLP is the strategy of choice for tracing the inheritance of the deleterious allele. The following example shows the power of linkage analysis. 1. Huntington disease is an autosomal dominant disorder with delayed onset. The disease
affects approximately 1 in 10,000 individuals and is characterized by symptoms consisting of personality changes, memory loss, and chorea. A family presents to a clinic for genetic counseling. Individual II-I's father has Huntington disease and II-I is in the early stages of the disease. With this pedigree information, the best estimate that can be made as to whether or not his children, III-lor 1II-2, inherited the Huntington allele is 0.5. 2. An RFLP called GS is located 3 cM from the Huntington locus. It detects two polymorphic HindIlI sites. In Figure IV-3-2, the polymorphic sites are labeled HI and H2, and the invariant sites are labeled H. The accompanying table lists the haplotypes (A-D) at this locus and the expected bands on electrophoresis.
15.0 kb
2.5 kb 3.7 kb 1.2 kb
Haplotype H1 A + B + C
o
H
H2
+ +
Bands 15 kb, 3.7 kb, 2.5 kb 15 kb, 6.2 kb 17.5 kb, 3.7 kb 21.2 kb
Figure IV-3-2. Diagram of the G8 RFLP.
3. A Southern blot is made from the genomic DNA of the living members of the family and probed with probe GS. The following patterns are seen (Figure IV-3-3). The labels at the top of the gel indicate the haplotypes of individuals shown in the pedigree in Figure IV-3-4.
1-1
AB
11-1
BD
11-2
AC
111-1
BC
111-2
AD
markers 21.2 kb
-
17.5 kb 15.0 kb
-
6.2 kb 3.7 kb 2.5 kb
Figure IV-3-3. Southern blot analysis of a family with Huntington disease using the G8 probe.
4. Using the information from the Southern blot, it is possible to assign linkage phases to the members of this family. The B haplotype is linked to the Huntington allele (H) in individual II -1. Ninety-seven percent of the time, a parental chromosome will be passed to the progeny, and 3% of the time a recombinant chromosome will be passed.
240
meClical ----
----
Linkage
Key:
~II~
• • Huntington disease
DO
Normal
~II~ ~II~ Figure IV-3-4. Example of a family with Huntington disease.
5. Knowing that individual III-I has inherited the B haplotype from his father means that he has a 97% chance that the Huntington allele was still linked to it and a 3% chance that a crossover event occurred between the loci, giving him a normal allele (h) at the Huntington locus linked to the B haplotype. 6. By similar reasoning, individual III -2 has a 97% chance of inheriting a normal allele with the D haplotype and a 3% chance of inheriting the Huntington allele. D. RFLPs are due to single nucleotide changes that create or destroy a restriction endonuclease site. Another type of polymorphism that can be used to track a gene of interest is variable number tandem repeats (VNTRs). VNTRs are short repeat sequences that occur multiple times in a tandem array. The number of repeats in the sequence varies from chromosome to chromosome. If a restriction enzyme can be found that cuts outside the tandem array and there is a probe to that region, the different polymorphisms can be visualized on a Southern blot. The probe can be to a unique sequence, which is useful to follow a given loci, or can detect a sequence that is repeated multiple times in the genome. The pattern detected by a probe to a repeated sequence displays multiple bands on a Southern blot and is referred to as a "DNA fingerprint." DNA fingerprinting is often used in forensic DNA analysis and paternity disputes. E. VNTRs are generally analyzed using Southern blots because their tandem arrays can be several thousand base pairs long. A class of polymorphisms that can be easily analyzed using peR are called simple sequence repeats (SSRs). These repeats also occur in tandem, but the repeated sequence is only two to four base pairs in length. SSRs are now extensively used in linkage analysis.
KAPLAlf I meillea
241
Population Genetics
The previous chapters have stressed gene transmission and chromosome structure in individuals and their cells. To predict the fate of a gene, however, knowledge about how it functions in the population of organisms must be known. Important factors that influence the transmission of the alleles of a gene through time include the size of the population, the genotypes of individuals in the population, and factors that involve the interactions between the gene and the environment.
TERMINOLOGY A. A population is a community of sexually interbreeding individuals. Matings between individuals in a population can be random or assortative. Random mating or panmixis is the condition in which an individual in a population has an equal chance of mating with any other individual in that population. Assortative mating is nonrandom mating in which certain individuals of a population are more likely to mate with one subgroup of a population than they are to mate with another subgroup.
B. The gene pool of a population is the total of all the genes in the reproductive gametes of the population. Each gene in the gene pool can have different alleles. 1. The allele frequency is the frequency of a specific allele of a gene in a population. It is
sometimes confusingly called the gene frequency. 2. The genotypic frequency is the frequency of individuals with a specific genotype in the population. 3. The phenotypic frequency is the frequency of individuals with a specific phenotype in the population; this frequency can reflect contributions from several different genotypes. All of these frequencies can be calculated from population data. The following example illustrates these terms. In humans, the ABO blood loci have three alleles, A, B, and o. A and Bare codominant and are completely dominant to allele o. A specific population consists of 100 humans, each of whom carries two alleles. The total number of alleles in the population is 2(100) = 200.
a. The allele frequency refers to the frequency of that specific allele relative to the total alleles. In mathematical terms this would be expressed as: number of a specific allele all alleles at that locus
KAPLA~. I 243 meulca
Genetics
In our example, if 40 of the 200 alleles were A alleles, the frequency of A would be:
~=IO.21 200 b. The genotypic frequency refers to the frequency of individuals in the population having a specific genotype. In our example, if 12 individuals were found to be genotypically AB, then the genotypic frequency of AB individuals in the population would be 0.12. c. The phenotypic frequency refers to the frequency of individuals in the population that share a phenotype. Notice, this frequency might include more than one genotype. For example: Frequency of blood type A = frequency of genotype AA + frequency of genotype AO
HARDY-WEINBERG EQUILIBRIUM Hardy-Weinberg equilibrium states that under certain conditions, if the population is large and randomly mating, the genotypic frequencies of the population will remain stable from generation to generation. A. Hardy-Weinberg conditions. The conditions that must be met for a population to be in Hardy-Weinberg equilibrium all focus on keeping allele frequencies constant. 1. No mutations-the DNA of a given allele must not undergo any changes such as a sub-
stitution or deletion of base pairs that will convert it to a different allele. 2. No selection against one of the genotypes-all combinations of alleles must be equally viable. 3. No migration or immigration-no changes can be made to the population that will alter the existing allele frequencies.
In a Nutshell • The equation for allele frequency for a gene with two alleles is p + q = 1, where p is the frequency of the dominant allele and q is the frequency of the recessive allele. • The equation for genotypic frequencies for a gene with two alleles is p2 + 2pq + q2 = 1, where p2 is the frequency of homozygous dominant individuals, 2pq is the frequency of heterozygous individuals, and q2 is the frequency of homozygous recessive individuals.
4. No consanguineous or incestuous matings-matings between related individuals are prohibited because it causes autozygosity. Autozygosity describes the condition in which a person is homozygous at a locus because he receives two copies of the same allele from a common ancestor down both lines of descent. Overall, autozygosity leads to an increase in homozygosity at a locus, with a concomitant decrease in heterozygosity. 5. If these conditions are met, after one generation of random mating, the allele frequencies and genotypic frequencies will remain the same in each subsequent generation.
B. Equations. Hardy-Weinberg equilibrium can be expressed by the following equations. In a large, randomly mating population, there is a gene with two alleles, A and a. The A allele is completely dominant to the a allele. Let:
The frequency of A allele = p The frequency of a allele
=q
Then: The allele frequencies at that locus can be expressed as: p+q=l The genotypic frequencies at that locus can be expressed as: p2 + 2pq + q2 = 1 Where p2
= frequency of individuals with genotype AA
Where 2pq = frequency of individuals with genotype Aa Where q2 = frequency of individuals with genotype aa
244
meClical
Population Genetics
C. Examples of Hardy-Weinberg equilibrium
1. The equations for allele frequencies and for genotypic frequencies are related through the frequency of individuals with the homozygous recessive genotype, q2. The square root of q2 yields q, which can be used to solve for p. Note that individuals that have the dominant phenotype consist of two groups, those that are homozygous dominant (p2) and those that are heterozygous (2pq). Thus, if the frequency of an autosomal recessive disease is known in a population, it can be used to find the allele frequencies in the current generation, which can be used to solve for other variables. This is illustrated in the following example.
In a Northern European population, the incidence of cystic fibrosis, an autosomal recessive condition, is 4 in 10,000 births. What is the frequency of carriers of the disease in this population? We are told that the frequency of cystic fibrosis or q2 = 4110,000 = 0.0004. So, Vq2 = q = 0.02. Then 1- q = P 1 - 0.02 = P = 0.9S.
And finally the frequency of heterozygotes is expressed by 2pq and equals 2(0.98)(0.02) or 0.0392. 2. Males have only one copy of the X chromosome. If a gene is located on the X chromosome, the genotypic frequencies equation is different for males and females. In males, p + q = 1 is the equation that expresses both allele frequencies and genotypic frequencies. In females, the allele frequencies equation is p + q = 1, whereas the genotypic frequencies equation is p2 + 2pq + q2 = 1. Note that if the incidence of an X-linked recessive disease in males is given, this frequency is equal to q. For example: Red-green colorblindness, an X-linked recessive condition, occurs in S% of the male population. What is the frequency of female carriers of this trait?
In a Nutshell For an X-linked recessive trait, the frequency of the disease in males is equal to the frequency of the recessive allele.
q = O.OS P = 1- q = 0.92 Female carriers = 2pq = 2(0.92)(0.08) = 0.147.
3. If a gene has more than two alleles, variables are added to the allele frequency equation to equal the number of alleles. The genotypic frequency equation is then the expansion of the square of the allelic frequency equation. An example is: The ABO blood group has 3 alleles, A, Band o. A and Bare codominant to each other, and both A and B are completely dominant to allele O. Let: The frequency of A alleles = p The frequency of B alleles = q The frequency of 0 alleles = r Then:
The allele frequencies at that locus can be expressed as: p+q+r=1 The genotypic frequencies at that locus can be expressed as:
Where p2 = frequency of individuals with genotype AA KAPLAlf
- I
meillea
245
Genetics
Where 2pr = frequency of individuals with genotype AO Where q2 = frequency of individuals with genotype BB Where 2qr = frequency of individuals with genotype BO Where 2pq = frequency of individuals with genotype AB Where r2
= frequency of individuals with genotype 00
Note that: The phenotypic frequencies of type A blood = p2 + 2pr The phenotypic frequencies of type B blood = q2 + 2qr The phenotypic frequencies of type AB blood = 2pq The phenotypic frequencies of type 0 blood = r2 4. If two genotypes look the same phenotypically, and if additional information is known from the family history, the initial probabilities can be refined under certain conditions to include the new information. There are two conditions in which this needs to be done: if the gene has two alleles and q is very large (greater than 0.15), or if there are multiple alleles of the gene and in combination one phenotype can result from multiple genotypes. For example: In a certain population, the frequency of the A allele at the ABO blood locus is 0.4, the frequency of the B allele is 0.3, and the frequency of the 0 allele is 0.3. a. What is the probability that a person picked at random from the population will be typeAO? The answer would be 2pr or 0.24 because all we know is that the person is from the population. b. What is the probability that a type A person from this population would be AO? Now we know something about the person. Since the person is blood type A we know that he is either AA or AO. The P(AOIA) [i.e., genotype AO given phenotype A] would be:
_ P(AO) -
peA)
P(AO) P(AA) + P(AO) 2pr p2 + 2pr 0.24 0.16 + 0.24
= \0.6\
246
meClical
Population Genetics
LINKAGE DISEQUILIBRIUM
In a Nutshell
A. Linkage disequilibrium is the tendency of specific combinations of alleles at two different loci to be transmitted together. When it is found in a population between a deleterious trait and another locus that can be easily followed, linkage disequilibrium can be a useful tool in indirectly assessing the probability of a person inheriting the trait.
Linkage disequilibrium is the preferential association of a certain allele at one locus with a specific allele at a nearby locus more frequently than is possible by chance alone.
B. To understand linkage disequilibrium, consider the following scenario. In a certain population there exists an RFLP with two haplotypes, A and B. It is linked to the Huntington disease locus. Huntington disease (HD) itself is an autosomal dominant. Initially, there were only (A hd) gametes and (B hd) gametes. A mutation happened on an (A hd) chromosome that converted it to (A HD). Now three types of gametes exist within the population, (A hd), (A HD), and (B hd). Note that if no new mutations occur, (B HD) gametes will not be made until there can be crossover events between homologues that are (A HD) and (B hd). At this point in time, knowing that an individual is BB at the RFLP means that he will not develop Huntington disease. If instead the individual is AA or AB at the locus, his probability of developing Huntington disease is proportional to the frequency of the (A HD) chromosome within the population. Over generational time, the (B HD) chromosome will be made by recombination events. How long the linkage disequilibrium will last depends upon the recombination frequency between the two loci. If () is very small, the disequilibrium will persist for a long time. If () is very large, the disequilibrium will disappear rapidly (Figure IV-4-1). Linkage disequilibrium is most useful as a predictive tool if () is very small.
l00't"=============
8=0 8is small
% Disequilibrium
Note If linkage disequilibrium is known to exist between a deleterious allele (e.g., the Huntington disease allele) at one locus and a specific allele (or RFLP haplotype) at another locus, and if it is possible to determine the presence of the alleles at the second locus but not the first, then it is possible to calculate the probability that an individual carries the deleterious allele.
8 is large
o
t (generations)
Figure IV-4-1. Duration of linkage disequilibrium as a function of time.
KAPLA~. I meulca 247
----
---~------
SECTION V
Microbiology
-----------
Introduction
The human body plays host to a vast number of microorganisms. This brief introductory chapter describes the normal microbial flora that colonize different anatomical sites as well as the variety of factors that can confer virulence to selected microorganisms.
NORMAL MICROBIAL FLORA A. Properties. Normal microbial flora describes the population of microorganisms that usually reside in the body. The microbiological flora can be defined as either "resident flora;' a relatively fixed population that will repopulate if disturbed, or "transient flora" that are derived from the local environment. These microbes usually reside in the body without invasion and can even prevent infection by more pathogenic organisms, a phenomenon known as bacterial interference. The flora have commensal functions such as vitamin K synthesis. However, they may cause invasive disease in immunocompromised hosts or if displaced from their normal area.
Note Normal flora prevent pathogen colonization by occupying the receptor sites.
B. Location. Microbial flora differ in composition depending on their anatomical locations and
microenvironments. The distribution of normal microbial flora is summarized in Table V-I-I.
MICROBIAL VIRULENCE FACTORS Microbial virulence factors are gene products required for a microbial pathogen to establish itself in the host. These gene products are located on the bacterial chromosome or on mobile genetic elements, such as plasmids or transposons. Primary pathogens express virulence factors that allow them to cause disease in the normal host. Opportunistic pathogens are environmental organisms or normal flora that lack the means to overcome normal host defense mechanisms. They cause disease only when the normal host defenses are breached or deficient. Virulence factors can be divided into several categories.
KAP LA
!!._
I
meulC8
251
Microbiology
Table V-I-I. Major species of microbial flora found in different anatomic locations. Location
Ma;or Organisms of the Normal Flora
Skin
Propionibacterium acnes, Staphylococcus epidermidis, diphtheroids; transient colonization by Staphylococcus aureus Viridans Streptococci, Branhamella species, Prevotella melaninogenicus, Actinomyces species, Peptostreptococcus
Oral cavity
species, other anaerobes Nasopharynx
Oral organisms; transient colonization by S. pneumoniae,
Haemophilus species, N. meningitidis Stomach
Rapidly becomes sterile
Small intestine
Scant
Colon
Bacteroides species, Clostridium species, Fusobacterium species, E. coli, Proteus species, Pseudomonas aeruginosa, Enterococcus species, other bacteria and yeasts Childbearing years: Lactobacillus species, yeasts, Streptococcus species
Vagina
Prepuberty/Postmenopause: colonic and skin flora
A. Enzyme production can be of several types depending on the needs of the organism, its requirements for survival, and the local environment. 1. Hyaluronidase breaks down hyaluronic acid to aid in the digestion of tissue. 2. Protease digests proteins to enhance the spread of infections. 3. Coagulase allows coagulation of fibrinogen to clot plasma. 4. Collagenase breaks down collagen (connective tissues). B. Toxins 1. Exotoxins are heat -labile proteins with specific enzymatic activities produced by many
Gram-positive and Gram-negative organisms. Exotoxins are released extracellularly and are often the sole cause of disease. a. Some toxins have several domains with discrete biologic functions that confer maximal toxicity. An example is A-B exotoxin, where the B subunit binds to host tissue cell glycoproteins and the A subunit enzymatically attacks a susceptible target. b. Many toxins are ADP-ribosylating toxins, as outlined in Table V-I-2.
252
meclical
Introduction
Table V-1-2. Properties of ADP-ribosylating exotoxins. Toxin
Structure
Substrate
Effects
Diphtheria Pseudomonas exotoxin A
A-B
Elongation factor II
J- Protein synthesis
Adenylate cyclase regulatory protein
i
60S ribosome Synaptobrevin
J- Protein synthesis Nerve dysfunction
Cholera E. coli enterotoxin
Pertussis
Shiga (dysentery) Tetanus/botulinum
1 5
Adenylate cyclase
2. Endotoxin is the heat-stable lipopolysaccharide moiety found in the outer membrane of Gram-negative organisms. When released by cell lysis, the lipid A portion of lipopolysaccharide can induce septic shock characterized by fever, acidosis, hypotension, complement consumption, and disseminated intravascular coagulation (DIe).
c. Surface components may protect the organism from immune responses such as phagocytosis or aid in tissue invasion. For example, the polysaccharide capsules of Haemophilus inJluenzae type b and the acidic polysaccharide capsule of Streptococcus pneumoniae interfere with phagocytosis. Other surface proteins, such as adhesins or fIlamentous appendages (fImbriae, pili), are involved in adherence of invading microorganisms to cells of the host.
In a Nutshell Exotoxin
Endotoxin
Protein Lipopolysaccharide Gram+ and Gram- GramReleased extracellularly Heat labile
Part of outer membrane; not secreted Heat stabile
meClical
253
Bacteriology Overview
This chapter revievvs the essential features of bacterial structure with an emphasis on the differences between Gram-')ositive and Gram-negative organisms. Also discussed are important concepts relating to bacterial growth, metabolism, sporulation, and the methods by which bacteria transfer genetic information.
CLASSIFICAIION AND IDENTIFICATION OF BACTERIA A. General prOl~erties can differentiate prokaryotic (single-celled) organisms from higher eukaryotic organisms. The most distinguishable features include: 1. Prokaryotes have 70S ribosomes, whereas eukaryotes have 80S ribosomes. This difference
allows some classes of antibiotics to specifically target prokaryotic protein biosynthesis. 2. Prokaryotes have a naked, single, circular chromosome of double-stranded DNA that replicates bidirectionally. There is no true nucleus. Prokaryotes lack a nuclear membrane and their DNA does not have basic proteins (histones) associated with it. 3. Prokaryotes lack membrane-bound organelles such as mitochondria. 4. The cell wall of most bacteria is a unique, rigid, peptidoglycan layer that allows the characteristic Gram-positive and Gram-negative staining of bacteria. Gram stain (positive versus neg;ative) is based on biochemical retention of dyes by the cell's outermost layer; Gram-positives have a larger amount of peptidoglycan. Acid-fast staining is based on the ability to resist acid decolorization due to a high content of waxes in the cell wall. Mycobacteria species are acid fast and Nocardia species are partially acid fast.
Note
The mycoplasmas (including Ureaplasma) are the only bacteria that do not have cell walls. Chlamydia have cell walls that lack muramic acid. Both Mycoplasma and Chlamydia are therefore resistant to beta-Iactam antibiotics.
5. Flagella are responsible for bacterial motility. 6. Pili or fimbriae are used for attachment to host cells and are required for conjugation in Gram-negative bacteria. These structures convey adhesive properties to bacteria (adhesin). B. Classification of bacteria is defined arbitrarily by the biochemical characteristics and/or
phenotypic Jeatures that allow look-alike organisms to be differentiated from each other. The genus and species of an isolate can be determined by morphology and Gram stain, and by biochemical and nutritional traits. Some specific examples include: 1. Biochemical characteristics such as substrate specificity (e.g., B. pertussis grows specifi-
cally on Bordet-Gengou agar), the ability to ferment specific sugars (e.g., E. coli is a lactose fermentor), and the production of unique metabolic products (e.g., Mycobacterium tuberculosis produces niacin). 2. Serologic reactivity-the identification with specific antibodies in diagnostic immunoassays. 3. Bacteriophage typing is useful epidemiologically in tracing the source of epidemics. 4. Animal p:ilthogenicity 5. Antibiotk sensitivity
KAPLAlf I medlea
255
Microbiology
BACTERIAL STRUCTURE A. The cell envelope is defined as all layers that enclose the cytosol of a bacterium. It is the main structural feature that differentiates Gram-positive from Gram-negative bacteria. Grampositive bacteria have a finely patterned surface consisting of the cytoplasmic membrane, peptidoglycan layer, and sometimes, an outer capsule. Gram-negative bacteria have a complex cell envelope consisting of a cytoplasmic membrane (inner membrane), periplasmic space containing peptidoglycan, an outer membrane, and sometimes, a capsule. 1. Capsule production is usually correlated with virulence because capsules are antiphago-
cytic. Most capsules are carbohydrate in nature. 2. The bacterial cell wall is a structure unique to prokaryotes and is a major site of antibiotic attack (e.g., penicillin blocks peptidoglycan synthesis).
Table V-2-1. Bacteria by Gram-staining characteristic and shape. Gram-Negative Bacteria Cocci
Moraxella, Neisseria, Veillonella Coccobacilli or rods Bacteroides, Bartonella, Bordetella, Brucella, Burkholderia, Capnocytophaga, Citrobacter, Coxiella, Edwardsiella, Enterobacter, Escherichia, Francisella, Fusobacterium, Haemophilus, Hafnia, Klebsiella, Legionella, Mobiluncus, Moraxella, Morganella, Pan toea, Pasteurella, Porphyromonas, Prevotella, Proteus, Providencia, Pseudomonas, Rickettsia, Salmonella, Serratia, Shigella, Stenotrophomonas, Streptobacillus, Yersinia Spirochetes Borrelia, Leptospira, Spirillum, Treponema Vibrios Aeromonas, Campylobacter, Helicobacter, Plesiomonas, Vibrio Other
Chlamydia, Ehrlichia Gram-Positive Bacteria Cocci
Enterococcus, Gemella, Peptostreptococcus, Staphylococcus, Streptococcus Coccobacilli or rods Actinomadura, Actinomyces, Arcanobacterium, Bacillus, Bifidobacterium, Clostridium, Corynebacterium, Erysipelothrix, Eubacterium, Lactobacillus, Listeria, Mycobacterium, Nocardia, Propionibacterium, Streptomyces, Tropheryma Bacteria Resistant to Gram Stain Mycoplasma, Ureaplasma
256
meClical
Bacteriology Overview
a. Gram-positive bacteria are composed of a thick layer of peptidoglycan, lipoteichoic acids, polysaccharides, and sometimes, teichoic acid. The surface proteins bind to extracellular material. b. Gram-negative bacteria have a trilayered outer membrane anchored to the cell membrane by lipoprotein. Endotoxin (lipopolysaccharide, somatic 0 antigen, and core polysaccharide) in the outer membrane is unique to Gram-negative bacteria. Protein porin channels allow the flow of extracellular material through the cell's outer membrane. 3. The periplasm is the space between the plasma membrane and the outer membrane. It contains proteins, peptidoglycan, hydrolytic enzymes, and plasmid-controlled penicillinases. The periplasmic space is important in osmoregulation of the cell. B. Plasma (cell) membrane functions primarily as an osmotic barrier. Its composition is 60-70% protein, 30-40% lipid, and small amounts of carbohydrate. If present, the bacterial electron transport chain is located within the cytoplasmic membrane. Structures associated with the plasma membrane are membrane polyribosome-DNA aggregates and mesosomes. Mesosomes are convoluted structures of cell membrane important in cell division. C. Cytoplasmic structures 1. The nucleoid region of bacteria consists of a circular chromosome of double-stranded
DNA that lacks introns, histones, and a nuclear membrane. In contrast, eukaryotic nuclei contain all of the above. 2. Ribosomes consist of 70% RNA and 30% protein. 70S ribosomes (monomers) are attached to messenger RNA. The 70S complex can be broken down into subunits of 30S and 50S. 3. Polyamines (e.g., putrescine) are located mainly in ribosomes and serve to prevent dissociation of the 70S ribosome. 4. Cytoplasmic granules function to accumulate food reserves such as glycogen, lipids in the form of poly-~-hydroxybutyrate, and phosphate in the form of volutin granules. 5. Spores (endospores) are found in Bacillus and Clostridium species. Spores promote the survival of the organism under adverse environmental conditions since they resist heat and drying. Spores are highly dehydrated and refractile. They convert into vegetative cells via germination when conditions of the environment are more favorable. Tables V-2-1 through V-2-4 summarize the important features of bacterial structure and the key differences between Gram-positive and Gram-negative organisms.
In a Nutshell Gram-Positives
• Thick peptidoglycan cell wall overlays cell membrane • No outer membrane • Cell wall contains lipoteichoic acids and some have teichoic acid (virulence factor) Gram-Negatives
• Thin peptidoglycan cell wall overlays cell membrane • Also have an outer membrane • Space between cell membrane and outer membrane includes peptidoglycan and is called the periplasmic space • Lipoprotein in the periplasmic space connects the outer membrane to the cell membrane • Lipopolysaccharide (LPS) is a component of the outer membrane: Lipid A = toxic portion
Clinical Correlate Autoclaving is employed to ensure that spores are killed.
I KAPLAlf medlea 257
Microbiology
Table V-2-2. Features common to all prokaryotes.
• Nucleoid-single, circular, ds DNA chromosome; not called a nucleus because it lacks a membrane • No sterols in membrane (exception: Mycoplasma) • 70S ribosomes • No membrane-bound organelles • Rigid cell wall of peptidoglycan (Note: cell envelope = all layers that encircle and retain cytoplasmic contents; cell wall = peptidoglycan [PDG]) N-acetylglucosamine N-acetylmuramic acid with tetrapeptide in a BOA) linkage (lysozyme breaks this linkage) D and L alternating amino acids, tetrapeptide cross-bridges linked by transpeptidase (All of the above contribute to PDG strength) Function-shape, barrier, sieve, prevents lysis (bacteria are subjected to 2-5x the pressure that tissues face) • Amino acids found in peptidoglycan - D-glutamic acid D-alanine -
L-alanine (primarily Gram-negatives) Diaminopimelic acid
- L-Iysine (primarily Gram-positives) • Cytoplasmic membrane Structure-normal membrane - Function-osmotic barrier; active transport of nutrients via permeases; DNA attachment site for nucleoid and plasmids; iron uptake via siderophores; protein export, since Golgi and ER are lacking; site of electron transport chain, since mitochondria are lacking • Mesosome - Structure-membrane invagination-more prominant in Gram-positive (some say only in Gram-positive) • • • •
258
meClical
Function-site of DNA replication, cell division Introns absent Transcription directly coupled to translation Polygenic mRNAs Initiator tRNA is formyl methionyl-tRNA instead of methionyl-tRNA
Baderiology Overview
Table V-2-3. Features found in some prokaryotes. • Unique metabolic capacities - Obligate anaerobes -
FixN2
• Capsule - Structure-acidic polysaccharides of 2-3 sugars characteristic of the organism - Function-antiphagocytic • Flagella Structure-single proteinaceous helical filament of globular protein flagellin. Adds at the tip. 3 parts: basal body (anchored in cell membrane), filament, and hook. Counterclockwise rotation = coordinated movement toward a substance. Clockwise rotation = disorganized tumble away from a source. Function-locomotion, chemotaxis Two variations: Peritrichous-all over, e.g., Enterobacteriacae Polar-at one end, e.g., Pseudomonas Other polar nomenclature: lophotrichous-tuft of several flagella; amphitrichousboth poles have flagella • Glycocalyx structure - Structure-adhesive polymer film containing polysaccharides - Function-inhibits phagocytosis and antibody access/adhesion • Storage granules Poly ~ hydroxybutarate = lipid - Glycogen = starch - Polymetaphosphate (volutin)-phosphate • Electron transport chains are located in the cytoplasmic membrane • Spores or endospores (in some medically important Gram-positives) Cryptobiotic = dormant, no metabolic activity. Resistant to heat, dessication, freezing, etc. The inner membrane is also called the germ cell membrane. Cortex-Unique peptidoglycan in 2 layers: outer layer has few cross-links, rapid autolysis; inner layer has more cross-links and osmotic stability. Coat-Keratin-like protein layers with many cross-linking disulfide bonds Germ cell membrane Core-Dipicolinic acid, Ca2 +, chromosome, protein, and materials for resuming growth exist here
Coat has 80% of protein Coat proteins can't be solublized unless the disulfide groups are reduced-this cross-linked layer is responsible for the resistance of spores to chemicals. Ca2+ and dipicolinic acid are chelated in equal amounts in the core-helps keep the water content down by displacing water when intercalation occurs with the DNA. Seen in aerobic Bacillus and anaerobic Clostridium species KAPLAIf . ._ I me lea 259
Microbiology
Table V-2-4. Features found in Gram-positive and Gram-negative bacteria. i
260
Gram-Positive
Gram-Negative
• Cell envelope: - PDG 100-800 A - Plasma (cytoplasmic) membrane • Lipoteichoic acid: - Structure-glycerol or ribitol residues with phosphodiester links and substitutions anchored to glycolipid in membrane (so it goes all the way through the PDG) - Function-anchoring and adhesion • Proteins excreted outside cell
• Cell envelope: Outer membrane-60-180 A-sieve - PDG 20-30 A - Plasma membrane • Periplasmic space-contains PDG, enzymes, PBP, binding proteins that soak up sugars and amino acids, etc. • Membrane-derived oligosaccharide (MDO): Structure-glucan polymer secreted into periplasmic space - Function-regulates osmolality of periplasmic space - adjusts viscosity to avoid lysis • Lipopolysaccharide (endotoxin): - Structure and functions-Lipid A, which is responsible for endotoxin manifestations (hypotension and DIC), and a long oligosaccharide side chain that is group-specific and hydrophilic (this helps to exclude hydrophobic compounds) • Porins: - Structure-protein trimer bound noncovalently to PDG - Function-restricts entry of >800 MW molecules • Adhesins and/or evasins-Function: an adhesin is a gene product promoting attachment and colonization. An evasin is a gene product promoting evasion of host defenses. • Lipoprotein: - Function-covalently anchors outer membrane onto PDG; also loosely linked to LPS • Fimbriae or pili: - Structure-filament of pilin, helical arrangement, addition at base Sex pili: - Genetic exchange (plasmiddetermined) - Only see a few per cell (3-4) Common pili or fimbriae: - Adhere to host cells - Several 100 per cell - Almost all Gram-negatives have them; some Gram-positives as well Can also act as evasins or aggresins
mallical --~-----
Bacteriology Overview
BACTERIAL GROWTH How rapidly an infection can progress before host defenses respond can determine the severity of disease. In a closed system, growth is dependent upon the availability of nutrients, the external environment (e.g., temperature), and the growth rate of the specific species. Figure V-2-1 depicts a typical bacterial growth curve.
c d
b
a FigureV-2-1. Growth curve in a closed system. a =lag phase; b =exponential or log phase; c =stationary phase; d =phase of decline (death phase).
A. Bacterial growth in a dosed system 1. The lag phase is a period of no growth when the organisms are adapting to a new envi-
ronment. 2. The exponential or log phase describes the steady state of growth, typically at the organism's fastest rate. It continues until the nutrients are depleted or toxic waste products accumulate. Many antibiotics, especially those that target cell wall synthesis, are maximally effective during this phase. 3. The stationary phase occurs when nutrients are exhausted or toxins accumulate. Cell number is stable (cell loss = cell formation). Different outcomes can occur depending on the species of bacteria. Some bacteria stop growing, but remain viable for long periods of time. Some organisms cannot maintain a viable, nongrowing state. When they reach the stationary phase, they immediatedly start to die. Other organisms, if conditions do not improve, start forming spores. 4. The phase of decline is observed when the death rate increases, due to cell starvation or sensitivity to toxins.
SURVIVAL IN OXYGEN Survival in oxygen is an important parameter used to classify bacteria. All bacteria produce the superoxide ion (° 2-) in the presence of oxygen. Three enzymes are important to detoxify this ion. Superoxide dismutase converts the superoxide ion to hydrogen peroxide. Catalase or peroxidase then metabolizes the hydrogen peroxide to water and oxygen. Obligate anaerobes (strict anaerobes) lack these enzymes or have such low levels that an oxygen environment is toxic for them. Examples of obligate anaerobes are Clostridium and Bacteroides. Facultative organisms grow with or without oxygen. Whether they ferment or respire is an independent issue.
In a Nutshell The ABCs of Anaerobes
• Actinomyces • Bacteroides • Clostridium
KAPLA~.
meulCa
I
261
Microbiology
ENERGY PRODUCTION Energy production requires a source of carbon. Some bacteria are very versatile, requiring only a few essential nutrients. Many pathogenic bacteria have become so host adapted that they have lost much of their metabolic machinery. They have many additional requirements and are termed fastidious bacteria. A. Siderophores are iron (Fe 3+)-chelating compounds that are essential for growth of many pathogenic bacteria. The siderophore is a low-molecular weight material such as a catechol that is excreted from the cell. This molecule binds iron and is then bound to a cell wall or outer membrane protein and transported into the cytosol of the cell, where it is utilized in energy metabolism. B. Mechanisms of energy production 1. Fermentation is the anaerobic degradation of glucose to obtain ATP.
a. It is much less efficient than respiration for generating energy. It can be used by both obligate anaerobes and facultative organisms. End products of fermentation differ depending upon the organism and are often useful in identification. b. Most obligate anaerobes and all Streptococcus species use fermentation. Streptococcus species can only ferment because they cannot make cytochromes or catalase. However, they do have superoxide dismutase and peroxidase, so they can survive in an oxygen environment. 2. Respiration completely oxidizes organic fuels and requires an electron transport chain to drive the synthesis of ATP. a. Respiration produces almost 20 times as much ATP as fermentation. It requires a terminal electron acceptor. The usual electron acceptor is oxygen; however, alternate electron acceptors, such as nitrate and fumarate, are used by some organisms. b. Given a choice, bacteria will opt for respiration over fermentation. However, bacteria differ in their intrinsic ability to use fermentation or respiration. (1) Strict or obligate aerobes respire only and must use oxygen as a terminal electron
acceptor. Mycobacterium tuberculosis is a good example of an obligate aerobe. (2) Some bacteria ferment only. (3) The majority of bacteria use the most versatile strategy, fermentation or respiration, depending upon the conditions. Figure V-2-2 summarizes this information.
262
iileilical
Baderiology Overview
....-_ _ _ _ _---,NO Obligate Can the organism aerobes; grow without Facultative oxygen? \
Obligate aerobe -respires only (Mycobacterium tuberculosis) Ferments only (Streptococcus; no cytochromes = no catalase)
'---------'YE~ Facultative
How does the organism get ATP?
(E. coli, Strep species, Pseudomonas aeruginosa )
YES
Obligate anaerobes The enzymes for processing the superoxide ion are absent or minimal. Need superoxide dismutase, catalase, and peroxidases to detoxify the superoxide ion.
~
Ferments or respires with oxygen as terminal electron acceptor (E. coli)
Ferments only ( Clostridium species)
How does the organism get ATP? Ferments and possesses a primitive respiratory chain (uses something other than oxygen as a terminal electron acceptor, e.g., fumarate in Bacteroides fragilis)
Figure V-2-2. Bacterial survival in oxygen and methods of ATP production.
SPORULATION A. A spore is a dormant structure capable of surviving prolonged periods of unfavorable envi-
ronmental forces. Spores are capable of re-establishing the vegetative stage of growth when environmental factors become more favorable. Spores are resistant to radiation, drying, and disinfectants. Thermal resistance to denaturation is due to the high content of calcium and dipicolinic acid in the core. Spore formation is observed in Bacillus and Clostridium species.
B. Initiation of sporulation is related to the guanosine triphosphate pooL Regulation is by means of negative feedback. In addition, the availability of carbon and nitrogen sources are important to sporulation activity. C. Germination and outgrowth occurs when environmental and nutritional factors allow for
renewed cell growth. 1. Vegetative growth is triggered by the exposure to stimulants such as glucose, nucleic acids, and amino acids. 2. Activation of autolysin results in autolysis of the cortex. The synthesis of protein and structural components follows. The spore core membrane develops into the cell wall.
meClical
263
Microbiology
GENETIC TRANSFER Genetic transfer refers to three principal mechanisms that result in the movement of genetic material into a host organism. A. Transformation is the uptake and integration of naked DNA from the environment. 1. Once inside the cell, homologous recombination with the chromosome of the recipient
must occur for the transformation to be successful. 2. Transformation can be induced in the laboratory with salt and heat shock. This technique is used to make cells take up plasmids carrying genes of interest (competency). 3. There are natural transformers among both the Gram-positive and Gram-negative bacteria. The medically important natural tranformers are: Streptococcus species, Haemophilus species, Neisseria gonorrhea, and Helicobacter pylori.
B. Transduction is the phage-mediated transfer of bacterial DNA. There are two kinds of transduction: generalized transduction and specialized transduction.
Note
1. In generalized transduction, bacterial DNA is mistakenly packaged into an empty phage
The gene for diphtheria toxin is carried on a lysogenic bacteriophage.
head. This is a very low frequency event, but any gene can be transferred. Once inside the recipient cell, homologous recombination must occur for the transduction of information to be successful. 2. During specialized transduction, a lysogenic bacteriophage that is integrated into the bacterial chromsome excises itself, accidentally taking some chromosomal DNA. When the phage replicates, any bacterial gene that it has picked up is also replicated. These genes will be carried into cells that the progeny viruses infect. Specialized transduction occurs at a higher frequency that generalized transduction. C. Conjugation is the direct transfer of bacterial DNA between organisms. It requires cell-to-
In a Nutshell • Transformation ~ Uptake and integration of naked DNA fragments • Transduction ~ Phagemediated exchange of information • Conjugation ~ Direct bacteria to bacteria transfer of DNA (bacterial sex)
cell contact. It is the most important mechanism for widespread transfer of genetic information between bacteria. 1. Most conjugation is plasmid-mediated. A plasmid is an extrachromosomal piece of cir-
cular DNA that can replicate itself. It often carries genes such as those that encode resistance to antibiotics, and virulence factors such as enterotoxins or adhesins. Plasmids vary in size, copy number per cell, and host range. 2. If a plasmid can exist only within a single species, it is called a narrow-host-rangeplasmid. If it can transfer between different genera of organisms, it is called a broad-host-range plasmid. 3. All plasmids can replicate themselves within the appropriate host, but not all plasmids can transfer themselves. a. A conjugative plasmid codes for the genes involved in transfer between cells. b. A nonconjugative, or mobilizable, plasmid requires the help of a conjugative plasmid to transmit itself to another bacteria. D. Insertion sequences are small (1,000 bp) pieces of DNA that code for the enzyme transpo sase, which allows them to jump into and out of DNA. 1. A transposon consists of two insertion sequences flanking another gene or set of genes.
2. Transposons and insertion sequences can insert into target DNA without significant homology at the site of insertion.
264
m8Ctical
--------
- - -
Bacteriology Overview
3. This ability to move between chromosomes, plasmids, or bacteriophages is an efficient mechanism for moving genes through a bacterial population. In fact, transposons are frequently associated with the formation of multiple-drug resistance plasmids.
DIFFUSION ACROSS BACTERIAL CELL MEMBRANES Clearly, bacteria must transport a number of macromolecules across the cell wall for survival. Larger ions and macromolecules diffuse slowly unless transported across the membrane by one of three mechanisms: facilitated diffusion, active transport, or group translocation. A. Facilitated diffusion Substrates that cross the membrane without the use of energy. Substrates bind to carrier proteins in the membrane whose affinity is equal both outside and inside the cell, allowing transport in both directions. Glycerol is transported into E. coli by this method and ATP may be brought into Rickettsia by this method. B. Active transport
Similar to facilitated diffusion except that energy is required. This allows substrates to be transported against a concentration gradient. Sugars, amino acids, and ions are transported by this mechanism. This mechanism utilizes ATP-binding cassette transport proteins. C. Group translocation
This mechanism does not expend energy to transport, but instead modifies the substrate to be transported (i.e., via phosphorylation of the substrate). Mannitol, mannose, and glucose are examples of substrates transported by this mechanism.
KAPLAlf I medlea 265
Bacteriology: Gram-Positive Cocci There are two medically important genera of Gram-positive cocci-staphylococci and streptococci. Both are nonmotile and do not form spores. Staphylococci are catalase positive, whereas streptococci are catalase negative.
STAPHYLOCOCCUS A. Genus characteristics and classification 1. Staphylococci are Gram-positive cocci that divide perpendicular to the last plane of divi-
sion, forming clumps or clusters. Depending on the age of the culture, they can be observed singly, in pairs, in short chains, or in grape-like clusters. 2. They are hardy organisms because they are relatively resistant to heat and drying. 3. Metabolically, the staphylococci are facultative aerobes and possess both superoxide dismutase and catalase. 4. Clinically, the most important distinction is between S. aureus and all other species that are nonpathogenic members of the normal flora. The coagulase test is a simple way to differentiate S. au reus from the coagulase-negative staphylococci. 5. Although there are six species of coagulase-negative staphylococci, the most numerous species on the skin is Staphylococcus epidermidis. The other coagulase-negative species of clinical relevance is S. saprophyticus. B. Staphylococcus aureus is a common infectious agent of humans and tends to cause localized or toxin-mediated disease. transiently colonizes the nasopharynx, skin, and vagina of up to 30% of the population.
1. Staphylococcus aureus
2. Table V-3-1 summarizes the conditions commonly caused by S. aureus.
I KAPLAlf medlea
267
Microbiology
Table V-3-1. Common conditions caused by Staphylococcus aureus. Direct infection Skin: Folliculitis, furuncles, carbuncles, abscesses, cellulitis, wound infection Deep infection: Osteomyelitis (often post-trauma and/or surgery) Systemic infections secondary to above Osteomyelitis, endocarditis, lung abscesses, pneumonia Toxin-mediated disease Food poisoning, scalded skin syndrome, bullous impetigo, toxic shock syndrome
3. Staphylococcus aureus does not produce a single factor that is necessary for virulence. The best host defense against infections are PMNs. No protective immune response is raised, so one can get infections again and again. Table V-3-2Iists the multiple virulence factors of s. aureus. 4. Treatment. The drug of choice is a penicillinase-resistant penicillin (e.g., methicillin, nafcillin, or oxacillin) or a first generation cephalosporin. Methicillin-resistant s. aureus (MRSA) requires therapy with vancomycin.
Note Unfortunately, there are now vancomycin-resistant MRSA.
C. Staphylococcus epidermidis is most commonly a nosocomial pathogen. In contrast to aureus, it is coagulase negative.
s.
1. The major virulence factor it produces is a viscous exopolysaccharide biofilm (slime).
2. When foreign bodies like IVs, catheters, and prosthetic valves are inserted into the host, Staphylococcus epidermidis can grow on their surface, embedded in the biofilm. This biofilm makes it difficult for the immune system to destroy the organism. 3. Clinical manifestations are typically related to instrumentation and procedures and include endocarditis and urinary tract infections. 4. Treatment is with vancomycin. D. Staphylococcus saprophyticus
1. Coagulase negative
2. Differentiated from S. epidermidis by its resistance to novobiocin. 3. Causes urinary tract infections in newly sexually active women. 4. Treatment is with penicillin. Table V-3-2. Major virulence factors of Staphylococcus aureus. I. Binding proteins and capsules 1. Protein A: • Binds IgG by the Fc portion-IgG can't react with the Fc receptor on phagocytes 2. Fibronectin, fibrinogen, vitronectin, and collagen type II binding proteins: • Localization and adherence through binding to body proteins 3. Capsule: • Carbohydrate • Prevents phagocytosis but most adults have opsonizing antibodies
268
meclical
(Continued)
Bacteriology: Gram-Positive Cocci
Table V-3-2. Major virulence factors of Staphylococcus aureus (cont'd). II. Enzymes 1. Coagulase: Exists in a bound form and a free form • Stimulates the conversion of fibrinogen to fibrin by binding coagulase-reacting factor (CRF), a derivative of prothrombin. This complex becomes active and initiates fibrin polymerization. • Coated with fibrin, staph are resistant to phagocytosis; the fibrin deposition in an area helps localize the infection 2. DNAse: • Production highly correlated with coagulase 3. Staphylokinase: • Clot dissolution, activates conversion of plasminogen to fibrinolytic plasmin 4. Hyaluronidase: • Hydrolyzes hyaluronic acids that are present in the extracellular matrix of connective tissue 5. Lipase: • Production associated with boils II. Exotoxins 1. Hemolysins-(alpha through delta): Alpha hemolysin or Alpha toxin • Most potent of hemolysins • Dermonecrotic and lethal when injected into rabbits • Causes membrane damage that lyses red blood cells and kills white blood cells by forming pores in eukaryotic membranes ~-hemolysin:
• A sphingomyelinase made by ",,20% of isolates 2. Leukocidin: • Lethal to PMNs, disrupts their membranes through pore formation 3. Epidermolytic toxin or exfoliatin: • Cleaves stratum granulosum layer per splitting desmosomes-no inflammatory response • Scalded skin syndrome in newborns, bullous impetigo in older kids and adults • Toxin is antigenic-circulating antibody confers immunity 4. Toxic shock syndrome toxin (TSST-1): • Symptoms = fever, desquamative skin rash, vomiting, diarrhea, hypotension, multiple system involvement • Induces production of interleukin 1 and tumor necrosis factor by macrophages • Antibody associated with resistance to shock 5. Enterotoxin: • Food poisoning • Types A through E • Heat stable • 1-6 hours post-ingestion; symptoms = increased intestinal peristalis, vomiting, diarrhea, no fever, rapid recovery • Toxin appears to act on neural receptors in UGI tract ~ stimulation of vomiting center • Pyrogenic exotoxins include TSST and the enterotoxins; they are super antigens (like streptococcal pyrogenic exotoxin A or erythrogenic toxin) and cause T-cell proliferation and release of toxic cytokines such as IL-1 and TNF (Continued)
meClical
269
Microbiology
Table V-3-2. Major virulence factors of Staphylococcus aureus (cont'd). IV. Resistance to penicillin and other ~-lactam antibiotics 1. (3-Lactamase production • Most often plasmid-encoded (few strains are chromosomal) 2. Intrinsic resistance-(aka methicillin resistance) • Chromosomal • Caused by a mutation in a penicillin-binding protein
Table V-3-3. Identification of Staphylococcus aureus versus Staphylococcus epidermidis. Staphylococcus aureus Coagulase Thermostable nuclease Mannitol fermentation Ribitol teichoic acid Glycerol teichoic acid
Staphylococcus epidermidis
+ + + +
+
STREPTOCOCCUS A. Genus characteristics 1. Streptococci are Gram-positive cocci that form chains.
2. Metabolically, the streptococci are facultative anaerobes because they derive energy from fermentation only (lack cytochromes). a. The principal end product of fermentation is lactic acid, and perhaps because of this they are more acid-tolerant than most bacteria. b. Although streptococci can live in conditions where oxygen is present, they lack catalase. Catalase is a cytochrome-containing enzyme that degrades hydrogen peroxide to oxygen and water. This feature is useful for differentiating the streptococci from other Gram-positive cocci such as the staphylococci. c. Almost all medically important streptococci are auxotrophs, meaning they require
one or more vitamins, amino acids, or nucleic acids for growth and therefore are not free-living in the environment.
B. Classification. The most common classification scheme for the streptococci is based upon their reaction in blood agar. 1. a-Hemolysis-the red blood cells surrounding the colonies are intact, but there is partial breakdown of the heme, resulting in a green (viridans) pigment.
2.
~-Hemolysis-the red blood cells surrounding the colonies are completely lysed. Betahemolytic streptococci are also classified serologically into Lancefield groups (A-O) based on their cell wall carbohydrate. Clinically, the most important group is Group A.
3. y-Hemolysis-no hemolysis or color change of the red blood cells is detected.
270
meClical
- -
-------------------------
------------------
Bacteriology: Gram-Positive Cocci
TableV-3-4 Species
Classification
Common Location
Associated Diseases
Streptococcus agalactiae*
Group B
Gastrointestinal tract, vagina, some animal sources, such as raw milk
Early-onset and delayed -onset neonatal disease (meningitis, respiratory distress, sepsis), puerperal sepsis, pharyngitis
Streptococcus bovis
Group D; a-hemolytic or nonhemolytic
Gastrointestinal tract
Endocarditis in patients with gastrointestinal tumors
Streptococcus dysgalactia and Streptococcus equi
Groups C and G; j3-hemolytic
Skin, mucosae
Pharyngitis, erysipelas, impetigo, neonatal meningitis, endocarditis, septic arthritis, wound infections
Streptococcus intermedius group
Groups A, C, F, and G; variable hemolysis
Mouth, gastrointestinal tract, vagina
Sinusitis, endocarditis, brain and liver abscesses
Streptococcus mitis, Streptococcus salivarius, and Streptococcus sanguis
Wide variety of Lancefield antigens; viridans streptococci; a-hemolytic
Mouth
Endocarditis
Streptococcus mutans
No Lancefield antigens; viridans streptococci; a-hemolytic
Mouth
Dental caries, endocarditis
Streptococcus pneumoniae*
No Lancefield antigens; a-hemolytic
Upper respiratory tract of 5-70% of general population
Pneumonia, meningitis, otitis media, sinusitis, conjunctivitis
Streptococcus pyogenes*
Group A;
Upper respiratory tract of 5-20% of general population
Pharyngitis, scarlet fever, pyoderma, erysipelas, necrotizing fasciitis, toxic streptococcal syndrome, rheumatic fever, heart disease, glomerulonephritis
Enterococcus faecalis*
Group D; variable hemolysis
Gastrointestinal tract, oral cavity, gallbladder, urethra, vagina
Endocarditis, bacteremia, urinary tract infections, abdominal infections, neonatal sepsis, soft tissue infections
Enterococcus faecium*
Group D; a-hemolytic or nonhemolytic
Gastrointestinal tract
Neonatal meningitis
*Boards' favorites.
~-hemolytic
~-hemolytic
KAPLA,..leaI me
271
Microbiology
c. (J.-Hemolytic streptococci can be distinguished from each other by their inhibition or growth in the presence of optochin or bile. This group includes Streptococcus pneumoniae and the viridans streptococci. 1. Streptococcus pneumoniae, also known as pneumococci, grows in pairs or short chains. a. It is lysed by optochin or bile and is the most autolytic of bacterial pathogens. At stationary phase, an autolytic enzyme, muramidase, is activated and destroys the bacteria.
In a Nutshell
b. It is a natural transformer since it can take up pieces of DNA from the surroundings and if there is sufficient homology, incorporate it into its genome.
S. pneumoniae • Alpha hemolytic; inhibited by optochin and bile
c. Transmission. Streptococcus pneumoniae is spread person-to-person through aerosol droplets. Twenty to 40% of normals are transiently colonized in their nasopharynx.
• Virulence conferred by polysaccharide capsule
d. Clinical manifestations. It is the most common cause of bacterial pneumonia and also causes otitis media, sinusitis, bronchitis, and bacteremia. It is the most common cause of meningitis in the elderly.
• Clinical correlations: - Pneumonia (#1 cause, especially middle-aged and older adults)
e. Risk factors for infection due to Streptococcus pneumoniae include poverty, a debilitated state of health, the absence of a spleen, and certain diseases such as sickle cell anemia, Hodgkin disease, multiple myeloma, and AIDS.
- Otitis media (#1 cause)
f. The most important virulence factor of Streptococcus pneumoniae is its carbohydrate capsule. Although there are more than 85 capsule types, 23 types cause the most virulence (85%). The capsule is thought to interfere with the opsonizing activity of the alternative complement pathway. Antibody against the capsule is necessary so C3b can attach without being buried.
- Sinusitis - Meningitis (#1 cause in elderly)
g. Prevention. A vaccine of 23 of the polysaccharide antigens exists. It should be given to the elderly, those undergoing splenectomy, and those with a condition predisposing them to Streptococcus pneumoniae disease. A vaccine of 7 of the polysaccharide antigens is administered to infants at 2, 4, 6, and 12-18 months as recommended by the CDC.
- Bacteremia • Certain populations are especially susceptible: elderly, smokers, alcoholics, children, asplenics
h. Treatment. In the past, all Streptococcus pneumoniae organisms were sensitive to penicillin. Penicillin resistance due to transformation with DNA from nonpathogenic streptococci in the oropharynx is becoming a problem. These cases can be treated with vancomycin or erythromycin.
• Vaccine available • Treatment with penicillin but resistance on the rise
2. Viridans streptococci are normal oral flora. a. In contrast to S. pneumoniae, they are not inhibited by optochin or lysed by bile.
Bridge to Cardiovascular and Renal Systems • Rheumatic fever is discussed in the Cardiovascular Pathology chapter of Organ Systems Book 1 (Volume III). • Poststreptococcal glomerulonephritis is discussed in the Renal Pathology chapter of Organs Systems Book 1 (Volume III).
272
mellical
b. They produce dextran, a substance that allows them to adhere to many surfaces. c. They are the major cause of subacute endocarditis (e.g., S. sanguis) in those with
abnormal heart valves. Streptococcus mutans causes dental caries. d. Treatment of choice is penicillin. D.
~-Hemolytic streptococci are further subdivided into groups A through D and F and G based on antibodies to a heat-stable, acid-stable carbohydrate in their cell walls. This antigen is called C carbohydrate or the Lancefield antigen, in honor of Rebecca Lancefield, the scientist who devised this classification system.
1. Group A streptococci (GAS) contains only one species, Streptococcus pyogenes, but it is
the most important streptococcal pathogen. a. It can be distinguished from the other by the antibiotic bacitracin.
~-hemolytic
streptococci because it is inhibited
b. Clinical manifestations of S. pyogenes are characterized as suppurative and nonsuppurative.
- - - - - - - - -
Bacteriology: Gram-Positive Cocci
Table V-3-S. Virulence factors of Streptococcus pyogenes. I. Cell constituents
1. M protein
• Required for virulence-80+ types • Externa-extends from cell envelope as fimbriae; carboxyterminal is attached to PDG and shows little variability; aminoterminal is outside-variable • Prevents phagocytosis by preventing complement opsonization. It has a site that binds factor H, leading to the hydrolysis of C3b to inactive form. • In conjunction with LTA, binds fibrinogen, hiding the C3-binding site • Antibody to a specific M-terminus provides immunity to that M type 2. Lipoteichoic acid or fibronectin-binding molecule • Attached to M protein; binds fibrinogen 3. F protein • Allows binding to fibronectin 4. Hyaluronic acid capsule • Inhibits phagocytosis 5. Cell-bound protease • Cleaves C5a component of complement and inhibits neutrophil chemotaxis II. Extracellular products
1. Hyaluronidase (spreading factor) • Destroys hyaluronic acid-could be important in the spread through tissue during cellulitis 2. Streptolysin 0
• Oxygen labile (inhibited by oxygen)-a hemolysin that is active only in its reduced form • Works by inserting directly into the host cell membrane, forming transmembrane pores • Immunogenic-can use ASO test for evidence of recent strep infection 3. Streptolysin S
• Oxygen stable; made in the presence of serum • Hemolysin causing l3-hemolysis-produced by most group A strains • Non-immunogenic 4. Streptococcal pyrogenic exotoxins (SPE) (erythrogenic toxins) • Rash of scarlet fever • Encoded by bacteriophage • Pyrogenic exotoxins are non specific activators of the immune system (superantigens)
KAPLA~_ I meulca 273
Microbiology
In a Nutshell S. pyogenes (Group A) • Beta hemolytic; sensitive to bacitracin • Many virulence factors, including M protein, capsule, F protein, hyaluronidase, Streptolysins 0 and S, and erythrogenic toxins • Clinical correlations - Pharyngitis (strep throat) - Scarlet fever - Skin: erysipelas, cellulitis, impetigo, necrotizing fasciitis, pyoderma - Secondary diseases: rheumatic fever and acute glomerulonephritis • Treatment with penicillin
(1) Suppurative complications of pharyngitis include otitis media, peritonsillar
cellulitis, peritonsillar and retropharyngeal abscesses, and bacteremic metastatic spread. Other suppurative infections include erysipelas (skin infection), pyoderma (impetigo), scarlet fever, cellulitis, lymphangitis, perianal cellulitis, puerperal sepsis, meningitis, pneumonia, and empyema. (2) Nonsuppurative sequelae occur weeks after initial infection. Inflammation occurs in organs not originally infected. These sequelae include acute glomerulonephritis, in which edema, hypertension, and hematuria occur after pharyngeal or skin infection. Also classified within this group is rheumatic fever, occurring 7-28 days after pharyngitis and results in fever, carditis, and polyarthritis. c. Transmission and epidemiology. Group A strep is an obligate human parasite spread person-to-person by respiratory secretion via droplets, direct contact with the skin, or fomites. Pharyngitis is most common in winter and spring, with the highest incidence among preadolescents. Contaminated milk or eggs have also been the cause of foodborne epidemics of pharyngitis. Impetigo-like skin infections are most prevalent in summer and are often due to the infection of insect bites. Group A strep produces a toxic enzyme called streptolysin 0 (SLO). Patients can be diagnosed in the lab based on the presence of antibodies to SLO. d. Virulence factors. Table V-3-5 summarizes the virulence factors of S. pyogenes. The most important virulence factor to remember is M protein. 2. Group B Streptococcus (Streptococcus agalactiae) is part of normal vaginal and intestinal flora in 25% of a given population. a. It is classified into serotypes based on polysaccharide and surface-protein antigens.
In a Nutshell
b. In contrast to S. pyogenes, S. agalactiae are resistant to bacitracin.
S. agaladiae (Group B)
c. The major virulence factor is an antiphagocytic polysaccharide capsule.
• ~-Hemolytic; resistant to bacitracin
d. Infants are more susceptible to disease from the organism than adults. They aspirate the organism during passage through the birth canal, and if they lack passive resistance from maternal IgG antibody, disease may ensue.
• Antiphagocytic capsule
e. Clinical manifestations include pneumonia, sepsis, and meningitis. Group B streptococci and E. coli are the major causes of these diseases in the neonatal population (under 1 month of age).
• Causes meningitis, sepsis, and pneumonia in neonates (acquired during passage through vaginal canal where organisms are part of normal flora)
f. Risk factors for acquiring pneumonia include: recent colonization of the mother, premature birth, low birth weight, and premature rupture of the membranes. Diabetics are presumably more susceptible to infection because high glucose concentration promotes capsule synthesis.
• *1 cause of neonatal
g. Therapy for S. agalactiae is a penicillinase-resistant synthetic penicillin.
meningitis Enterococci • Variable hemolysis • Normal fecal flora • Cause urinary tract infections in hospitalized patients; rare cause of subacute endocarditis
274
meClical
3. Enterococcus, formerly group D Streptococcus, include the important pathogens Enterococcus faecalis and Enterococcus faecium. a. Both organisms are part of the normal fecal flora. These organisms were classified as group D, ~-hemolytic streptococci; however, hemolysis is not a consistent feature since it is encoded on a plasmid. b. Enterococci can grow in 40% bile and 6.5% sodium chloride, as would be expected of a fecal organism. c. These organisms can cause infection when they spread to the urinary tract. When the intestine is disrupted, they are one of the organisms found in an abscess. Enterococcus species also cause approximately 10% of cases of subacute endocarditis.
- - - - - - - - -- -
--
---
----- - - - - - - - - - -
Baderiology: Gram-Positive Cocci
d. Unlike the streptococci, enterococci exhibit penicillin tolerance since they are inhibited, but not killed, by the antibiotic. Recently, vancomycin-resistant enterococci have appeared. During peptidoglycan synthesis, vancomycin binds to the D-ala-D-ala residues and prevents the construction of the cell wall. Vancomycin-resistant enterococci use D-lactic acid instead of D-ala to form the "peptide" bridges.
Positive Positive Gram-positive cocci
Catalase Test
Staphylococcus species
Coagulase Test
Resistant
Negative
Negative
Staphylococcus aureus
- - - - - - - 1 Novobiocin
Streptococcus species
Resistant
Sheep Blood Agar
a<
AlphaHemolysis
K
Sensitive
Staphylococcus epidermidis
Viridans Streptococci
Optochin
Sensitive
BetaHemolysis
I
Staphyloco?cuS saphrophyt/cus
Streptococcus pneumoniae (+ Quellung)
Bacitracin
Other /Hemolytic streptococci
Streptococcus pyogenes
Figure V-3-1. Gram-positive cocci flow chart.
UP~~.
I 275
mvulC8
Bacteriology: Gram-Positive Bacilli The four most important genera of Gram-positive bacilli are Listeria, Corynebaderium, Bacillus, and Clostridium. Listeria and Corynebaderium do not form spores, whereas Bacillus and Clostridium do.
LISTERIA MONOCYTOGENES A. Characteristics 1. L. monocytogenes is a small Gram-positive coccobacillus that does not form spores. It is
catalase positive, a feature that distinguishes it from other Listeria and from Streptococcus. 2. Microscopically, the organism resembles nonpathogenic members Corynebacterium genus ("diphtheroids"), which are part of normal skin flora.
of
the
3. Unlike the diphtheroids, Listeria monocytogenes is motile at room temperature and produces ~-hemolysis on blood agar. B. Transmission. Listeria is a facultative intracellular pathogen; it infects phagocytic cells. It also
produces listeriolysin 0, which is a beta-hemolysin similar to streptolysin 0. Listeria is most often acquired through ingestion of contaminated meat, unpasteurized dairy products, or food contaminated with animal fecal material. C. Risk factors. Groups at risk of serious disease from Listeria monocytogenes include neonates,
pregnant women, immunosuppressed patients, and alcoholics. D. Clinical manifestations
1. Neonatal infections can arise by genital tract colonization in pregnant women with transmission to the offspring across the placenta or during delivery. a. Granulomatosis infantisepticum is an in utero infection presenting within two days of birth. It causes widespread granulomas and has a very high mortality rate. b. Meningitis in neonates will occur as a result of infection during delivery. It accounts for 10% of neonatal meningitis. 2. Adult infections
a. Meningitis in immunocompromised hosts (steroids, chemotherapy, transplants, alcoholics, etc.). b. Bacteremia in pregnant women E. Therapy is ampicillin with sulfamethoxazole/trimethoprim as an alternative.
KAPLA!._
I 277
meulC8
Microbiology
CORYNEBACTERIUM DIPHTHERIAE A. Characteristics. C. diphtheriae is a nonmotile, club-shaped, non-spore-forming, Grampositive rod. E. Diphtheria toxin is responsible for the clinical symptoms.
1. A lysogenic phage encodes diphtheria toxin.
2. Iron restriction activates toxin production. 3. It is synthesized as a single amino acid chain, but must be cleaved for activity. Fragment A has ADP-ribosyltransferase activity, and fragment B allows binding and insertion into the host cell membrane. 4. Diphtheria toxin catalyzes the ADP-ribosylation of elongation factor 2, thereby inhibiting host protein synthesis.
e. Clinical manifestations
of diphtheria include upper respiratory infection resulting in a tonsillar grayish pseudomembrane that may spread to the pharynx and larynx, and can compromise the airway. Although the organism is not invasive, the toxin is absorbed systemically and acts on other tissues. Diphtheria toxin is especially toxic to the heart and can cause cardiac failure.
D. Treatment consists of antitoxin and erythromycin and should be administered as soon as possible. E. Prevention. A vaccine containing diphtheria toxoid is administered during the first year of life. Boosters are required every ten years.
BACILLUS Bacillus species are a group of large, nonmotile, Gram-positive rods that produce spores. A. Bacillus anthracis is the major pathogenic species. 1. Spores produced by the organism persist in soil or in products from infected herbivores for many years.
Note The anti phagocytic capsule of B. anthracis is unique in that it is composed of D-glutamate, not polysaccharide.
2. Encoded on a plasmid are an antiphagocytic capsule and three virulence factors that act in concert. What is commonly called anthrax toxin is actually a combination of these three toxins. a. Protective antigen (PA) binds to target cells to promote uptake of lethal factor (LF) and edema factor (EF). b. Lethal factor is toxic to macrophages. c. Edema factor is an adenylate cyclase that increases cyclic-AMP levels in target cells following its insertion in the membrane. In a phagocyte, this decreases phagocytic activity. 3. Transmission. Infection commonly occurs through skin cuts or abrasions, although the organism may also be inhaled. 4. Clinical manifestations of anthrax may be cutaneous or systemic. a. Cutaneous anthrax accounts for 95% of all infections. The characteristic presentation is papules that develop into ulcers with necrotic centers. Regional lymphadenopathy can occur. Edema is a major complication and this infection may be fatal in 20% of untreated cases.
278
meclical
Bacteriology: Gram-Positive Bacilli
b. Systemic anthrax is acquired through the respiratory (inhalation anthrax-woolsorter disease) or gastrointestinal route, and results in lymphadenopathy and septicemia. It is almost always fatal. 5. Therapy and prevention a. The drug of choice for Bacillus anthracis infection is penicillin or ciprotloxacin. b. Anthrax is controlled through prevention and clean up of contaminated areas. e. In the United States, a killed vaccine is available for individuals with a high risk of exposure and for livestock. B. Bacillus cereus produces two enterotoxins and usually grows in foods, especially in cereal
grains such as rice. 1. The principal clinical manifestation is food poisoning of two types: a. A short incubation food poisoning (1-6 hours; emetic type) causes severe nausea and vomiting. Epidemics of this type have been known to be associated with fried rice. It is often confused with staphylococcal food poisoning due to its short incubation. b. Food poisoning of long incubation (10-24 hours; diarrheal type) is observed as abdominal cramps and diarrhea. This type may be confused with clostridial food poisoning.
Clinical Correlate Because of the threat of biologic warfare, the Department of Defense has decided to vaccinate members of the armed forces against anthrax.
2. Therapy and prevention include support for food poisoning, such as as administration of fluids. If an antibiotic is indicated, vancomycin can be used.
CLOSTRIDIA Clostridia are characterized as large, obligate anaerobic, spore-forming rods. They are Grampositive. A. Characteristics 1. Clostridia are usually found in the soil or human gastrointestinal tract and grow on blood agar or chopped meat glucose media. 2. The four major pathogenic species, C. perfringens, C. difficile, C. tetani, and C. botulinum, produce many toxins and destructive enzymes, including collagenase, protease, hyaluronidase, and lecithinase. 3. Most infections are mixed, that is, an aerobic organism grows first and reduces the environment, thus allowing the anaerobic Clostridia to grow. B. Clostridium perfringens is a fast growing, nonmotile organism found in the soil and the
intestine. 1. Characteristics a. When cultured on blood agar, a double zone of hemolysis is seen. It will not produce spores on artificial media. b. There are five types, A through E, based on the production of four toxins, alpha, beta, epsilon, and iota. All strains produce alpha toxin, a calcium-dependent phospholipase C that is also known as lecithinase. It causes the lysis of erythrocytes and other cells. 2. Transmission of C. perfringens occurs through infection of disrupted skin, bowel, or other epithelial tissues. Infection may be due to traumatic injury, surgery, or septic abortion. The organism is part of the normal intestinal flora. Spores are frequently found in soil. KAPLAlf _ I meillea 279
Microbiology
3. Clinical manifestations take on several forms depending on the site and severity of infection. A diffusely spreading organism may cause cellulitis and fasciitis and/or bacteremia. a. Gas gangrene or myonecrosis is a life-threatening illness characterized by muscle and connective tissue necrosis. Gas, an end product of fermentation, forms in the muscle tissue and causes crepitation. Approximately 80% of the cases of gas gangrene are caused by C. perfringens. b. Food poisoning can be caused by C. perfringens. It is thought to be the third most common cause of bacterial food-borne epidemics, after Staphylococcus aureus and Salmonella. The enterotoxin causes a self-limited gastroenteritis by binding to a brush border membrane receptor and interrupting ion exchange. This results in the loss of low-molecular weight metabolites and ions. Onset of clinical symptoms is 8-16 hours after ingestion of the organism. The infection is characterized by abdominal pain and diarrhea for 12-24 hours; systemic effects are uncommon. c. Skin and soft tissue infections are typically localized infections. Tissue infection is characterized by crepitant cellulitis, stump infection in amputees, perirectal abscesses, diabetic foot ulcers, and decubitus ulcers.
d. Suppurative infection is usually polymicrobial in origin. Intra-abdominal infection may cause bowel perforation and emphysematous cholecystitis. Pelvic infection may be seen as tubo-ovarian and pelvic abscesses and as septic abortion. 4. Therapy for gas gangrene consists of surgical debridement plus pencillin. Food poisoning due to the enterotoxin of type A is usually self-limiting and hence is not treated with antibiotics. C. Clostridium difficile
1. Clostridium difficile is a component of the normal bowel flora in a small percentage of adults. 2. The organism can produce two heat-labile toxins, enterotoxin (exotoxin A) and cytotoxin (exotoxin B).
3. Clinical manifestations. C. difficile causes over 25% of antibiotic-associated diarrhea and 95% of the cases of pseudomembranous colitis. a. Two antibiotics that commonly precipitate pseudomembranous colitis are clindamycin and ampicillin. b. Pseudomembranous colitis presents with a history of nausea, vomiting, abdominal pain, and voluminous green diarrhea. c. Proctoscopy demonstrates pseudo membranes with an erythematous mucosa.
d. Diagnosis is confirmed by demonstrating toxin in the stool. 4. Treatment. Oral vancomycin or metronidazole are the current treatments. D. Clostridium tetani 1. Characteristics
a. Spores are abundant in the soil. When they are inoculated into a site of injury, a drop in the redox potential leads to germination. In 50% of cases, there is no history of a wound. b. The organism produces tetanospasmin, a plasmid-encoded neurotoxin that blocks the normal inhibition of spinal motor neurons. It prevents the release of the inhibitory neurotransmitters glycine and gamma-amino butyric acid, leading to spastic paralysis. Death can occur from respiratory failure.
280
meClical
Bacteriology: Gram-Positive Bacilli
2. Clinical manifestations. Tetanus has four clinical presentations: a. Local infection can cause persistent local muscle contraction. It has low mortality and is noninvasive. b. Cephalic infection is rare in presentation. It can follow chronic otitis media and can progress to the generalized form. c. Generalized tetanus infection is the most recognized form. It is painful and presents with "lockjaw" progressing to opisthotonos. Mortality is approximately 60%. d. Neonatal tetanus infects the umbilical stump. It is the major cause of infant mortality in developing countries. 3. Therapy for tetanus includes surgical debridement of the wound, the use of human tetanus antitoxin, respiratory support (if required), and muscle relaxants (curare-like drugs). The antibiotic treatment of choice is metronidazole.
In a Nutshell . Virulence Factors of Gram+ Bacilli
Corynebacterium diphtheriae
Phage-encoded toxin that inactivates EF-2 by ADP ribosylation. Protein synthesis inhibited in host.
Bacillus anthracis
Antiphagocytic capsule
4. Prevention. Because the same toxin is found in all strains, tetanus can be prevented by immunization with tetanus toxoid. Booster shots are required every ten years. In contrast to diphtheria, a patient who survives tetanus is not immune to the disease, since the minute amount of toxin necessary to cause disease is not sufficient to elicit an immune response. E. Clostridium botulinum is found ubiquitously in soil.
1. Characteristics
+ [protective
a. It produces a powerful, heat-labile neurotoxin that is usually ingested pre-formed with improperly canned food. The toxin blocks the release of acetylcholine from motor neurons in the peripheral nervous system, producing flaccid paralysis.
Anthrax toxin
b. There are seven immunologic types of toxins, some of which are phage-encoded. 2. Clinical manifestations a. There are a constellation of clinical signs associated with C. botulinum intoxication. (1) Dilated unreactive pupils (bulbar paralysis)
Bacillus cereus
2 enterotoxins
Clostridium perfringens
4 toxins; key one is alpha toxin (lecithinase)
Clostridium difficile
Enterotoxin (exotoxin A) Cytotoxin (exotoxin B)
Clostridium tetoni
Plasmaencoded neurotoxin (tetanospasmin) blocks release of inhibitory neurotransmitters-spastic paralysis
Clostridium botulinum
Neurotoxin blocks release of acetylcholineflaccid paralysis
(2) Descending weakness or paralysis usually starting with the cranial nerves (3) Progressive respiratory weakness (4) Absence offever (5) Dry mucous membranes (6) Unexplained postural hypotension b. Infant botulism is also called floppy baby syndrome. When an infant is colonized by the organism, extremely low levels of toxin can be produced, leading to failure to thrive and eventually to progressive muscular weakness and poor motor development. Older children and adults do not seem to be afflicted. Infant botulism is the most common form in the u.s. and is the reason why infants should not be fed honey. c. In contrast to tetanus, the autonomic dysfunction that results from botulism is not
life-threatening if the patient is intubated and appropriate ventilator management is used.
antigen Lethal factor Edema factor (adenylate cyclase)
3. Therapy for botulism toxin poisoning includes respiratory support and human trivalent antitoxin therapy that targets three toxins-A, B, and E.
KAPlA~.
meulC8
I
281
~-----------
---
--------------
Bacteriology: Gram-Negative Organisms The Gram-negative bacteria are a very heterogeneous group with a large number of medically relevant species. This chapter reviews the important Gram-negative cocci (Neisseria) as well as the various groups of Gram-negative bacilli (enteric organisms, zoonotic organisms, and respiratory organisms).
GRAM-NEGATIVE COCCI A. Neisseria 1. Genus characteristics a. Neisseria are nonmotile, nonspore-forming, Gram-negative cocci. They are characteristically arranged in pairs (diplococci) with flattened adjacent sides facing each other. On Gram stain, they resemble coffee beans. b. They are oxidase positive. The oxidase test detects the c component of the cytochrome oxidase complex. It is positive in Neisseria, as well as in the Vibrios and some pseudomonads. c. Eight species have been identified. Two of these, N. meningitidis and N. gonorrhoeae,
are pathogenic for humans. 2. Isolation of the pathogenic Neisseria. The pathogenic Neisseria are fastidious organisms. They are very susceptible to heat, cold, and drying, so specimens require special handling. a. The pathogenic Neisseria require a rich media for growth. They grow nicely on a heated blood preparation called chocolate agar with 2-8% CO 2 (a candle jar). If cultures are obtained from usually sterile sites, like the cerebral spinal fluid, chocolate agar alone can be used for culture media. If the culture is obtained from a site that is usually occupied by many species of organisms, such as a cervical smear, antimicrobial agents must be added to the chocolate agar. Thayer-Martin media consists of chocolate agar plus vancomycin, colistin, and nystatin to inhibit normal vaginal flora. b. N. meningitidis and N. gonorrhoeae are differentiated based upon sugar utilization. N. gonorrhoeae can ferment glucose, but not maltose. N. meningitiditis can ferment glucose and maltose. 3. Virulence factors of the pathogenic Neisseria are detailed in Table V-S-1.
Mnemonic Think MGM (as in the studio): Meningitidis ~ glucose + maltose (gonorrheae = glucose only)
meCtical
283
Microbiology
Table V-5-1. Summary of the major virulence factors of Neisseria.
Neisseria meningitidis (Meningococcus)
Neisseria gonorrhoeae (Gonococcus)
Sugar utilization
Glucose and maltose
Glucose
Capsule
Acidic polysaccharideantiphagocytic and anticomplementary 9 serotypes; vaccine = 4 serotypes
Present, but role in virulence is uncertain
Pili
Adhesion Small antiphagocytic role Necessary for DNA uptake
Adhesion necessary for DNA uptake; contributes to resistance to neutrophil killing See antigenic phase variation (a switch between alternative states like pili or nonpili)
Porins
Present
Present
Endotoxin
Lipopolysaccharide (LPS)
Lipooligosaccharide (LOS)
IgAl protease
Present
Present
Penicillinase R plasmid
No
Yes, in some stains
B. N. meningitidis (meningococcus)
1. Features a. Ferment glucose and maltose b. The key virulence factor for N. meningitis is its antiphagocytic capsule. The capsule is the basis of serotyping and serves as the antigen for vaccines. Thirteen different capsule types have been identified. c. Endotoxin and IgA protease are also important virulence factors. 2. Transmission of meningococcus is via respiratory droplets. The carriage rate in adult nasopharyngeal tissue is approximately 10-30%. Most carriers are asymptomatic. It enters the upper respiratory tract and may eventually disseminate. The risk of disseminated disease is greatest in individuals with late complement (C6, C7, and C8) deficiencies. 3. Clinical manifestations a. Meningitis, usually of sudden and fulminant onset b. Meningococcemia, a vasculitic purpura causing disseminated intravascular coagulation (DIC) c. Meningococcus is responsible for Waterhouse-Friderichsen syndrome, characterized
284
iiie&ical ~--------
~-~-.~---
....
-------~
Bacteriology: Gram-Negative Organisms
by coagulopathy, hypotension, adrenal cortical necrosis, and sepsis, which is usually fatal. In addition, metastatic lesions may appear in lung, pericardium, joints, eyes, etc. 4. Diagnosis is made by identifying Gram-negative cocci in the spinal fluid and confirmed by culture of the CSF or blood and demonstration of oxidase production and maltose fermentation. 5. Therapy and prevention a. Penicillin G or ceftriaxone are the antibiotics of choice. b. Carriers and close contacts can be treated prophylactically with rifampin for two days. c. A quadrivalent vaccine exists to capsule types A, C, Y, and W135. The vaccine does not protect against type B, which has a capsule that is not immunogenic. C. N. gonorrhoeae (gonococcus)
1. Features a. Ferment glucose but not maltose b. Many strains produce 13-lactamase 2. Transmission of the gonococcus is via sexual contact, but may also involve fomites. It has an increased incidence of infection in sexually active young adults (15-30 years old), nonwhites, low socioeconomic groups, and urban settings. 3. Clinical manifestations are primarily associated with the urogenital tract, although disseminated disease can occur. a. Acute urethritis and gonorrhea in men is observed as a yellow purulent discharge with dysuria. Ninety percent of men are symptomatic. Common complications of acute urethritis include urethral stricture, epididymitis, and prostatitis. Proctitis is especially common in male homosexuals. b. Gonorrhea in females is asymptomatic in 20-S0% of cases, most likely due to the inability to observe a discharge. Complications include pelvic inflammatory disease (15-20% of cases), generalized peritonitis, and infertility. c. Disseminated disease can be observed as meningitis, subacute bacterial endocarditis, and arthritis. (1) Arthritis is manifested as a dermatitis syndrome called tenosynovitis. Cultures of joint and skin pustules are positive in <30% of cases. (2) Host factors that increase susceptibility to disseminated disease include deficiencies of terminal complement components C6, C7, and CS. d. Ophthalmia neonatorum results from maternal transmission to the infant during birth. Ophthalmic tetracycline, erythromycin, or silver nitrate is given to the neonate for prevention. Neonatal infection may cause gonococcal arthritis. e. Pharyngitis. Diagnosis is established by identifying Gram-negative cocci in PMNs from the infected site and is confirmed by culture. This may occur in neonates, but is much more common in individuals who engage in oral sex. 4. Diagnosis of gonococcal urethritis in males is made by the observation of Gram-negative diplococci and neutrophils in the urethral exudate. In females, culture and biochemical testing is required due to the presence of other Gram-negative coccal forms as part of normal vaginal flora. The specimen is cultured on a medium such as Thayer-Martin agar, which contains antibiotics to control the growth of the normal flora organisms. The observation of Gram-negative diplococci that are oxidase positive and able to ferment both glucose and maltose is considered definitive for the meningococcus.
meClical
285
Microbiology
5. Treatment and prevention
In a Nutshell Gonococcus Meningo· coccus Ferment
Glucose
Glucose and maltose
Spread
Sexual; passage through birth canal
Aerosol
No
Yes
Vaccine
a. Ceftriaxone is the antibiotic of choice for treating infection. N. gonorrhoeae is no longer susceptible to penicillin because of two mechanisms: a plasmid-mediated ~-lactamase, and chromosomally mediated decreased affinity of penicillin-binding proteins. b. Because combined infections are so common, treatment regime should include an antichlamydial agent (e.g., doxycycline). c. Safe sexual practices can decrease the incidence of gonorrhea. d. All cases of gonorrhea must be reported to the Public Health Department.
Treatment Ceftriaxone Penicillin
GRAM-NEGATIVE BACILLI: ENTEROBACTERIACEAE In a Nutshell Medically Important Enterobacteriaceae include: • Enterobader
• Escherichia • Klebsiella • Proteus • Salmonella • Serratia • Shigella • Yersinia
The family Enterobacteriaceae includes many Gram-negative, nonspore-forming, facultative bacilli with simple growth requirements. The majority of Enterobacteriaceae are normal gastrointestinal flora. In the gastrointestinal tract they exist in a symbiotic relationship with the host. They synthesize vitamin K and deconjugate bile salts and sex hormones for recirculation to the liver. They also prevent the colonization of intestinal mucosa by primary pathogens. Colonization is inhibited by colicin/bacteriocin synthesis and receptor competition. The normal flora of Enterobacteriaceae, which include Escherichia, Citrobacter, Klebsiella, Enterobacter, Serratia, and Proteus, generally lack the virulence factors of the pathogenic species. They act as opportunistic pathogens when they breach the normal anatomic barriers or when the host is severely immunocompromised. Opportunistic Enterobacteriaceae are the most common cause of intra-abdominal sepsis and urinary tract infections. A subset of Enterobacteriaceae are considered primary pathogens because they contain virulence factors capable of overcoming normal host defenses. They are not part of the normal flora. This subset includes Shigella species, Salmonella species, Yersinia species, and some strains of Escherichia coli. A. General characteristics. There is no universally accepted taxonomic classification for this group. The CDC scheme is based on DNA homology techniques used to determine the degree of relatedness between species. Antigenic and biochemical differences are utilized in classification. B. Physiology 1. The Enterobacteriaceae are facultative organisms; they can ferment or respire, depending
upon the conditions. 2. All members of Enterobacteriaceae ferment glucose and reduce nitrates to nitrites. 3. All are oxidase negative, meaning they lack cytochrome c, although they have an electron transport chain. 4. If motile, they have peritrichous flagella. Klebsiella and Shigella are nonmotile. 5. Enterobacteriaceae can be divided into lactose fermenters and nonlactose fermenters by their colony appearance on selective/differential media. The most commonly used media are eosin methylene blue agar (EMB) and MacConkeyagar. If the lactose is fermented, the colony changes color. a. Important lactose fermenters are Escherichia coli, Citrobacter, Klebsiella, and Serratia. b. Important nonlactose fermenters include Shigella, Salmonella, Proteus, and Yersinia. 6. Enterobacteriaceae are easily destroyed by heat and by common disinfectants or germicides. They are sensitive to drying or desiccation. In contrast, they survive best in a high-
286
meCtical
Bacteriology: Gram-Negative Organisms
moisture environment. Respiratory care or anesthesia equipment are common sources of nosocomial infections. Contaminated ice machines or water supplies may harbor these organisms, causing epidemics. C. Antigenic structure 1. K antigens (Vi antigen) are acidic polysaccharide capsules. They are antiphagocytic by
blocking the access of complement or antibodies to the organism. The K1 antigen of nephritogenic E. coli strains is associated with adherence to lectins of the GU epithelium. K1 is also associated with neonatal meningitis because it is antiphagocytic, anticomplementary, and resembles sialic acid. The capsule antigen in Salmonella typhi is called Vi antigen. 2. H antigens are the flagellar proteins and are present only in motile organisms. H antigen may exist in one of two phases in Salmonella. Shigella are not motile and do not express H antigens. 3. 0 antigen, or somatic antigen, causes a "smooth" appearance in culture and is the name for repeating oligosaccharide units found in the endotoxin in the outer membrane of Enterobacteriaceae. Certain 0 antigens promote adherence to gastrointestinal or genitourinary epithelium. D. Pathogenicity is due primarily to endotoxin (also called LPS; the lipopolysaccharide por-
tion of the cell wall) present in all Enterobacteriaceae. 1. Toxicity lies in the lipid A portion. LPS may cause endotoxic shock when the enteric
bacilli enter the bloodstream (septic shock). Endotoxic shock is characterized by blood pools forming in the microcirculation, resulting in hypotension. Vital organs lack adequate blood supply, leading to decreased tissue perfusion, acidosis, ischemia, and cellular hypoxia. DIC may also occur to further compromise the patient. 2. Enterotoxins are produced by some members of the family (some E. coli, Shigella) that exert their toxic effects on the small intestine. Enterotoxins cause secretion of fluid into the lumen, resulting in secretory diarrhea. 3. Pili, or fimbriae, promote adherence to tissues.
E. Shigella 1. Characteristics a. Shigella is an obligate human pathogen. There are four species of Shigella: S. dysenteriae, S. flexneri, S. sonnei, and-S. boydii. b. It is a slender, nonmotile organism that does not ferment lactose or produce H 2 S. 2. Transmission. The primary mode of transmission is fecal-oral. These organisms are not killed by stomach acid, therefore, only a small number of organisms «100) are needed to cause disease. 3. Pathogenesis. The site-of disea~e is in the colon, where Shigella invades and superficially destroys the intestinal mucosa:'"Virulence factors of Shigella include adhesins, invasins, and toxins. Most are encoded on plasmids.
In a Nutshell
All Enterobacteriaceae • Gram-negative bacilli • Facultative anaerobes • Ferment glucose • Reduce nitrates • Oxidase negative • Have endotoxin • Found in GI tract (exception: Y pestis)
Some Enterobacteriaceae • Motile (all except Klebsiella and Shigella) • Have polysaccharide capsule (Klebsiella, Salmonella)-K antigen • Ferment lactose (E coli, Citrobader, Klebsiella, Serratia)
Note Shigella and Salmonella typhi are the only Enterobacteriaceae that are human-only pathogens,
a. Plasmid-encoded outer membrane proteins attach by binding to integrins. Invasive plasmid antigens (ipa) mediate entry of the organism through M cells in Peyer patches, and the eventual phagocytosis by mucosal cells. b. Once inside a cell, the phagosome ruptures, and Shigella multiples within the cytoplasm. Since the organisms are nonmotile, they are pushed through the cytoplasm and into the next cell by rearrangement of the cytoskeleton. KAPLAN
'.
med lea
I 287
Microbiology
c. Shiga (S. dysenteriae) and Shiga-like toxins are the major toxins of Shigella species. They are chromosomally encoded cytotoxins. During bacterial cell lysis, they are released and bind to the surface of other cells by a glycolipid. Once absorbed byendocytosis, they exert neurotoxic, cytotoxic, and enterotoxic effects.
d. Hemolytic-uremic syndrome due to Shigella may be explained by the effects of these toxins on the microvasculature.
Clinical Correlate An examination of a fecal sample for PMNs is a key component of the workup of infectious diarrhea. If they are present, you are dealing with an invasive organism such as Shigella, Sa/manella, or Campy/abader (an inflammatory diarrhea). If there are no PMNs, you are more likely to be dealing with a toxinproducer such as ETEC or V cha/erae (a noninflammatory diarrhea).
e. Finally, like all Gram-negative bacteria, Shigella have endotoxin. This endotoxin increases the local inflammatory response, but seldom causes septic shock since the organisms do not invade beyond the submucosa. 4. Clinical manifestations (shigellosis) a. Bacillary dysentery characterized by abdominal cramps and diarrhea. The feces contain blood, polymorphonuclear leukocytes, and mucus. b. One to four weeks after the disease, a carrier state may be set up if the organism is not cleared. Carriers experience long-term, recurrent bouts of disease. 5. Therapy and prevention includes hydration and electrolyte replacement. Fluoroquinolones are now considered antibiotics of choice. a. Alternatively, ampicillin, tetracycline, or trimethoprim-sulfamethoxazole decreases the duration of symptoms and development of the carrier state. b. Prevention is facilitated through personal hygiene, proper garbage disposal, and water purification. F. E. coli are motile, ferment lactose (which helps differentiate E. coli from Shigella and Salmonella), and will form colored colonies on EMB or MacConkey agar. The gastrointestinal tract is a natural reservoir for E. coli. 1. Pathogenicity in strains causing neonatal meningitis or uropathogenic strains is related
to the presence of the Kl capsular antigen, which inhibits phagocytosis. Nephropathogenicity is associated with plasmid-mediated hemolysin production.
Note An enterotoxin is a protein exotoxin that is released locally in the intestine.
2. Enterotoxigenic Escherichia coli (ETEC) is a major cause of infant death in developing countries and is the most common cause of "traveler's diarrhea:' a. More than 100 serotypes of E. coli cause this noninflammatory, secretory diarrhea that is similar to cholera, but less severe. b. The organism is acquired through the ingestion of fecally contaminated food or water. c. Disease is noninvasive and occurs in the small intestine.
d. Major virulence factors are plasmid-encoded, including enterotoxins and pili-termed colonization factor antigens (CFA) that act as adhesins.
Note
(1) Heat-labile toxin (LT) ADP ribosylates G stimulatory (Gs) protein, destroying
LT is a classic A-B toxin. The B portion binds to the epithelium in the small intestine. The A portion is enzymatically active and ADP ribosylates the adenylate cyclase regulatory protein, thus increasing cAMP levels in the cell.
288
meClical
its GTPase activity. Without it, the alpha subunit of Gs constantly stimulates adenylate cyclase to produce cyclic AMP, leading to a loss of electrolytes and water. LT toxin shares DNA homology with cholera toxin. (2) Heat-stable (ST) toxin is a small peptide toxin that mimics the peptide hormone guanylin. It binds to the guanylate cyclase receptor and increases the cellular cGMP level, causing mucosal cells to release fluids. 3. Enteroaggregative Escherichia coli (EAggEC) causes persistent watery diarrhea in children and traveler's diarrhea.
Bacteriology: Gram-Negative Organisms
a. The organism is acquired by ingestion. b. Virulence factors include pili, an enterotoxin, and a cytotoxin. The pili promote adherence. The enterotoxin is similar to ST toxin. 4. Enteropathogenic Escherichia coli causes non-inflammatory diarrhea. a. Infants, especially in the developing world, are very susceptible. b. Enteropathogenic Escherichia coli infection causes effacement of microvilli without gross ulceration. The stools are nonbloody. It is more invasive than ETEC or EAggEC, but less invasive than the pathogens causing dysentery. e. This bacteria has no known toxins, but several kinds of adhesins.
5. Enterohemorrhagic Escherichia coli (EHEC) causes bloody diarrhea, similar to dysentery. a. Its reservoir is livestock, especially beef cattle. b. The organism is acquired by ingestion of poorly cooked ground beef. Epidemics associated with fast-food chains or processed food have occurred, although the organism has also been transmitted in milk, cider, and water. e. One serotype, 0157:H7, is the predominant cause of disease.
d. It is not significantly invasive; however, the verotoxin (Shiga-like toxin) can result in hemorrhagic colitis. e. Virulence factors include adhesins that efface the microvili and a bacteriophageencoded Shiga-like toxin. f. Enterohemorrhagic Escherichia coli can precipitate hemolytic-uremic syndrome, which is most common in kids <5 years old. 6. Enteroinvasive Escherichia coli (EIEC) causes dysentery that is clinically indistinguishable from dysentery due to Shigella. a. It lacks Shiga toxin, but contains a virulence plasmid that is essentially identical to those of Shigella. b. The organism is acquired through the ingestion of contaminated food. e. It produces a severe, but self-limited dysentery in most adults, but is often fatal in
young children. 7. Other clinical manifestations of E. coli infection a. E. coli is the most common causative organism in urinary tract infections (UTIs). b. Neonatal pneumonia is usally the result of nosocomial infection due to aspiration during the birth process. Sepsis may also occur. e. Neonatal meningitis is also caused by exposure during birth. It is a serious infection resulting in 40-80% mortality.
In a Nutshell E. coli • Most common cause of UTls • Most common cause of traveler's diarrhea • Causes neonatal pneumonia, sepsis, and meningitis
8. Therapy and prevention. Antibiotic therapy is based on the site, severity, and sensitivity of the infectious organism. a. UTI is usually treated with Bactrim (sulfa + TMP) or a fluoroquinolone. b. Pneumonia, meningitis, and sepsis are commonly treated with a third-generation cephalosporin such as cefotaxime and/or an aminoglycoside.
KAPLAlf I meillea
289
Microbiology
c. Diarrheal syndrome is usually treated with fluids and electrolytes only. Bismuth subsalicylate inactivates and binds enterotoxins. G. Salmonella. Salmonella are motile (in contrast to Shigella) and do not ferment lactose. 1. Nontyphoidal Salmonella infections cause inflammatory diarrhea with fever and vari-
able septicemia. a. Infection is acquired through the ingestion of eggs, chicken, and other contaminated food or water. Contact with reptiles can also cause Salmonella. Nausea, vomiting, and diarrhea arise 8-24 hours after ingestion of contaminated food. b. In contrast to Shigella, a large inoculum (> 1 million cells) is needed to survive gastric acid and cause disease. c. Disease is more severe in children under the age of 10.
d. Septicemia is more likely to occur in infants or the immunocompromised. Organisms especially likely to cause septicemia include S. choleraesuis and S. enteritidis.
Note Unlike the other salmonellae,
5. typhi inhabit only the human colon.
e. Known virulence factors include antiphagocytic (Vi antigen) capsules, outer membrane protein adhesins, and LPS. LPS and outer membrane proteins prevent complementmediated killing during bacteremia. Also, the organism can grow within macrophages. 2. Typhoidal Salmonella infections are caused by Salmonella typhi and Salmonella paratyphi A, B, and CI. Typhoid or enteric fever is a progressive, subacute, febrile-wasting illness. It is common in developing countries, and the most severe manifestations occur in young children. a. Transmission is by ingestion of a large inoculum of bacteria in food or water contaminated by feces from a human. b. The intestine shows local inflammation with mucosal ulcerations and perforations. The organisms spread to the bloodstream and the reticuloendothelial system. c. LPS and other outer membrane proteins inhibit complement-mediated killing. Vi
Clinical Correlate Salmonella is the most common cause of osteomyelitis in sickle cell patients.
antigen, the polysaccharide capsule, inhibits phagocytosis and may contribute to the resistance of S. typhi to complement-mediated killing. d. Clinically, there are three phases of typhoid fever. (1) The first week is expressed as fever, lethargy, constipation, and pain. (2) The second week is when bacteremia occurs. Biliary and organ involvement arise along with a sustained fever with temperature/pulse dissociation (i.e., high fever, low pulse rate), abdominal pain, rose spots, and diarrhea. This period of time is when the gastrointestinal tract is reinfected. (3) With the third week, exhaustion and fever improve unless other complications arise. Complications of typhoid fever include relapse (20%), severe bleeding, thrombophlebitis, abscess formation, pneumonia, cholecystitis (in acute and chronic colonization), and death (2-10%). e. Treatment. Third-generation cephalosporins and fluoroquinolones are the drugs of choice in developed countries. Chloramphenicol is much cheaper and is still used in developing countries. Attenuated oral vaccines and killed parenteral typhoid vaccines are available for treatment. H. Yersinia pestis is discussed along with the other Gram-negative zoonotic organisms. Yersinia enterocolitica and Y. pseudotuberculosis both cause a gastrointestinal disease clinically indistinguishable from that caused by Salmonella or Shigella species. Symptoms include severe
abdominal pain (often mimics appendicitis), diarrhea, fever, and blood in the stool.
290
meClical
Bacteriology: Gram-Negative Organisms
Complications such as septicemia or hepatic abscesses are rare and occur in patients with underlying diseases such as diabetes, pre-existing liver disease, or neutropenia secondary to steroid therapy. Wild and domestic animals are the common reservoir for humans; hence, the disease has a sporadic occurrence although local outbreaks in families or school groups have been reported. Drug sensitivities are variable, so sensitivity testing should be done; most strains are susceptible to aminoglycosides and trimethoprim/sulfamethoxazole. I. Common opportunistic Enterobacteriaceae l. Genus Klebsiella are nonmotile, lactose-fermenting rods. The colonies appear large and
mucoid due to the presence of the large capsule. The major pathogen, Klebsiella pneumoniae, causes severe lobar pneumonia in individuals with underlying conditions such as alcoholism, diabetes, and chronic obstructive pulmonary disease. 2. Genus Proteus are highly motile organisms that cause urinary tract infections. On agar plates, motility can be visualized by swarming from the initial colony. Proteus species produce urease, which raises the urinary pH to levels that promote the production of struvite. These stones obstruct urinary flow and serve as a hiding place for the organism. Up to 10% of urinary tract infections are due to this organism. The two clinically important species are P. vulgaris and P. mirabilis. 3. Other genera of Enterobacteriaceae that are normal flora, but that can cause opportunistic infections, include Citrobacter (pyelonephritis), Enterobacter (pneumonia), and Serratia (pneumonia and UTIs).
Mnemonic The As of Klebsiella • Alcoholics • Aspiration pneumonia • Abscesses in the lungs
Klebsiella pneumoniae is sometimes characterized by thick, bloody sputum classically described as "currant jelly" sputum.
GRAM-NEGATIVE BACILLI: ADDITIONAL ENTERIC ORGANISMS A. Vibrios have a highly characteristic comma-shape morphology. They are oxidase positive, a feature that differentiates Vibrio from Enterobacteriaceae. They are naturally found in both fresh and salt water and in several cold-blooded animals. l. Vibrio cholerae is the most clinically important member of this group.
a. Pathogenicity is related to the presence of a pilus that mediates adherence to the small intestine epithelium. It is a noninvasive infection with clinical effects mediated by the enterotoxin (choleragen). The principal enterotoxin effect is an increase in intracellular cyclic AMP, resulting in electrolyte/fluid secretion into the small intestine lumen. There are two major enterotoxin subunits:
Note A related organism, Vibrio vulnificus, is associated with diarrheal disease, as well as wound infections acquired by fishermen, ocean swimmers, etc.
(1) A subunit, which promotes activation of adenylate cyclase. (2) B subunit, which binds toxin to small intestinal ganglioside receptor. b. Transmission is via fecal-oral spread from contaminated water and food. c. Clinical manifestations of cholera are severe, watery ("rice water") diarrhea (20 liters/day) with the loss of sodium, chloride, potassium, and bicarbonate. Other important clinical manifestations include nausea, vomiting and abdominal cramps, metabolic acidosis, and hypovolemic shock. The mortality rate without treatment is 25-50%.
d. Therapy and prevention includes rapid rehydration and electrolyte replacement. The antibiotic of choice is either tetracycline or doxycycline. It reduces the number of organisms, decreases diarrhea, and helps eliminate the chronic carrier state of an individual. 2. Vibrio parahemolyticus resembles V. cholerae structurally as a comma-shaped organism. It is halophilic, requiring at least 2% NaCl for growth. The 0 and K surface antigens are useful for serologic typing. KAPLAlf I meillea
291
Microbiology
a. Clinical manifestations are primarily diarrhea, attributed to ingestion of raw or improperly handled seafood (especially shellfish). The incubation period is 12-24 hours. Symptoms include explosive watery diarrhea (may be bloody), headache, abdominal cramps, fever, and vomiting. Septicemia may occur, particularly with underlying liver disease.
Note
Aeromonas and Plesiomonas are two other genera belonging to the Vibrionaceae family. Aeromonas hydrophilia lives in water and can cause gastroenteritis and wound infections. Plesiomonas shigel/oides is also associated with water sources and causes gastroenteritis.
b. Therapy and prevention. Mild disease is usually self-limiting, subsiding within 2-4 days, with no therapy required. For severe cases, fluid and electrolyte replacement and antibiotics are required. Organisms are usually sensitive to chloramphenicol, tetracycline, and cephalosporins. Adequate refrigeration of raw and cooked seafood aids in prevention.
B. Campylobacter and Helicobacter. Campylobacter are small, curved Gram-negative rods. Campylobacter jejuni is the most common cause of bacterial gastroenteritis in the United States. 1. C. jejuni is spread person-to-person via the fecal-oral route, but the primary route of infection is via consumption of undercoked poultry.
a. It is a primary pathogen that causes enterocolitis, an invasive enteritis with bloody diarrhea, crampy abdominal pains, malaise, and fever. b. Inflammatory proctitis is a clinical manifestation in homosexuals. c. Reactive arthritis may follow in individuals who have HLA-B27. d. It is gut flora of many domestic animals, including chickens, pigs, sheep, goats, and cattle. e. The antibiotic treatment of choice is either erythromycin or ciprofloxacin. 2. C. fetus is an opportunistic pathogen that causes bacteremia and metastatic infections in immunocompromised patients. a. In contrast to C. jejuni, it does not grow at 42°C and is resistant to nalidixic acid but sensitive to cephalothin. b. Once in the bloodstream, C. fetus can attach to the endothelium on blood vessel walls. c. The antibiotic treatment of choice is now imipenem.
In a Nutshell H. pylori and Proteus both produce urease and create an alkaline environment.
3. Helicobacter pylori is a spiral-shaped, motile rod that produces urease and surface adhesins that promote its pathogenicity.
a. The major reservoir is humans; however, Helicobacter can be found in the intestinal tracts of other mammals. b. H. pylori exhibits age-dependent colonization rates and familial clustering. For example, it is present in the gastric mucosa of fewer than 20% of people less than 30 years old but increases to greater than 50% of people over 60 years old. c. It lives in the gastric mucus in close proximity to the gastric epithelial cells. d. Colonization may be asymptomatic; however, there is a high association with idiopathic chronic and acute antral gastritis as well as duodenal ulcer (90%). Enhanced occurrence of gastric adenocarcinoma is also observed. e. Diagnosis can be made either noninvasively by serology or breath test, or invasively via endoscopy and biopsy. f. Therapy consists of bismuth salts, metronidazole and tetracycline, or amoxicillin for 2-4 weeks.
292
meClical
Bacteriology: Gram-Negative Organisms
C. Pseudomonas is a genus of Gram-negative rods that are widespread in soil and water. They
are also a minor component of the bowel flora. 1. Characteristics and physiology. The following characteristics are relatively simple ways
to distinguish pseudomonads from enterobacteria. a. All members of the genus Pseudomonas are oxidase positive. b. Pseudomonads are nonfermentors; they do not ferment sugars. c. Pseudo monads are motile due to polar flagella.
d. They produce large quantities of extracellular proteins, including toxins and enzymes. e. Pyocyanin pigment is an important product useful in the laboratory identification of the organism and gives the organisms a blue-green appearance. f. Humans are very resistant to infection with Pseudonomas species. More than one host defense must be breached for infection to occur. The major host defenses are intact body surfaces, normal bacterial flora, complement lysis, and killing by polymorphonuclear leukocytes. 2. Pseudomonas aeruginosa is the most important member of the genus. It is an important nosocomial infection in immunocompromised and chronically ill patients. a. It possesses many virulence factors, and no single factor is decisive for virulence. Virulence factors include: (1) Pili-adhesin (2) Slime layer capsule-antiphagocytic alginate capsule; seen mainly in cystic fibro-
sis patients (3) Endotoxin (4) Exotoxins A and S inhibit protein synthesis. Exotoxin A works by ADP ribosylating (inactivating) EF2 and thus shutting down host protein synthesis. This is the same mechanism used by diphtheria toxin, but the two toxins are unrelated. (5) Many enzymes (e.g., gelatinase, collagenase, phospholipase C, elastase); elastase is an important virulence factor because it allows the organism to invade blood vessels. Elastase allows P. aeruginosa to cause ecthyma gangrenosum. (6) R factors b. Risk groups incude immunocompromised patients and hospitalized patients with underlying disease. Groups at particular risk are radiation therapy patients, burn patients, patients with metastatic or metabolic disease, patients on prolonged immunosuppressive or antimicrobial therapy, patients with prior instrumentation or manipulation, and patients with cystic fibrosis. c. Clinical manifestations
(1) Wound and burn infections (2) Ecthyma gangrenosum-skin lesion with vascular invasion leading to hemor-
rhage and necrosis (excreted elastase is important in the development of this lesion). Usually seen in neutropenic patients. (3) Ear infections-otitis extern a (swimmer's ear, mild); in diabetics-malignant otitis externa (4) Pulmonary infections-especially in cystic fibrosis patients and the immunocompromised
meClical
293
Microbiology
(5) Corneal infections in contact wearers (6) Urinary tract infections d. Treatment will include antipseudomonal penicillin (e.g., ticarcillin, piperacillin) and aminoglycoside (e.g., tobramycin). 3. Pseudomonas pseudomallei are small, nonmotile, aerobic rods. The organism is a common soil inhabitant in Southeast Asia and is transmitted to humans through local abrasions or inhalation. It causes a disease called melioidosis that resembles glanders in equine animals. Recommended therapy for P. pseudomallei is ceftazidime.
ZOONOTIC ORGANISMS There are four genera of Gram-negative bacilli that are harbored by animal reservoirs: Yersinia, Francisella, Pasteurella, and Brucella. Borrelia, a zoonotic spirochete, is discussed in Chapter 9, Bacteriology: Spirochetes. A. Yersinia pestis is a member of family Enterobacteriaceae. It is a bipolar-staining, Gramnegative bacillus that can multiply intracellularly. "", 1. Pathogenesis. A virulence plasmid is responsible for intracellular survival and growth.
2. Transmission a. Animal reservoirs include rats, squirrels, prairie dogs, mice, cats, and rabbits. b. The organism is transmitted by infected fleas. c. In the United States, all plague cases have occurred in the Southwest. 3. Clinical manifestations. Disease can present with several clinical pictures. a. Bubonic plague is characterized by fever and a painful bubo caused by lymphadenopathy. b. Septicemic plague is characterized by fever and hypotension without bubo. c. Pneumonic plague presents with cough and hemoptysis. This form can be transmitted by respiratory droplets from human to human and is highly contagious with a high mortality rate (>90% if untreated). 4. Treatment and prevention a. Treatment consists of streptomycin or gentamicin with chloramphenicol or tetracycline as alternatives. b. A killed vaccine is available for travelers to endemic areas or those who work with the organism. B. Francisella
1. Characteristics. Francisella are small, nonmotile, Gram-negative coccobacilli with bipolar staining. They are aerobic organisms that require cysteine or cystine for growth. The clinically-important species is Francisella tularensis, the cause of tularemia.
2. Transmission. Francisella tularensis can be transmitted by the bite of an infected arthropod, usually a tick, or by direct contact with tissues and body fluids of infected animals. 3. Clinical manifestations. Tularemia is plague-like with lymphadenopathy and sepsis. Skin lesions often occur at the site of entry. They begin as a small papule, and progress to an ulcer with central necrosis.
294
meclical
Baderiology: Gram-Negative Organisms
4. Treatment and prevention. Antibiotic of choice is streptomycin. A live, attenuated vaccine exists for people at high risk.
e. Pasteurella 1. Characteristics. Pasteurella are nonmotile, Gram-negative coccobacillary and rod-shaped
organisms that exhibit bipolar staining. They are facultative anaerobes that live as commensals in the oropharynx mariyaflimals and birds.
of
2. Transmission. The human pathogen, Pasteurella multocida, is acquired from animal
bites, especially cat bites. 3. Clinical manifestations. Infections in humans are usually localized soft tissue infection
(cellulitis), the majority of which arise from bites. 4. Treatment consists of penicillin G with doxycycline as an alternative.
D. Brucella 1. Characteristics. Brucella are facultative intracellular parasites that can replicate inside
macrophages. Other animals are the primary hosts. The clinically important species and their primary hosts are B. melitensis (goats), B. abortus (cattle), B. suis (swine), B. ovis (sheep), and B. canis (dogs). 2. Transmission. Humans usually acquire the organism through handling infected animals, or through the ingestion of unpasteurized dairy products. It is typically an occupational
disease of farmers, veterinarians, butchers, and slaughterhouse workers. 3. Clinical manifestation. Symptoms of brucellosis are nonspecific, including fever,
headache, and arthralgia. If untreated, the fever begins to follow an undulating pattern, from which the disease takes its name, undulant fever. 4. Treatment and prevention. Treatment consists of ~o~~s:I~E~ phlS~~~!~~~~~" or§
RESPIRATORY PATHOGENS A. Haemophilus 1. Characteristics. Haemophilus are small, p~~~:p'~~.c."c~c<:~bacilli.
a. All species require factors X, V, or both. (1) X is defined as hematin or precursors from the cytochrome biosynthetic pathway. It is heat stable.
(2) V is nicotinamide adenine dinucleotide (NAD). It is heat labile.
(3) Haemophilus species are cultured on chocolate agar in which blood has been heated to release factor X. NAD is supplied by supplementation. (4) Alternatively, X and V can be added to the media, or blood agar plated with Haemophilus can be cross-streaked with Staphylococcus. Haemophilus species can grow near the Staphylococcus because the latter releases enough X and V for the needs of the Haemophilus. This is called satellitism. b. Many species of Haemophilus are normal flora of the human pharynx. c. The major pathogen of the group is Haemophilus injluenzae.
KAPLA~. I meulCa 295
Microbiology
d. Serotyping in Haemophilus inJluenzae is based on the polysaccharide capsules. There are six serotypes, designated a through f. Disease due to Haemophilus inJluenzae is caused chiefly by serotype b, which is composed of polyribosyl ribitol phosphate (PRP). This capsule type prevents phagocytosis of the organism. 2. Clinical manifestations. Diseases caused by Haemophilus inJluenzae type b include meningitis, otitis media, and epiglottitis. Primarily children under the age of 5 are affected. a. Meningitis. Until the development of a vaccine, Haemophilus inJluenzae type b was the most common cause of bacterial meningitis in the 3-month to 6-year age group. b. Acute epiglottitis occurs with rapid onset and can compromise the airway. c. Nontypable strains cause pneumonia and otitis media. Haemophilus ducreyi is the cause of the veneral disease chancroid. It is characterized by painful, nonindurated, ragged ulcers confined to the genitalia and perianal areas. 3. Treatment. Recommended treatment for Haemophilus inJluenzae includes cefotaxime or ceftriaxone for meningitis or epiglottitis, and amoxicillin plus clavulanate for non-lifethreatening illnesses. Resistance due to ~-lactamases is encountered in greater than 30% of isolates. 4. Prevention. A vaccine now exists for Haemophilus inJluenzae type b. PRP is conjugated to a carrier, such as tetanus toxoid or an outer membrane protein of N. meningitidis. This vaccine is given to children in four doses (2 months, 4 months, 6 months, and 15 months).
In a Nutshell
Pertussis toxin, cholera toxin, and the heat-labile toxin of E coli (LT) all work by ADPribosylation of G protein and the consequent increase in cAMP. There is a difference, however: cholera toxin and E coli heat-labile toxin act by activating the stimulatory unit of G protein (Gs); pertussis toxin acts by inactivating the inhibitory unit of Gprotein (G).
B. Bordetella 1. Characteristics. Bordetella are very small, Gram-negative fastidious coccibacilli. They are
strict aerobes. a. B. pertussis causes whooping cough, and B. parapertussis causes a relatively mild disease, parapertussis. b. B. pertussis contains many virulence factors. (1) Attachment to the host is mediated by pili, also called fimbriae or filamentous
hemagglutinins. (2) Toxins include pertussis toxin, adenylate cyclase toxin, tracheal cytotoxin, and lipopolysaccharide. Pertussis toxin blocks the inhibition of host cell adenylate cyclase by ADP-ribosylation of G inhibitory portion of G protein (GJ The resulting inactivation of Gi in effect stimulates adenylate cyclase, leading to an increased cAMP level in the cell. B. pertussis-encoded adenylate cyclase also enters mammalian cell membranes, raising the internal cAMP levels. It is responsible for the systemic manifestations of the disease, such as increased insulin sensitivity. Tracheal cytotoxin causes ciliostasis. c. Clinical manifestations. Whooping cough is the clinical manifestation of B. pertussis infection. This disease is highly communicable by the respiratory route, and humans are the only known reservoir. Whooping cough develops in three stages following an incubation period of 7-10 days. (1) Catarrhal or prodromal state occurs as a mild upper respiratory infection. (2) Paroxysmal cough, followed by the characteristic whoop on inspiration, then develops. Children may be anoxic, and vomiting may occur. (3) Convalescence is characterized by a slow decline in the "whoop." This stage lasts for months.
296 m~ical
---------~-
~----------------------
Bacteriology: Gram-Negative Organisms
d. The diagnostic gold standard is isolation of the organism on Bordet-Gengou agar. Direct fluorescein-labeled antibody detection has been developed as a rapid diagnostic alternative. e. Treatment and prevention. Erythromycin is the drug of choice for Bordetella pertussis infection. However, antibiotic treatment has no effect on the course of disease if therapy is begun after the catarrhal stage. The best protection is immunization. There are two vaccines for pertussis, a killed-cell vaccine and an acellular vaccine. The acellular vaccine was developed to avoid the other serious side effects of the killed-cell vaccine.
e. Legionella is a genus of Gram-negative bacteria that has over 40 species. The most important is Legionella pneumophila, a facultative intracellular parasite that uses the complement receptor to infect macrophages and then multiplies within the phagosome. It causes a wide spectrum of disease in humans. 1. Characteristics
Clinical Correlate We have now reviewed all three elements of the DPT vaCCIne: • Diphtheria • Pertussis
a. Legionella pneumophila is widely distributed in aquatic environments.
• Tetanus
b. It is an aerobic organism that requires iron and cysteine for growth. It will not grow on routine agar, but must have a buffered (pH 6.9) charcoal yeast extract agar instead.
DPT is administered in 5 doses:
c. Legionella pneumophila is flagellated, and positive for catalase, oxidase, gelatinase, and ~-lactamase. It also contains a high proportion of branched-chain fatty acids.
2. Transmission is by aerosols.
2 months, 4 months, 6 months, 15 months, and upon entry to school (4-6 years). DT boosters are recommended at lO-year intervals thereafter.
a. The source for humans is often air conditioning equipment, respiratory therapy devices, humidifiers, shower heads, or whirlpools. b. It is not transmitted person-to-person. c. Risk factors include immunocompromised status, alcohol abuse, and cigarette smok-
ing. 3. Clinical manifestations. Disease caused by Legionella pneumophila varies greatly in its intensity. Infection can be asymptomatic. a. Pontiac fever is a mild, febrile illness without pneumonia caused by Legionella pneumophila. b. It causes a mild, atypical pneumonia that may progress to Legionnaires disease. c. Legionnaires disease is a severe, often fatal, pneumonia.
4. Diagnosis. Direct fluorescent antibody staining is most commonly employed. Serology showing a four-fold rise in antibody titer is more useful in epidemiologic studies than clinical decision making. 5. Treatment. The drug of choice for Legionella pneumophila is erythromycin.
meCtical
297
Bacteriology: Anaerobes
Obligate anaerobes are bacteria that require a reducing environment. They cannot survive in an environment that contains oxygen because they are unable to detoxify the superoxide anion.
GENERAL CHARACTERISTICS A. Morphology and physiology 1. This group includes Gram-positive and Gram-negative cocci, bacilli, and coil-shaped
spirochetes that are often pleomorphic. 2. What unites these diverse organisms is the inability to detoxify the superoxide ion. The most essential enzyme in this process is superoxide dismutase. It catalyzes the conversion of the superoxide ion to hydrogen peroxide. The hydrogen peroxide can be further processed to water and oxygen through the action of catalase or peroxidase. Almost all obligate anaerobes lack these enzymes and hence require a reducing environment. 3. The greatest natural defense against anaerobic infection is healthy tissue that has a high oxidation-reduction potential and hence will not support the growth of the anaerobes. 4. Obligate anaerobes are normal inhabitants of anaerobic niches in the oral cavity, the vagina, and the gut. They can cause opportunistic infections in tissues adjacent to their normal habitat when they are displaced due to tissue injury or vascular compromise.
In A Nutshell Oxygen is toxic to obligate anaerobes because they lack superoxide dismutase and catalase/peroxidase.
B. Pathology 1. The primary pathology is frequently purulent malodorous abscess formation.
2. Culture of the abscess most often reveals a polymicrobial infection with multiple facultative and anaerobic species. C. Treatment. Therapy includes surgical drainage plus antibiotics. Penicillin G, clindamycin, metronidazole, and chloramphenicol are usually the most effective antimicrobials. Cefoxitin is also effective against most anaerobes.
ANAEROBIC GRAM-NEGATIVE BACILLI A. Bacteroides are the primary organisms of the colon, accounting for 30% of fecal isolates. Bacteroides are the most frequent cause of anaerobic infections and Bacteroides fragilis is the most common clinical infectious isolate.
meCtical
299
Microbiology
Clinical Correlate
1. Bacteroides fragilis is a Gram-negative, non-spore-forming, nonmotile bacilli.
Bacteroides are part of the
a. It inhabits the intestinal and genital tracts.
normal gastrointestinal flora. They can cause disease when there is a break in the surface of the mucosa.
b. It has four major virulence factors. (1) Unlike other group members, B. fragilis contains a polysaccharide capsule that is antiphagocytic and chemotactic. Capsular antigen alone can produce an abscess. (2) Because it is a Gram-negative organism, Bacteroides fragilis contains endotoxin (although it is much less toxic than the endotoxin produced by E. coli). Bacteroides fragilis also has the ability to deconjugate bile salts, making it resistant to bile. (3) It can produce a small amount of superoxide dismutase, allowing it to survive oxygen exposures for long periods of time.
(4) Bacteroides fragilis contains
~-lactamases
that confer resistance to penicillin.
c. Clinical manifestations include intra-abdominal infections, including abscesses and peritonitis. It is a primary cause of Gram-negative bacteremia. d. Therapy consists of metronidazole with clindamycin or chloramphenicol alternatives. Surgical debridement and drainage may be necessary to eradicate the organisms.
2. Prevotella melaninogenicus, formerly Bacteroides melaninogenicus, is a small coccobacilli that can be found primarily in the oral pharynx. a. On blood agar, it forms black pigmented colonies. b. The virulence factors of Prevotella melaninogenicus include an antiphagocytic capsule and collagenase. c. Prevotella melaninogenicus is an important agent in oral and pulmonary infections.
B. Fusobacteria are pleomorphic, Gram-negative rods with tapered ends. They normally inhabit the mouth, gastrointestinal tract, and female genital tract. 1. Fusobacteria do not have a capsule, but do possess an extremely potent endotoxin.
2. Fusobacterium nucleatum is the most common isolate. It is an important agent in oral infections, lung abscess, and other pleuropulmonary infections. 3. Fusobacterium necrophorum is often found in liver abscesses. It contains both a leukocidin and a hemolysin. 4. Most isolates of Fusobacterium are susceptible to penicillins, cephalosporins, and clindamycin.
ANAEROBIC GRAM-POSITIVE BACILLI A. Spore-forming. Clostridium species were discussed previously in Chapter 4, Gram-Positive Bacilli, in this section. B. Non-spore-forming 1. Propionibacteria normally inhabit the skin. These organisms may infect shunts and prosthetic devices, and are a cause of acne.
2. Actinomyces-see next chapter.
300
mectical
-------------------------.-------------------------------
Bacteriology: Anaerobes
ANAEROBIC COCCI A. Anaerobic Gram-positive cocci 1. Peptostreptococcus is the only genus of anaerobic cocci important in clinical infections.
a. They are almost always isolated from a mixed infection. b. As a group, they are frequently recovered from cutaneous, oral, respiratory, and female genital tract infections. c. Pep to streptococci are sensitive to penicillin, cephalosporins, clindamycin, and
metronidazole. B. Anaerobic Gram-negative cocci. Veillonella species are small bacteria that resemble the Neisseria species. Part of normal mouth, nasopharynx, and vaginal flora, they are rarely a cause of infection. They may be confused with Neisseria on Gram stain.
meclical
301
Bacteriology: Mycobacteria and Actinomycetes The mycobacteria are acid-fast bacilli notable for the high-lipid content of their cell wall. They are responsible for tuberculosis (M. tuberculosis), disseminated disease in AIDS patients (M. aviumintracellulare), and leprosy (M. leprae). Actinomycetes are Gram-positive organisms with a characteristic branching filament growth pattern that resembles fungi. These organisms are abundant in soil. The actinomycetes include two genera of clinical relevance: Actinomyces and Nocardia.
MYCOBACTERIA A. Mycobacterium tuberculosis 1. Characteristics
a. Obligate aerobes and Gram-positive acid-fast bacilli (AFB). Once stained, M. tuberculosis resists decolorization with an acidic alcohol rinse (hence the name acid-fast, based on ability to retain the stain). This property is dependent on the waxy lipid cell wall, which includes mycolic acids. The organism is facultatively intracellular (can grow inside of host cells). Mycobacteria often grow within monocytes and/or macrophages within the immune system. b. The cell wall contains lipoproteins or glycolipoproteins essential for tuberculin activity and confers the ability to induce type IV hypersensitivity reactions (DTH, delayed-type hypersensitivity). c. The organism expresses cord factor (trehalose-6,6-dimycolate), which correlates with
virulence. Cord factor inhibits leukocyte migration and stimulates immune responses (important in reactivation of disease).
~~id~e, . to.I.I1II11~~olC).1Y Type IV hypersensitivity reactions are discussed in detail in the Basic Immunology chapter of the Immunology section of this book.
d. M. tuberculosis is slow-growing, requiring 20-60 days before growth can be visualized; its doubling time is 18 hours. e. These organisms produce niacin, a characteristic that distinguishes them from other mycobacteria. 2. Antigenicity a. Purified-protein derivative (PPD) of the cell wall is the preferred antigenic material for skin testing. b. Amphipathic polar lipids in the plasma membrane (termed phosphatidyl inositol mannosides) are also immunogenic and serologically active.
c. Wax D, or muramyl dipeptide, is a heterogeneous group of peptidoglycolipids from the cell wall that elicit strong immune responses. KAPLA~. I meulca
303
Microbiology
3. Pathogenicity a. Cord factor is associated with virulence and characteristic serpentine grouping pattern that is seen in virulent strains. Cord factor inhibits polymorphonuclear leukocytic migration, elicits granuloma formation, and attacks mitochondrial membranes. b. Sulfatides are responsible for neutral red reactivity and act synergistically with cord factor. Sulfatides inhibit phagolysosomal membrane fusion in macrophages, thus protecting the microorganism from attack by the hydrolytic enzymes of the lysosome. 4. Epidemiology. M. tuberculosis is found only in humans. It is more common in lower socioeconomic groups. There has been a rapid, recent rise in cases in the U.S., partially related to the AIDS epidemic and to immigration patterns. 5. Transmission a. Occurs primarily through droplet nuclei inhalation. b. The most infectious person is one with untreated cavitary pulmonary tuberculosis who is actively expelling bacilli. c. The risk of infection is much greater than the risk of disease (i.e., more people are infected than have clinical disease) since disease may be related to weakened immune responses. 6. Pathogenesis is dependent on immunologic responses. First, delayed-type hypersensitivity (a T-cell immune response) occurs within 3--4 weeks after infection and correlates with positive tuberculin reaction. Acquired cellular immunity is associated with "resistance" or protection from reinfection.
Clinical Correlate The primary lung infection is usually found subadjacent to the pleura in the lower part of an upper lobe or in the upper part of a lower lobe of one lung. This localization reflects the areas receiving the greatest flow of air.
(1) Exudative type occurs when the organism is inhaled and spreads via alveolar macrophages to the hilar lymph nodes. Hematogenous dissemination may occur at this time; however, signs of infection are minimal and immune-competent hosts will successfully limit the organism to the pulmonary location. (2) Productive type is characterized by the tubercle forms (with or without caseation) and depends on the host's immune response. (3) The primary site of infection forms calcified lesions (referred to as Ghon complex). Delayed-type hypersensitivity develops and infection becomes quiescent in pulmonary as well as metastatic sites (the PPD test is now positive). Immunocompromised or debilitated patients may have progressive primary disease from local sites or more distant sites without the disease becoming quiescent. b. Secondary infection (reactivation) is usually localized, particularly in lung apices, due to the higher oxygen tension (P0 2 ). Tubercle formation occurs histologically with caseation, necrosis, and fibrosis. Secondary infection results from either a breakdown of quiescent foci or from new infection, despite the acquisition of cellular (T-cell) immunity.
Note Eighty percent of pulmonary TB cases in adults are due to reactivation of an infection acquired years or even decades earlier.
304
a. Primary infection
meClical
7. Clinical features of tuberculosis. The clinical presentation may include nonspecific constitutional symptoms such as fatigue, weight loss, anorexia, weakness, fever, and night sweats. a. Pulmonary TB. Eighty-five percent of cases are pulmonary, although infection may involve any organ of the body. Pulmonary disease may present with cough, hemoptysis, and pneumonitis.
Bacteriology: Mycobacteria and Actinomycetes
b. Miliary or disseminated masses develop anywhere, but some sites are favored, signifying an advanced stage of the disease. These favored sites include bone and joints (osteomyelitis), meninges (meningitis), kidneys, peritoneum, and lymph nodes. 8. Diagnosis a. Abnormal chest x-ray b. Acid-fast bacteria (AFB) in sputum; culture of M. tuberculosis on Lowenstein-Jensen medium c. Skin testing (1) PPD-S, the designated standard, containing 50,000 tuberculin units per mg of
protein (purified-protein derivative) is injected under the skin. Tuberculin tests should be read from 48-72 hours after intradermal injection. (2) The interpretation is based on diameter of induration and recorded in millimeters: ~5 mm in HIV-positive patients or in anyone with recent TB exposure; ~1O mm in high-risk populations (intravenous drug users, immunocompromised patients, those at the poverty level); ~15 mm in low-risk populations. (3) False negative reactions are usually the result of tuberculin injections too deep into skin. Other causes include the improper storage or handling of PPD, concurrent infectious diseases, or immunosuppression or anergy due to overwhelming infection, steroids, malignancy, etc. (4) False positive reactions are usually caused by hypersensitivity to mycobacteria other than M. tuberculosis. False positives can also result from previous immunization with BCG (Bacille Calmette-Guerin) vaccine (not administered in the United States, but widely used outside U.S.). (5) Diagnostically, a positive PPD test does not prove active disease only exposure. The tubercle bacilli must be isolated and identified in culture. Microscopic examination of a specimen stained with Ziehl-Neelsen or Kinyoun stain will give presumptive evidence of active disease if acid-fast organisms are seen. Cultures are then initiated by inoculation of either egg-potato-base media (LowensteinJensen) or agar-base media followed by incubation in 5-10% CO 2 atmosphere for 3-6 weeks. Unlike other mycobacteria, M. tuberculosis produces niacin. 9. Treatment. Therapy should be for a period of 6-9 months with a combination of at least three antituberculous drugs. If the patient is HIV-positive, therapy should be continued for a longer period (9-12 months). The emergence of drug-resistant strains, particularly in large metropolitan areas, is a growing problem that can best be controlled by sensitivity testing of the isolate from the patient. When resistance is detected, additional drugs (ethionamide, streptomycin, ciprofloxicin) may be added to the regimen.
10. Prevention a. Isoniazid (INH) prophylaxis of household contacts of patients with newly diagnosed active disease or treatment of recently converted (within the past two years) PPD-positive individuals. Children under 5 years of age are treated without exception while adults greater than 55 years old are generally followed clinically. Treatment of adults 35-55 years of age is based on the clinical risk of infection outweighing the risk of INH -induced hepatitis. b. BCG immunization. This treatment is given only to PPD-negative individuals in countries where incidence of tuberculosis is high. It is used to establish cell-mediated immunity to TB, although it must be remembered that individuals will become skin test-positive for PPD (thus eliminating its utility as a diagnostic tool). BCG is a live attenuated strain of Mycobacterium bovis.
Clinical Correlate Emergence of multiple-drugresistant strains has prompted the Centers for Disease Control to recommend four drug regimens. Currently, the drugs considered "first line" include: • Isoniazid • Rifampin • Ethambutol • Pyrazinamide KAPLA~.
meulCa
I
:505
Microbiology
B. Mycobacterium bovis 1. M. bovis is the etiologic agent of tuberculosis in cattle. It can also cause human TB, usu-
ally through the ingestion of unpasteurized, contaminated milk. 2. The most common clinical manifestations are lesions in the cervical and mesenteric lymph nodes with possible dissemination to the bones and joints. Pulmonary TB is also possible through the inhalation of infected droplets (for example, by dairy farmers). 3. In contrast to M. tuberculosis, M. bovis does not produce niacin. It will, however, result in a positive PPD skin test. 4. The BCG vaccine is derived from a live, attenuated M. bovis strain. C. Nontuberculous mycobacteria ("atypical"). The nontuberculous mycobacteria encompass
approximately 20 species, including M. kansasii, M. marinum, M. scrofulaceum, M. fortuitumchelonei and most importantly, M. avium-intracellulare. They cause mycobacteriosis. The agents of mycobacteriosis are not spread from human to human; they are environmental agents and found predominantly in immunocompromised individuals. 1. General characteristics of non-TB mycobacteria. There is no known primary animal
host. The organisms usually occur as natural inhabitants of the soil. 2. Non-TB mycobacteria are very diverse. a. Most are slow growers like the TB bacillus, but M. fortuitum has a growth rate equal to most other bacteria. b. M. avium and M. intracellulare are nonchromogenic, as is M. tuberculosis, but other species produce yellow pigments under particular growth conditions (e.g., M. kansasii develops pigmented colonies when grown in the presence of light). 3. Clinical manifestations a. Pulmonary disease is usually found in older white men with chronic bronchitis and emphysema. Pathogens include M. kansasii, M. avium-intracellulare, and M. fortuitum-cheloni complex. b. Lymphadenitis is caused by M. scrofulaceum and most commonly occurs in children. c. Cutaneous lesions are caused by M. marinum when this organism contaminates an open wound; the disease is called "swimming pool" granuloma. d. Disseminated disease can arise from M. kansasii or from M. avium-intracellulare, particularly in patients with acquired immunodeficiency syndrome (AIDS). 4. Treatment of nontuberculous mycobacterium. Many of the mycobacteria are resistant to the usual antituberculosis drugs. Antibiotic regimens may require as many as six drugs, including rifampin (which is quite effective against M. kansasii) and clarithromycin (good against M. avium-intracellulare complex). Surgical resection is also recommended on occaSIOn. D. Mycobacterium leprae
1. Species characteristics a. Cannot grow in vitro on any culture medium. b. Organisms are acid fast and induce a delayed-type hypersensitivity in patients. 2. Leprosy (Hansen disease) a. Leprosy is endemic in Mrica, South and Southeast Asia, and South America. Small endemic areas are found in the U.S. (Hawaii, Texas, California, Louisiana, and Florida).
306
meClical
Baderiology: Mycobaderia and Adinomycetes
b. Transmission is through contact with organisms from nasal secretions or ulcer exudates from infected individuals. Lesions classically involve the cooler regions of the body, including the skin of nasopharynx, cartilage, eyes, testicles, and larynx. Incubation period for the infection to progress to clinical disease is 5-7 years. c. Disease forms (1) Tuberculoid leprosy is indolent and nonprogressing. Clinical findings show mature granuloma in the dermis, which also contains epithelioid cells, giant cells, and lymphocytes (predominantly TDTh cells). Acid-fast bacilli are usually not found in lesions of the skin. Schwann cells are the targets of bacterial colonization. Nonspecific nerve damage occurs with asymmetric involvement. Tuberculoid leprosy reveals a positive lepromin skin test (cell-mediated immunity intact). (2) Lepromatous leprosy is a progressive and invasive disease. Pathologic examination shows foamy histiocytes with an absence of epithelioid and giant cells. Cellmediated immunity is suppressed (negative lepromin skin test) and T8lymphocytes infiltrate the skin lesions. Numerous acid-fast organisms are present in the lesions. Schwann cells are infected, but less nerve damage occurs in comparison with tuberculoid leprosy. Skin lesions are of an invasive and nodular nature. d. Immunity to M. leprae is mediated primarily by CD4+ T helper 1 cells. The disease is marked by a low infectivity rate and occurs more frequently in individuals with defective cell-mediated immunity. (1) Tuberculoid leprosy exhibits strong delayed-type hypersensitivity immune
responses where CD4+ T helper 1 cells infiltrate the skin lesions. (2) Lepromatous leprosy arises primarily in patients with a loss of cell-mediated immunity. Patients will be anergic (unresponsive) to skin testing with the antigen (i.e., no delayed-type hypersensitivity). There is a strong serologic (antibody) response marked by polyclonal hypergammaglobulinemia (T helper 2 response). e. Lepromin test determines the immunologic response or status of the patient. The test is not for diagnostic use and there is no serological test for diagnosis due to delayedtype hypersensitivity in the patient. f. Diagnosis is made by acid-fast staining analysis of scrapings from the affected skin or nasal mucosa. A biopsy of infected nerve or cartilage can be histologically diagnostic. g. Therapy requires long-term (3-5 years) antibiotic treatment to eradicate the organism. Tuberculoid leprosy responds to dapsone plus rifampin. Lepromatous leprosy is treated with dapsone plus rifampin and clofazimine. Close contacts should also be treated.
ACTINOMYCETES Actinomycetes (Actinomyces, Nocardia, Streptomyces) are characterized by their filamentous form. A. Actinomyces. Several species from this genus can cause actinomycosis. The most important
species are A. israelii and A. naeslundii. 1. Species characteristics a. A. israelii organisms are anaerobic, nonacid-fast, Gram-positive bacilli.
IlAPLAN"dme leaI
307
Microbiology
b. They are part of the normal oral flora (not found in soil) and are usually pathogenic only after oral trauma. 2. Clinical manifestations (termed actinomycosis) a. Cervicofacial actinomycosis causing lower jaw involvement following the development of dental caries (about 50% of actinomycotic infections) or after dental work. Pyogenic abscesses may develop with swelling, tenderness, and erythema (lumpy jaw). Granules consist of Gram-positive mycelial filaments surrounded by eosinophils and leukocytes. Osteomyelitis (bone infection) is a frequent occurrence. Chronic, poorly healed oral cavity abscess will spread by direct extension. Fortunately, the incidence of oral actinomycosis is declining due to improved oral hygiene practices. b. Thoracic actinomycosis is caused by the extension from cervicofacial infection in approximately 20% of cases. c. Abdominal actinomycosis is due to traumatic perforation of the intestinal mucosa (approximately 20% of cases), such as a ruptured appendix or perforated ulcer.
d. Pelvic actinomycosis arises in women with intrauterine devices. The organism may simply colonize the tissue or produce infection. 3. Diagnosis is made by examination of secretions or tissues for granules. Crushed "sulfur granules" contain Gram-positive, nonacid-fast rods. Actinomycetes are grown anaerobically in thioglycolate broth. 4. Therapy consists of penicillin or ampicillin for several weeks. Infection may require surgical drainage because antibiotics achieve poor penetration through abscesses. B. Nocardia. N. asteroides is the most common isolate found in soil and aquatic environments. 1. Characteristics. Nocardia species are aerobic, Gram-positive, partially acid-fast, filamen-
tous organisms. 2. Clinical manifestations (nocardiosis) a. Half of patients have underlying disease. It is an opportunistic infection in patients with hematological malignancies or immunodeficiencies. Seventy-five percent of cases occur in males.
In a Nutshell
• Actinomyces is an anaerobe; Nocardia is not. e
Nocardia is partially acidfast; Actinomyces is not.
b. Infection begins as a chronic lobar pneumonia following inhalation of the organism and may be subclinical. c. The central nervous system (brain) is the most common site of metastatic infection, occurring hematologically. The kidneys and skin may also become involved (in metastatic infection). Abscess formation is the most common pathologic finding.
3. Diagnosis is determined from the evaluation of histological appearance of specimens, culture, and modified acid-fast stain. 4. Treatment is usually with sulfonamides and may require surgical drainage of abscesses.
308
meClical
Bacteriology: Rickettsiae and Chlamydiae Rickettsia and Chlamydia are obligate intracellular parasites. Rickettsial diseases include Rocky Mountain spotted fever, typhus, cat scratch disease, and Qfever. Chlamydia species are responsible for ocular trachoma and are the number one bacterial cause of sexually transmitted diseases in the United States.
RICKETTSIACEAE A. General characteristics and physiology
1. Rickettsiaceae are a family of small, pleomorphic Gram-negative coccobacilli. They Gram stain poorly but can be stained using the Giemsa or Macchiavello methods.
2. The Rickettsiaceae family comprises four main genera: Rickettsia, Bartonella, Coxiella, and EhrZichia. The members of the family share several unique characteristics. a. All members are transmitted by arthropods, except Bartonella (where direct contact is the mode of transmission) and Coxiella burnetii (acquired by humans primarily through aerosol inhalation). b. Most species are obligate intracellular parasites of endothelial cells (Rickettsia) or leukocytes (other genera). c. Most cause zoonotic disease with humans as an accidental host. Chlamydia trachomatis is the exception; it is a human pathogen with no reservoirs. d. All are susceptible to tetracyclines (e.g., doxycycline). 3. Each genus has a set of common pathogenic features associated with the diseases caused by its members. a. The genus Rickettsia is disseminated through the bloodstream, causing vasculitis, thrombosis, and capillary leaks leading to the characteristic rash. Release of the endotoxin leads to fever, disseminated intravascular coagulation, and shock. b. Coxiella burnetii acute disease presents as pneumonia. Rare chronic infections include hepatitis and endocarditis. c. EhrZichia invasion of PMNs and monocytes causes leukopenia. Thrombocytopenia is
also seen. The acute symptoms resemble Rocky Mountain spotted fever, but a rash is far less common; often seen as coinfection with Lyme disease. d. The Bartonella organism invades the blood and lymphatic vessel walls and causes local lymphadenopathy and angiomas.
IlAP~~.
I
m.ulC8
309
Microbiology
Note
B. Rickettsial diseases
Tick-borne infections can include bacteria from other groups, including Borrelia burgdorferi, human granulocytic ehrlichiosis (HGE), and Babesia. Also, ticks may carry one or more of these organisms at the same time
Clinical Correlate Lesions in the palms of the hands and the soles of the feet are valuable clinical clues. Causes include RMSF, meningococcemia, and secondary syphilis.
1. Rocky Mountain spotted fever (RMSF) is caused by R. rickettsii and accounts for 95% of
rickettsial diseases in the United States. a. Epidemiology. RMSF is found throughout the United States, particularly in the south central and eastern portions of the country. b. Transmission. The arthropod vectors of R. rickettsii are various species of ticks. The bite of the infected tick transmits the organism. The reservoirs for the agent include rodents, dogs, and ticks. c. Clinical features (1) After a 3-12 day incubation period, the disease begins with malaise, frontal headache, and fever.
(2) Skin manifestations appear within 2-4 days after onset of symptoms. Initially, a maculopapular rash appears on the hands and feet (including palms and soles) and spreads centripetally to involve the trunk. The rash will initially appear petechial, but may coalesce to become hemorrhagic. (3) Other manifestations may include splenomegaly, hepatomegaly, thrombocytopenia, and disseminated intravascular coagulation. 2. Epidemic typhus (louse-borne typhus) is caused by Rickettsia prowazekii. a. Transmission. The agent is transmitted by the human body louse. Rickettsia prowazekii are found within the louse feces and enter individuals via skin excoriations. The louse is the vector, but not a reservoir, for Rickettsia prowazekii (humans are the primary reservoir). b. Clinical features are similar to those of RMSF but the rash is less prominent and spares the palms and soles. c. Brill-Zinsser disease is the recurrent form of R. prowazekii infection. R. prowazekii can remain dormant in lymph nodes, and the individual is asymptomatic during the intervening time period. Years after the primary attack, a milder form of the illness may occur. Symptoms include headache, myalgia, and malaise with an erratic fever. 3. Endemic or murine typhus is caused by R. typhi cycled by the rat and its ectoparasites (through feces). a. Transmission. The rat flea is the most common vector. It becomes infected when it feeds on the reservoir-the rat-during the acute part of the rat's illness. Organisms are passed in the flea feces, and can be scratched in at the site of the bite. b. Clinical manifestations are similar to but less severe than in epidemic typhus. 4. Scrub typhus is caused by Orienta (formerly Rickettsia) tsutsugamushi. It occurs endemically in Japan, China, Southeast Asia, Australia, the South Pacific Islands, and the Asian subcontinent. a. Transmission. O. tsutsugamushi is transmitted by mites (chiggers). Since there is transovarial passage of the organism, the mite is a reservoir as well as the vector. Other reservoirs include rats, field mice, and shrews. Humans are accidental hosts. b. Clinical features. Clinically, the disease resembles epidemic typhus. 5. Q fever is caused by Coxiella burnetii.
310
meClical
Baderiology: Rickettsiae and Chlamydiae
a. Transmission. Q fever does not have an arthropod vector in the human disease cycle. It is spread mainly by inhaling infected dusts, by handling infected hides or tissues, or by drinking milk contaminated with Coxiella burnetii. The organism is widely distributed in nature. Reservoirs include ticks, small wild animals, sheep, cows, and goats. b. Clinical features (1) Q fever is characterized by vague symptoms such as fever and chills, headache, malaise, and myalgia. It is unique among the Rickettsial diseases in that it does not cause a skin rash. (2) Many cases are asymptomatic or present with a self-limited febrile illness. (3) The classic presentation of the disease is as a pneumonia with fever and no pulmonary symptoms. Atypical pneumonia and a rapidly progressive pneumonia also occur.
Note
(4) Chronic Q fever can manifest as myocarditis or hepatitis. 6. Human ehrlichiosis is caused by Ehrlichia chaffeensis. It has a tick vector. The clinical course can range from asymptomatic to fatal. The classic presentation includes fever, headache, and myalgia. Important laboratory features are leukopenia, thrombocytopenia, and anemia. Fewer than half of patients develop a rash. It is commonly found as a coinfection with Lyme disease because it is spread via the same tick vector. 7. Bartonella henselae causes cat scratch disease (a benign local lymphadenopathy that follows contact with cats) and bacillary angiomatosis. The latter occurs in AIDS patients and is characterized by proliferative vascular lesions in the dermis (resembles Kaposi sarcoma) and internal organs. C. Diagnosis of rickettsial disease
1. The diagnosis is based on clinical presentation and epidemiological information. Due to the danger of infection to ancillary personnel, Rickettsiaceae are cultured in reference laboratories. 2. Diagnosis is most often aided by serology using convalescent serum to detect IgM- and IgG-specific antibodies to Rickettsiaceae. A four-fold or greater increase in antibody titers between acute and convalescent serum supports acute infection. The obvious disadvantage of this method is that serologic evidence of infection occurs no earlier than the second week of illness.
Q fever is an outlier among the Rickettsiaceae:
• It does not have an arthropod vector. • It does not cause a rash. • It does not elicit a positive Weil-Felix test.
In a Nutshell Organism R. rickettsii
Vector Tick
Disease Rocky Mountain spotted fever (think rashpalms/soles moving to trunk)
R. prowozekii Louse
Epidemic typhus (think rash-trunk spreading to extrem ities)
R. typhi
Flea
Endemic (murine) typhus
a. Patients with rickettsial disease will have antibodies that react with Proteus vulgaris antigens and will agglutinate these organisms.
O. tsutsugomushi
Mite
Scrub typhus
b. The procedure is simple and inexpensive but lacks specificity for Rickettsiaceae.
£ choffeenis Tick
Ehrlichiosis
C. burnetii
Qfever (no
3. Some hospital and public health laboratories use direct immunofluorescence to demonstrate organisms in skin biopsy specimens. 4. These Rickettsia-specific techniques have largely replaced the Well-Felix test. This test is based upon cross-reactions between anti-rickettsial antibodies and Proteus polysaccharide o antigen (Proteus OX-19 and OX-2).
c. Coxiella burnetii does not elicit a positive Weil-Felix test. D. Treatment. Treatment with antibiotics has greatly reduced the morbidity and mortality due to rickettsial infections. Whereas all rickettsial diseases were traditionally treated with tetracycline, newer antibiotic regimens include doxycycline, ciprofloxacin, or chloramphenicol for Rickettsia and Ehrlichia. Coxiella burnetii can be treated with doxycycline or ciprofloxacin.
None
rash!)
B. hense/oe
None
CJt scratch fever and bacillary angiomatosis
meltical
311
Microbiology
CHLAMYDIAE A. General characteristics and physiology 1. Chlamydiae are obligate intracellular parasites infecting birds and mammals.
2. They possess a gram-negative envelope that contains a genus-specific lipopolysaccharide but lacks muramic acid. 3. Their genome is very small, so they lack the capacity to carry out many metabolic pathways, including the production of ATP. This makes them dependent upon their host for energy. 4. Three species of Chlamydia are pathogenic for humans: Chlamydia trachomatis, Chlamydophila psittaci, and Chlamydophila pneumoniae (TWAR).
In a Nutshell Life Cycle of Chlamydia Elementary body (EB): • Extracellular • Infectious • Cannot multiply • Enter cells through endocytosis Reticulate body (RB): • Intracellular • Can undergo binary fission
5. The life cycle of Chlamydia contains morphologically distinct infectious and reproductive forms. The infectious form is known as the elementary body (EB). It is incapable of multiplication. The intracellular form capable of binary fission is called the reticulate body (RB). This form is not infectious. a. The first step is the attachment of the elementary body to the host cell and endocytosis without lysosomal fusion. b. Next, the elementary body is transformed into the reticulate body inside an endosome. c. Eventually, the reticulate bodies undergo DNA condensation and disulfide bond
bridgings of the major outer membrane protein (MOMP) to form EBs from RBs. Shortly thereafter, the elementary bodies are released by cell lysis. B. Chlamydia trachomatis. Chlamydia trachoma tis is transmitted by fomites, sexually or perinatally. It infects humans only. Infected cells develop oval vacuolar inclusions that contain glycogen and hence will stain with iodine. 1. Clinical features a. Ocular trachoma is the leading cause of blindness in developing countries. It is caused by repeated infections that result in chronic conjunctivitis, leading to scarring, eyelid deformities, and progressing to pannus formation and total blindness. It is associated with serovars A, BI and B2 , and C. b. Inclusion conjunctivitis (1) In infants, it is associated with maternal genital infection. If untreated, it may develop into pneumonia. (2) Adult conjunctivitis is often associated with contaminated swimming pools and hot tubs. (3) Associated with serovars D-K. c. Reiter syndrome is strongly associated with genitourinary or gastrointestinal infection with C. trachoma tis. Reiter syndrome is characterized by conjunctivitis, urethritis, and
reactive arthritis. d. Sexually transmitted diseases. C. trachoma tis is the number one cause of bacterial STDs in the U.S. (1) In men: nongonococcal urethritis, epididymitis, prostatitis, and proctitis. Associated with serovars D-K.
312
meClical ~-.----------
- - - - -
Baderiology: Rickettsiae and Chlamydiae
(2) In women: cervicitis, urethritis, salpingitis, and pelvic inflammatory disease. Associated with serovars D-K. (3) Lymphogranuloma venereum (LGV) is a venereal disease. LGV is more common in males and blacks. There are three antigenic types (Ll, L2, L3) differentiated by immunofluorescence. The primary lesion is a painless, vesicular site on any part of the genitalia, anus, or rectum. The lesion becomes painful and suppurative and can spread into the inguinal and femoral lymph nodes. 2. Treatment and prevention. C. trachomatis has been traditionally treated with tetracyclines or erythromycin. Its spread can be minimized through improved hygiene and safe sexual practices. C. Chlamydophila psittaci. Chlamydophila psittaci is transmitted by inhalation of the organ-
isms from infected birds and their droppings. 1. Risk factors. Anyone coming in contact with an infected bird is at risk, but those that have close contact with birds such as veterinarians, pet store employees, poultry farmers, or bird handlers are at an increased risk. 2. Clinical features. The disease has a 5-15-day incubation period. Severity of the illness ranges from asymptomatic disease to a fatal systemic illness with severe pneumonia.
In a Nutshell C
trachomatis
• Obligate intracellular parasites; cytoplasmic inclusions stain with iodine. • Diseases - Trachoma (serovars A-C) - Neonatal conjunctivitis and pneumonitis (serovars D-K) - Ongonococcal urethr~is (D-K) - Cervicitis, salpingitis, PID (D-K) - Lymphogranuloma venereum (L 1-L3)
a. Pulmonary symptoms include a nonproductive cough and rales. The pulmonary exudate is predominantly monocellular and chest x-ray suggests atypical pneumonia or bronchopneumonia.
In a Nutshell
b. CNS manifestations are characterized by severe frontal headaches. Toxic encephalitis may occur, leading to death.
C psittaci.
D. Chlamydophila pneumoniae. Chlamydophila pneumoniae (formerly TWAR) is a humanonly pathogen that is believed to be transmitted by inhalation. This organism is a cause of pharyngitis, bronchitis, and a relatively mild atypical pneumonia, although life-threatening infections have occurred. E. Diagnosis of chlamydial diseases 1. Chlamydia trachomatis can be identified through cell culture, serology, antigen detection,
or nucleic acid hybridization. Inclusion bodies can be detected in cell culture after staining with Giemsa, Macchiavello, or Gimenez stain, or by using immunofluorescence. 2. Chlamydia psittaci is cultured in reference laboratories. F. Treatment. The drugs of choice for chlamydial infections are tetracyclines (doxycycline) or
erythromycins.
Birds + pneumonia, think
Note Epidemiologic studies have also associated atherosclerosis and coronary artery disease with antibody to
Chlamydophila pneumoniae, and this organism has been found in plaques of coronary arteries. However, its role in the pathogenesis of atherosclerosis is still unknown.
KAPlAN'iII me 1C8
313
Bacteriology: Spirochetes The spirochetes are motile, helically coiled organisms that divide by transverse fission. Spirochetes contain an axial fibril, an outer sheath, a protoplasmic cylinder (cell wall and membrane), and cytoplasm. There are three genera of spirochetes that can cause disease in humans: Treponema (syphilis, yaws, pinta, bejel), Borrelia (Lyme disease, relapsing fever), and Leptospira (leptospirosis). This chapter focuses primarily on the two most clinically relevant spirochetes: Treponema pa//idum, the etiologic agent of syphilis, and Borrelia burgdorferi, the tick-borne cause of Lyme disease.
TREPONEMA A. Treponema pallidum is the most important species. It has a capsule-like outer coat and a tapered end. Organisms are highly motile and constantly rotate about an axial filament. An important characteristic is that T. pallidum does not grow on artificial media and therefore cannot be cultured in the laboratory. T. pallidum is the etiologic agent of syphilis. 1. Transmission and epidemiology a. Syphilis is primarily a sexually transmitted disease. It can also be transmitted across the placenta and rarely, from blood transfusions. b. Risk groups include individuals with multiple sex partners and infants born to infected mothers. 2. Clinical manifestations a. Primary syphilis arises within 2-10 weeks following exposure. Organisms spread locally from the site of inoculation to the lymph nodes and bloodstream. A chancre forms at the site of inoculation. Initially, the chancre is a firm, painless reddish lesion with a raised border. The center usually erodes into an ulcer that heals within 3-6 weeks without scarring. The chancre contains numerous spirochetes. Symptoms may be overlooked in females owing to poor visualization of the genitourinary tract. Lymph nodes may be enlarged but nontender. If untreated, disease progresses to the secondary stage. b. Secondary syphilis occurs 1-3 months following primary syphilis. Symptoms represent disseminated disease and commonly include rash, fever, sore throat, headache, and generalized lymphadenopathy (especially in the epitrochlear region). White patches occur on mucous membranes (condylomas). Condyloma lata occur in moist areas, including the anus, vagina, axilla, and mouth. These lesions are highly infectious and are teaming with Treponema.
Clinical Correlate The rash of secondary syphilis appears on the palms of the hands and the soles of the feet (as in Rocky Mountain spotted fever and meningococcemia).
meClical
315
Microbiology
----~----------------------~--------------- -~-----
c. Latent syphilis develops in 30-40% of infected individuals. Mucocutaneous relapses are most common, with the lesions remaining infectious. After two years, contagious lesions rarely develop. d. Tertiary (late) syphilis arises in approximately 30% of untreated cases of primary syphilis. (1) Benign tertiary syphilis is marked by indolent granulomatous lesions (gummas) in the skin, mucocutaneous tissue, liver, or skeletal system. Spirochetes are rarely seen. (2) Cardiovascular syphilis is manifested as aortitis and occurs 10-20 years after untreated primary disease. Medial necrosis can occur with the destruction of elastic tissue. Saccular or fusiform aneurysms may develop and rarely dissect. (3) Neurosyphilis. Can occur more than 20 years after the initial infection. One or more CSF abnormalities may be apparent, including pleocytosis, elevated protein, or decreased glucose. Other neurologic symptoms are ''Argyll-Robertson pupils" and tabes dorsalis. In the former condition, the pupil constricts on accommodation but fails to react to light. Tabes dorsalis, or the demyelination of posterior columns, causes the loss of proprioception. Tabes dorsalis is observed as a widebased gait with long "slapping" motions of legs upon ambulation. e. Congenital syphilis results from the transplacental transmission of spirochetes to the developing fetus. It most commonly occurs if the mother has primary or secondary disease. There is approximately 25% mortality if left untreated, with a high incidence of spontaneous abortions and stillbirths. Adequate treatment of the mother will prevent disease in the fetus. Early manifestations in the newborn include hepatosplenomegaly, hemolytic anemia, pneumonia, skin lesions, and snuffles (obstructed nasal breathing). Late manifestations may include Hutchinson triad (abnormal teeth, interstitial keratitis, eighth-nerve deafness), saddlenose deformity, mulberry molars, and central nervous system and developmental abnormalities. 3. Serology diagnostics use two methods of analysis: antigen nonspecific and antigen spe-~ cific. Whereas darkfield microscopy can be used to visualize organisms from lesions, these serologic tests are the most common method of diagnosis. a. Nontreponemal tests use cardiolipin as the antigen and can be performed as a complement fixation (CF) test or as a flocculation test (called VDRL or RPR assays). (1) Patients' antibodies are of the IgM and IgA class and are termed reaginic antibodies. The CF test will fix (consume) complement if the IgM reaginic antibodies are present and combine with antigen. (2) The flocculation test causes lipid antigen to clump when combined with reagin. Tests are positive within 2-3 weeks after infection and revert to negative 6-18 months after appropriate treatment. (3) False positive reactions are an important problem with these serologic tests. The tests may show false positive results using serum from patients with other acute illnesses such as pneumonia, hepatitis, vaccination, viral exanthems, and collagen vascular diseases. Some drugs can also cause a false-positive VDRL. b. Fluorescent antibody tests (fluorescent treponemal antibody, FTA) are specific for treponemal antigens. The assay detects specific antibodies and is used for the confirmation of positive nontreponemal tests. Once positive, it remains positive for life and therefore cannot be used to monitor therapeutic response.
316
meClical
Bacteriology: Spirochetes
4. Treatment and prevention a. Long-acting benzathine penicillin is used for early syphilis, and penicillin G is still used for urogenital late syphilis. b. Erythromycin, tetracycline, and ceftriaxone are less-suitable alternatives. c. Long-term follow-up is required to see that reaginic antibody serology decreases. d. Spread can be minimized through use of safe sexual practices. e. Like gonorrhea, cases of syphilis must be reported to the Board of Health. f. Many patients with secondary syphilis have a Jarisch-Herxheimer reaction (fever, headache, and myalgia) 2-12 hours after penicillin G therapy. It is caused by spirochete lysis and release of endotoxin. Plasma concentrations of tumor necrosis factor IL-6 and IL-8 are increased. B. Other treponema! diseases 1. Yaws is caused by T. pertenue in the tropics and is transmitted by direct contact. It is main-
ly a disease of children and is manifested as a painless erythematous lesion usually on the arm or leg. 2. Pinta is caused by T. carateum and is acquired by person-to-person contact, rarely via sexual transmission. 3. Bejel is caused by T. pallidum subspecies endemicum. Poor hygiene plays a role and is responsible for endemic syphilis in the Middle East, Africa, and Southeast Asia. Transmission is by direct contact; skin lesions are highly infectious.
BORRELIA A. Genera! characteristics 1. Borrelia species are transmitted by arthropods (ticks) to humans.
2. Borrelia species are coarse, irregular coils that are very flexible and motile. They can be visualized with light microscopy using Wright or Giemsa stains. Silver stains like WarthinStarry are also useful.
B. Lyme disease 1. Transmission and epidemiology. Lyme disease is caused by Borrelia burgdorferi. a. The organism resides in tick vectors (Ixodes) that have fed on infected deer or mice reservoirs. b. The highest incidence of disease is found during the spring and summer when the nymph and adult stages of the tick require blood meals. c. The disease was first described in Lyme, Connecticut, and is now found throughout the U.S. and in Europe and Australia.
d. It is not uncommon for the patient to have no memory of a tick bite. 2. Clinical manifestations a. The hallmark initial finding is erythema chronicum migrans (a red macule, progressing to annular erythema with central clearing, "bull's-eye") at the site of the tick bite. The rash occurs within the first 10 days of infection and fades within 3-6 weeks. Infection, however, is still active. Constitutional symptoms include fever, headache, malaise, myalgias, adenopathy, and mild meningeal irritation. These early symptoms
meClical
317
Microbiology
typically last for approximately 4 weeks. b. Untreated infection may lead to late neurologic and cardiac disease. (1) Neurologic symptoms include severe headaches, meningitis, cranial nerve palsies (Bell palsy), and painful peripheral neuropathies. These symptoms resolve after several months. (2) Cardiac symptoms include fluctuating cardiac arrhythmias (resolving after several weeks), myocarditis, and pericarditis. c. Late-stage disease is marked by arthritis, occurring weeks to years after disease onset.
3. Diagnosis of Lyme disease is made from the clinical picture and a history of tick bite or exposure, in combination with laboratory identification by serology. a. Spirochetes have been seen in CSF, synovia, blood, and skin lesions, but culture is difficult. b. Serology is marked by a peak in IgM in the third to sixth week (followed by IgG) typically determined by ELISA assays. Because of the frequency of false positives, a Western blot is used to confirm the diagnosis. 4. Therapy consists of doxycycline for early disease; also amoxicillin, cephalosporins, and erythromycin. High-dose intravenous penicillin is used for cardiac, neurologic, and arthritic complications. Ceftriaxone is effective in refractory cases. C. Relapsing fever is named for its numerous antigenic shifts and variations. It is caused by B.
recurrentis and is transmitted by the human body louse. 1. Clinical manifestations a. The incubation period is approximately one week (3-10 days) and is marked by the acute onset of high fever, severe headache, myalgia, photophobia, cough, and meningismus. Symptoms are associated with spirochetes in the bloodstream. b. The initial fever lasts 3-6 days and can be associated with hemorrhage, rash, and neurologic manifestations. c. The initial fever is followed by an afebrile period of 4-10 days. d. Subsequent fevers are less intense and last a shorter period of time. Antigenic shifts occur during this time. The afebrile times allow a new virulent variant to emerge and cause disease. 2. Diagnosis is made by the observation of spirochetes by darkfield microscopy, or by Giemsa-stained or Wright-stained blood smears of febrile patients. 3. Therapy. Treatment with tetracycline or erythromycin rapidly leads to recovery.
LEPTOSPIRA A. General characteristics
1. Leptospira species are visible by darkfield microscopy and appear as a tightly coiled spiral with right angle hooks at both ends. 2. Two principal species exist. a. L. interrogans is pathogenic and includes many of the serovarieties that cause leptospirosis.
318
meclical
Bacteriology: Spirochetes
b. 1. biflexa are the saprophytic or water forms. B. Pathogenicity is mediated by a thermolabile hemolysin produced by virulent strains. Some
strains contain small amounts of endotoxin. C. Transmission and epidemiology
1. Domestic animals (dogs, sheep, goats, cattle, horses, etc.) and rats are major sources for human infection. Ingestion or contact with water contaminated by urine from infected reservoirs is the primary mode of infection.
2. Leptospira enters the host through broken skin or mucous membranes. 3. The organism is an occupational hazard for farmers, veterinarians, abattoir workers, and hunters and jet skiiers. D. Leptospirosis
1. Leptospirosis occurs within a lO-12-day incubation period. The clinical expression is marked by an abrupt onset of fever, chills, headache, conjunctival suffusion, gastrointestinal complaints, and myalgia. At this stage, spirochetes enter the bloodstream. It is a biphasic illness.
a. The first leptospiremic stage is approximately 1 week in duration. The Leptospira infect organs, especially the liver and kidneys, leading to jaundice, bleeding, and uremia. The termination of fever and leptospiremia corresponds with a humoral immune response to the organism. b. The second stage usually occurs about 2 days after the fever disappears and lasts 4-30 days. The second stage is associated with a rise in IgM titers. Aseptic meningitis, hepatitis, nephritis, uveitis, myositis, and rash may develop. 2. Weil syndrome (icteric leptospirosis) is hepatitis associated with elevated CPK. Renal failure occurs as a result of tubular damage; glomeruli usually remain unaffected. 3. Diagnosis is made by the isolation and culture of organisms from blood or CSF in the first stage of illness. a. Direct examination is performed by darkfield microscopy and must be done early in infection. b. Serologic responses peak 5-8 weeks after acute illness. A rapid screen can be performed by a slide agglutination test. E. Treatment and prevention. Treatment includes penicillin, tetracycline, and macrolide antibiotics. A vaccine is available for at-risk individuals.
meClical
319
Bacteriology: Mycoplasma and
Ureaplasma Mycoplasmataceae are the smallest free-living organisms. They are prokaryotic cells resembling Gramnegative bacteria, but they lack the cell wall. The family contains the genera Mycoplasma and Ureaplasma. The organisms are classed into one or the other genus based on the ability to hydrolyze urea. The species of medical importance in humans are Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum. Disease in humans involves the respiratory and urogenital tracts.
MYCOPlASMATACEAE A. General characteristics and physiology 1. Morphologically, they are filamentous and pleomorphic. They lack cell walls and are
therefore penicillin resistant. 2. They are facultative organisms that are mainly fermentative.
3. They grow very slowly, and may require up to 3 weeks to visualize colonies on agar. 4. These organisms are unique among the prokaryotes because they require sterols for
growth and their cell membranes contain cholesterol. B. Mycoplasma pneumoniae 1. Epidemiology and transmission. Mycoplasma pneumoniae is found throughout the world. Transmission occurs via aerosol droplets. Clinical illness is more likely in ages 5-20. 2. Pathogenesis. Once in the upper respiratory tract, Mycoplasma pneumoniae are found
among the cilia of the epithelial cells. They attach by way of neuraminidase-like adherence protein to a sialic acid containing glycoprotein on the host cell. Oxidants produced by the organism, especially hydrogen peroxide and the superoxide ion, injure the mucosa. 3. Clinical manifestations. M. pneumoniae is the most common cause of pneumonia in
young adults (walking pneumonia). a. Frequent clinical manifestations of this atypical pneumonia include nonproductive cough, low-grade fever, and an insidious headache. b. Nonpurulent otitis media or bullous myringitis occur in about 20% of patients with mycoplasmal pneumonia. The presence of these conditions concomitantly with pneumonitis in a teenager is a strong indication of M. pneumoniae infection. c.
Rare extrapulmonary manifestations include myocarditis, pericarditis, aseptic meningitis, meningoencephalitis, Guillain-Barre syndrome, peripheral neuropathies, and polyarthralgias.
meClical
321
Microbiology
4. Diagnosis is primarily based on clinical findings and serology.
In a Nutshell M.
pneumoniae
• Lack cell walls • Transmitted via respiratory droplets • Cause atypical pneumoniacause of pneumonia in young adults
*1
• Cold agglutinins (lgM) used in presumptive diagnosis • Treatment: erythromycin, tetracycline, or fluoroquinolones
a. During acute infection, cold agglutinins are produced. These agglutinins are capable of clumping human red blood cells at 4.0°C, but this process can be reversed by heating the blood to 37.0°C. These cold agglutinins are IgM antibodies directed against the I antigen on the surface of the erythrocyte. Although cold agglutinins do not develop in every patient with M. pneumoniae, this remains a rapid test for acute disease. b. Another useful antibody is the Strep MG agglutinin, which many patients produce. The antibody agglutinates Streptococcus salivarius strain MG at normal incubation temperatures. c. Confirmation of the diagnosis can be accomplished using the complement fixation test.
5. Treatment consists of macrolides (e.g., erythromycin or azithromycin), tetracyclines, or fluoroquinolones. Because the family Mycoplasmataceae lacks a cell wall, all members are resistant to the ~-lactam antibiotics. C. Mycoplasma hominis
1. Sexually transmitted agent 2. A major source of infection in postpartum women. 3. Clinical manifestations include postabortal and postpartum fevers and bacteremia, as well as pelvic inflammatory disease. 4. Treatment with tetracyclines; in contrast to other Mycoplasma species, it is resistant to macrolides. D. Ureaplasma urealyticum
1. Sexually transmitted agent 2. Unlike other Mycoplasma species, it produces urea 3. A minor cause of nongonococcal urethritis 4. Treated with tetracycline or erythromycin
322
meClical
Virology
Viruses are the smallest agents of infection, ranging from 20-300 nm in diameter and consisting of either RNA or DNA surrounded by a protective protein shell (capsid). The protein shell may be surrounded by an envelope containing lipid and protein. Virus multiplication occurs only within host cells and is accomplished by the separate synthesis and subsequent assembly of component parts. Some viruses have the unique capacity to become latent and even to integrate their genomes into the host cells. In this situation, the integrated viral genome is replicated as part of the host genome and is transmitted to each daughter cell without production of infectious virus.
CLASSIFICATION AND IDENTIFICATION Classification and identification of viruses is based on common characteristics shared by viral families (such as the presence of single- or double-stranded viral nucleic acids, DNA or RNA). A. Morphology is based on structures and components (nucleic acids, envelope, etc.) common to the viruses and is a basis for viral classifications (see Table V-ll-l). 1. Terminology a. Virion is a term used to describe the complete infectious virus particle. b. Capsid is the protein shell that encloses and protects the nucleic acid genome (either RNA or DNA). The individual protein units are called capsomeres. These structures protect the viral genome from destruction in the extracellular environment. Capsids also control the host range and cell tropism of the naked viruses as they are the molecules that adsorb to the cell surface.
In a Nutshell • Smallest infectious agents • Only one type of nucleic acid (DNA or RNA) • No metabolic activity outside of living cells; obligate intracellular parasite
c. Nucleocapsid denotes the protein shell plus the nucleic acid.
d. Peplomers are the protein spikes found in the envelope of some viruses. 2. Nucleocapsids have characteristic symmetry that is usually helical or icosahedral (see Figure V-ll-l).
KAPLA~. I meulCa 323
Microbiology
Nucleic acid } ~~~rlltr-Protein
Nucleocapsid
Envelope Glycoprotein spikes Enveloped helical nucleocapsid
Capsid {
• • •
~
~~ ~~
~
• •
~:t.
-=
:t.
~
Nucleic acid Capsomere
~~
Icosahedral nucleocapsid
Figure V-11-1. Viral nucleocapsids.
a. A helical nucleocapsid is marked by an extended nucleic acid cavity surrounded by helically arranged proteins with an outer lipid envelope. Examples of viruses with helical structure include ortho- and paramyxoviruses and rhabdoviruses. b. Icosahedral symmetry is marked by condensed nucleic acids forming a central portion of cuboidal nucleocapsid structure. The icosahedral structure may be enveloped or naked. Examples of icosahedral symmetry include parvovirus, adenovirus, herpesvirus, and picornavirus. 3. Envelopes are lipid-containing structures surrounding some viral particles. a. Envelopes are derived from nuclear or plasma cell membranes acquired during viral maturation. The viral envelope is usually acquired when the viral nucleocapsid buds through the host's membrane. b. Envelopes lack rigidity and appear heterogeneous by electron microscopy.
Note Antibody to the gp 120 glycoprotein of HIV is used to monitor the course of HIV infection. The level of the capsomere protein p24 is used to determine the virus load in the blood.
324
meCtical
c. Viral glycoprotein peplomeres are contained in the viral outer envelope. Glycoproteins serve an important role in antigenic structure and host immune responses. These viral attachment proteins (VAP) mediate viral binding (see below) and entry into host cells. d. Lipids are the major component of the viral envelope. They are a complex mixture of phospholipids, glycolipids, and neutral lipids that are a part of the host cell membrane in which the virus multiplied. 4. Virus classification (see Table V-ll-!) is based on nucleic acid composition such as the presence of single-stranded or double-stranded DNA or RNA. Positive-sense RNA (+ RNA) serves directly as mRNA, whereas negative-sense RNA (-RNA) must use an RNA polymerase to synthesize a complementary positive strand to serve as mRNA.
Virology
Table V-II-I. RNA versus DNA viruses. RNA viruses Arenavirus Bunyavirus Calicivirus Coronavirus Filovirus Flavivirus Orthomyxovirus Paramyxovirus Picornavirus Reovirus Retrovirus Rhabdovirus Togavirus DNA viruses Adenovirus Hepadnavirus Herpesvirus Papovavirus Parvovirus Poxvirus
Enveloped helical nucleocapsid (-RNA) Enveloped helical nucleocapsids (-RNA) Naked icosahedral nucleocapsid (+RNA) Enveloped helical nucleocapsid (+RNA) Enveloped helical nucleocapsid (-RNA) Enveloped icosahedral nucleocapsid (+RNA) Enveloped helical nucleocapsid (-RNA) Enveloped helical nucleocapsid (-RNA) Naked icosahedral nucleocapsid (+ RNA) Naked icosahedral nucleocapsid (dsRNA) Enveloped icosahedral (+ RNA) Enveloped helical nucleocapsid (-RNA) Enveloped icosahedral nucleocapsid (+ RNA)
Naked icosahedral nucleocapsid (dsDNA) Enveloped icosahedral nucelocapsid (dsDNA with ss portions) Enveloped icosahedral nucleocapsid (dsDNA) Naked icosahedral nucleocapsid (dsDNA) Naked icosahedral nucleocapsid (ssDNA) Enveloped dsDNA with complex structure
5. Viral proteins are important in the initial contact with the host cell; they dictate which cells will be infected. Viral proteins also determine the antigenic structure of a virus and protect the genome against host nucleases. a. Hemagglutinins are viral proteins that agglutinate red blood cells. The hemagglutinin of influenza virus promotes attachment of the virus to host cells. It can also function in the fusion of the virion with the host cell membrane. They are excellent vaccine antigens. b. Enzymes serve several biological functions for the virus. (1) Neuraminidase acts to hydrolyze sialic acid. It functions to help release virus particles from the cells in which they were formed to further propagate infectivity. (2) RNA polymerase is required for viral replication of RNA viruses. This enzyme must be brought into the cell as a part of the virion in negative-sense RNA viruses. (3) Reverse transcriptase in retroviruses transcribes single-stranded RNA into double-stranded DNA. Transcribed DNA can then be integrated into the host genome by an integrase enzyme. B. Replication. Viruses are dependent on the host cell to provide the synthetic mechanisms and metabolic machinery for replication. 1. The replication cycle of the virus may either lyse the host cell or form a stable interaction that allows the host cell to survive. A stable interaction causes the viral genome to become
In a Nutshell • All RNA viruses have singlestranded RNA except for Reoviruses Cds) • All RNA viruses are enveloped except Reoviruses, Caliciviruses, and Picornaviruses • All DNA viruses have double-stranded DNA except Parvoviruses (ss); Hepadnavirus has ss regions in the DNA • All DNA viruses have an icosahedral nucleocapsid except Poxviruses • All viruses with helically symmetrical nucleocapsids are RNA viruses KAPLAN· . I medlea 325
Microbiology
incorporated into the host cell. The virus may be latent (e.g., herpesvirus) or it may continue to multiply without causing overt disease. The cycle of viral replication has discrete stages: a. Adsorption, or attachment, is the first step. It is highly specific, involving the attraction and physical interaction of viral surface proteins (capsomere or peplomere units) with a host cell surface receptor. Adsorption is host-specific and tissue-specific (e.g., poliovirus attaches primarily to eNS and GI tract cells). b. Penetration and uncoating follows the adsorption step and is typically mediated by receptor-specific endocytosis. The virus usually loses its coat or envelope directly following penetration. Uncoating separates the capsid (and envelope) from the nucleic acids.
In a Nutshell Positive-sense RNA viruses are mRNA and can directly encode all the proteins needed for replication. Other viruses require enzymes in the core such as RNA-dependent or DNA-dependent RNA polymerases to produce mRNA for viral replication.
c. The synthetic period begins when uncoating is complete. Its time course is variable depending upon the virus. Specific mRNA must be transcribed from viral nucleic acid by host cell mechanisms. Macromolecular synthesis begins with an eventual accumulation of viral components (including empty capsids or nonenveloped nucleocapsids). Minus-strand RNA virus, double-stranded RNA viruses, and DNA viruses initiate nucleic acid synthesis to produce mRNA, whereas positive-sense RNA viruses can immediately initiate protein synthesis. This stage is marked by an orderly sequence of synthetic events (with some proteins synthesized early and others later in the synthetic processes). d. Production of viral proteins (1) In positive-sense RNA viruses like polio, the viral RNA (mRNA) is read directly
by the host cell ribosome and enzymes for RNA synthesis are produced. Other proteins that are synthesized at this time will inhibit host biosynthetic processes, whereas others will serve as capsid (structural) proteins. (2) In other viral groups, the viral genome (-RNA, double-stranded RNA, or DNA) must first synthesize the messenger RNA molecules. They do this by an RNAdependent RNA polymerase (transcriptase) that is contained in the virion and encoded by the viral genome in the case of RNA viruses; or by transcription of the viral DNA to synthesize the mRNAs necessary for protein synthesis. Some of the proteins will be structural units (capsomeres, peplomeres), others will be enzymes necessary for progeny DNA synthesis (DNA polymerase). e. Replication of viral genome (nudeic acid) (1) Plus-stranded RNA viruses can immediately begin protein synthesis without nucleic acid replication or transcription events. RNA synthesis will occur when sufficient amounts of RNA polymerase are formed (using the host cell machinery for synthesis). A minus-strand copy is made from the parental strand RNA that serves as the template (replicative intermediate) for the transcription of plus-strand progeny_
Note • All DNA viruses replicate entirely in the nucleus except for Poxviruses. • All RNA viruses replicate entirely in the cytoplasm except for Influenza viruses and Retroviruses.
326
meClical
(2) Minus-strand and double-stranded RNA viruses must first synthesize mRNA for the eventual translation into viral proteins. The minus-strand acts as a negative template for synthesis of mRNA. These viral genomes carry RNA-dependent RNA polymerase required to synthesize mRNA from the (-) strand. (3) Double-stranded RNA viruses (Reo and Rota) synthesize a positive strand of RNA from the negative strand of the parent. This acts both as mRNA and as the replicative intermediate to make the negative-sense RNA that will be assembled with a complimentary positive strand to make the progeny genome. (4) Retroviruses use the negative strand of the DNA intermediate to make positivesense progeny RNA.
Virology
(5) Double-stranded DNA viruses replicate by the same process employed by the host cell; each strand serves as the template for synthesis of the complimentary DNA copy. Hepatitis B virus contains a viral RNA-dependent DNA polymerase (a reverse transcriptase) that uses the viral mRNA as a template to synthesize the missing portion of the viral genome, which is then duplicated by host cell DNA polymerase. (6) Single-stranded DNA viruses (Parvovirus) synthesize a double-stranded intermediate to use as the replicative template for the single-stranded DNA progeny. f. Viral assembly occurs toward the end of the synthetic period. Complete intracellular virus assembly begins. The viral genomes and capsid polypeptides assemble, forming infectious viral offspring. g. Release of the complete nucleocapsid is the final stage of the replication cycle.
In a Nutshell Viral Growth Cycle • Attachment of virus to cell • Penetration of cell • Uncoating of viral genome • Transcription of genome into mRNA
(1) Enveloped viruses are released gradually by a budding process. Nucleocapsids bud through virally altered membrane patches, thus gaining viral specific glycoproteins.
• Translation into proteins
(2) Poxviruses and naked capsid viruses burst out rapidly from the cell, causing the cell to disintegrate.
• Assembly of particles into new viruses
• Replication of viral genome
• Release of virus
DNA VIRUSES A. Adenoviruses
Mnemonic
1. Characteristics. Adenoviruses are medium-sized linear double-stranded DNA viruses
with a naked icosahedral nucleocapsid. They contain penton fibers that serve as viral attachment sites. There are 41 adenovirus serotypes, with approximately one third accounting for the bulk of human disease. After infection, adenoviruses typically travel and replicate in local lymph nodes. 2. Transmission usually occurs person-to-person through respiratory and ocular secretions (usually infecting mucous membranes or lymphoid tissue). Humans are the only known host. 3. Clinical manifestations a. Acute respiratory disease (ARD) that may induce a latent infection in tonsils, adenoids, and other lymphoid tissues. Most infections are acute and self-limited. Influenza-like illness occurs in the late fall and winter, characterized by pharyngitis, fever, cough, and malaise.
To remember which viruses are RNA versus DNA, just memorize the DNA viruses (there are fewer) and know that all the rest are RNA viruses. To help remember the DNA viruses, think about how HHAPPP you will be once you finish studying. The tough part is recalling that the PPP represents papova-parvo-pox (picorna and paramyxo are RNA viruses).
b. Acute febrile pharyngitis may be seen in infants and children and military recruits. c. Conjunctivitis ("pink eye")
d. Diarrhea and gastroenteritis e. Pneumonia and pharyngoconjunctivitis are less frequent complications except in the military, where frequent epidemics may occur. 4. Diagnosis is made by clinical presentation, culture of stool, urine, throat swabs, or conjunctival scrapings. Serology can be performed by ELISA or complement fixation techniques. 5. Treatment and prevention a. Treatment is supportive. KAPLA~. I meulCa 327
Microbiology
b. A vaccine consisting of live, nonattenuated viruses is used in the military. It is administered in three separate doses (one for each serotype, 4, 7, and 21) in enteric capsules that protect the virus from the pH of the stomach. An asymptomatic intestinal infection results that induces respiratory tract immunity. The viruses are administered separately because they interfere with each other if given simultaneously. B. Papovavirus family includes Papilloma, Polyoma, and Vacuolating viruses. 1. Characteristics. Papovaviruses are small double-stranded circular DNA viruses with a
naked icosahedral nucleocapsid. 2. Human papillomaviruses (HPV) are distributed worldwide. They cause skin warts (prevalent in children) and genital warts (condyloma acuminata) and are the most common cause of viral STD. a. Transmission occurs via contact with warts. b. In addition to warts, HPV has also been implicated in benign laryngeal papillomas. c. Serotypes 16 and 18 are associated with penile, laryngeal, and, especially, cervical cancer. d. Treatment includes removal by electrocautery, cryotherapy, or chemicals. Recurrence is common. 3. BK virus is distributed widely in the human population, with 75% serologic positivity in children aged 6 and older. Infection remains latent. Disease (virus in urine) is limited to patients undergoing immunosuppressive therapy and is thought to be a reactivation of infection acquired in childhood. 4. JC virus is a polyoma virus associated with human progressive multifocalleukoencephalopathy. 5. SV40 is one of the serotypes of the simian vacuolating viruses. Transcription products of infection include tumor (T) antigens required for infectivity and oncogenesis. Late proteins synthesized are viral capsid proteins. Transformation of the host cell involves the integration of viral DNA into cellular DNA. This virus has not been associated with disease in humans. C. Herpesviruses 1. Characteristics. Herpesviruses are large double-stranded DNA viruses with an enveloped
icosahedral nucleocapsid. Herpesviruses are characterized by latent infections with recrudescence of disease (increasingly prevalent in immunocompromised patients). 2. Herpes simplex virus, types 1 and 2 (HSV-I and HSV-2) cause oral and genital lesions by infecting epithelial cells. Upon the resolution of acute illness, latent infections are commonly found in neurons. Humans are the only known host. Direct contact with the infected lesion or secretions are necessary for transmission. a. HSV-I is typically acquired early in life. It is usually associated with oral lesions ("fever blisters") and with neurologic disease. HSV-l is the leading cause of sporadic encephalitis in the U.S. Note that HSV-l can cause genital lesions as well. b. HSV-2 is acquired after the onset of sexual activity. It is associated with genital lesions and with neurological disease. It is transmitted through sexual contact.
328
meClical
-----
- - -
----
----
Virology
c. Primary infection may be asymptomatic or characterized by vesicular lesions with
edema, leading to ulceration and crusting. The lesions heal without scarring. Infection is characterized by primary gingivostomatitis (HSV-I) or by primary herpes genitalls (HSV-2). Neonatal herpes may be acquired in utero or during birth. d. Recurrent infection occurs at the site of primary infection. It involves the activation of latent virus from neurons of cervical or sacral ganglia. Stresses that lead to reactivation include hormonal changes (menses), fever, sunlight, physical trauma, and immune suppression. e. Diagnosis is made by identification of the clinical lesions as well as with viral isolation by tissue culture. The Tzanck smear will demonstrate multinucleated giant cells on the stains of scraped lesions (differential includes varicella-zoster virus). Immunofluorescent stain of the lesions will demonstrate viral intranuclear inclusion bodies. The latter test is preferred. f. Antiviral therapy with acyclovir is instituted upon diagnosis in serious infections (see the Antimicrobial Agents chapter of this section). 3. Varicella-zoster virus (VZV) is isolated from patients with chickenpox and shingles. Shingles is reactivation of latent varicella infection. a. Chickenpox (varicella) caused by herpes zoster virus is a mild self-limited illness in children expressed as fever followed by a macular then papular eruption on skin and mucous membranes. Chickenpox usually occurs in epidemics and is highly contagious. The virus is spread by respiratory secretions with approximately a 2-week incubation period. The papules are pruritic and become vesicular on skin and mucous membranes (all stages of the lesions are found simultaneously). Disease is more severe in adults, with pneumonia common in immunocompromised patients. Encephalitis is a rare but severe complication. b. Shingles is a recurrent infection, usually in adults, that may be activated by trauma, neoplasm, drugs, or immunosuppression. Shingles occur from virus that remains latent in the sensory ganglia of spinal or cranial nerves. Severe dermatomal pain occurs with vesicular eruption, fever, and malaise. Pain and neuralgia may precede dermal eruption by 1-3 days. The pain may persist for months (postherpetic neuralgia), especially in older patients. c. Diagnosis is primarily made by serologic assay and by the history of exposure to the
virus. Scrapings oflesions stained with fluorescein-labeled antivaricella antibodies will reveal multinucleated giant cells with viral intranuclear inclusions.
Note Both herpes simplex and varicella-zoster encode a thymidine kinase. The enzyme is the starting point for the antiviral action of acyclovir. It is phosphorylated to an active triphosphate form that blocks viral DNA polymerase.
Clinical Correlate Due to the delay betvveen the onset of pain and the development of skin lesions, zoster should be considered in anyone presenting with pain in a dermatomal distributioneven if the skin appears normal.
d. Treatment and prevention (1) Varicella infections can be treated with acyclovir. Second choices include foscar-
net or vidaribine. (2) Immunosuppressed patients can be treated prophylactically with human varicellazoster immunoglobulin (VZIG). (3) An attenuated varicella vaccine was approved for use in the U.S. in 1995. Children should be vaccinated between 12 and 18 months of age because maternal antibody can interfere with attenuated viral vaccine efficacy. 4. Epstein-Barr virus is the etiologic agent of infectious mononucleosis (1M). 1M is spread by saliva and respiratory secretions and is initiated in the oropharynx. EBV replicates in epithelial cells prior to infecting the B lymphocytes. EBV polyclonally transforms B lymphocytes, leading to the secretion ofIgA, IgG, or IgM. Heterophile antibodies that agglutinate sheep erythrocytes are present in 90% of adults during the illness. EBV infection is
meClical
329
Microbiology
Note The Monospot test is a rapid serologic procedure that detects agglutinins to formalinized RBCs in patients with Epstein-Barr infection.
Clinical Correlate Due to the severe splenomegaly, patients with mononucleosis may undergo splenic rupture during physical exam.
associated with Burkitt lymphoma and nasopharyngeal carcinoma in particular populations. It is also the etiologic agent of hairy oral leukoplakia in immunocompromised hosts. In Burkitt lymphoma cell lines the c-myc oncogene translocates from chromosome 8 to one of the chromosomes involved in immunoglobulin synthesis, where it is activated by the enzymes involved in the VDJ recombination events. The gene product is thought to act as an activator of genes involved in cell proliferation. a. Clinical manifestations last 2-4 weeks and include fatigue, malaise, tender lymphadenopathy, pharyngitis, fever, headache, and splenomegaly. Hepatitis and meningitis are less frequent clinical symptoms. Atypical lymphocytes with a foamy cytoplasm (Downey cells) are noted on peripheral blood smear. (These are reactive T cells.) b. Nonspecific serologic responses to EBV infection are due to the viral infection of B lymphocytes. Heterophile antibodies that arise will agglutinate sheep and horse red blood cells (as measured by the classic Paul-Bunnell test). c. Specific antibodies also arise to the viral capsid proteins. IgM class antibodies indicates recent infection, whereas IgG antibodies persist for more than 1 year.
Epstein-Barr Virus
d. Diagnosis. Ten percent or more of patients fail to make heterophile antibodies. In these individuals diagnosis is made by ELISA assay, isolation of virus, and/or nucleic acid hybridization technology.
• Herpes virus
e. Treatment is supportive. Acyclovir can be used in severely ill patients.
In a Nutshell
• Causes infectious mononucleosis • Hairy oral leukoplakia in immunocompromised patients • Associated with Burkitt lymphoma and nasopharyngeal carcinoma • Heterophile antibodies; Monospot test • Atypicallymphocytes (reactive T cells)
5. Cytomegalovirus (CMV). CMV is species-specific (i.e., human CMV only infects humans). a. CMV infection of nonimmunocompromised (normal) humans elicits a mononucleosis illness that is clinically indistinguishable from EBV-mononucleosis. The majority of human infections are subclinical (with no overt symptoms) but may lead to lifelong latent infection. CMV has a 4-8 week incubation period. Less common clinical sequelae include pneumonia, hepatitis, myocarditis, and meningoencephalitis. b. Illness in immunosuppressed patients (cancer, transplant [especially kidney), chemotherapy-induced, and AIDS patients) is often due to the reactivation of previously acquired infection. Infection in the immunosuppressed is more severe and is marked by fever, adenopathy, leukopenia, hepatosplenomegaly, and myalgias. Interstitial pneumonia, hepatitis, and gastrointestinal ulceration may also arise in immune compromised individuals. CMV retinitis is seen in AIDS patients. c. Congenital disease arises when the fetus acquires CMV virus transplacentally, causing cytomegalic inclusion disease. Infection can be acquired during any trimester. A severe fatal form of the illness is characterized by large intranuclear inclusion bodies in salivary glands, kidneys, brain, liver, and lungs. Periventricular calcifications are seen in the CNS; the infant will be deaf and have hemorrhagic cutaneous lesions (blueberry muffin baby). Breast milk is a significant source of CMV infection from mother to newborn.
Note In contrast to EBV, CMV mononucleosis is heterophile antibody (monospot) negative.
d. Diagnosis is confirmed by tissue culture and isolation of CMV (usually from pharyngeal swabs or urine). Serology by ELISA is also simple and virus-specific. Histological examination of specimens will reveal the classic inclusions within infected cells when stained by immunofluorescence techniques. CMV infection is common. Surveys indicate that 40-100% of adults have been infected with CMV at some time in their life. e. Antiviral therapy is instituted in severe disease with ganciclovir. Mononucleosis in normal patients is usually self-limiting without antiviral treatment.
330
meClical
Virology
6. Human herpesvirus-6 (HHV-6) is a lymphotrophic human herpesvirus. It is thought to be the etiologic agent of pediatric "sixth disease;' or roseola infection (exanthem subitum). 7. Human herpesvirus-8 (HHV-8) is a cofactor in Kaposi sarcoma. D. Poxviruses 1. Characteristics. Poxviruses are the largest of all the viruses. They are linear doublestranded DNA enveloped viruses that replicate entirely in the cytoplasm of infected cells. They appear ovoid or brick-like in shape. The virion contains several enzymes for replication, including both DNA and RNA polymerases. 2. Variola virus (smallpox virus) is confined to humans and is spread by direct person-toperson contact. Smallpox is now officially considered eradicated after years of worldwide vaccination. 3. Molluscum contagiosum causes umbilicated wart-like skin lesions and satellite nodules on the periphery of the parent nodule. In children, the lesions are more commonly found on the trunk, face, or limbs. The sexually transmitted virus will be expressed as genital lesions. a. The disease is typically benign and self-limiting but may require up to 3 years to resolve (particularly genital lesions). The lesions may be numerous in immunocompromised (especially AIDS) patients. b. The diagnosis is usually clinical, although the virus can be seen on electron microscopy. 4. Cowpox is an occupational disease transmitted to humans by contact with infected cow udders. Infection is usually restricted to fingers and hands and is self-limited. The disease is usually milder in vaccinated individuals. E. Hepadnaviruses are DNA viruses that include the hepatitis B virus (HBV), which is discussed in the section on hepatitis viruses, beginning on page 339. F. Parvoviruses are small single-stranded DNA viruses. Serotype B19 is the only human pathogen in the family. It causes erythema infectiosum ("fifth disease") in children (charac-
terized by slapped cheek rash), aplastic crisis in individuals with chronic hemolytic diseases such as thalassemia and sickle cell (the virus infects premature RBCs and kills them), and fetal infections that may cause hydrops fetalis or stillbirth of fetuses that are profoundly anemic.
RNA VIRUSES A. Picornaviruses are small (+) single-stranded RNA viruses with a naked nucleocapsid. The RNA genome is positive sense (can serve as mRNA) and replication of picornaviruses occurs in the cytoplasm of the host cell. The picornaviruses can be divided into enteroviruses (poliovirus, coxsackie A and B, echovirus, and enterovirus) and rhinoviruses. Enteroviruses are acid-resistant and are able to survive in the gastrointestinal tract; rhinoviruses are acidsensitive. 1. Polioviruses bind to receptors in the gut and on neurons. Disease occurs only in pri-
mates, with the majority of infections expressed as subclinical disease. Three antigenically distinct immunologic subtypes exist. Serologic positivity is found most commonly in low socioeconomic areas.
Note Vaccinia virus, thought to be an attenuated variant of cowpox, is being extensively studied as a vaccine vector for carriage of multiple immunogens. The work involves inserting DNA that encodes toxins, adhesins, etc. into the viral genome.
Note Other erythemas are measles, rubella, scarlet fever, roseola, and exanthem subitum (HHV-6).
Note Polioviruses are polycistronic, which means that the RNA is read as large polyprotein messages (i.e., no stop codolls in the genome). The individual proteins are produced by the action of a viral protease that "chops up" the polyprotein product of translation. Similar replicative processes occur in HIV; the newest AIDS drugs being used today are protease inhibitors.
meclical
331
Microbiology